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UPDATE STATEMENT
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1998.  This edition supersedes any previously released draft or final profile.  
Toxicological profiles are revised and republished as necessary, but no less than once every three years. 
For information regarding the update status of previously released profiles, contact ATSDR at:
Agency for Toxic Substances and Disease Registry
Division of Toxicology/Toxicology Information Branch
1600 Clifton Road NE, E-29
Atlanta, Georgia  30333
.
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QUICK REFERENCE FOR HEALTH CARE PROVIDERS
Toxicological Profiles are a unique compilation of toxicological information on a given hazardous
substance. Each profile reflects a comprehensive and extensive evaluation, summary, and interpretation of
available toxicologic and epidemiologic information on a substance.  Health care providers treating
patients potentially exposed to hazardous substances will find the following information helpful for fast
answers to often-asked questions.
Primary Chapters/Sections of Interest
Chapter 1:  Public Health Statement: The Public Health Statement can be a useful tool for
educating patients about possible exposure to a hazardous substance.  It explains a substance’s
relevant toxicologic properties in a nontechnical, question-and-answer format, and it includes a
review of the general health effects observed following exposure.
Chapter 3:  Summary of Health Effects of Ionizing Radiation: Specific health effects of ionizing
radiation are reported by route of exposure, by type of health effect (death, systemic,
immunologic, reproductive), and by length of exposure (acute, intermediate, and chronic). In
addition, both human and animal studies are reported in this section. 
NOTE: Not all health effects reported in this section are necessarily observed in
the clinical setting.  Please refer to the Public Health Statement to identify
general health effects observed following exposure.
Pediatrics: Three new sections have been added to this Toxicological Profile to address child health
issues:
Section 1.6 How Can Ionizing Radiation Affect Children?
Section 1.7 How Can Families Reduce the Risk of Exposure to Ionizing
Radiation?
Section 3.2.2 Children’s Susceptibility
Other Sections of Interest:
Section 3.2.1.4 Teratogenic/Embryotoxic Effects
Section 3.2.3 Carcinogenic Effects from Ionizing Radiation Exposure
ATSDR Information Center 
Phone:  1-888-42-ATSDR
             or 404-639-6357  Fax:    404-639-6359
E-mail: atsdric@cdc.gov  Internet: http://www.atsdr.cdc.gov
The following additional material can be ordered through the ATSDR Information Center:
Case Studies in Environmental Medicine: Taking an Exposure History—The importance of taking an
exposure history and how to conduct one are described, and an example of a thorough exposure
history is provided. Other case studies of interest include Reproductive and Developmental
Hazards; Skin Lesions and Environmental Exposures; Cholinesterase-Inhibiting Pesticide
Toxicity; and numerous chemical-specific case studies.
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Managing Hazardous Materials Incidents is a three-volume set of recommendations for on-scene
(prehospital) and hospital medical management of patients exposed during a hazardous materials incident. 
Volumes I and II are planning guides to assist first responders and hospital emergency department
personnel in planning for incidents that involve hazardous materials.  Volume III—Medical Management
Guidelines for Acute Chemical Exposures—is a guide for health care professionals treating patients
exposed to hazardous materials.
Fact Sheets (ToxFAQs) provide answers to frequently asked questions about toxic substances.
Other Agencies and Organizations
The National Center for Environmental Health (NCEH) focuses on preventing or controlling disease,
injury, and disability related to the interactions between people and their environment outside the
workplace.  Contact: NCEH, Mailstop F-29, 4770 Buford Highway, NE, Atlanta, GA 30341-
3724 • Phone: 770-488-7000 • FAX: 770-488-7015.
The National Institute for Occupational Safety and Health (NIOSH) conducts research on occupational
diseases and injuries, responds to requests for assistance by investigating problems of health and
safety in the workplace, recommends standards to the Occupational Safety and Health
Administration (OSHA) and the Mine Safety and Health Administration (MSHA), and trains
professionals in occupational safety and health.     Contact: NIOSH, 200 Independence Avenue,
SW, Washington, DC 20201 • Phone: 800-356-4674 or  NIOSH Technical Information Branch,
Robert A. Taft Laboratory, Mailstop C-19, 4676 Columbia Parkway, Cincinnati, OH 45226-1998
• Phone: 800-35-NIOSH.
 The National Institute of Environmental Health Sciences (NIEHS) is the principal federal agency for
biomedical research on the effects of chemical, physical, and biologic environmental agents on
human health and well-being. Contact: NIEHS, PO Box 12233, 104 T.W. Alexander Drive,
Research Triangle Park, NC 27709 • Phone: 919-541-3212.
Referrals
The Association of Occupational and Environmental Clinics (AOEC) has developed a network of clinics
in the United States to provide expertise in occupational and environmental issues.  Contact: 
AOEC, 1010 Vermont Avenue, NW, #513, Washington, DC 20005 •   Phone: 202-347-4976 •
FAX: 202-347-4950 • e-mail: aoec@dgs.dgsys.com  •      AOEC Clinic Director:
http://occ-env-med.mc.duke.edu/oem/aoec.htm
 
The American College of Occupational and Environmental Medicine (ACOEM) is an association of
physicians and other health care providers specializing in the field of occupational and
environmental medicine.  Contact:  ACOEM, 55 West Seegers Road, Arlington Heights, IL
60005 • Phone: 847-228-6850 • FAX: 847-228-1856.
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CONTRIBUTORS
CHEMICAL MANAGER(S)/AUTHORS(S):
Sam Keith, M.S., CHP
ATSDR, Division of Toxicology, Atlanta, GA
H. Edward Murray, Ph.D.
ATSDR, Division of Toxicology, Atlanta, GA
Wayne Spoo, DVM, DABT
Research Triangle Institute, Research Triangle Park, NC
THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS:
1. Health Effects Review.  The Health Effects Review Committee examines the health effects
chapter of each profile for consistency and accuracy in interpreting health effects and classifying
end points.
2. Minimal Risk Level Review.  The Minimal Risk Level Workgroup considers issues relevant to
substance-specific minimal risk levels (MRLs), reviews the health effects database of each
profile, and makes recommendations for derivation of MRLs.
.
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PEER REVIEW
A peer review panel was assembled for ionizing radiation.  The panel consisted of the following
members:  
1. Herman Cember, Ph.D., CHP, Consultant, Lafayette, IN;
2. Richard Toohey, Ph.D., CHP, Consultant, Oak Ridge, TN;
3. Kenneth Mossman, Ph.D., Professor, Scottsdale, AZ;
4. John Poston, Ph.D., Professor, College Station, TX; and
5. Darrell Fisher, Ph.D., Senior Scientist, Richland, WA.
These experts collectively have knowledge of ionizing radiation's physical and chemical properties,
toxicokinetics, key health end points, mechanisms of action, human and animal exposure, and
quantification of risk to humans.  All reviewers were selected in conformity with the conditions for peer
review specified in Section 104(i)(13) of the Comprehensive Environmental Response, Compensation,
and Liability Act, as amended.
Scientists from the Agency for Toxic Substances and Disease Registry (ATSDR) have reviewed the peer
reviewers' comments and determined which comments will be included in the profile.  A listing of the
peer reviewers' comments not incorporated in the profile, with a brief explanation of the rationale for their
exclusion, exists as part of the administrative record for this compound.  A list of databases reviewed and
a list of unpublished documents cited are also included in the administrative record.
The citation of the peer review panel should not be understood to imply its approval of the profile's final
content.  The responsibility for the content of this profile lies with the ATSDR.
.
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IONIZING RADIATION 1
1.  PUBLIC HEALTH STATEMENT
This public health statement tells you about ionizing radiation and the effects of exposure.  It
does not tell you about non-ionizing radiation, such as microwaves, ultrasound, or ultraviolet
radiation.
Exposure to ionizing radiation can come from many sources.  You can learn when and where
you may be exposed to sources of ionizing radiation in Section 1.3 of this chapter.  One source
of exposure is from hazardous waste sites that contain radioactive waste.  The Environmental
Protection Agency (EPA) identifies the most serious hazardous waste sites in the nation.  These
sites make up the National Priorities List (NPL) and are the sites targeted for federal cleanup. 
However, it’s unknown how many of the 1,467 current or former NPL sites have been evaluated
for the presence of ionizing radiation sources.  As more sites are evaluated, the sites with
ionizing radiation may increase. This information is important because exposure to ionizing
radiation may harm you and because these sites may be sources of exposure.
When a substance is released from a large area, such as an industrial plant, or from a container,
such as a drum or bottle, it enters the environment.  This release does not always lead to
exposure.  Even in the event that you are exposed, it does not necessarily mean you will be
harmed or suffer long-term health effects from exposure to ionizing radiation.
If you are exposed to ionizing radiation, many factors determine whether you’ll be harmed. 
These factors include the dose (how much), the duration (how long), and the type of radiation.
You must also consider the chemicals you’re exposed to and your age, sex, diet, family traits,
lifestyle, and state of health.
1.1 WHAT IS IONIZING RADIATION?
To explain what ionizing radiation is, we will start with a discussion of atoms, how they come to
be radioactive, and how they give off ionizing radiation.  Then, we will explain where radiation
comes from.  Finally, we will describe the more important types of radiation to which you may
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be exposed.  Of the different types and sources of ionizing radiation, this profile will discuss the
three main types:  alpha, beta, and gamma radiation. 
The Atom.    Before defining ionizing radiation, it is useful to first describe an atom. Atoms are
the basic building blocks of all elements.  We have models of an atom that are supported by
measurements.  An atom consists of one nucleus, made of protons and neutrons, and many
smaller particles called electrons.  The electrons normally circle the nucleus much like the
planets or comets circle the sun.  The number of protons in the atom’s nucleus determines which
element it is.  For example, an atom with one proton is hydrogen and an atom with 27 protons is
cobalt.  Each proton has a positive charge, and positive charges try to push away from one
another.  The neutrons neutralize this action and act as a kind of glue that holds the protons
together in the nucleus.  The number of protons in an atom of a particular element is always the
same, but the number of neutrons may vary.  Neutrons add to the weight of the atom, so an atom
of cobalt that has 27 protons and 32 neutrons is called cobalt-59 because 27 plus 32 equals 59.  If
one more neutron were added to this atom, it would be called cobalt-60.  Cobalt-59 and cobalt-
60 are isotopes of cobalt.  Isotopes are forms of the same element, but differ in the number of
neutrons within the nucleus.  Since cobalt-60 is radioactive, it is called a radionuclide.  All
isotopes of an element, even those that are radioactive, react chemically in the same way.  Atoms
tend to combine with other atoms to form molecules (for example, hydrogen and oxygen
combine to form water).  Radioactive atoms that become part of a molecule do not affect the way
the molecule behaves in chemical reactions or inside your body.
What Ionizing Radiation Is.    Ionizing radiation is energy that is carried by several types of
particles and rays given off by radioactive material, x ray machines, and fuel elements in nuclear
reactors.  Ionizing radiation includes alpha particles, beta particles, x rays, and gamma rays. 
Alpha and beta particles are essentially small fast moving pieces of atoms.  X rays and gamma
rays are types of electromagnetic radiation. These radiation particles and rays carry enough
energy that they can knock out electrons from molecules, such as water, protein, and DNA, with
which they interact.  This process is called ionization, which is why it is named “ionizing
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radiation.”  We cannot sense ionizing radiation, so we must use special instruments to learn
whether we are being exposed to it and to measure the level of radiation exposure.  The other
types of electromagnetic radiation include radiowaves microwaves, ultrasound, infrared
radiation, visible light, and ultraviolet light.  These types of radiation do not carry enough energy
to cause ionization and are called non-ionizing radiation.  This profile will only discuss ionizing
radiation.
 
What Ionizing Radiation Is Not.    Ionizing radiation is not a substance like salt, air, water, or a
hazardous chemical that we can eat, breathe, or drink or that can soak through our skin. 
However, many substances can become contaminated with radioactive material, and people can
be exposed to ionizing radiation from these radioactive contaminants.
How Does an Atom Become Radioactive?    An atom is either stable (not radioactive) or
unstable (radioactive).  The ratio of neutrons to protons within the nucleus determines whether
an atom is stable.  If there are too many or too few neutrons, the nucleus is unstable, and the
atom is said to be radioactive.  There are several ways an atom can become radioactive.  An
atom can be naturally radioactive, it can be made radioactive by natural processes in the
environment, or it can be made radioactive by humans.  Naturally occurring radioactive
materials such as potassium-40 and uranium-238 have existed since the earth was formed.  Other
naturally occurring radioactive materials such as carbon-14 and hydrogen-3 (tritium) are formed
when radiation from the sun and stars bombards the earth’s atmosphere.  The elements heavier
than lead are naturally radioactive because they were originally formed with too many neutrons. 
Human industry creates radioactive materials by one of two different processes.  In the first
process, a uranium or a plutonium atom captures a neutron and splits (undergoes nuclear fission)
into two radioactive fission fragments plus two or three neutrons.  In a nuclear reactor, one of
these “fission neutrons” is captured by another uranium atom, and the fission process is repeated. 
In the second process, stable atoms are bombarded either by neutrons or by protons that are
given a lot of energy in a machine called an accelerator.  The stable atoms capture these
bombarding particles and become radioactive.  For example, stable cobalt-59, found in the steel
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surrounding a nuclear reactor, is hit by neutrons coming from the reactor and can become
radioactive cobalt-60.  Any material that contains radioactive atoms is radioactive material.
How Does a Radioactive Atom Give off Ionizing Radiation?      Because a radioactive atom is
unstable, at some time in the future, it will transform into another element by changing the
number of protons in the nucleus.  This happens because one of several reactions takes place in
the nucleus to stabilize the neutron-proton ratio.  If the atom contains too many neutrons, a
neutron changes into a proton and throws out a negative “beta” (pronounced bay’ tah) particle. 
If the atom contains too many protons, normally a proton changes into a neutron and throws out
a positive “beta” particle.  Some atoms that are more massive than lead, such as radium,
transform by emitting an “alpha” (pronounced al’-fah) particle.  Any excess energy that is left
can be released as “gamma” rays, which are the same as x rays.  Other reactions are also
possible, but the final result is to make a radioactive atom into a stable atom of a different
element.  For example, each atom of cobalt-60 is radioactive because it has too many neutrons. 
At some time in the future, one of its neutrons will change into a proton. As it changes, the atom
gives off its radiation, which is a negative beta particle and two gamma rays.  Because the atom
now has 28 protons instead of 27, it has changed from cobalt into nickel.  In this way, unstable
atoms of radioactive cobalt-60 give off radiation as they transform into stable atoms of nickel-60.
How Long Can Radioactive Material Give Off Ionizing Radiation?    Theoretically, it gives
off ionizing radiation forever.  Practically, however, after 10 half-lives, less than 0.1% of the
original radioactivity will be left and the radioactive material will give off infinitesimally small
amounts of ionizing radiation.  The half-life is the time it takes one-half of the radioactive atoms
to transform into another element, which may or may not also be radioactive.  After one half-life,
½ of the radioactive atoms remain; after two half-lives, half of a half or 1/4 remain, then 1/8,
1/16, 1/32, 1/64, etc.  The half-life can be as short as a fraction of a second or as long as many
billions of years.  Each type of radioactive atom, or radionuclide, has its own unique half-life. 
For example, technetium-99m and iodine-131, which are used in nuclear medicine, have 6-hour 
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and 8-day half-lives, respectively.   The naturally occurring radionuclide, uranium-235, which is
used in nuclear reactors, has a half-life of 700 million years.  Naturally occurring potassium-40,
which is present in the body, has a half-life of 13 billion years and undergoes about 266,000
radioactive transformations per minute in the body.  Thus, technetium-99m will remain
radioactive for 60 hours, and iodine-131 will remain radioactive for 3 months.  On the other
hand, long-lived naturally occurring uranium and potassium will remain, practically speaking,
radioactive forever.
What Are the Three Types of Radiation?    The three main types of ionizing radiation are
called alpha, beta, and gamma radiation.  These are named for letters of the Greek alphabet, and
they are often symbolized using the Greek letters α (alpha), β (beta), and γ (gamma).
Alpha Radiation (or Alpha Particles).  This type of radiation can be called either alpha radiation
or alpha particles.  Alpha radiation is a particle, consisting of two protons and two neutrons, that
travels very fast and thus has a good deal of kinetic energy or energy of motion.  The two
protons and neutrons make an alpha particle identical to a helium atom, but without the
electrons.  Although it is much too small to be seen with the best microscope, it is large
compared to a beta particle.  The protons give it a large positive charge that pulls hard at the
electrons of other atoms it passes near.  When the alpha particle passes near an atom, it excites
its electrons and can pull an electron from the atom, which is the process of ionization.  Each
time the alpha particle pulls an electron off from an atom in its path, the process of ionization
occurs.  With each ionization, the alpha particle loses some energy and slows down.  It will
finally take two electrons from other atoms at the end of its path and become a complete helium
atom.  This helium has no effect on the body.  Because of their large mass and large charge,
alpha particles ionize tissue very strongly.  If the alpha particle is from radioactive material that
is outside the body, it will lose all its energy before getting through the outer (dead) layer of your
skin.  This means that you can only be exposed to alpha radiation if you take radioactive material
that produces alpha radiation into your body (for example, if you breathe it in or swallow it in
food or drink).  Once inside the body, this radioactive material can be mixed in the contents of
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the stomach and intestines, then absorbed into the blood, incorporated into a molecule, and
finally deposited into living tissue such as the bone matrix.  The alpha particles from this
radioactive material can cause damage to this tissue.
Beta Radiation (or Beta Particles).  This type of radiation can be called either beta radiation or
beta particles.  Beta particles are high-energy electrons that some radioactive materials emit
when they transform.  Beta particles are made in one of two ways, depending on the radioactive
material that produces them.  As a result, they will have either a positive charge or a negative
charge. Most beta particles are negatively charged.   They are much lighter and much more
penetrating than alpha particles.  Their penetrating power depends on their energy.   Some, such
as those from tritium, have very little energy, and can’t pass through the outer layer of dead skin. 
Most have enough energy to pass through the dead outer layer of a person’s skin and  irradiate
the live tissue underneath.  You can also be exposed to beta radiation from within if the beta-
emitting radionuclide is taken into the body.  A beta particle loses its energy by exciting and
ionizing atoms along its path.  When all of its kinetic energy is spent, a negative beta particle
(negatron) becomes an ordinary electron and has no more effect on the body.  A positive beta
particle (positron) collides with a nearby negative electron, and this electron-positron pair turns
into a pair of gamma rays called annihilation radiation, which can interact with other molecules
in the body.
Gamma Radiation (or Gamma Rays).  This type of radiation can be called either gamma
radiation or gamma rays.  Unlike alpha and beta radiation, gamma radiation is not a particle, but
is a ray.  It is a type of light you cannot see, much like radio waves, infrared light, ultraviolet
light, and x rays.  When a radioactive atom transforms by giving off an alpha or a beta particle, it
may also give off one or more gamma rays to release any excess energy.  Gamma rays are
bundles of energy that have no charge or mass.  This allows them to travel very long distances
through air, body tissue, and other materials.  They travel so much farther than either alpha or
beta radiation that the source of the gamma rays doesn’t have to be inside the body or near the
skin.  The gamma ray source can be relatively far away, like the radioactive materials in nearby
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construction materials, soil, and asphalt.  A gamma ray may pass through the body without
hitting anything, or it may hit an atom and give that atom all or part of its energy.  This normally
knocks an electron out of the atom (and ionizes the atom).  This electron then uses the energy it
received from the gamma ray to ionize other atoms by knocking electrons out of them as well. 
Since a gamma ray is pure energy, once it loses all its energy it no longer exists.
More information about alpha, beta, and gamma radiation can be found in Chapter 2 of this
profile.
1.2 HOW DOES RADIOACTIVE MATERIAL ENTER AND SPREAD THROUGH THE
ENVIRONMENT?
Radioactive material can be released to the air as particles or gases as a result of natural forces
and from human industrial, medical, and scientific activities.   Everyone, with no exception, is
exposed to ionizing radiation that comes from natural sources, such as cosmic radiation from
space and terrestrial radiation from radioactive materials in the ground.  Ionizing radiation can
also come from industrially produced radioactive materials (such as iridium-192); nuclear
medicine (such as thyroid cancer treatment with iodine-131 and thyroid scans using iodine-125,
or bone scans using technetium-99m); biological and medical research using carbon-14, tritium,
and phosphorus-32; the nuclear fuel cycle (producing fission products  such as cesium-137 and
activation products such as cobalt-60); and production and testing of nuclear weapons. 
Radioactive material released into the air is carried by the wind and is spread by mixing with air. 
It is diluted in the atmosphere and can remain there for a long time. When the wind blows across
land contaminated with radioactive materials,  radioactive particles can be stirred up and
returned to the atmosphere.  Radioactive material on the ground can be incorporated into plants
and animals, which may later be eaten by people.  
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Water can contain man-made and naturally occurring radioactive materials that it dissolves from
the soil it passes over or through.  Rain and snow also wash man-made and naturally occurring
radioactive material out of the air.  Radioactive material may be added to water through planned
or accidental releases of liquid radioactive material from sources such as hospitals, research
universities, manufacturing plants, or nuclear facilities.  Radioactive material can also reach
surface waters when airborne radioactive materials settle to the earth or are brought down by rain
or snow, and when soil containing radioactive material is washed away into a river or lake.  The
movement of liquid radioactive material is limited by the size of the bodies of water into which
the radioactive materials have drained.  Like silt, some radioactive material may settle along the
banks or in the bottoms of ponds and rivers.  In public health and ecological contexts, it is
sometimes important to distinguish between dissolved radioactivity and radioactivity bound to
suspended or settled solid particles.  Radioactive material may also concentrate in aquatic
animals and plants.  Eventually, radioactive material in liquid runoff that goes into rivers and
streams may reach the oceans (there are approximately one million radioactive transformations
per minute of the naturally occurring radioactive potassium in one cubic meter of ocean water). 
Radioactive material moves very slowly in soil compared to its speed of movement in air and
water.  Radioactive material will often stick to the surface of the soil.  The organic material in
soils can bind radioactive material, which slows its movement through the environment.  If crops
are watered with water containing radioactive material, the radioactive material may be taken up 
through the roots of the plant or may contaminate the outside of the plant.  The plants may then
be eaten by both animals and people.  Radioactive materials that occur naturally in the soil
(uranium, radium, thorium, potassium, tritium, and others) are also taken up by plants, and
become available for intake by animals and people. 
More information about what happens to radioactive material when it enters the environment can
be found in Chapters 5 and 6 of this profile.
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Figure 1-1.  Sources of Radiation Exposure to the Average U.S. Citizen
(adapted from NCRP 1987a)
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Figure 1-2.  Detailed Breakdown of Radiation Exposures
(adapted from NCRP 1987a)
1.3 HOW MIGHT I BE EXPOSED TO IONIZING RADIATION?
The earth is continually  irradiated with
low levels of ionizing radiation, so all
animals, plants, and other living
creatures are exposed to small amounts
of ionizing radiation from several
sources every day.  Figure 1-1 shows
that most of  your radiation dose comes
naturally from the environment. Smaller
portions come from medicine, consumer
products and other sources.
Figure 1-2 is another breakdown of the
sources of radiation dose to the average
American.  The natural background
levels (81%) shown in Figure 1-1
include the radon, terrestrial, cosmic,
and natural internal sources shown in
Figure 1-2.  Most of your daily
radiation dose is from radon (55%),
which is found in all air.  Higher levels
are normally found indoors (especially
in the basement).  Figure 1-3 shows
that indoor levels of radon vary depending on where you live.  Higher levels can be found in
underground areas, such as mines.  You are always exposed to radiation from cosmic sources
(mostly from outer space, some from the sun, 8%), terrestrial sources (rocks and soil, 8%), and
natural internal sources (radioactive material normally inside your body, 10%).  You may also be
exposed to radiation from x ray exams (11%), nuclear medicine exams such as thyroid scans (4%),
and consumer products including TV and smoke detectors (3%), as well as other sources.  
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Less than 1% of the total ionizing radiation dose to people living in the United States comes from
their jobs, nuclear fallout, the nuclear fuel cycle, or other exposures.  However, people in some types
of jobs may have higher doses (pilots and flight attendants, astronauts, industrial and nuclear power
plant workers, x ray personnel, medical personnel, etc.).  Some groups of people have been exposed
to higher-than-normal levels of ionizing radiation from weapons testing, and some individuals from
accidents at nuclear facilities or in industry.  Some of these exposures are discussed in Chapter 3 of
this profile. 
Not everyone will be exposed to every source or the same percentage of radiation shown in
Figure 1-2.  Since the percentages shown in Figure 1-2 are averages, half of the population will
receive greater doses and half will receive smaller doses from the several sources shown in the
figure. For example, if you are not regularly x rayed, you may receive less total radiation dose than
what is shown.  However, if you live in a town or city at a high altitude, you may receive a greater
radiation dose from outer space cosmic rays than someone who lives in a town or city near the ocean
at sea-level.  Table 1-1 shows you that where you live and what you do determines how much
ionizing radiation you will receive.
“Dose” is a broad term that is often used to mean either absorbed dose, or dose equivalent,
depending on the context.  The absorbed dose is measured in both a traditional unit called a rad
and an International System (S.I.) unit called a gray (Gy).  Both grays and rads are physical units
(1 Gy = 100 rad) that measure the concentration of absorbed energy.  The absorbed dose is the
amount of energy absorbed per kilogram of absorber.  Physical doses from different radiations
are not biologically equivalent.  For this reason, a unit called the dose equivalent, which
considers Both the physical dose and the radiation type, is used in radiation safety dosimetry. 
The unit of dose equivalent is called the rem in traditional units and the sievert (Sv) in S.I. units
(1 rem = 0.01 Sv).  For beta and gamma radiation, 1 rad = 1 rem (1 gray = 1 sievert).  For alpha
radiation, however, 1 rad = 20 rem (1 gray = 20 sievert).  Small radiation doses can be expressed
using small dose units such as the millirem (mrem) and the millisievert (mSv), where 1 mrem =
0.001 rem and 1 mSv = 0.001 Sv.
The average annual dose to a person in the United States is about 360 mrem (3.6 mSv).  An
individual’s exact dose depends on several factors, such as the natural background where the
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person lives, and the person’s medical history and occupational experience with sources of
radiation.
More information about exposure to ionizing radiation can be found in Chapters 2 and 6 of this
profile.
Table 1-1.  Approximate Doses of Ionizing Radiation to Individuals
Activity
Approximate doses of
radiation received Comments
Average American exposure to ionizing radiationa
Total yearly dose 360 mrem/yr (3.6 mSv/yr)
     From natural sources 300 mrem/yr (3.0 mSv/yr)
     From man-made sources 60 mrem/yr (0.6 mSv/yr)
     From nuclear power Less than 1 mrem/yr 
(<0.01 mSv/yr)
Approximate doses of ionizing radiation (cosmic + terrestrial) for different locations
Kerala, India, resident 1300 mrem/yr (13 mSv/yr)  Concentrated radioactive material in
the soil
Colorado state resident 179 mrem/yr (1.79 mSv/yr)  High altitude above sea level
Boston, Massachusetts, resident 100 mrem/yr (1 mSv/yr)
Louisiana state resident 92 mrem/yr (0.92 mSv/yr) Low altitude above sea level
Approximate doses of ionizing radiation above background radiation and some activitiesb
Anyone near a patient released after a
nuclear medicine test. 
Less than 500 mrem/patient
(5 mSv/patient) 
Guidance for medical facilities. 
Quantity depends on the quantity of
radioactive material.
A person who works inside a nuclear
power plant
< 300 mrem/yr (<3 mSv/yr)
A person who gets a full set of dental
x rays
40 mrem (0.4 mSv)
A flight attendant flying from New York
to Los Angeles
5 mrem/flight
 (0.05 mSv/flight)
Watching a color TV set 2–3 mrem/yr 
(0.02–0.03 mSv/yr)
A person who lives directly outside of
a nuclear power plant
1 mrem/yr (0.01 mSv/yr)
A person who lives in a multi-storied
apartment building
~1 mrem/yr for each 
5 stories above the 
ground floor
(<0.01 mSv/yr)
Difference between Los Angeles and
Denver = 87 mrem/5000 feet = 
2 mrem/100 feet = 1 mrem/5 stories
A person who watches a truck carrying
nuclear waste pass by
Less than 0.1 mrem/truck
(0.001 mSv)
aTaken from NCRP 1976a
bTaken from NCRP 1987b, 1987e, 1989a, 1989c
mrem = millirem for each occasion; mrem/yr = millirem per year
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1.4 HOW CAN IONIZING RADIATION ENTER AND LEAVE MY BODY?
Ionizing radiation exposure can occur from a radiation source outside of the body.  Exposure can
also occur as a result of taking radioactive material into your body.  The answer to the question
of how you can be exposed to ionizing radiation can be broken into two parts.  The first
paragraph below describes ionizing radiation that comes from a source outside your body and
some distance away (external radiation).  The second paragraph describes ionizing radiation that
comes from a source inside your body (internal radiation).
External radiation comes from natural and man-made sources of ionizing radiation that are
outside your body.  Part of the natural radiation is cosmic radiation from space.  The rest is given
off by radioactive materials in the soil and building materials that are around you.  As a result of
human activities, higher levels of natural radioactive material are left in products or on the land. 
Examples of such activities are manufacturing fertilizer, burning coal in power plants, and
mining and purifying uranium.  Ionizing radiation from human activities adds to your external
radiation exposure.  Some of this radiation is given off by x ray machines, televisions,
radioactive sources used in industry, and patients who have had recent nuclear medicine tests
and therapy.  The rest is given off by man-made radioactive materials in consumer products,
industrial equipment, atom bomb fallout, and to a smaller extent by hospital waste and nuclear
reactors.  Gamma rays are the main type of ionizing radiation that are of concern when you are
exposed to external sources of ionizing radiation.  Gamma rays (like x rays) are special bundles
of light energy that you cannot see, feel, or smell. Gamma rays from natural and man-made
sources pass through your body just like x rays do, at the speed of light.  Gamma rays  may pass
directly through your body without hitting anything.  When one gamma ray hits a cell, it leaves a
small bit of energy behind that can cause damage.  Other types of ionizing radiation, like alpha
and beta particles, hit your body but normally do not have enough energy to get inside to harm
you.  Your external radiation dose depends on the amount of energy that ionizing radiation gives
to your body as it passes through.  Exposure to external radiation does not make you radioactive.
The average yearly dose from external radiation in the United States is about 100 mrem per
person (1 mSv/person).
Internal radiation is ionizing radiation that natural and man-made radioactive materials give off
while they are inside your body.  You take radioactive materials into your body every day since
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they are in the air you breathe, the food you eat, and the water you drink.  Examples of natural
radioactive materials that enter, reside in, and leave your body every day include potassium-40,
carbon-14, radium, and radon.  Man-made radioactive materials also get into your body from the
decreasing amounts of fallout from past nuclear weapons testing.   Sometimes, natural conditions
or industrial activities concentrate radioactive materials.  If you are exposed to these, you will
take in more radioactive material.  Low amounts of material that act as sources of ionizing
radiation may also be put into your body for medical purposes to test for or treat some types of
disease, such as cancer.  Scientists and clinicians have made sure that the benefits of exposing
you to ionizing radiation far outweigh any bad health effects you may get from the ionizing
radiation by itself.  (Medical tests use small amounts of radiation or radioactive material, but
some radiotherapy uses large doses that are beneficial to the patient.)  Hospitals, coal-fired
electricity generating plants, and nuclear reactors release radioactive materials in ways that keep
your dose low.  Radioactive materials build up in your body if you take them in faster than they
leave in urine and feces and by radioactive transformation.  If the internally deposited
radioisotope is short lived and decays before the body eliminates it, then, of course, it will
disappear faster from the body than by biological elimination alone.  Thus, retention or
elimination of internally deposited radioisotopes is measured by the effective half-life, which
considers the combined effect of biological elimination and radioactive decay.  
Internally deposited radioisotopes may emit gamma rays, beta particles, or alpha particles,
depending on the isotope.  Many gamma rays escape your body without hitting anything.  When
a gamma ray does hit a cell, it transfers energy to the cell.  When all their energy is transferred,
they vanish.  Alpha and beta particles travel short distances, giving energy to cells they hit. 
They lose energy and quickly come to a stop.  Their energy is totally absorbed inside your body. 
When alpha particles come to a stop, they become helium that you breathe out later.  When beta
particles come to a stop, they become electrons and attach to atoms near them.  Your internal
dose is a measure of the energy deposited by all the ionizing radiation that is produced inside
your body.  The average yearly dose in the United States from internal radiation is about 260
mrem per person (2.6 mSv/person).
More information about how ionizing radiation enters and leaves your body can be found in
Chapters 2, 3 and 5 of this profile.
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1.5 HOW CAN IONIZING RADIATION AFFECT MY HEALTH?
How radiation affects your health depends on the size of the radiation dose.  Scientists have been
studying the effects of ionizing radiation in humans and laboratory animals for many years. 
Studies so far have not shown that the low dose of ionizing radiation we are exposed to every
day causes us any harm.  We do know that exposure to massive amounts of ionizing radiation
can cause great harm, so it is wise to not be exposed to any more ionizing radiation than
necessary.
Overexposure to high amounts of ionizing radiation can lead to effects like skin burns, hair loss,
birth defects, cancer, mental retardation (a complex central nervous system functional abnorm-
ality), and death.  The dose determines whether an effect will be seen and its severity.  For some
effects such as skin burns, hair loss, sterility, nausea, and cataracts, there is a certain minimum
dose (the threshold dose) that must be exceeded to cause the effect.  Increasing the size of the
dose after the threshold is exceeded makes the effect more severe. Psychological stress has been
documented in large populations exposed to small doses of radiation (Three Mile Island and
Chernobyl).  Neurological injury (CNS syndrome) resulting in compromised mental function has
also been documented in individuals exposed to several thousand rads of ionizing radiation.
Ionizing radiation is called a carcinogen because it may also increase your chance of getting
cancer.  Increasing the size of the dose increases your chance of getting cancer.  Scientists base
radiation safety standards on the assumption that any radiation dose, no matter how small, carries
with it a corresponding  probability of causing a cancer.  This is called a “zero threshold” dose
response relationship.  Cancers that are actually caused by radiation are completely
indistinguishable from those from other causes, so we can never be certain whether any
individual cancer was not caused by radiation.  To determine how likely it is that a certain dose
of radiation will cause cancer, scientists measure the radiation dose to a group of exposed
people, like the Japanese atomic bomb survivors.  Then they compare the frequency of cancers
(the observation period for cancer extends over decades) in this exposed group with a similar
group of people who were not exposed.  They also look at factors like age, sex, and time since
the exposure ended.  Finally, they calculate risk factors for various cancer types.  Using these
factors, it is possible to estimate the chance of getting cancer from a dose of radiation.  Even
though they assume a zero threshold, researchers have not actually seen an increase in cancer
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frequency for people in the exposed Japanese group who had a radiation dose below 20 rad (0.2
Gy).  No increase in any type of leukemia has been found in people whose radiation dose was
below 10–40 rad (0.1–0.4 Gy). 
The effects of internally deposited radioactive material are similar to those of external radiation. 
The effects depend on the size of the dose and factors like your sex and age when you were
exposed.  The radiation absorbed dose, in turn, depends on the radioactive material, the amount
of activity, the type and energy of the radiation, the effective half-life of the radioactive material,
its chemical form, how it was taken into your body, and how quickly it leaves your body.  
Many people are exposed to radiation and radioactive materials used in medical testing and
therapy.  Radiation treatments for medical reasons carry the same risk as radiation from other
sources.  As with any medical treatment, the potential health benefits should be balanced against
the potential harmful health effects.  
One way to better understand the effects of radiation is to study its effects on test animals.  
Without laboratory animals, scientists would lose a basic method to get information needed to
make  informed decisions to protect public health.  Scientists have the responsibility to treat
research animals with care and compassion.  Laws today protect the welfare of research animals,
and scientists must comply with strict animal care guidelines.
More information about the biological effects of ionizing radiation can be found in Chapters 2, 3,
and 5 of the profile.
1.6 HOW CAN IONIZING RADIATION AFFECT CHILDREN?
This section discusses potential health effects from exposures during the period from conception
to maturity at 18 years of age in humans.  Potential effects on children resulting from exposures
of the parents are also considered.
Like adults, children are exposed to small background amounts of ionizing radiation that comes
from the soil around where they live, in the food and water that they eat and drink, in the air that 
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they breathe, and from sources that reach earth from space.  How much background radiation
you receive depends on where you live.  Some places naturally have more than others.  There are
no reports that say exposure to background levels of ionizing radiation causes health effects in
children or adults.
If a pregnant woman is exposed to high levels of ionizing radiation, it is possible that her child
may be born with some brain abnormalities. There is an 8-week period during early pregnancy
when an unborn child is especially sensitive to the effects of higher than normal levels of
ionizing radiation.  As the levels of ionizing radiation increase, so does the chance of brain
abnormalities.  These abnormalities may eventually result in small head size, decreased
intelligence as measured by Intelligence Quotient (IQ) tests, and other defects.  These effects are
not reversible.
A child will be exposed to small amounts of radiation from the environment all during prenatal
development and throughout its life.  There are no reports that say children suffer health effects
from normal amounts of background radiation.  If children are exposed to higher than
background levels of ionizing radiation, they are likely to have the same possible health effects
as adults exposed to similar levels.
1.7 HOW CAN FAMILIES REDUCE THE RISK OF EXPOSURE TO IONIZING
RADIATION?
If your doctor finds that you have been exposed to significant amounts of ionizing radiation, ask
whether your children might also be exposed.  Your doctor might need to ask your state health
department to investigate.
The best way to reduce your risk of exposure to higher than background amounts of radiation is
to not let yourself be exposed at all. However, this is not always possible or sensible.  A common
way to be exposed to ionizing radiation is by receiving an x ray, but a few x rays every year will
not hurt you.  When you or your children receive an x ray, be sure to correctly wear any
protective garments that are provided.  The technician will make sure that only the area that
needs to be x rayed will be exposed to the x ray beam.
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It may be necessary to inject you with a chemical that has some amount of radioactive material
in it to help a doctor diagnose or treat a disease.  Many studies have shown that these drugs, used
correctly, will not harm you.  Be sure to follow the doctor’s directions after you have been
treated with these drugs.
Many places make or use various types of radioactive material or ionizing radiation for medical
or research purposes.  If you visit one of these facilities, be sure to follow all of the
recommended safety precautions.  Do not go into unauthorized areas.  You may be asked to wear
a special device on your shirt that records the amount of ionizing radiation you are exposed to
while in the facility.  This is a safety precaution.  Do not put it in your pocket or let someone else
wear it.
1.8 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN
EXPOSED TO IONIZING RADIATION?
There are no easy or accurate medical tests to determine  whether you have been exposed to low
doses of ionizing radiation, but tests are available for determining whether you have been
exposed to radioactive material.  
Tests for Recent Exposure to Ionizing Radiation.    A great degree of overexposure is
necessary to cause the clinical signs or symptoms of radiation exposure.  In the absence of
clinical signs or symptoms there are two kinds of tests scientists use to see if you have been
overexposed to ionizing radiation; they look for changes in blood cell counts and changes in
your chromosomes.  If you are exposed to no more than 10 rad (0.1 Gy) of ionizing radiation,
there are no detectable changes in blood cell counts.  The most sensitive measure of radiation
exposure involves a study of your chromosomes.  This is a special test for doses that are too low
to produce clinically observable signs or symptoms;  this test may be useful for doses greater
than about 3 times the maximum annual permissible dose for radiation workers.  Changes in the
white blood cell count may be seen in people whose doses exceeded about 5 times the
occupational maximum permissible annual dose.  Radiation doses at or above these levels can be
reliably estimated using these two special tests. 
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Tests for Radioactive Material Inside Your Body.    Scientists can also examine your blood,
feces, saliva, urine, and even your entire body to see if measurable amounts of radioactive
material are  being excreted from your body.  Different tests are used for different types of
radioactive material.  Several types of instruments are available to look for each type of
radiation.  These instruments are not available at your doctor’s office.  They are normally large,
heavy, and available only in laboratories.  Equipment usually consists of a “detector,” electrical
cables, and a “processor.”  The detector contains material sensitive to one or more types of
radiation, so the detector is chosen based on the type of radiation to be measured.  Alpha, beta,
and gamma radiation have different energies that depend upon the radioactive isotope from
which they come.  By determining the type and energy of the radiation, scientists can tell which
radioisotope is on your skin or inside your body.
More information about the detection of ionizing radiation and biomarkers for ionizing radiation
exposure can be found in Chapter 2 of this profile.
1.9 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO
PROTECT HUMAN HEALTH?
Recommendations and regulations are periodically updated as more information becomes
available.  For the most current information, check with the federal or state agency or
organization that provides it.  
The current federal and state regulations limit radiation workers' doses to 0.05 Sv/year
(5 rem/year).  The limit for the unborn child of a female radiation worker is 0.005 Sv (0.5 rem)
per 9-month gestation period.  For the general public, the limit is 0.001 Sv/year (0.1 rem/year),
with provisions for a limit of 0.005 Sv/year (0.5 rem/year) under special circumstances.  The
public dose limit is set at least 10 times lower than the occupational limit to give the public an
extra margin of safety.  A factor of 10 is also used for public protection in other industries. 
We have seen health effects from very high doses of ionizing radiation, but not at normal
everyday levels.  To be cautious, scientists and regulating agencies assume that there could be
some harmful effects at any dose, no matter how small.  Because ionizing radiation has the 
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potential to cause harmful health effects in overexposed people, regulations and guidelines have
been established for ionizing radiation by state, national, and international agencies.  The basic
philosophy of radiation safety is to allow only a reasonable risk of harm using the concept of “as
low as reasonably achievable” (ALARA).  More specific information about the regulations in the
United States and in your state can be found in Chapter 7 of this profile.  Some regulations and
recommendations for ionizing radiation include the following:
Radiation protection standards for radiation workers and members of the public are
recommended by the International Commission on Radiological Protection (ICRP) and the
National Council on Radiation Protection and Measurements (NCRP).  These standards are not
regulations, but they provide the scientific basis for the making of regulations by federal
agencies.  The ICRP and NCRP are authoritative bodies that analyze current scientific and
epidemiological data and make recommendations to government and non-government
organizations that set standards.  ICRP and NCRP do not issue standards themselves.
Federal agencies, such as the EPA, the Nuclear Regulatory Commission (NRC), and the
Department of Energy (DOE), as well as individual states are responsible for making federal and
state regulations about exposure to ionizing radiation. The NRC regulates nuclear power plant
operations and regulates the use of radioactive material in research and medical applications. 
The DOE has issued employee dose limits for its facilities.   
The EPA is responsible for federal radiation protection guidance for environmental radiation
standards and regulations to implement specific statutory requirements, such as the Safe
Drinking Water Act and the Clean Air Act.  Natural background radiation, of course, cannot be
regulated but EPA recommends that the concentration of indoor radon not exceed 4 picocuries
per liter (4 pCi/L) of air.  EPA's National Emission Standards for Hazardous Air Pollutants
(NESHAPs) contain regulations that limit the dose from radionuclides released to the air to 0.1
mSv/year (10 mrem/year).  The EPA sets limits on the maximum acceptable concentration of
radionuclides in public drinking water supplies.  Based on the Safe Drinking Water Act, the EPA
has issued drinking water standards for radionuclides, which include dose limits of
0.04 mSv/year (4 mrem/year) for man-made sources of beta and gamma emitters.  EPA also sets
limits on several alpha emitters in drinking water, such as radium and radon.
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The NRC regulations apply to all types of ionizing radiation that are emitted from special
nuclear material (such as nuclear reactor fuel) and from by-product material (materials made
radioactive in the use of special nuclear material), and from source material (material from which
nuclear fuel is made).  The NRC sets limits on the total dose of ionizing radiation above
background from these sources.  It also sets limits for the amounts and concentrations of
radioactive material that will give these doses if taken into the body.  These are called Annual
Limits on Intake (ALI) and derived air concentrations (DAC).  
The NRC has also issued a standard for cleaning up sites contaminated with radioactive
materials.  It requires that the radiation dose to the public from these sites will not be more than
0.25 mSv per year (25 mrem per year).
Radiation doses from procedures used by licensed physicians in diagnosis and treatment of
disease is not limited by regulations.  However, physicians and medical technicians must be
specially trained and licensed to use radiation-producing machines and licensed to use
radioisotopes for these purposes.  They are required to limit exposures to the members of the
public who are inside their facilities to 100 mrem per year, which is the same level as required
by the NRC.  Also, patients with radioactive materials inside their bodies from the treatment are
kept until it is likely that they will not expose anyone around them to more than 0.5 mSv (500
mrem) from that radioactive material.
States also regulate radioactive materials and other sources of radiation that are not regulated by
the NRC.  These include sources of natural radioactivity, such as radium, and
radiation-producing machines, such as x ray machines and radioactive material produced by
particle accelerators. 
1.10 WHERE CAN I GET MORE INFORMATION?
If you have any more questions or concerns, please contact your community or state health or
environmental quality department or
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road NE, Mailstop E-29
Atlanta, GA 30333
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* Information line and technical assistance
Phone: 1-888-42-ATSDR (1-888-422-8737)
Fax:  (404) 639-6315 or 6324
ATSDR can also tell you the location of occupational and environmental health clinics.  These
clinics specialize in recognizing, evaluating, and treating illnesses resulting from exposure to
hazardous substances.
* To order toxicological profiles, contact
National Technical Information Service
5285 Port Royal Road
Springfield, VA 22161
Phone: (800) 553-6847 or (703) 605-6000
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2.1 INTRODUCTION
This chapter provides an overview of the principles of ionizing radiation before a discussion of the health
effects in Chapter 3.
The primary purpose of this chapter is to provide public health officials, toxicologists, and other
interested individuals and groups with an overall perspective of the health physics and toxicology of
ionizing radiation.  It contains descriptions and evaluations of radiological and toxicological studies and
epidemiologic investigations and provides conclusions, where possible, on the relevance of health
physics, toxicity, and toxicokinetic data to public health.  A glossary and list of acronyms, abbreviations,
and symbols can be found at the end of this profile, along with an index.  This profile focuses on “ionizing
radiation” (alpha, beta, gamma, x ray) as opposed to “non-ionizing” radiation (radio waves, microwaves,
radar, ultrasound, visible light, ultraviolet light), so the term “radiation” without further qualification refers
only to ionizing radiation. 
“Radioactive material” is defined as any material containing radioactive atoms that emit radiation as they
transform into other radioactive or stable atoms.  The frequently used terms “radiation,” and “ionizing
radiation” are defined in this toxicological profile as a specific form of radiation that possesses sufficient
energy to remove electrons from the atoms in the tissues that they penetrate (Borek 1993).  This process is
called ionization and is the reason for the name “ionizing radiation.”  When this energy is received in
appropriate quantities and over a sufficient period time, it can result in tissue damage.   The clinical
manifestations of radiation can be negligible (no effect), acute (occurring within several hours after very
large doses), or delayed or latent (occurring several years after the exposure), depending on the dose and
the rate at which it was received and the type of damage produced.
All organisms (i.e., bacteria, plants, or animals, including humans) are exposed each day to some amount
of radiation.  In the United States, as shown in Figure 1-2, 81% of the dose received from radiation comes
from natural sources: 55% from radon; 8% from cosmic radiation; 8% from rocks and soil; and 10% from
internal exposures to radiation from the radioactive materials in food and water consumed in the daily
diet, such as potassium-40 (40K) (NCRP 1987).  The remaining 19% of the daily dose may originate from
man-made sources; it is composed of medical x ray exposure (11%), nuclear medicinal exposure (4%),
consumer products (3%), and other sources (<1%).  This last category includes occupational sources,
nuclear fallout, the nuclear fuel cycle radioactive waste, hospital radioactive waste, radioactively
contaminated sites, and other miscellaneous sources.    
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Radiation dose is expressed in units of rad and millirad (mrad) (1 rad = 1,000 mrad), or grays (1 Gy =
100 rad) and milligrays (mGy).  For administrative, regulatory, and radiation safety purposes, a unit
called the rem or the sievert (Sv) (1 rem = 0.01 Sv) is used.  For beta and gamma radiation, 1 rad = 1 rem,
while for alpha radiation, 1 rad = 20 rem.  For the population of the United States, the average annual
total effective dose equivalent (natural and anthropogenic), is approximately 360 millirem (mrem)
(3.6 mSv) per year (BEIR V 1990).
A survey of the open literature found comprehensive information and many discussions of the biological
and toxicological effects of radiation.  Much of the information on these effects was obtained from
laboratory animal studies and human epidemiological studies (see Chapters 3, 4, and 5).  The human data
are mostly from studies of World War II atomic bomb survivors, medical patients exposed to radiation
and radioactive material, uranium miners and millers, and radium dial painters.  A great deal is currently
known about the biological, toxicological and toxicokinetic aspects of radionuclides, as well as the
general mechanisms of action of radiation.  Although much remains to be learned about the specific
mechanisms by which radiation exerts its effects, how these effects can be minimized in living tissues,
and what the effects of very low doses of radiation over long periods of time will be (see Chapter 3), we
know enough to safely use radioactive materials and radiation in commerce, industry, science, and
medicine.  For the purposes of this toxicologic profile, discussions on the effects of radiation will be
limited to alpha (α), beta (β), and gamma (γ) radiation, since these three types of radiation are the most
likely to be encountered at Department of Energy (DOE) National Priorities List (NPL) hazardous waste
sites (see Chapter 3, Table 3-1).  This profile provides an in-depth discussion of radiation biology and
radiation toxicology.  Chapters 3 and 5 provide  a comprehensive overview of a representative cross-
section of the available literature that pertains to the effects of radiation, both in humans and laboratory
animals.  Data on specific radionuclides were used to demonstrate how toxicological effects can occur,
but these effects can also be caused by other radionuclides that emit the same or other types of radiation
(see Chapters 3 and 5).  Several excellent texts and review documents are currently available in the open
literature that provide important background material used in developing other sections of this profile
(BEIR IV 1988; BEIR V 1990; Cember 1996; Faw and Shultis 1993; Harley 1991; Roesch 1987;
UNSCEAR 1993).
This toxicological profile contains tables that summarize the effects of radiation for both humans and
laboratory animals (see Observed Health Effects from Radiation and Radioactive Material tables in
Chapter 8).  In radiation biology, the term "dose" has a very specific meaning.   The term "dose" used in
these tables refers to the amount of radiation energy absorbed per unit mass by the organ, tissue, or cell;
dose is typically expressed either in grays (Gy) or in rad (1 Gy = 100 rad).  For example, estimation of the
dose to lung tissue or specific cells in the lung from a given exposure to plutonium-239 (239Pu) is
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accomplished by modeling the sequence of events involved in the inhalation, deposition, clearance, and
transformation of 239Pu within the lung.  While based on the current understanding of lung morphometry
and experimental data for other radionuclide toxicokinetics, different models make different assumptions
about these processes, thereby resulting in different estimates of dose and risk coefficient.  The units of
measure in the studies that describe the health effects of radiation vary from one report to another.  Some
studies reported the amount of radioactive material introduced into the body (curies [Ci] or becquerels
[Bq] where 1 Ci = 37 billion Bq) when describing the biological effects related to radiation, while other
authors reported units of absorbed dose (rad, Gy) or dose equivalent (rem, Sv).  Although the units did
differ among the many reports, attempts were made to standardize the reporting of doses in units of rad in
order to minimize confusion and provide a basis by which dose responses could be determined and
evaluated.
An understanding of the basic concepts in radiation physics, chemistry, and biology is important to the
evaluation and interpretation of radiation-induced adverse health effects and to the derivation of radiation
safety principles.  This chapter presents a brief overview of radiation physics, chemistry, and biology and
is based to a large extent on the reviews of Eichholz (1982), Hendee (1973), Early et al. (1979), Faw and
Shultis (1993), Harley (1991) and Roesch (1987).
2.2 HISTORY, BACKGROUND INFORMATION, AND SCIENTIFIC PRINCIPLES OF
IONIZING RADIATION
2.2.1  Historical Perspective on Ionizing Radiation
Ionizing radiation has been present since the earth was created.  Before the 1890s, there were only natural
sources of radiation such as radiation from cosmic sources, and radioactive material inside the body and
in rocks, soil, and air.  Much of the radiation exposure was in the form of low-level cosmic and terrestrial
radiation.  Since radiation cannot be observed using any of the five senses, humans were not aware of its
existence.  
About 1,800,000 years ago, the only known natural "nuclear reactor" operated for about 100,000 years in
the uranium-rich soil around what is now Oklo, Gabon.  The first known use of uranium occurred in
79 AD, when Roman artisans were producing yellow-colored glass in a mosaic mural near Naples; this
activity produced low levels of radiation.  The first reports of adverse health effects that were probably
related to radiation from inhaled radon gas and its radioactive progeny occurred around 1400 AD, when a 
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mysterious malady resulted in the deaths of miners at an early age in the mountains around Schneeberg
and Joachimsthal in the Sudetenland (The Czech Republic).  This mysterious disease was known as
"mountain sickness” and is now believed to have been lung cancer.  When mountain sickness was first
described, radon was not known and was not linked to the disease until the 1920s, when radon gas was
identified as a cause of lung cancer.
It was not until the discovery of mystery rays or “x rays” in 1895 that people began to be aware of the
almost magical presence of these invisible “rays” that could allow us to see inside the body.  In the
summer of 1894, Wilhelm Roentgen began experiments with cathode ray tubes; on November 8, 1895, he
observed that a few crystals of barium platinocyanide, which were lying on a table, produced a
fluorescent glow.  He subsequently discovered that some unknown component (“X”) from the cathode ray
tube could also penetrate solid substances, and that “x rays” had the same effect on a photographic plate
as visible light.  What followed was the first "Roentgen exposures," or “Roentgenograms,” which were
photographs that were able to show the shapes of metal objects locked in a wooden case and the bones
inside his wife’s hand.  A month after his discovery, Roentgen sent a manuscript about his extraordinary
findings to the Physical-Medical Association in Wuerzburg, titled Concerning a New Kind of Ray:
Preliminary Report.  Other periodicals such as Nature and Science published the report in the following
year, and Roentgen received wide acclaim for his discovery, both in the scientific and lay communities, in
the years to come.  Others quickly found practical applications for x rays (also called “Roentgen rays”). 
In 1896, the first diagnostic x ray in the United States was performed by E. Frost.  Within the next 2
years, the first x ray picture of a fetus in utero was taken; this was followed by the first use of an x ray in
dentistry.  Adverse health effects due to exposure to x rays were soon reported.  These  included a report
by Thomas Edison asserting that eye injuries can be produced by exposure to x rays, and a report by
Daniel identifying alopecia and erythema (skin reddening) 3 weeks after he radiographed the head of
Edison’s assistant, Mr. Dudley.
 
Roentgen’s discovery of x rays was followed by Henri Becquerel’s discovery of radioactivity in
November 1896.  Becquerel found that photographic plates that were lying near pitchblende (a uranium
ore) were exposed despite being sealed in light-tight envelopes.  The exposure, he found, was due to
radiations emitted from the pitchblende.  Subsequent studies showed that there were three uniquely
different radiations, which he called alpha, beta, and gamma.  Later, it was shown that Roentgen’s x rays
and Becquerel’s gamma rays were the same kind of radiation.
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After these discoveries, scientific interest in the properties of radiation increased dramatically. 
Radioactive thorium (Th) was discovered by Schmidt in 1898.  A few months later, Marie and Pierre
Curie isolated polonium (Po) from pitchblende, a variety of the mineral uraninite (largely UO2), that
occurs as a constituent of quartz veins and is a source of radium (Ra) and uranium (U).  The Curies later
isolated radioactive 226Ra from pitchblende and explained the natural transformation of an unstable atom
of a higher atomic number to one of a lower atomic number, referred to as transformation or “decay.” 
The Curies ultimately coined the word “radioactivity.”  In the years to come, other notable scientists
contributed to this new area of science: Villard discovered gamma rays; Rutherford discovered
radioactive gas emanating from thorium and coined the term “half-life” and used alpha particles to
develop a new theoretical model of the atom (Friedlander et al. 1964); Planck created quantum theory;
Einstein discovered mass-energy relationship and photoelectric effect; and Hess reported the existence of
“cosmic rays” (ionizing radiation) at high altitudes.
In 1904 Ernest Rutherford said, “If it were ever possible to control at will the rate of disintegration of
radio-elements, an enormous amount of radiation could be obtained from a small amount of matter.”  This
statement expressed the obvious implications for the use of radionuclides (in particular uranium and
plutonium) in generating large amounts of electric energy in nuclear reactors and in the production of
nuclear weapons approximately 40 years later.  The use of the “atomic bomb” (this term is somewhat of a
misnomer since it is the nucleus from which this energy derives) would make an important contribution to
ending the second World War.  Much scientific research was required to move from theory to application. 
“The Manhattan Project” was the code name for the project responsible for taking many of the theoretical
ideas on atomic energy proposed since Roentgen’s discovery and applying them in a real-world
application that would result in the creation of the first atomic weapon.
The Manhattan Project was named for the Manhattan Engineering District of the U.S. Army Corps of
Engineers, because much of the early theoretical research on the potential of nuclear energy was done at
Columbia University and because the Manhattan District of the U.S. Army Corps of Engineers was
located near Columbia University in New York City.  Initiated by President Roosevelt on the
recommendation of several physicists who had fled Europe, the program was slowly organized after
nuclear fission was discovered by German scientists in 1938.  Many U.S. scientists began to express the
fear that the Germans, under their dictator Adolf Hitler, would attempt to build a fission bomb which
would pose a serious threat to the world.  It was subsequently decided that the United States must be the 
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first country to harness this new technology in order to maintain the future balance of world power.  In
1942, General Leslie Groves was chosen to lead the Manhattan Project.  He immediately purchased a site
at Oak Ridge, Tennessee, and constructed the facilities to extract and purify the 235U isotope fuel needed
to power the weapon.  He also secured a 550-square mile site in Eastern Washington State, later called the
“Hanford Works,” for the highly secret reactor production and chemical refinement of plutonium metal. 
The first plutonium in gram quantities was produced in early 1945 by the Hanford “B” reactor, which has
been designated a National Historic Site.  Groves appointed theoretical physicist Robert Oppenheimer as
director of a weapons laboratory built on an isolated piece of land at Los Alamos, New Mexico.  In 1945,
235U of adequate purity was shipped to Los Alamos and was used in the testing in the first of two
prototype weapons.  In the first prototype, one subcritical piece of uranium was fired at another
subcritical piece down a gun barrel; the combined pieces formed a supercritical, explosive mass.  The
second prototype was constructed using plutonium.  In the plutonium prototype, the plutonium was
surrounded with explosives to compress it into a superdense, supercritical mass far faster than could be
done in a gun barrel.  The result was tested (Pu weapon only) at Alamogordo, New Mexico, on July 16,
1945, and was the first detonation of an atomic-type weapon. Two more atomic weapons were
subsequently manufactured in the United States and detonated over Hiroshima and Nagasaki, Japan, in
August 1945.  The use of these devices, the most destructive weapons at the time, quickly brought the war
in the Pacific to an end, thus saving Allied and Japanese soldiers who would have been lost in a ground
invasion of the Japanese mainland using only the conventional weapons of the time.
The two bombs detonated over Japan in the final days of World War II were made from two different
types of explosive material.  The Hiroshima bomb was made from the highly enriched 235U, extracted
from ore containing the much more abundant isotope 238U.  This bomb, which was released over Japan's
seventh largest city on 6 August 1945, contained approximately 60 kg of highly enriched uranium; its
detonation destroyed 90% of the city.  The explosive charge for the bomb detonated over Nagasaki 3 days
later was provided by about 8 kg of 239Pu, which caused a similar amount of destruction.
Both atomic devices were detonated in the air over the cities.  The devastating effects of the bombs
depended essentially upon the blast, shock, and heat released at the moment of the explosion, causing
immediate fires and destructive blast pressures.  Since the bombs were detonated about 600 meters above
the ground, only a relatively small proportion of the radioactive fission products was deposited on the
ground near the “ground zero” point below the site of detonation.  Some deposition occurred in areas near 
IONIZING RADIATION 29
2.  PRINCIPLES OF IONIZING RADIATION
each city due to local rainfall soon after the explosions, specifically at positions a few kilometers to the
east of Nagasaki and in areas to the west and northwest of Hiroshima.  Generally, the majority of the
fission products were carried into the upper atmosphere by the heat generated by the explosion.  When the
fallout returned to earth, it contributed to global human radiation exposure.
In Hiroshima, with a resident civilian population of about 250,000 people, an estimated 45,000 died on
the first day after the bombing and an additional 19,000 died during the subsequent 4 months.  In
Nagasaki, with a resident population of about 174,000, an estimated 22,000 died on the first day and an
additional 17,000 deaths were reported within the next 4 months.  Actual totals may be higher due to
unrecorded deaths of military personnel and foreign workers.  Teratogenic effects on fetuses were severe
among those heavily exposed, resulting in many birth deformities and stillbirths over the next 9 months. 
No genetic damage has been detected in the survivors' children and grandchildren, despite careful and
continuing investigation by the Radiation Effects Research Foundation (RERF), which is a joint
Japanese-U.S. foundation.  Since then, some of the surviving adults developed leukemias and other
cancers (see Chapter 3).  The major source of radiation dose to the population in both cities was from the
penetrating gamma radiations.  The study of the Japanese survivors has proven to be an important
historical confluence for major health effects studies at low doses.  Prior to World War II, radiation
mutagenesis, teratogenesis, and carcinogenesis studies developed along separate lines.  The study of the
atomic bomb survivor populations allowed these separate lines of research to converge with studies in a
single population.
The atomic bombs used in Japan in 1945 and the bombs tested during the following 7 years used  235U or
239Pu.  The explosive power of the Hiroshima bomb was about 15 kilotons (equivalent to 15,000 tons of
trinitrotoluene [TNT]) and that of the Nagasaki bomb was approximately 25 kilotons.  For comparison,
the total TNT equivalent explosive power of all atmospheric weapon tests made by the end of 1951 was
approximately 600 kilotons.
After 1951, the atomic bombs being tested included hydrogen bombs, which became more sophisticated
and had explosive effects about a thousand times greater than those of the Hiroshima and Nagasaki type
bombs; by the end of 1962, the total of all atmospheric tests had risen from the 1951 value of 0.6 million
tons of TNT equivalent, to about 500 million tons of TNT equivalent.  This vast increase in scale was due
to the testing of the “thermonuclear” weapons or (hydrogen bombs or “H-bombs”), which depended not
on the fission of a critical mass of fissile material alone, but on a two- or three-stage process initiated by a 
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fission reaction.  Briefly, the hydrogen bomb uses the same process that the sun uses to release its
tremendous amounts of energy.  In the hydrogen bomb, the nuclei of two light atoms (usually hydrogen)
are fused together to form a heavier atom, helium.  A fission reaction, in which a heavier atom is split into
lighter ones, generates the energy to trigger the fusion reaction.  The United States exploded its first
hydrogen bomb in November 1952 at Eniwetok Atoll in the South Pacific.  Atomic weapons development
by the United States and other nations continues in the 1990s.
The development of the “atomic bombs” has frequently received more attention than the peaceful use of
atomic energy and radiation.  Peaceful uses of radiation have also been developed quite successfully.  An
important application has been in the generation of safe, controlled and long-term power sources for the
civilian population.  On December 20, 1951, the first usable electricity produced from nuclear energy was
manufactured at the National Reactor Testing Station, now called the Idaho National Engineering and
Environmental Laboratory (INEEL), in Idaho Falls, Idaho.  The electricity produced lit four light bulbs
across a room of the Experimental Breeder Reactor I (EBR-I).  In 1953, these scientists demonstrated that
a reactor could create more fuel than it used, "breeding" fuel from 238U as it created electricity with 235U. 
EBR-I operated as a research reactor until 1963, at which time EBR-II became active; EBR-II is now a
historical monument.  In July 1955, Arco, Idaho, became the first U.S. town to be powered by nuclear
energy, supplied by power from the Borax-III reactor, an early prototype of a boiling water-type nuclear
reactor.  The Sodium Reactor Experiment in Santa Susanna, California, generated the first power from a
civilian nuclear reactor on July 12, 1957, using sodium instead of water as the primary coolant.  The first
large-scale nuclear power plant in the world began operating in Shippingport, Pennsylvania, in December
1957. Today, nearly 25% of the electricity generated in the United States (75% in Maine and Illinois and
50% in South Carolina) comes from nuclear power.  Other countries generate much larger proportions of
their electricity with nuclear energy.  In oil-poor countries, such as France, 80% of the electricity is
generated with nuclear energy and in Japan nuclear energy accounts for 30% of the electricity generated. 
Other countries using nuclear power include Canada (17%), Germany (29%), Sweden (47%), and the
former Soviet Union (42%) (USNRC 1997b).  Although nuclear reactors continue to be used as a source
of power for many states and countries, public concerns about nuclear reactor safety have intensified due
to well-publicized accidents (see Chapters 4 and 6).  However, only two of these accidents involved
nuclear power reactors: Three Mile Island and Chernobyl.  At Three Mile Island, although the reactor
melted down, no one was overexposed or injured, and there was no significant  contamination outside the 
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containment and auxiliary buildings.  At Chernobyl, the reactor melted down, causing serious public
health consequences which could have been prevented if the reactor design had included a containment
building.
Medical uses of machine-produced radiation and radionuclides emitting radiation have also been
developed that play a significant role in medical diagnosis and treatment.  Controlled amounts of
radiation in the form of x rays have been used for a century, and beta particles have used more recently,
as an aid in the diagnosis and treatment of diseases in humans and animals.  Today, much is known about
the health effects of high doses of x rays, as well as other radiation; however, this has not always been the
case.  In 1947, doctors in Israel and many other countries treated ringworm of the scalp with up to 400 rad
(4 Gy) of x rays to cause the hair to fall out (alopecia); it was later found that this treatment regimen led
to a greater than expected incidence of thyroid tumors and brain cancers.  Radium-224 (224Ra) was used in
the treatment of ankylosing spondylitis in Germany in the 1940s; these treatments later were associated
with an increased incidence of bone cancers.  In addition to x rays, radionuclides such as iodine-131 (131I)
and metastable technetium 99 (99mTc) are being used to successfully diagnose and/or treat a wide range of
diseases.  Laboratory research has benefitted from the use of radionuclides, typically in the form of
radiolabeled tracers that enabled us to learn the details of the biochemistry of health and disease, and to
develop new diagnostic techniques and new (non-radioactive) drugs for treatment of disease.  Carbon 11
is a short half-life (20 minutes) radionuclide produced in cyclotrons in conjunction with several medical
facilities and used in positron emission tomography (PET) studies that enable physicians to see inside the
body and precisely locate sites of medical concern.  
2.2.2 Basic Information on Ionizing Radiation
Ionizing radiation is any of several types of particles and rays given off by radioactive material, nuclear
reactions, and radiation producing machines.   Those that are primarily addressed in this profile because
of their relevance to public health are alpha particles, beta particles, and gamma rays, which are also
called alpha, beta, and gamma radiation.  The term “ionizing” refers to the ions or charged atoms and
molecules that radiation produces along its path by knocking electrons from atomic orbits.  The term
“radiation” refers to the way these particles and rays move away or radiate from their sites of production
at speeds ranging from a few tenths of the speed of light to the speed of light.  Our senses cannot detect
radiation since it is odorless, tasteless, and invisible, and cannot be heard or felt.    All life on earth is 
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exposed to low levels of ionizing radiation from terrestrial and cosmic sources every day. This profile will
not address non-radiation, such as radiowaves, microwaves, infrared light, visible light, ultrasound, and
ultraviolet light.
To explain exactly what radiation is, we begin at the atomic level with atoms, how they come to be
radioactive, and how they give off radiation.  The materials we call elements are composed of atoms,
which in turn are made up of neutrons, protons, and electrons.  Protons (positively charged particles) and
neutrons (neutral particles with no charge) reside in and primarily comprise the nucleus of any atom,
while electrons exist in a “cloud” of orbits around the nucleus.  Nuclide is a general term referring to any
atom.  All atoms of an element have the same number of protons (the number of protons = the atomic
number) but may have different numbers of neutrons (this is reflected in the atomic mass or atomic
weight of the element).  Atoms with the same atomic number but different atomic masses are referred to
as isotopes of an element.  An isotope is a specific nuclide that is characterized by the composition of its
nucleus (by the number of protons and neutrons in the nucleus). 
Radioactivity is the characteristic of any atom that is unstable due to the binding of the protons and
neutrons within its nucleus.  If the number of neutrons is too small or too large for the number of protons,
the nucleus is unstable and the atom is said to be radioactive.  Radioisotope refers to any radioactive
isotopes of an element, and radionuclide is a generic term applying to any radioactive species of any
element.  Every radioactive nucleus will eventually change its neutron/proton ratio by one of four basic
methods and simultaneously emit radiation to obtain a more stable energy configuration.  These methods
can involve the ejection of an alpha particle (a 2-proton 2-neutron packet) directly from the nucleus, the
conversion within the nucleus of a neutron to a proton or a proton to a neutron with the emission of a beta
particle and gamma rays, or the splitting or spontaneous fission of the nucleus.  Each  radionuclide has a
unique configuration, so the radiation types, energies, and intensities are unique to it, and these are keys
to its identification.  The unstable radionuclide is transformed during this process into a new nuclide,
which is typically stable.  Radionuclides that are still radioactive after one transformation, continue
through a series of one or more further transformations until a stable atom is formed.  This series of
transformations, called a “decay” chain, is typical of the very heavy natural elements like uranium and
thorium.  The first radionuclide in the chain is called the parent radionuclide, and the subsequent products
of the transformation are called progeny, daughters, or transformation products.  To summarize, radio-
active decay results in a stable nuclide or a less unstable nuclide than the parent.  
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Naturally-occurring radionuclides can be classified as either primordial (present from ancient times) or
cosmogenic (produced by cosmic rays).  Primordial radionuclides include 40K, 238U, 235U, and 232Th, which
have existed since the earth was formed, and the series of radionuclides which each of the last three
isotopes transform through before becoming stable isotopes of lead.  40K and about half of the decay chain
radionuclides emit beta and gamma radiation while 238U, 235U, 232Th and the other half of their decay chain
isotopes emit alpha particles.  Cosmogenic radionuclides (3H, 7Be,14C, etc.) are those which are constantly
being formed in the atmosphere as cosmic rays and particles from space interact with and transform
atmospheric gases.  All of these transform by emitting beta and gamma radiation. 
Natural background radiation is the combined radiation field produced by the primordial and cosmogenic
radioactive materials that are around us plus cosmic radiation from space.  Everyone is exposed to this
background radiation throughout their lives, at levels that depend on the ambient concentration of those
radioactive materials and the altitude at which we live.  This background radiation is the major source of
radiation exposure to humans and arises from several sources.  Natural background dose rates are
frequently used as a standard of comparison for doses from various man-made sources of radiation.  Man-
made radiation is that which is produced by machines, such as x ray machines, and from the decay of
radioactive materials that we make.  Man-made radioactive materials are those associated with nuclear
reactor operation (fission products of uranium and plutonium, and neutron activated by-product material)
and high-energy physics equipment (cyclotrons and particle accelerators that bombard targets with
charged particles).  A number of short-lived radionuclides are produced and used daily in the medical
field to diagnose and treat illness.  Currently-available equipment and methods can be used to produce
radionuclides of any known element, and to even create new elements as scientists attempt to understand
the atom more completely.  Both naturally occurring and anthropogenic radionuclides have numerous
applications in diagnostic and therapeutic medicine, industrial products, consumer products, and in
scientific and industrial research.  Trace amounts of some specific radionuclides remain in the
environment, or have been redistributed in the environment, as a result of these applications and also from
the production, testing, and use of nuclear weapons.
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2.2.3 Principles of Radioactive Transformation
The stability of an atom is the result of the balance of the forces among the components of the nucleus. 
High-energy physicists exploring the nucleus have developed the field of quantum mechanics and
semiempirical equations to express the binding energies or stability of nucleons in the nucleus.  One
general finding of those studies is that a nucleus with too many or too few neutrons for a given number of
protons is unstable (radioactive) and will eventually undergo transformation to achieve a more stable
energy state.  Most radioactive atoms can achieve stability in one transformation, but most with atomic
masses greater than lead require several successive transformations and are said to be in a decay chain. 
Any radionuclide can be uniquely characterized by its rate of transformation and the types, energies, and
intensities of its radiations.  Table 2-1 summarizes the basic characteristics of the more common types of
radiation.
Table 2-1.  Characteristics of Nuclear Radiations 
Typical
energy range
Path length
Radiation Rest massa Charge Air Solid Comments
Alpha (α) 4.0026 amu +2 4–10 MeV 3–10 cm 25–80 µm An electron-stripped
He nucleus
Negatron (β–) 5.48x10-4 amu;
0.51 MeV
–1 0–4 MeV 0–15 m 0–1 cm Identical to electron
Positron (β+) 5.48x10-4 amu;
0.51 MeV
+1 0-4 MeV 0–15 m 0–1 cm Identical to electron
except for sign of
charge
Neutron 1.0086 amu;
939.55 MeV
0 0–15 MeV b 0–100 cm Free half-life: 
10.4 min
x ray (e.m.  photon) – 0 5 keV–100 keV b b Photon from transition
of an electron
between atomic orbits
Gamma (p)(e.m.  photon) – 0 10 keV–3 MeV b b Photon from nuclear
transformation
aThe rest mass (in amu) has an energy equivalent in MeV that is obtained using the equation E=mc2, where 1 amu = 9 32 MeV.
bPath lengths are not applicable to x- and gamma rays since their intensities decrease exponentially
amu = atomic mass unit; e.m.  = electromagnetic; keV = KiloElectron Volts; MeV = MegaElectron Volts
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The mode of transformation refers to the way the parent radionuclide undergoes its transformation.  The
modes that are most significant to public health are alpha and beta decay with the subsequent emission of
gamma radiation, although others, such as electron capture and spontaneous fission, also occur in certain
radionuclides.  Alpha decay occurs among those radionuclides, such as the uranium isotopes, with
sufficient excess nuclear energy to eject part of their mass, which is always a packet containing two
protons and two neutrons, called an alpha particle.  One of two types of beta decay occurs among the
other radionuclides, and the type (negatron or positron) depends on the availability of neutrons to stabilize
the nucleus.  For neutron-rich nuclei, like those formed in nuclear reactors, a neutron converts to a proton
and a negatively charged beta particle called a negatron, or simply a beta particle.  For neutron-poor
radionuclides, such as those produced using particle accelerators, a proton converts to a neutron and the
nucleus emits a positively-charged beta particle called a positron.  The two types of beta decay are often
referred to generically as beta decay.  One reason is that both positrons and negatrons are the same
particle, an electron, but with different charges.  Another mode of transformation for a neutron-poor
nucleus is electron capture, in which the nucleus captures an orbital electron and uses it to convert a
proton into a neutron.  A transformation that is available to only a few radionuclides, such as 238U, is
spontaneous fission in which the nucleus splits into two fragments of unequal mass releasing a few
neutrons and a large amount of energy.  Spontaneous fission neutrons can be used to induce the chain
reactions in nuclear reactors.  Some radionuclides, such as 238U, follow multiple modes with specific
frequencies.  The various decay modes often leave the nucleus with a small amount of excess energy that
is released as a gamma ray.  When alpha, beta, or gamma radiation interact with atoms along their paths,
the electrons they knock from interior orbitals produce vacancies which the atom corrects by cascading
electrons down from higher energy orbitals to fill the inner ones.  In doing so, each electron drops to a
lower energy state and the atom emits the energy difference in the form of a photon, called an x ray.  X
and gamma rays are different in their origin (electron shells or nucleus) but are indistinguishable in their
characteristics.  Both are massless bundles of electromagnetic energy with sufficient energy to ionize
matter.  During these transformations, the atom changes from one element into another, modifying the
structure of the electron orbitals, and in some cases emitting x rays with energies characteristic of the new
element.  Characteristic x rays are useful in determining a material’s elemental makeup. 
The type of radiation may be categorized as charged particle (alpha, negatron, positron), uncharged
particle (neutron), or electromagnetic radiation (gamma and x ray).  The type of radiation can also be
characterized as directly ionizing (alpha, negatron, positron, or proton) or indirectly ionizing (neutron, 
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Figure 2-1.  Transformation of 100 µCi of 32P
gamma, or x ray).  X- and gamma rays are categorized as indirectly ionizing radiation because they have
no charge and it is the electrons that they liberate from atoms that produce most of the ionization.
 
Except for delayed neutrons emitted during the nuclear fission process, no radionuclides emit neutrons. 
For example, californium-252 (252Cf), which undergoes spontaneous nuclear fission as well as alpha
transformation, emits neutrons during the fission process.  When neutrons are needed for neutron
activation analysis or for radiography, they can be produced by a nuclear reactor, a sealed 252Cf source, or
a neutron generator (an alpha emitter surrounded by an appropriate target element).  An example of such a
neutron source is a mixture of a finely powdered alpha emitter, such as 210Po and beryllium (Be).  The
alpha particle bombards the 9Be isotope to produce 12C and a neutron. 
Each radionuclide has a characteristic rate of decay called the half-life, which is the time it takes for 50%
of its atoms to decay.  Each radionuclide transforms at a constant rate, which is independent of the
temperature, pressure, or chemical form in which it exists.  A high rate of transformation leads to a short
half-life, while a long half-life means a slow rate of transformation.  During one half-life, 50% of the
radioactive atoms transform; during the next half-life, 50% of the remaining radionuclide transforms, and
so on.  For example, 32P has a half-life of about 14 days.  If one starts with 100 µCi of 32P on day 1, on
day 14 there will be exactly one-half, or 50 µCi of 32P remaining.  After another 14 days pass, exactly 25
µCi of 32P will remain, and so on.  This decrease in radioactivity is illustrated in Figure 2-1.
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Half lives of the various radionuclides range from fractions of a second to billions of years.  The amount
of radioactive material is expressed in terms of activity, which is defined as the number of disintegrations
(or transformations) in the radioactive material during 1 second or 1 minute.  The traditional unit for
measurement of activity is the curie (Ci).  The curie was originally defined as the activity of 1 gram of
226Ra, which is about 3.69x1010 transformations or disintegrations per second (dps).  Now it is defined as
that quantity of radioactive material in which an average of 3.7x1010 atoms transform in 1 second.  In the
International System (SI), the unit of activity is the becquerel (Bq).  One Bq is defined as the amount of
radioactive material in which an average of 1 atom disintegrates in 1 second.
The activity of a radionuclide at time t may be calculated by the equation:
A = Aoe-0.693t/T(phys)
where A is the activity in appropriate units, such as Ci, Bq, or dps; Ao is the activity at time zero; t is the
time that has elapsed; and Tphys is the physical radioactive half-life of the radionuclide.  Tphys and t must be
in the same time units.
2.2.4 Interaction of Radiation with Matter
Radiation will interact with matter: it will lose kinetic energy to any solid, liquid, or gas through which it
passes; this occurs by several mechanisms and at different rates.  The partial or complete transfer of
energy to a medium by either electromagnetic (gamma) or particulate (alpha or beta) radiation may be
sufficient to excite electrons or to “knock out” electrons from the absorber atoms or molecules.  For those
electrons that are knocked out of the atom, the process is called ionization and is the source of the name
“ionizing radiation.”  Compared to other types of radiation that may be absorbed (e.g., ultraviolet
radiation), ionizing radiation deposits a relatively large amount of energy into a small volume of matter,
possibly resulting in harmful biological effects. 
Radiation may interact with a biological medium to cause damage either directly or indirectly.  A direct
effect occurs when an ionizing event disrupts a critical molecule (such as an enzyme, DNA, or RNA) by
knocking out an intramolecular bonding electron.  Indirect effects occur when ionized or disrupted
molecules, mainly water (since the body is about 80% water), recombine to form chemically toxic
compounds, such as hydrogen peroxide (H2O2) (Casarett and Doull 1996). Indirect effects also involve 
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free radicals.  Indirect effects occur when these radiolysis products diffuse and damage a nearby
biological molecule along their path.  Further discussion of the direct and indirect effects of radiation is
presented in Chapter 5.
Each type of radiation is also classified as to its directness (directly or indirectly ionizing) and its ionizing
density (linear energy transfer).  Radiations that produce significant ionization themselves (alpha, beta)
are called directly ionizing radiation, while those that produce minimal primary ionization (gamma, x ray,
neutron) are called indirectly ionizing radiation.  The amount of energy that the radiation transfers per
unit of path length is called its linear energy transfer (LET) and is measured in units of MeV/µm.  This
feature reflects a radiation’s ability to produce biological damage.  Radiation is classified as either high
linear energy transfer (high LET) or low linear energy transfer (low LET), based on the amount of energy
it transfers per unit path length it travels.  Alpha radiation is high LET; beta and gamma radiation are low
LET.  Alpha particles are classified as high LET radiation because their large +2 charge and relatively
large mass (about 7,200 times that of an electron) cause them to move relatively slowly and interact
strongly with any material they pass through, producing dense ionization along its path.  Beta particles,
which are energetic electrons, are classified as low LET radiation.  Even though they interact with matter
in a manner similar to alpha particles, their smaller +1 or -1 charge and smaller mass result in a greater
distance between ionizing collisions and, thus, a lower rate of energy transfer.  Gamma rays are indirectly
ionizing radiation.   Depending on its energy and the atomic number of the absorbing material, a gamma
ray photon interacts with an absorber atom by one of  three primary mechanisms (photoelectric
interaction, Compton scattering, and pair production), which results in the production of highly energetic
electrons, which dissipate their energy by interacting with other atoms in their path in exactly the same
manner as beta particles (which are electrons) and excite and ionize these atoms.  Since the ionizations
resulting from gamma radiation are due to electrons, gamma radiation is a low LET radiation.  
Both high and low LET interactions can cause significant damage to the DNA and can result in a wide
array of biological effects.  Radiation can also react with molecules other than DNA (lipids, proteins,
water, etc.) to produce free radicals, which can then go on to adversely react with the DNA molecule. 
Regardless of the method of energy transfer, DNA is the primary molecule of concern for effects from
low level radiation because DNA damage from radiation and from other sources is cumulative and can
(but does not always) result in carcinogenesis or other adverse cellular events months or years after
exposure. 
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2.2.5 Characteristics of Emitted Radiation
2.2.5.1 Alpha Radiation 
Alpha radiation has little penetrating power compared with other types of radiation. The alpha particle is
hazardous only if there is internal exposure (i.e., from a radionuclide that has been ingested, inhaled, or
otherwise absorbed internally) (see Table 2-2). 
An alpha particle is composed of two protons and two neutrons, and thus is a helium nucleus.  When a
parent radionuclide emits an alpha particle, its atomic mass number (number of protons plus neutrons)
decreases by four and its atomic number (number of protons) decreases by two, resulting in the formation
of a different element.  In nature, alpha particles come from the radioactive transformation of heavy
elements (e.g., uranium, radium, thorium, and radon) where long transformation chains produce several
successive alpha and beta particles until the resulting nuclide has a stable configuration.  A specific alpha
emitting radionuclide emits monoenergetic alpha particles of discrete energies and relative intensities,
making it possible to identify each alpha emitting radionuclide by its alpha energy spectrum. 
The alpha particle’s electrical charge of +2 and mass number of 4, both of which are larger than most
other types of radiation, cause it to interact strongly with matter.  This relatively slow-moving, highly
charged, high LET particle spends a relatively long time in the vicinity of each atom it passes; this
enables it to pull electrons easily off those atoms.  With a mass about 7,200 times that of each electron,
each interaction has only a small effect on its velocity, but the strong interaction with each atom it
encounters causes it to lose energy very quickly.  As a result of these characteristics, the alpha particle has
less penetrating power than other types of radiation.  Typically, an alpha particle cannot penetrate an
ordinary sheet of  paper.  Its range in air (the distance the charged particle travels from the point of origin
to its resting point) is approximately 3–10 cm; in biological tissue, the range decreases dramatically to
25–80 µm (see Table 2-1).  Thus, alpha particles deposit all of their energy in a small volume.  Once its
energy is expended, the alpha particle will combine with two electrons to become a helium atom, which
does not chemically react with biological material.
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Table 2-2.  Effective Half-Lives of Selected Radionuclides in Major Adult Body Organs
Half-life
Radionuclide Critical organ Physical Biological Effective
Tritium (3H) a Whole body 12.3 yr 12 d  12d
Iodine-131 (131I) Thyroid 8 d 138 d 7.6 d
Strontium-90 (90Sr) Bone 28 yr 50 yr 18 yr
Plutonium-239 (239Pu) Bone 24,400 yr 200 yr 198 yr
Lung 24,400 yr 500 yr 500
Cobalt-60 (60Co) Whole body 5.3 yr 9.5 d 9.5 d
Iron-55 (55Fe) Spleen 2.7 yr 600 d 388 d
Iron-59 (59Fe) Spleen 45.l d 600 d 41.9 d
Manganese-54 (54Mn) Liver 303 d 25 d 23 d
Cesium-137 (137Cs) Whole body 30 yr 70 d 70 d
a  Mixed in body water as tritiated water
d = days; yr = years
2.2.5.2 Beta Radiation 
A beta particle is a high-velocity electron ejected from a transforming nucleus.  This occurs when a
nuclide has a nucleus that is very unstable because it has too many or too few neutrons to stabilize the
number of protons. The particle may be either a negatively charged electron, called a negatron (β-), or a
positively charged electron, called a positron (β+).  
Beta minus or negatron (β-) transformation is a process by which a radionuclide with too many neutrons
achieves stability.  It does not stabilize by emitting an extra neutron; instead, a neutron changes into a
proton and the nucleus emits a negatron (β-) and an antineutrino (see glossary).  This nuclear transfor-
mation results in the formation of a different element with one more proton, one fewer neutron, and the
same mass number as the original nucleus.  The energy spectrum of a beta particle ranges from zero to a
specific maximum, which is a characteristic of that particular radionuclide, with the mean energy of the
beta spectrum being about one-third of the maximum.  Overexposure to negatron-emitting radionuclides
outside the body can cause more injury to the skin and superficial body tissues than alpha particles or
gamma radiation.  They are even more harmful as an internal radiation hazard when excessive amounts
are taken into the body.  
Beta positive (β+), or positron, transformation occurs when there are not enough neutrons (or too many
protons) in the nucleus.  In this case, a proton changes into a neutron and the nucleus emits a positron (β+) 
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and a neutrino (see glossary).  This nuclear transformation results in the formation of a different element
with one more neutron, one less proton, and the same atomic mass number as the original nucleus.  The
positron is a very reactive species; when sufficiently slowed through successive ionizing collisions, it will
combine with an electron.  At this point, the electron-positron pair is annihilated (their combined mass is
converted into energy in the form of two gamma ray photons of 0.51 MeV each).  The gamma radiation
resulting from the annihilation (see glossary) of the positron makes all positron-emitting isotopes more of
an external radiation hazard than pure negatron (β-) emitters of equal energy.  The neutrino in β+
transformation and the antineutrino in β- transformation are not known to produce any biological damage.
2.2.5.3 Gamma Radiation 
Gamma radiation is the main source of external radiation hazard because it is highly penetrating.
Radioactive transformation by alpha or beta emission often leaves the nucleus in an excited energy state
with some residual energy. The nucleus cannot remain in this elevated energy state indefinitely, and will
eventually release this energy and achieve ground state, or the lowest possible stable energy level.  The
energy is released in the form of gamma radiation (high-energy photons) and is equal to the change in the
energy state of the nucleus.  Gamma rays are low LET because the average distance between ionizations
is large and they liberate energetic electrons when absorbed in matter.  The liberated electrons are also
low LET.
Gamma radiation and x rays are types of electromagnetic radiations that behave identically but differ in
their origin; gamma emissions originate in the nucleus while x rays originate in the orbital electron
structure, or from the slowing down or stopping of highly energetic beta particles or electrons.  The x rays
that originate in the orbital structure are called characteristic x rays, and are useful in chemical analysis
while those due to stopping high speed electrons are called bremsstrahlung.
2.2.6 Estimation of Energy Deposition in Human Tissues
Humans can be exposed externally from radiation sources outside the body, or internally from radioactive
material deposited inside the body.  Internally deposited radioactive material is more hazardous than
external (superficial or skin) deposition. Internal exposures occur when radionuclides that have entered
the body through the inhalation, ingestion, or dermal pathways undergo radioactive transformation 
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resulting in the deposition of energy to internal cells and organs.  This radioactive material may be
eliminated quickly (hours to days) or may result in a long-term retention pattern of the radionuclide
(weeks to years).  
When radioactive material is inside a living organism, either naturally or as the result of an accidental
intake, the radioactive material is eliminated by both radioactive transformation and biological removal. 
A rate constant called the biological half-time (Tbiol) is the time required for the sum of all of the available
biological processes to eliminate one-half of the retained radioactivity.  This time is the same for both
stable and radioactive isotopes of any given element since they behave identically in the body.  The time
required for a radioactive element to be halved as a result of the combined action of radioactive
transformation and biological elimination is the effective half-time (Teff), and is described in the equation:
Teff = (Tbiol x Tphys)/(Tbiol + Tphys).
This basic equation is typically more complicated in reality because the biological half-time can differ
from one organ to another within the body.  In addition, radioactive material distributes throughout the
body and its radiations may penetrate to and expose tissues other than those in which it was deposited. 
Current internal dosimetry methods account for these multiple clearance rates and the distribution of
radioactive material in the body.  (See Table 2-2 for representative effective half-times of some
radionuclides.)
External exposures occur when the body is irradiated directly from sources located outside the body, such
as radiation from radionuclides on ground surfaces, dissolved in water, or dispersed in the air.  In general,
external exposures are from gamma-emitting radionuclides, from which the radiation readily penetrates
the skin and internal organs.  Beta and alpha radiation from external sources are far less penetrating and
deposit their energy primarily on the skin's outer layer.  High levels of beta contamination of the skin may
lead to skin burns.  However, while the skin dose from beta radiation may be very high, the beta
contribution to the total body dose from external radiation, compared to that contributed by gamma rays,
may be small.
Characterizing the radiation dose to persons or laboratory animals from external radiation is relatively
simple, but determining the dose from internal radiation is a complex issue.  However, through the use of
physiologically-based mathematical models, the dose from internal exposure can be estimated with a
sufficient degree of accuracy to establish reliable radiation safety standards. 
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2.3 FUNDAMENTALS OF IONIZING RADIATION DOSIMETRY
2.3.1 Dose Units
In radiation biology, the term “dose” refers to the amount of energy that radiation deposits in an organ or
tissue as it passes through rather than to the energy of that radiation or the quantity of radioactive material
that is present. 
Absorbed dose is the energy absorbed per unit mass of the absorber.  The traditional unit of absorbed dose
is the rad, with 1 rad  = 100 ergs of energy deposited in 1 gram = 0.01 joule of energy/kg in any irradiated
medium.  The SI unit of absorbed dose is the gray (Gy), which is equivalent to 100 rad or 1 J/kg. 
External radiation dose is obtained by multiplying the radiation dose rate (measured using instruments) by
the exposure time.  Internal radiation dose at different sites within the body can be obtained from a
knowledge of the quantity of radioactive material present; the uptake fraction and the distribution and
retention kinetics of the chemical species involved; the type, energy, and intensity of its radiations; and
the energy transfer parameters for those radiations to the tissues involved; and the radioactive half-life. 
An exposure is classified as "acute" or "chronic" depending on how long an individual or organ was
exposed to the radiation.  For internally deposited radionuclides, it is the effective half-life (which
accounts for clearance by radioactive decay and chemical elimination) which determines whether the
radiation dose is of acute, intermediate, or chronic duration.  For an acute-duration intake of a radioactive
material, a very short effective half-life results in an acute-duration radiation dose, but a very long
effective half-life results in an intermediate- or chronic-duration radiation dose.
The roentgen (R) is the unit of x ray or gamma radiation exposure related to the intensity of an x ray or
gamma radiation field, and is measured by the amount of ionization caused in air by x ray or gamma
radiation.  One roentgen produces 2.58x10-4 coulomb per kg of air.  In the case of gamma radiation, over
the commonly encountered range of photon energy, the energy deposition in tissue for an exposure of 1 R
is 0.0096 J/kg of tissue (0.96 rad) which for most purposes is about equal to 1 rad.  Thus, although the
roentgen is a unit of x ray exposure (not dose), it continues to be used for radiation safety measurements 
because an exposure of 1 R leads to a dose of approximately 1 rad.  An exposure of 1 R is considered a
dose equivalent of 1 rem (0.01 sievert).  The dose equivalent units, the rem and the sievert, are discussed 
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below in Section 2.3.3.  Health physics survey meters that are used to measure external x ray or gamma
radiation are usually calibrated in units or subunits of R (roentgens) per hour.
External doses are measured directly with radiation dosimeters or calculated from hand-held survey meter
readings as the product of the exposure time and the dose rate in rad/unit time.  Internal doses, however,
are not measured directly; they are calculated with data obtained from measurements of radiation
emissions from the body or from the radioactivity in excreta samples in counts/unit time.  The radioactive
material(s) are identified and their radiation characteristics are used to calculate the activity inside the
body in curies or becquerels.  Physiologically based biokinetic models are then used to calculate the dose
from the radioactive materials take into the body.  For radiation safety purposes and for regulatory
requirements, the dose is multiplied by the quality factor Q rem/rad, for that specific radiation to convert
rad to rem.  Special units are used to describe the concentration and exposure to radon and its progeny.
Certain types of radiation with short-lived progeny are measured in units called working levels (WL). 
The potential inhalation hazard from atmospheric radioisotopes 222Rn and 220Rn (thoron) is due to their
short-lived progeny.  The concentration of these short-lived progeny (218Po through 214 Po from 222Rn and
216Po through 212Po from 220Rn) is measured by the working level (WL).  One WL is defined as any
combination of short-lived radon daughters per L of air that will result in the emission of l.3x105 MeV of
alpha energy.  An activity concentration of 100 picocuries (pCi) of 222Rn per L of air,  in equilibrium with
its daughters, corresponds to 1 WL.  The WL unit for thoron (220Rn) daughters at 50% equilibrium is 14.8
pCi/L.  Thoron daughters in radioactive equilibrium with thoron at a concentration of 7.43 pCi/L
represents 1 WL.  The total radiation dose to radon progeny is commonly expressed in working level
months (WLM) units.  One WLM corresponds to exposure to a concentration of 1 WL for the reference
period of 170 working hours per month, or to a concentration of 0.5 WL for 340 hours, etc.
2.3.2 Dosimetry Models
Physiologically based biokinetic dosimetry models are used to estimate the dose from radioactive material
taken into the body.  The models for internal dosimetry consider the quantity of radionuclides entering the
body, the factors affecting their movement or transport through the body, the distribution and retention of
radionuclides in the body, and the energy deposited in organs and tissues from the radiation that is
emitted during spontaneous transformation processes.  The dose pattern for radioactive materials in the 
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body may be strongly influenced by the route of entry of the material.  The most frequent exposure routes
for industrial workers have been inhalation of radioactive particles with pulmonary deposition and
puncture wounds with subcutaneous deposition.  
Ingestion.    Ingestion of radioactive materials is most likely to occur from contaminated food and
water, or by eventually swallowing inhaled compounds initially deposited in the lung but transported to
the throat by the mucociliary clearance pathway.  Ingestion of an excessive amount of radioactive
material may result in toxic effects as a result of either absorption of the radionuclide from the intestine,
irradiation of the gastrointestinal tract during passage through the tract, or a combination of both.  The
fraction of radioactive material absorbed from the gastrointestinal tract is variable, depending on the
specific element, its chemical and physical form, the diet, and the individual’s own metabolic and
physiological factors.  The absorption of some elements is influenced by age, usually with higher
absorption rates in very young animals. These factors are quantitatively considered in the model that
describes the gastrointestinal tract in terms of four compartments—stomach, small intestine, upper large
intestine, and lower large intestine—and a fifth compartment that includes all the body fluids (NCRP
1988).
Inhalation.    The inhalation route is a major route of exposure for radioactive materials.  The deposition
site of particles within the lung is largely dependent upon the size of the particles being inhaled.  After the
particle is deposited, the retention will depend upon the physical and chemical properties of the dust, the
physiological status of the lung, and the site of deposition.  There are at least three distinct mechanisms
that operate simultaneously to remove or clear radioactive material from the lung.  Ciliary clearance acts
only in the upper respiratory tract (i.e., trachea and the major and minor conducting airways of the lung). 
Cilia, short hairlike filaments growing out of the lining cells of the upper respiratory tract, are covered by
the layer of mucous in the upper respiratory tract.  The cilia move in a synchronized beating motion that
pushes the mucous blanket, on which the large sized inhaled particles are deposited, upwards into the
throat.  There the particles can be coughed up or swallowed.  The second and third mechanisms,
phagocytosis and systemic absorption following dissolution of a particle, act mainly in the deep
respiratory tract.  Phagocytosis is the engulfing of foreign bodies by alveolar macrophages and their
subsequent removal either up the ciliary "escalator" or by entrance into the lymphatic system.  These
factors are considered by the biokinetic model of the respiratory tract.  This model includes four major
compartments— extra-thoracic region (nasal airways and throat), tracheo-bronchial region (windpipe and
bronchi), pulmonary region (alveolar area from which oxygen and carbon dioxide diffuse into and out of
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the blood), and pulmonary lymph node region.  Dosimetric lung models are reviewed by NCRP (1994),
James (1987, 1994) and James and Roy (1987).
Internal emitters.    When a radionuclide is ingested or inhaled, it becomes an internal emitter.  The
absorbed dose from an internally deposited radionuclide is determined by the concentration of absorbed
energy in the tissue.  Thus, the dose to an organ or tissue depends on its mass, the quantity of radioactive
material introduced into the organ, the length of time that the radioactivity remains in the organ
(represented by the effective half-life), and the energy and type of radiation.  Since alpha and beta
particles travel only short distances, all alpha particle energy and all or most beta particle energy is
absorbed in the tissue that contains the radioactive material.  Many common radionuclides also emit
gamma rays that are so penetrating that a significant number escape from that tissue and interact with
remote portions of the body, or pass out of the body entirely without interacting.  For this reason, the
gamma radiation dose to an organ considers both the dose from radioactive material in that organ plus the
exposure from the gamma emitter deposited in other organs in the body.  For a radionuclide distributed
uniformly throughout an infinitely large medium, the concentration of absorbed energy must be equal to
the concentration of energy emitted by the isotope.  An infinitely large medium may be approximated by
a tissue mass whose dimensions exceed the range of the particulate radiation.  All of the alpha radiation
(due to its very short traveling distance in biological tissue) and most of the beta radiation will be
absorbed in the organ (or tissue of reference).
2.3.3 Terms Used in Radiation Safety Practice and Regulation
The terms defined below are also included in the glossary in Chapter 9.
Absorbed dose.    The energy imparted by radiation per unit mass of irradiated material is called the
absorbed dose.  The units of absorbed dose are the rad, in traditional units, and the gray (Gy), in SI units. 
(See “Units of radiation dose” for more information on absorbed dose).
ALARA.    This acronym for “As Low As is Reasonably Achievable” refers to the practice of making
every effort to keep exposure to radiation as far below the dose limit as possible while still achieving the
purpose for which the radiation is intended to be used.  It takes into account the state of technology, the
economics of improvements in relation to state of technology, the economics of improvements in relation 
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to benefits to the public health and safety, and other societal and socioeconomic considerations.  In
addition, ALARA is applied to the utilization of nuclear energy and licensed materials in the public interest.
ALI.    This acronym for “Annual Limit on Intake” is the derived limit for the amount of radioactive
material taken into the body of an adult worker by inhalation or ingestion in a year.  For a given
radionuclide, ALI is defined as the smaller of the intakes that would result in a committed effective dose
equivalent of 5 rem (0.05 Sv) or a committed dose equivalent of 50 rem (0.5 Sv) to any individual organ
or tissue.  Committed dose equivalent is the total dose equivalent that radioactive material internalized in
a particular year will deliver to the body in that and all subsequent years out to 50 years after the intake. 
For radionuclides with effective half-lives of a month or less, essentially all the radiation dose will be
delivered in the same year as the radioactive material intake, and the committed dose equivalent equals
the dose equivalent received that year.  However, radionuclides with longer half-lives remain in and
expose the body for more than 1 year, and the committed dose equivalent accounts for this by summing
the estimated dose equivalents produced by the radioactive material during the current year and every
year out to 50 years.
Dose equivalent (H).    The dose equivalent is used in radiation safety dosimetry to account for
differences in biological effectiveness among the various radiations.  The same energy imparted
(absorbed dose) may result in different levels of biological effects for α, β, and γ rays.  To account for the
differences in biological effectiveness, a normalizing factor is used.  The normalizing factor (Q) is used as
a multiplier of the radiation absorbed dose (D) to give the dose equivalent.  The dose equivalent,
symbolized by H, is expressed in units of rem in the traditional system of units and in sievert (Sv) units in
the SI (international) measuring system (100 rem = 1 sievert).  This relationship is expressed as
H = D×Q
Effective dose equivalent (HE).      The effective dose equivalent is used for radiation safety purposes
and for regulatory purposes to account for the relative susceptibility of the various organs and tissues to
radiation-induced non-deterministic or stochastic effects (principally cancer) in cases of non-uniform
irradiation.  The basis for the effective dose equivalent concept is that the probability of a non-
deterministic effect from non-uniform irradiation should be equal to that due to uniform whole body
irradiation.  The effective dose equivalent is found by multiplying the dose equivalent (HT) to each
irradiated tissue or organ by a tissue weighting factor, WT, and then summing these products for all the
irradiated tissues, as shown in the equation
HE = G(WT×HT)
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WT represents the fraction of the probability of a non-deterministic effect resulting from irradiation of that
tissue to the total probability of a non-deterministic effect when the whole body is uniformly irradiated. 
The values for WT used by the USNRC and ICRP are listed below in Table 2-3.
For occupational exposure, the USNRC specifies an upper limit of 5 rem (0.05 Sv) in 1 year for the
effective dose equivalent.  The regulations also specify an upper annual limit of 50 rem (0.5 Sv) for all
organs and tissues except the lens of the eye, for which an annual maximum of 15 rem (0.15 Sv) is
prescribed.
Table 2-3.  Tissue Weighting Factors Used by the USNRC and ICRP to Calculate 
Effective Dose
Tissue USNRC Weighting factor
for Effective Dose Equivalent
(ICRP 1977; USNRC 1997a)
ICRP Weighting factor
for Effective Dose
(ICRP 1991)
Whole body 1.00 a –
Gonads 0.25 0.20
Breast 0.15 0.05
Red bone marrow 0.12 0.12
Lung 0.12 0.12
Thyroid 0.03 0.05
Bone surface 0.03 0.01
Colon – 0.12
Stomach – 0.12
Bladder – 0.05
Liver – 0.05
Esophagus – 0.05
Skin – 0.01
Remainder 0.30 b 0.05
aThe whole body weighting factor was introduced by the USNRC and is not addressed by either the ICRP or the
NCRP.
b0.30 results from 0.06 being assigned to each of the five remaining organs (excluding the skin and lens of the eye)
that receive the highest doses.
External dose.    Radiation dose from a radiation source originating from outside of the body.
Health physics.  Health physics is the science concerned with recognition, evaluation, and control of
health hazards from ionizing and non-ionizing radiation.  Health physics covers environmental,
occupational, and medical areas, and includes radiobiology and the study of mechanisms of health effects. 
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The scientific and engineering aspects of health physics deal with the measurement of radiation and
radioactivity, the establishment of dose-response relationships for radiation exposure, movement of
radioactivity through the body and the environment, the design of radiologically safe processes and
equipment, and the maintenance of a radiologically safe environment.  The health physicist is the
professional who deals with radiation safety.
Internal dose.    Radiation dose from radioactive material inside the body.
Quality factor (Q).  For health physics purposes, a normalizing factor, called the quality factor (Q), is
applied to the radiation absorbed dose to account for the relative biological effectiveness (RBE) of the
different radiations.  The numerical values for the quality factors are determined by a committee of
experts, and are based on a conservative upper limit of the RBE for the biological effect believed to be of
the greatest interest to humans.  Values for Q that are used in the USNRC safety standards in the Code of
Federal Regulations (CFR) 10, Part 20, are listed below in Table 2-4.
Table 2-4.  Quality Factors Used in USNRC Radiation Safety Regulations
Type of radiation Quality factor (Q)
Alpha particles, multiple charged particles, fission fragments, and heavy charged
particles
20
x rays, gamma rays, electrons, negatrons, or positrons 1
Thermal neutrons 2
Fast neutrons, neutrons of unknown energy, or high-energy protons 10
  Source: USNRC 1997a 
Relative biological effectiveness (RBE).  The toxicity of a given absorbed radiation dose depends
on the LET of the radiation: the higher the LET, the more toxic is the radiation and the smaller is the dose
needed to produce a specific biological end point.  To account for this LET effect, radiobiologists use the
term relative biological effectiveness (RBE).  The RBE for any radiation is typically defined as the ratio
of the dose from 200 keV x rays required for a given biological effect to the dose that would produce the
same effect with that radiation.  RBEs can also be defined for specific scenarios that compare the effects
of different radiation types or energies on producing the same end point.  The term RBE is restricted in
application to radiobiology.  
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Units of radioactive material.  The following two units of radioactivity are commonly used when
describing the quantity of radioactivity:
Becquerel (Bq).   The SI unit of measure for radioactive material; one becquerel equals that
quantity of radioactive material in which one atom disintegrates in one second.
Curie (Ci).  The conventional unit used to measure the quantity of radioactive material.  The curie
is equal to that quantity of radioactive material in which 37 billion atoms transform per second. 
This is approximately the activity of 1 g of radium.  
Units of radiation dose.    The International Commission on Radiation Units and Measurements
(ICRU 1980), International Commission on Radiological Protection (ICRP 1984), and National Council
on Radiation Protection and Measurements (NCRP 1985) now recommend that the traditional units: rad,
roentgen, curie, and rem be replaced by the SI units: gray (Gy), coulomb per kilogram (C/kg), becquerel
(Bq), and sievert (Sv), respectively.  However, the regulations used in the United States are written with
the traditional units or with both traditional and SI units.  The following four dosimetric units are
commonly used:
Gray (Gy).  The SI unit of absorbed dose.  One gray  = 1 J/kg = 100 rad.
Rad.  The unit of absorbed dose.  One rad = 100 erg/g = 0.01 Gy.
Sievert (Sv).  The SI unit of dose equivalent, equal to absorbed dose in  gray multiplied by the
quality factor.  One Sv = 100 rem.
Rem.  The conventional unit of dose equivalent.  One rem = 0.01 Sv.
The relationship between the traditional units and the international system of units (SI) for radiological
quantities is shown in Table 2-5.
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Table 2-5.  Common and SI Units for Radiation Quantities
Quantity Traditional units SI units Relationship
Activity (A) curie (Ci) becquerel (Bq) 1 Ci = 3.7x1010 Bq
1 Bq = 1 dps, 1 S-1
Absorbed dose (D) rad gray (Gy) 1 rad = 0.01 Gy
1 Gy = 1 Jkg-1
Dose equivalent (H) rem sievert (Sv) 1 rem = 0.01 Sv
1 Sv = 1 Jkg-1
dps = transformations per second; Jkg-1 = Joules per kilogram; S-1 = per second
Source:  Shleien 1992
Weighting factor (WT).     This factor is used for radiation safety purposes to account for the different
sensitivities of the various organs and tissues to the induction of non-deterministic radiation effects.
Other terms used in discussions of radiation protection and regulation include: bioassay, collective dose,
embryo/fetus, eye dose equivalent, public dose, shallow dose equivalent, total effective dose equivalent,
whole body, and working level.  These terms and their definitions may be found in Chapter 9.
2.4 BIOLOGICAL EFFECTS OF RADIATION
Radiation interactions within the body produce microscopic subcellular-level effects that may result in
cellular responses and, in the aggregate, may ultimately produce macroscopically observable effects on
specific organs or tissues, such as the skin, eye lenses, and thyroid. 
Irradiation of biological tissue sets into motion a series of intracellular biochemical events that start with
ionization of a molecule, and which may ultimately lead to cellular injury.  Injury to a large number of
cells may, in turn, lead to further injury to the organ and to the organism.    Many factors may modify the
response of a living organism to a given dose of radiation.  Factors related to the dose include the dose
rate, the energy and type of radiation, and the temporal pattern of the exposure.  Biological factors include
species, age, sex, the portion of the body tissues exposed, and repair mechanisms.  A generally applicable
rule of thumb is the Law of Bergonie3 and Tribondeau, based on their research in 1906, which states that
cells are sensitive to radiation damage if they have a high mitotic rate, a long mitotic cycle, and are not
specialized (undifferentiated) (Casarett and Alison 1968).  In addition, the concurrent exposure to 
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radiation and other substances may result in antagonistic, additive, or synergistic effects, such as the
synergism between ionizing and ultraviolet radiation to produce skin cancer.
The DNA is considered to be the primary target molecule for radiation toxicity.  Molecular damage,
which includes damage to the DNA, can occur in one of two ways from an exposure to radiation.  First,
radiation can interact directly with the DNA, resulting in single or double-strand DNA breaks or
unbonding base pairs.  Second, radiations can interact directly with other surrounding molecules within or
outside of the cell, such as water, to produce free radicals and active oxygen species.  These reactive
molecules, in turn, interact with the DNA and/or other molecules within the cell (cell membranes,
mitochondria, lipids, proteins, etc.) to produce a wide range of damage at the cellular and tissue levels of
the organism.  High LET radiation is an efficient producer of free radicals and H2O2, both of which can
act directly on macromolecules.  About 66% of the damage from low LET radiation and about 50% of the
damage from high LET radiation comes from aqueous radiolytic products.
Regardless of how the DNA is damaged, the mammalian body has remarkable abilities to repair its
damaged DNA.  Mammalian DNA repair schemes, classified as either direct or indirect repair
mechanisms, include many mechanisms such as nucleotide excision (via endonuclease), base excision
(via DNA glycosylase), and mismatch repair.  The success or failures of these inherent DNA repair
systems depend on many factors, such as the dose and dose rate of radiation received and the tissue that
received the radiation.  Depending on the dose and the tissue exposed, inherent DNA repair mechanisms
may be highly successful, resulting in total repair of the DNA.  These mechanisms may fail completely if
the repair mechanism is overwhelmed with very high doses of radiation, or may fail to repair all of the
DNA damage caused by lower doses of radiation.  This failure can result in necrosis due to cell death,
apoptosis (programmed cell death), altered cell function, or the development of neoplastic cells several
years after the damage occurred.  DNA repair systems may be able to adequately repair the radiation
damage to the DNA itself, but may do nothing to protect the irradiated cell from damage to other cellular
structures (membranes, mitochondria, etc.) by the radiation (Zajtchuk 1989).  Other repair mechanisms
must be employed to protect the cell against these injuries.
Several protective strategies are used to minimize the damage from free radicals and reactive oxygen
species that occur in cells exposed to high acute doses of radiation.  Some of these methods include
hypoxia (protective at high dose; can be observed for cell killing at doses >1 Gy), which decreases the 
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amount of oxygen available to form such reactive species; hypothermia; the use of free radical scavenging
agents (aminothiols, vitamins A, E, and C); and eicosanoids.  These methods have been used in special
cases, such as in radiation therapy of tumors, to protect the surrounding healthy tissue.  Genetic methods
(repair by hydrogen transfer, regeneration) are also being investigated (Zajtchuk 1989).
The study of the mechanisms by which radiation exerts its toxicological effects is an important and
constantly evolving field of toxicology.  More information on the mechanisms of action of radiation can
be found in Chapter 5 of this toxicological profile.  Several excellent reviews of the biological effects of
radiation have been published, and the reader is referred to these for a more in-depth discussion (BEIR V
1990; ICRP 1984; Kondo 1993; Rubin and Casarett 1968).  A general overview of the health effects of
alpha, beta, and gamma types of radiation in some types of biological tissue is presented below; more in-
depth information on the health effects of radiation is presented in Chapters 3 and 5 of this toxicological
profile (UNSCEAR 1993).
2.4.1 Radiation Effects at the Cellular Level
According to Mettler and Moseley (1985), at acute doses up to 10 rad (0.1 Gy), single-strand breaks in
DNA may be produced.  These single-strand breaks may be repaired rapidly.  With doses in the range of
50 to 500 rad (0.5–5 Gy), irreparable double-strand DNA breaks are likely, resulting in cellular
reproductive death after one or more divisions of the irradiated cell.  At large doses of radiation, usually
greater than 500 rad (5 Gy), direct cell death before division (interphase death) may occur from the direct
interaction of free radicals with essential cellular macromolecules.  Morphological changes at the cellular
level, the severity of which is dose-dependent, may also be observed at this dose level.  Specific clinical
symptoms and other health effects associated with different doses of radiation are discussed in Chapter 3
of this profile.
The sensitivity of various cell types within an organism may vary widely, depending on specific cell and
tissue characteristics.  According to the Law of Bergonie and Tribondeau, the sensitivity of cell lines is
directly proportional to their mitotic rate and inversely proportional to the degree of differentiation
(Mettler and Moseley 1985; Rubin and Casarett 1968).  This means that cells that undergo frequent
mitosis under normal physiologic circumstances or are not well-differentiated in histologic cell-type
characteristics will tend to be more susceptible to the effects of radiation than those cells in which the
converse is true.  Rubin and Casarett (1968) devised a classification system that categorized cells 
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according to type, function, and mitotic activity.  The five categories range from the most sensitive type,
"vegetative intermitotic cells," found in the stem cells of the bone marrow and the gastrointestinal tract, to
the least sensitive cell type, "fixed postmitotic cells," found in striated muscles or long-lived neural
tissues.  This classification system is shown in Table 2-6.
Cellular changes in susceptible cell types may result in cell death; extensive cell death may produce
irreversible damage to an organ or tissue, or may result in the death of the individual.  If the cells recover,
altered metabolism and function may be the ultimate sequelae, and the damage imposed may be repaired
to a normal state, produce some characteristic manifestation of clinical symptoms, or result in apoptosis
(programmed cell death).  If the cells are adequately repaired and relatively normal function is restored,
the more subtle DNA alterations may also be expressed at a later time as mutations and/or tumors.  More
information on the genetic effects of radiation is presented in Chapter 5 of this profile.
Table 2-6.  Relative Radiosensitivity of Mammalian Cells
Class Category Characteristics Cell types
I Vegetative intermitotic cells Rapidly dividing, short-lived; daughter
cells  will either differentiate or form
more cells like the parent cell
Hemocytoblast, lymphoblast,
erythroblast, myelobalst,
primitive intestinal crypt cell, type
A spermatogonia, primitive
oogonia, lymphocytes
II Differentiated intermitotic
cells
Somewhat less radiosensitive than
Class I cells; rapid proliferation rates,
but daughter cells become more
radioresistant than the parent cell
Type B spermatogonia, oogonia,
cells of the intermediate stages
of erythropoiesis and
myelopoiesis
III Multipotential connective
tissue cells
Cells divide regularly in response to
injury and irritation
Endothelium, fibroblast,
mesenchymal cells.
IV Reverting postmitotic cells Normally do not undergo cell division Epithelial cells of salivary glands,
liver, kidney, pancreas, lung;
parenchymal cells of sweat
glands and endocrine glands. 
Interstitial cells of testis and
ovary
V Fixed postmitotic cells Cells that will not divide; highly
radioresistant
Mature nerve cells, muscle cells,
sperm, erythrocytes.
Source:  Sanders and Kathren 1983
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2.4.2 Radiation Effects at the Organ Level
In most organs and tissues, the injury and the underlying mechanism for that injury are complex and
involve a combination of events.  The extent and severity of this tissue injury depend on the dose and the
radiosensitivity of the various cell types in that organ system.  Rubin and Casarett (1968) describe and
schematically display the events following radiation in several organ system types.  These include: a rapid
renewal system, such as the gastrointestinal mucous; a slow renewal system, such as the pulmonary
epithelium; and a nonrenewable system, such as neural or muscle tissue.  In the rapid renewal system,
organ injury results from the direct destruction of highly radiosensitive cells, such as the stem cells in the
bone marrow.  Injury may also result from constriction of the microcirculation and from edema and
inflammation of the basement membrane, which is called the histohematic barrier (HHB); the injury may
progress to fibrosis.  In slow renewal and nonrenewable systems, the radiation may have little effect on
the parenchymal cells, but ultimate parenchymal atrophy and death over several months may result from
HHB fibrosis and occlusion of the microcirculation.
2.4.3 Acute and Delayed Somatic Effects
2.4.3.1 Acute Effects
The result of acute overexposure to radiation is commonly referred to as Acute Radiation Syndrome
(ARS).  This effect is seen only after whole-body exposures to relatively high doses (>100 rad,  >1.0 Gy)
such as might occur in a serious nuclear accident, close to a nuclear weapon detonation, or after a period
of exposure to the high radiation field of irradiator sources, such as occurred to Chernobyl on-site
responders and individuals in Goiania, Brazil (see Chapter 4).  The four stages of ARS are prodrome (or
initial), latent stage, manifest illness stage, and recovery or death. The probability of the prodromal phase
is characterized by nausea, vomiting, malaise and fatigue, increased temperature, and blood changes.  The
latent stage is similar to an incubation period.  Subjective symptoms may subside, but changes may be
taking place within the blood-forming organs and elsewhere that will subsequently give rise to the next
stage.  The manifest illness stage gives rise to signs and symptoms specifically associated with the
radiation injury:  hair loss, fever, infection, hemorrhage, severe diarrhea, prostration, disorientation, and
cardiovascular collapse.  Convulsions are possible at extremely high doses.  The severity and time of
onset of the signs and symptoms depend upon the radiation dose received (see Chapter 3), with the time
of onset decreasing with increasing dose.  
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2.4.3.2 Delayed Effects
The level of exposure to radiation and radioactive materials that may be encountered in the environment, 
even large exposures spread over a long enough period of time, is expected to be too low to result in the
acute effects described above.  Occupational and medical radiation may produce long-term effects that
manifest themselves years after the original exposure and may be due to a single elevated exposure or a
continuous low-level exposure.
Exposure to radiation has resulted in a number of adverse health effects.  The rapidly dividing cells in the
developing fetus put it at a higher risk of the adverse biological effects of radiation than a post-partum
child, who in turn is more radiosensitive than an adult.  External alpha (because it is non-penetrating) and
beta radiation are of little concern due to the protection afforded by the mother’s body tissues and the
placental sac; however, gamma radiation can provide a more uniform exposure to the fetus.  Analysis of
the human data from the children exposed in utero by the bombing of Hiroshima and Nagasaki suggests
that the cells of the developing central nervous system are the cells most sensitive to the effects of
radiation in the developing human fetus.  The major clinical effect on these susceptible cells is impaired
intelligence and mental retardation that is observed during childhood development, mainly for those
fetuses exposed to doses of radiation during weeks 8–15 after conception.  A “no observable effect”
threshold exists for doses in the range of 20–40 rad (0.2–0.4 Gy); at a dose of 100 rad (1 Gy), the
frequency of observed mental retardation was 43% (BEIR V 1990).  
The lens of the eye is also susceptible to the effects of radiation. Sufficient exposure of the lens to
radiation  results in cataract formation, ranging from mild visual impairment to blindness.  The lens fibers
are normally transparent and function in focusing light entering from the pupil onto the retina; however,
after exposure to large doses of radiation, these cells fail to divide to produce lens fibers of the
appropriate length or transparency.  This results in increased opacity of the crystalline lens of the eye
(cataracts).  Cataracts have been induced by as little as 200 rad (2 Gy) of acute gamma or x ray exposure
of the eye (Adams and Wilson 1993), but 500 rad (5 Gy) is required when fractionated over 5 weeks. 
Chronic occupational exposures to 70–100 rad (0.7–1.0 Gy) of gamma and x ray radiation have not
caused cataracts, and the higher doses at which they have been observed require the dose to be delivered
at a threshold dose rate of greater than 15 rad/yr (0.15 Gy/yr) (UNSCEAR 1993; NRC 1990).  Data from
victims exposed to large doses of radiation after the bombings of Hiroshima and Nagasaki give a cataract
threshold of 60–150 rad (0.6–1.5 Gy); however, typical human exposure over a long period of time is
thought to have a threshold greater than 800 rad (8 Gy) (BEIR V 1990).  This is an established example of
a radiation effects threshold that does not follow the standard linear, no-threshold theory that is applied 
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only to non-deterministic effects (cancer).  This observation may mean that the effect on the lenses is
actually below an effects threshold, or it could mean that the latency period for developing the effect is
longer than the current human life span.
Sufficient evidence exists from high dose studies of both human populations and laboratory animals to
establish that radiation can be carcinogenic and that the incidence of cancer increases with the dose of
radiation.  Human data are extensive and include epidemiological studies of atomic bomb survivors, many
types of radiation-treated patients, underground miners, and radium dial painters.  Reports on the
survivors of the atomic bomb explosions at Hiroshima and Nagasaki, Japan (with whole-body external
radiation doses  up to 200 rad [2 Gy]), indicate that cancer mortality has increased in that exposed
population compared to control (non-exposed) individuals (BEIR V 1990; Kato and Schull 1982; NCRP
1990b,1993; NRC 1990; UNSCEAR 1993).  The use of x rays (at doses of approximately 100 rad [1 Gy])
in the medical treatment for ankylosing spondylitis and other non-cancerous conditions, and for
diagnostic purposes has resulted in excess cancers in the irradiated organs (BEIR 1980, 1990; UNSCEAR
1977, 1988).  Leukemia has been observed in children exposed in utero to doses of 0.2 to 20 rad
(0.02–0.2 Gy) (BEIR 1980, 1990; UNSCEAR 1977, 1988).  The medical use of Thorotrast (colloidal
thorium dioxide) resulted in increases in the incidence of cancers of the liver, bone, and lung (ATSDR
1990b; BEIR 1980, 1990).  Occupational exposure to radiation provides further evidence of the ability of
radiation to cause cancer.  Numerous studies of underground miners exposed to radon and radon
daughters (which are α emitters),  in combination with silica dust, diesel fumes, and other potential
toxicants in uranium and other hard rock mines, have demonstrated increases in lung cancer in exposed
workers, especially smokers (Harley 1990b, 1996c).  Workers who ingested 226Ra while painting watch
dials had an increased incidence of osteogenic sarcoma (ATSDR 1990d).  Animal studies indicate that,
depending on the radiation dose and the exposure schedule, radiation can induce cancer in nearly any
tissue or organ in the body.  However, radiation has not been shown to cause cancer of the prostate,
uterus, testis, and mesentery in humans (Sanders and Kathren 1983).  Radiation-induced cancers in
humans are found to occur in the hemopoietic system, lung, thyroid, hepatic, bone, skin, and many other
tissues.
The effects of sex, age, smoking, and other susceptibility factors have also been reviewed (BEIR V 1990). 
Generally, cancer rates after exposure to radiation are age-dependent and increase with age.  The effect of
smoking on lung cancer incidences in those individuals who also have prolonged exposure to inhaled
alpha emitters indicates a multiplicative risk (or near multiplicative risk); however, this may not be the
case for acute exposures to x rays or gamma rays.  In contrast, the data on lung cancer and smoking in the
Japanese atomic bomb survivors indicate an additive risk (no interaction between radiation and smoking). 
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It is not presently clear how a person’s sex influences cancer rates.  Males appear to be more susceptible
to lung and non-sex-specific cancers than are females; however, this may be related to the male’s
increased exposure to carcinogens and promoting agents in occupational situations, as well as a number of
lifestyle factors, and not necessarily due to increased radiation dose.
Laboratory animal data show that high doses of radiation are carcinogenic and mutagenic, and can result
in cell lethality.  These effects are not seen at low doses.  This raises a question about the relationship
between high and low doses.  There is uncertainty regarding the shape of the dose response curve with
regard to extrapolating from high-dose effects to effects of low doses or doses received over protracted
periods of time, where no effects have been seen.  If the dose-response relationship is assumed to be
linear all the way down to zero dose, then a proportional decrease in the incidence of the effect being
measured (cancer, reciprocal chromosome translocations, locus mutations, life-span shortening, etc.) 
would be expected as the dose or dose rate of radiation decreases.  However, in laboratory studies with
high doses, a dose rate effect was found.  That is, an acute-duration exposure delivered over several days
required a higher dose to produce a given effect than if delivered within hours.  To account for this, a
compensation factor or Dose Rate Effectiveness Factor (DREF) can be incorporated into the dose
response models to extrapolate cancer risk from high to low doses or low dose rates.  For low LET
radiation, DREF factors from 2 to 10 have been suggested, with a DREF of 2.5 for human leukemia. 
Assumptions about DREF are largely based on laboratory animal data.  A comprehensive discussion of
radiation-induced cancer is found in BEIR IV (1988), BEIR V (1990), and UNSCEAR (1988) and in
Chapters 3 and 5 of this toxicological profile.
Lifetime radioactive material feeding studies using Beagle dogs indicate that radiation effects may be
viewed from a perspective of life-span shortening which is linear with dose rate rather than with dose. 
Time-to-death plots as a function of dose rate show three separate sections, representing mortality from
acute radiation syndrome, cancer, and old age, each with separate linear slopes that intersect at points of
equal competing causes of death.  At extreme dose rates, death is caused exclusively by acute radiation
syndrome, with time-to-death increasing with a steep linear slope as the dose rate decreases.  At a low
enough dose rate, cancer replaces ARS as the primary cause of death, and the time to death curve assumes
a shallower slope.  At a low enough dose rate, cancer deaths are replaced by the limit of the normal life
span (Raabi 1993, 1996).
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2.4.4 Genetic Effects
All genes have a natural and spontaneous mutation rate, but radiation can induce additional genetic
damage, such as gene mutations and a variety of chromosomal aberrations, by causing changes in the
structure, number, or genetic content of chromosomes in the cell nucleus.  Radiation increases the
mutation rate.  No new types of mutations are known to be produced by radiation. The evidence for the
mutagenicity of radiation is derived from studies in laboratory animals, primarily mice (BEIR 1980, 1988,
1990; UNSCEAR 1982, 1986, 1988, 1993).  Evidence for genetic effects in humans is derived from tissue
cultures of human lymphocytes from persons exposed to ingested or inhaled radionuclides (ATSDR
1990d, 1990e).  Evidence for mutagenesis in human germ cells (cells of the ovaries or testis) is not
conclusive (BEIR 1980, 1988, 1990; UNSCEAR 1977, 1986, 1988,1993).  Chromosome aberrations
following radiation exposure have been demonstrated in humans and in experimental animals (BEIR
1980, 1988, 1990; UNSCEAR 1982, 1986, 1988,1993).   This finding is not thought to be in conflict with
results of animal studies that indicate induction of mutations by radiation; instead, the finding may result
from the difficulty of demonstrating a slight increase of effects of this type in a human population
(UNSCEAR 1993).  However, no genetic effects have been observed in any human population exposed to
any radiation at any dose level.  An important source of data on genetic effects in humans are Japanese
survivors of the atomic bombs and their offspring.  More information on the genetic effects of radiation
can be found in Chapters 3 and 5 of this toxicological profile.  
2.4.5 Teratogenic Effects
There is sufficient evidence from x ray and gamma ray studies to suggest that some forms of radiation
produce teratogenic effects in animals.  Rapidly multiplying cells tend to be more sensitive to the adverse
effects of radiation than slowly multiplying cells.  Leukemia and other childhood cancers are the principle
effects of in utero exposure at low doses (<100 rad [<1 Gy]).  It appears that the developing fetus is more
sensitive to radiation than the mother and is most sensitive to radiation-induced damage during the early
stages of organ development (first trimester) due to the rapid cellular proliferations occurring at that time. 
The type of malformation depends on the stage of development and the cells that are undergoing the most
rapid differentiation at the time.  Studies of mental retardation, intelligence reduction, microcephaly, and
growth retardation in children exposed in utero to high doses of radiation from the atomic bombs at
Hiroshima and Nagasaki provide evidence that radiation can produce teratogenic effects in human fetuses
if delivered in large enough doses during weeks 8 through 25 after conception (Otake and Schull 1984;
Zajtchuk 1989).  The damage to the child was found to be related to the dose that the fetus received in
utero.  In addition, numerous studies have been conducted on the carcinogenicity of in utero irradiation, 
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and some appear to indicate that in utero exposure may produce a larger cancer risk per unit dose than
postnatal irradiation (NCRP 1995).  Chapters 3 and 8 contain more information on the teratogenic effects
of radiation.
2.4.6 Internal Exposure to Ionizing Radiation
For the purposes of this profile, internal exposure is defined as the energy deposited in the body by the
transformation of radioactive material that is inside the body.  The pathways by which radioactive
materials enter the body include inhalation, ingestion, dermal absorption, and injection.  The material’s
solubility and chemical nature, and not its radioactive properties, determine the degree to which the
material will stay in one place or redistribute throughout the body.  Thus, the internal radiation dose is
determined from the types and energies of emitted radiation, the rates of radioactive transformation and
biological elimination, and the distribution of the material throughout the body.  The dose to one part of
the body is the sum of the doses to that part from radiation emitted from all other organs and tissues that
contain the radionuclide.
2.4.6.1 Inhalation
Inhalation is an important route by which internal exposure to radionuclides can occur.  Many of the
inhalation studies discussed in Chapter 3 are further indexed by no-observed-adverse-effect level
(NOAEL) and lowest-observed-adverse-effect level (LOAEL) in Chapter 8 of this toxicological profile. 
The total absorbed radiation dose to a specific site, such as the lungs and any surrounding structures, is
dependent on the physicochemical characteristics of the radioactive element, the molecule in which it is
present, or the particle to which the radioactive element is bound or incorporated when deposited in the
respiratory tract.  In many of the studies reported in Chapters 3 and 8 of this profile, laboratory animals
were exposed to a radionuclide that was bound to a particle of some type.  The radionuclide “piggy-
backing” on that particle was inhaled, the initial lung burden was determined, and the health effects on the
animal observed over a period of days or over its lifespan.  Particle kinetics are a major determinant in the
size of the total absorbed radiation dose that lung tissue and other tissues and organs receive from inhaled
radioactive material.  Several excellent reviews are available that discuss the deposition and clearance of
inhaled particles in humans and in laboratory animals (Gore and Patrick 1978; Lippmann and Esch 1988;
Lippman and Schlesinger 1984; Schlesinger 1989; Snipes 1989; Stahlhofen et al. 1980, 1981).  A brief
review is presented below.  Internal radionuclide exposures may occur from direct medical administration
for diagnosis or treatment of disease, or from passive inhalation of radionuclides that are present in
normal breathing air.
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Particle deposition and clearance mechanisms in the respiratory tract are complex.  The patterns of
deposition and clearance differ among animal species, but some generalities have been reported (Snipes
1989).  As a rule of thumb, the larger the particle inhaled, the more likely that particle will be deposited in
the upper airways (nasal tract and upper conducting airways); the smaller the particle, the more likely that
alveolar and deep penetration of the particle into the lung will occur, regardless of the particle's solubility. 
Particles that are soluble in the lung fluid milieu generally have shorter residence times or biological half-
lives than those that are insoluble in lung fluid.  These concepts are important when considering inhaled
radioactive particles.  For example, particles that are 3 µm in diameter and that are also insoluble (such as
fused aluminosilicate particles [FAP]) containing a radionuclide such as 144Ce are likely to be largely
deposited deep in the lung (bronchioles and alveoli).  Retention of particles deep within the lung may be
due to a number of factors, including the lack of cilia and less mucous in the smaller airways than in
larger airways (trachea and bronchi) (Snipes et al. 1996).  These insoluble particles are also likely to be
cleared slowly from the respiratory tract over a period of several months or years, thereby subjecting the
tissues around that particle to long-term exposure to radiation.  On the other hand, particles that are very
large (10–12 µm and above) may not reach the deep lung and will either lodge in the nasal cavity or be
cleared by mucociliary clearance from the conducting airways, resulting in a low radiation dose to the
respiratory tract (but may increase the dose to the gastrointestinal tract or nasal passages).  Soluble
particles will dissolve, releasing the material into the surrounding tissue, where it will behave toxico-
kinetically like its nonradioactive counterpart.  Leaching of radionuclides from insoluble particles has
also been reported to occur.  
Factors that influence particle clearance include:  (1) particle characteristics, such as geometric size,
shape, density, hygroscopicity, and electrical charge; (2) respiratory tract characteristics, such as the
individual airway caliber, branching patterns of the conducting (tracheobronchial) airway tree, and the
path length to the terminal airways, all of which contribute further to the disposition of particles in the
respiratory tract; (3) mode of breathing (oral, nasal, oronasal), respiratory rate, tidal volume, interlobular
distribution of ventilated air, length of respiratory pauses, etc; and (4) other factors (lung disease, age of
the animal, irritant exposure, etc.) which also play significant roles in how long a particle remains lodged
in the respiratory tract.  Several natural body mechanisms function to clear the respiratory tract of these
foreign bodies.  Such mechanisms include sneezing, coughing, mucociliary transport, dissolution (for
highly as well as slightly soluble particles), and removal by macrophages; these decrease the particle
residence time in the respiratory tract, thereby decreasing the total radiation dose to the tissues
(Schlesinger 1989).  Deposition and clearance mechanisms are important factors influencing radiation
dose from a radionuclide to lung tissue and in relating that dose to a corresponding health-related effect.  
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2.4.6.2 Ingestion
Oral exposure to radionuclides may occur with the ingestion of contaminated food or water.  There is
little literature available that describes the toxicity of ingested radioactivity in humans.  The main source
of information on oral toxicity of a radionuclide is the experience of the radium dial painters who "tipped"
their paint brushes with their lips and/or tongues, subsequently ingesting radioactive radium.  The radium
in the paint contained both the long-lived 226Ra and the shorter-lived 228Ra isotopes.  Some of these
exposed individuals later developed bone sarcomas and head carcinomas that appeared from 5 to 50 years
after their first exposure to these isotopes (Mays 1988; Spiess and Mays 1970).  On the other hand,
millions of people have been given individual administrations of 200–500 MBq (5–14 mCi) of
radioiodine orally to aid in the diagnosis of thyroid disorders, with no apparent harmful effects.  Although
a number of radionuclides are in widespread use, the use of 131I to treat thyroid conditions predominates
worldwide, and radiopharmaceuticals administered by various routes currently produce an estimated
population dose of 930,000 man-rem/yr (9,300 man-Sv/yr) (UNSCEAR 1993).  
For most radionuclides present at chemical waste sites containing low-levels of radioactive isotopes, oral
exposure is not a major route of exposure; however, the oral exposure route cannot be disregarded
because of the potential for groundwater contamination, consumption of animals that have ingested
radioactive compounds in their diet, and uptake by plants following erosion of ground cover from a
contaminated site.
2.4.6.3 Dermal
Dermal exposure to radionuclides is a minor route of exposure at low-level radioactive waste sites. 
Swimming or bathing in water containing soluble radioactive compounds in the water itself or water-
insoluble radioactive compounds in sediment or sludge are potential sources of dermal exposure in highly
contaminated areas.  Contact with tritiated water is another situation in which skin absorption of a
radionuclide can be significant.  Depending on the specific physical properties of the radionuclide that
may reside on the skin, the percutaneous absorption of radionuclides from particles is usually negligible
(especially if the skin is thoroughly washed immediately following exposure), with long-term biological
effects being demonstrated locally at the level of the dermis (and its vasculature) and epidermis; however,
these effects depend greatly on the size of the dose and length of exposure.  More soluble forms of the
radionuclides may result in a small percentage of the nuclide being absorbed if it was not removed from
the skin's surface.  This absorption may, in turn, affect tissues other than the skin.  
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2.4.7 External Exposure to Ionizing Radiation
External radiation is also a major source of exposure to radiation.  External radiation is defined here as
radiation exposure from a radioactive source that is outside of the body.  Common natural sources are
terrestrial radiation (originating from the soil, water, building materials, and air) and cosmic radiation
from outer space.  Common sources of man-made external radiation include medical and dental x rays,
consumer products, licensed radioactive sources, and being near someone undergoing a medical
radionuclide treatment.  Technologically enhanced sources consist of concentration of naturally
radioactive elements, such as uranium mine and mill tailings or the uranium-containing slag from
phosphate rock processing.
In situations involving external exposure to radiation, radionuclides that are gamma emitters are of
greatest importance.  Alpha particles travel only a few inches in the air and are not capable of penetrating
a piece of paper or the stratum corneum (the dead outer layer of the skin); beta particles are less energetic
and have only limited penetrating ability.  In contrast, gamma radiation is highly penetrating, and thus
more capable of irradiating the whole body from distant sources.
2.5 MEASURING INTERNAL AND EXTERNAL SOURCES OF IONIZING RADIATION
The radiation from some internally deposited radionuclides cannot be measured directly.  The
radioactivity of such radionuclides within the body is determined by bioassay methods, and the data
obtained are applied to physiologically-based biokinetic models to calculate the dose.  
Dose rates for external radiation can be directly measured with appropriate instruments; the total dose is
determined by multiplying the dose rate by the exposure time.  Total dose from external sources can be
easily measured.  This is usually done with a personal monitoring device, such as an electronic dosimeter,
a pocket dosimeter and film badge, or a thermoluminescent dosimeter (TLD).  Table 2-7 lists some of the
methods and instruments used by the health physicist to determine a person’s radiation dose.  The Multi-
Agency Radiation Survey and Site Investigation Manual (MARSSIM) manual provides information on
how various types of field and laboratory equipment are used to measure radiation dose rates and
quantities of radioactive material (MARSSIM 1997).
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2.5.1 Internal Radiation Measurements
The amounts of radioactive material in the body are measured by in vivo or in vitro methods or a
combination of in vivo and in vitro techniques.  These types of measurements, called bioassays, are used
to determine the type, quantity, location, and retention of radionuclides in the body.  In vivo techniques
measure the quantities of internally deposited radionuclides directly, while in vitro analyses are performed
on the materials excreted or removed from the body.  A synopsis of the analytical methods used to
measure the quantity of radioactivity both inside and outside of the body is presented in Table 2-7.
Table 2-7.  Common Analytical Methods for Measuring Radioactive Material Inside 
and Radiation Outside the Body 
Sample matrix Preparation method Device used Reference
Whole body, portion of
body, or organ (x or γ
radiation)
Position individual in front of
detector with area of interest
shielded from extraneous radiation
Multichannel analyzer with
NaI detector for up to a few
γ-emitters, a germanium
detector for any number of
γ-emitters, or a planar
germanium detector for
α-emitters that also emit
x rays.
NCRP 1978
Urine, blood or feces Put any solids into solution; do
chemical separation if multiple
radioactive elements are present;
deposit thin layer on a planchet or
mix with liquid scintillation cocktail.
Liquid scintillation for α- or
β-emitters; alpha
spectroscopy for α-emitters;
GM counter for high-energy
β-  or γ-emitters;
multichannel analyzer for
γ-emitters.
Jia et al.
1994
Personal monitoring:
external radiation dose (β-
and γ-radiation)
Heat dosimeter to produce
thermoluminescence
TLD Lynch et al.
1994
Develop film
None
Film badge
Electronic dosimeter
Shapiro
1990c
Contamination monitoring:
surfaces, skin, clothing,
shoes (β- and γ-radiation)
None GM counter NCRP 1978
Contamination monitoring:
surfaces, skin, clothing
(α-radiation)
None Proportional counter NCRP 1978
α = alpha; β = beta; γ = gamma; GM = Geiger-Mueller; TLD = thermoluminescent dosimeters
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Figure 2-2.  Whole Body Counter.  The linear geometry NaI based WBC
pictured here is designed to maximize sensitivity and accuracy for internally
deposited fission/activation products such as isotopes of Cs and Co.
(Photograph courtesy of Canberra Nuclear/Packard BioScience Co.)
One in vivo or direct method of measuring
radionuclides in the body is performed with
a radiation detection system and its
associated electronics, called a whole-body
counter (see Figure 2-2).  Equipment for
whole-body counting varies from facility to
facility and is selected based on the needs
of each facility.  Equipment changes also
continue as the state of the art advances.
Commonly, the subject is seated in front of
a single large detector; however, the subject
can remain standing during the count, as
shown in Figure 2-2.  This system measures
the emission of gamma rays or x rays from
internally deposited radionuclides.  The use
of whole-body counters is limited to
assessment of radionuclides that emit x ray
or gamma radiation as these counters are
insensitive to the alpha and beta particles
emitted from radionuclides.  Whole-body
counting systems can vary from single,
unshielded detectors that can be used in the
field to shielded multi-detector scanning
systems (NCRP 1987).  
The complexity of whole-body counting systems depends on their intended uses and the radionuclides to be
measured, as well as the accuracy and precision required of the measurement.  Multiple, fixed position
detectors may also be used for simultaneously assessing multiple areas of the body (e.g., lung and thyroid
detectors).  The detector is placed a short distance from the body, such as over the chest when a lung count
is desired. Examples of types of detectors used include solid, inorganic scintillators (e.g., sodium iodide), and
semiconductors (e.g., germanium detectors).  
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Figure 2-3.  Low Energy Germanium (LEGe) Based Lung Counter.  This
instrument is designed to maximize sensitivity for internally deposited U, Pu and
Am isotopes.  Germanium is used to provide the system with the ability to
resolve the differences between photons which are close in energy to each
other.  (Photograph courtesy of Canberra Nuclear/Packard BioScience Co.)
Examples of radionuclides that may be
readily identified and quantified using
whole-body counting techniques are
134Cs, 137Cs, 58Co, 60Co, 131I, 99mTc, and
133Xe.  If a particular portion of the
body requires monitoring after
exposure to alpha particle emitters that
also emit x rays or gamma rays, such as
uranium, plutonium, and americium, a
low-energy germanium lung counter
can be used to maximize detection
sensitivity for x rays or gamma rays
that are emitted from such internally
deposited radionuclides (see Figure 2-
3).  Typical count time for the
instrument shown in Figure 2-3  is
15–30 minutes.  Another detector
variation consists of moving one or several detectors along the length of the subject, or moving the subject
in relation to a fixed detector, and determining radioactivity in the body as a function of the position of the
detector (NCRP 1987).  Photons from the radionuclides  in the body enter the detector and interact with the
detection medium.  In the case of a sodium iodide detector, this interaction produces flashes of light
(scintillations).  The intensity of each scintillation is proportional to the interaction energy of the photon
producing it.  Photomultiplier tubes convert the light energy to an electrical pulse with an output voltage
proportional to the intensity of the scintillation.  The output pulses are then amplified and sorted by energy
level.  If a germanium semiconductor detector is used, the photon interaction directly produces an electrical
impulse whose magnitude is proportional to the photon’s energy.  With either detector, qualitative and
quantitative analyses of the energy profiles are then performed to identify the radionuclides present and their
activities.
In vivo counting systems are calibrated using tissue-equivalent phantoms.  These phantoms have shapes
similar to the human torso and are made of polystyrene or other tissue equivalent material.  Standard
radioactive sources of known activities are inserted into the phantom at locations or geometries
approximating internal depositions of particular radionuclides in the human body.  Relationships are thus
determined between the radiations detected and the known activity in the phantom (DOE 1988; HPS
1996).
The Health Physics Society developed the American National Standard on Performance Criteria for
Radiobioassay (HPS 1996) to establish performance criteria for accuracy, bias, and precision for
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bioassays.  The sensitivity of a whole-body counting system is specified by the acceptable Minimum
Detectable Amount (MDA) which is the smallest activity or mass of an analyte in a sample or the body
that will be detected, given assigned type I and type II error limits.  The criterion imposed on a
participating laboratory is the Minimum Testing Level (MTL) or the amount of radioactive material that
the service laboratory should be able to measure.  When the analysis facility can measure an acceptable
MTL with acceptable bias and precision, the performance requirements of the ANSI standard are
considered to have been met.  Some examples of MTLs are 9 kBq (0.24 µCi) of 239Pu or 3 kBq (81 nCi)
of 60Co in the lung by direct test methods, or 0.01 Bq (0.27 pCi) of 239Pu or 2 Bq (54 pCi) of 60Co per liter
of biological material by indirect methods (HPS 1996).
For radionuclides that transform by alpha or beta particle emission and do not emit readily measurable
gamma rays, in vitro or indirect analyses can be performed.  In vitro analyses may also be performed in
support of an in vivo monitoring program, or in cases where the size of an operation does not justify the
cost of a whole-body counting facility.  These analyses usually involve measurement of radionuclides in
urine, but other body materials such as feces, blood, or tissue samples may also be measured.  Urine
sample analysis is a rapid way to determining whether an intake of radioactive material has occurred. 
Urine samples are easily obtained and easy to analyze; however, fecal, blood or tissue samples are
difficult to obtain, and thus these analyses are not routinely performed.  3H, 14C, various isotopes of
uranium and plutonium, and many other β- or α-emitting radionuclides are often assessed by in vitro
techniques.
Gamma ray measurements of excreta may not require chemical processing and separation prior to counting
due to the penetrating characteristic of gamma radiation.  For alpha and beta radiation measurements, the
energy spectra of the various radionuclides overlap.  In such cases, chemical separation of samples prior to
quantification of the radioactivity may be required.  If only the total activity, not the identity of the
radionuclide, is needed, gross alpha and gross beta quantification can be performed with minimal sample
preparation.  There are no standard chemical separation or preparation procedures for in vitro analysis that
are recommended by any recognized authority; however, many acceptable procedures are available and in
use at a large variety of laboratories and facilities, and DOE and EPA laboratories have some standard
procedures that they routinely follow.  Regardless of the procedures used by each laboratory, the methods
should be capable of meeting the acceptable MTLs identified by HPS (1996).
Detectors commonly used to quantify alpha, beta, and gamma radiation in in vitro samples include
scintillation (Figures 2-4) and liquid scintillation detectors (Figure 2-5), Geiger-Mueller (GM) detectors, gas-
filled proportional counters, and semiconductor detectors.  In scintillation counters, photons from the
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Figure 2-4.  Components of a Scintillation Detector (adapted from
http://tweedledee.wonderland.caltech.edu/derose/labs/exp12.html)
Figure 2-5.  Liquid Scintillation Counting (LSC) System.  Shows system (left) and closeup view  of
sample vials to be loaded (right).   (from Canberra/Packard Bioscience Co.)
radionuclides exit the sample (i.e., urine, feces, tissue) and interact with the scintillator (e.g., zinc sulfide for
α-emitters,  toluene for α- and β-emitters; NaI crystals for γ-emitters) to produce flashes of light
(scintillations).  Photomultiplier tubes convert the light energy into an electrical pulse with an output voltage
proportional to the energy of the radiation interaction.  The output pulses are then amplified and sorted by
energy level.  Gamma rays interact, producing a broad energy spectrum from Compton interactions
superimposed by peaks from photoelectric events.  The peak centroids and areas are used to identify the
i s o t o p e s
a n d t h e i r
a c t i vities.
  
  
Liquid scintillation counters (Figure 2-5) are used to isotopically identify and measure the activity of alpha
or beta radionuclides in a range of sample matrices.  This method is useful in avoiding some of the difficulties
that arise when
analyzing alpha
or low-energy
beta emitters,
such as 3H and
14C, where self-
a b s o r p t i o n
w i t h i n  t h e
sample matrix
c a n  b e
s i g n i f i c a n t .
The sample is
dissolved directly into a liquid scintillator and placed inside a light-tight system. The radiation from the
sample activates the scintillator, causing flashes of light (scintillations) whose intensities are proportional to
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the radiation energy.  These scintillations are measured by an integral photomultiplier tube.  The counting
efficiency of current generation photomultiplier tubes is about 90%.  Most liquid scintillation fluids
(cocktails) are organic-based solvents, such as toluene.  The signal from the dissolved sample is reduced or
quenched through partial absorption of the light by the dissolved sample, so an optical comparison of pure
and sample laden scintillation cocktail is made to correct for this phenomenon (Knoll 1989).
GM counting systems consist of a gas-filled detector tube, associated electronics, and counting circuit and
display.  The tube end can have a thin covering (window) that allows low-energy beta particles to enter the tube.
When an incident particle from a radionuclide enters the tube window and interacts with at least one gas
molecule, it initiates a series of ionizations that result in generation of a voltage pulse of about 1 volt.  These
radiation-induced electrical pulses trigger a circuit which counts the pulses.  The GM counter is not capable of
discriminating among various types of radiation (alpha, beta, gamma); the instrument simply records the number
of pulses.  However, the use of different window thicknesses allows the user to discriminate among the different
radiations.  An aluminum window 0.1 mm thick will stop all beta particles emitted from 14C; to measure alpha
particles, an aluminum window thickness of less than 0.02 mm is required.  Gamma radiation does not require
a special window because gamma rays will penetrate the tube from all directions (Shapiro 1990).
Gas-filled proportional counters are used to measure alpha and beta particles; they are particularly well-suited
for low-level alpha measurements due to their large counting areas and low background.  Like the GM
counters, the voltage pulse output signal produced in proportional counters is a result of an electrical charge
resulting from the ionization of the gas by the incident particle.  Electrons released by the ionization are
drawn toward the positively charged central wire.  As they travel toward the wire, the electrons collide with
other gas molecules, producing more ionizations and an amplification effect.  At certain counter operating
voltages, the amplified charge produced is proportional to the energy absorbed in the detector and facilitates
energy discrimination techniques.  Alpha particles, due to their larger size, large charge, and lower speed,
interact with more gas molecules over a given path-length than beta particles.  Thus, the alpha-to-beta particle
pulse height ratio is substantial (Shapiro 1990).  Proportional detectors use this difference to distinguish
between alpha and beta particles, based on pulse-height discrimination.  
 
Semiconductor detectors are characterized by their use of crystalline silicon or germanium as the ionization
medium.  A sensitive volume is produced in the crystal by electrochemical means.  The interaction of
radiation with the crystalline lattice within the sensitive volume generates electrons by ionization, and the
collection of these electrons leads to an electrical output pulse whose size is proportional to the energy of the
radiation.  A semiconductor detector requires only about one-tenth as much energy to produce an ionization
as other types of detectors.  This leads to a great increase in the detector’s resolving power (i.e., in the ability
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of the detector to separate pulses from particles whose energy differences are very small).  For this reason,
semiconductor detectors find their main use in nuclear spectroscopy, where they can simultaneously separate,
accurately identify, and quantify various radionuclides.  Several types of semiconductor systems are available,
including in-situ spectrometers and both portable and stationary systems equipped with multichannel
analyzers (Cember 1996; Shapiro 1990).
2.5.2 External Radiation Measurements
People who could be occupationally exposed to radiation are routinely monitored for external radiation dose
by several different devices called dosimeters.  The most commonly used personal monitoring dosimeters are
thermoluminescent dosimeters (TLDs) and nuclear emulsion monitors (film dosimeters), which can be used to
measure exposure to β, x ray, and γ radiation doses.  The TLDs and the film  dosimeters are integrating devices
that measure the total dose over the period that the TLD or film badge is used or worn.
The most widely used thermoluminescent material for measuring beta and gamma radiation is a lithium
fluoride crystal.  The energy absorbed from the radiation raises the electrons in the lattice structure of the
crystal to a higher energy level, where a portion are trapped by added impurities.  The electrons remain in
these excited states until the TLD is heated to temperature high enough to return the material to its normal
energy level (Lynch et al. 1994).  Light is emitted which can be measured; the amount of light is proportional
to the radiation dose to which the TLD was exposed.  Automated systems called TLD readers for measuring
the light output from the heated TLDs are commercially available. TLDs are normally worn from 1 day to
1 quarter before results are processed; TLDs posted around occupied areas to assess doses to unmonitored
individuals are normally posted for 1 month to 1 year; the TLD can be used again (Shapiro 1990).
When individuals are exposed to mixed radiation fields (e.g., mixtures of beta/gamma radiation), measure-
ments for each radiation type must be performed.  Either film badges or TLDs can be made to distinguish
among various radiations, and are commonly used to monitor personal exposures to β, x, and γ radiation, but
not α radiation.  Due to the limited range of beta particles in tissue, the exposure of concern is primarily to
the skin, although beta particles whose energy exceeds 0.8 MeV can penetrate to the lens of the eye.
Penetrating x ray and gamma radiation can expose the whole body, including the lens of the eye.  These types
of radiation are assessed simultaneously using multiple TLDs individually covered with absorbers of various
materials, or a strip of film with sections covered with absorbers that separate the radiations according to their
penetrability.  The skin dose, called the shallow dose equivalent (SDE), is measured with the dosimeter
behind a very thin absorber that is 7 mg/cm2 thick and represents the dead skin layer above live tissue.  The
dose to the lens of the eye, called the eye dose equivalent (EDE), is measured behind 300 mg/cm2 of material
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equal to the thickness of the cornea plus liquid that covers the lens.  The whole-body dose, called the deep
dose equivalent (DDE), is measured behind an absorber whose thickness of 1,000 mg/cm2 which is equal to
about 1 cm of tissue or the depth inside the body where the dose from high energy gamma rays tends to be
the highest.  For example, most TLDs and film badges have a small beta window shielded only by a thin sheet
of mylar, and a gamma ray detection area consisting of one or more sections shielded with thin sheets of
plastic, metal (like copper, aluminum, steel, tin, or lead), or combinations of these.  The radiation exposure
of the film is determined by the degree of darkening of the photographic film.  A densitometer is used to read
the film darkening, which is proportional to the absorbed dose in the tissue (Shapiro 1990).
In addition to wearing TLDs and film badges, many radiation workers also carry self-reading  pocket dosi-
meters to provide the wearer an indication of the radiation dose received during the day.  Because the pocket
dosimeters may be read by the individual locally, it gives the worker the necessary information to prevent
an overexposure and the worker can leave an area before a particular radiation dose is exceeded.  The
dosimeters are usually worn beside the primary dosimeter and typically measure x ray or γ radiation. They
respond to betas but are not meant to measure betas.   By lining the interior of the chamber with boron,  the
devices may also be made to monitor thermal neutron exposure.  In this instrument, a quartz fiber is
electrostatically displaced by charging the dosimeter to a potential of about 200 volts.  As with other dosi-
meters, ionizations caused by radiation discharge the dosimeter which returns the fiber to its usual position
as it loses its charge.  The relative position of the fiber is calibrated to an exposure scale, usually in the range
of 0 to 200 mR.  The position of the fiber against the scale may be viewed through the end of the instrument.
There are two type of pocket dosimeters.  The second type, called a condenser-type dosimeter, is an indirect
reading dosimeter.  An additional device, referred to as a charger-reader, is needed to charge and read the
dosimeter.  The dosimeter is basically a capacitor with an exterior wall made of an electrically conducting
plastic or metal and an interior central wire which is insulated from the outer wall.  Using the charter-reader,
a positive charge is placed on the central wire.  When exposed to x or gamma radiation, the ionizations
discharge the unit.  The amount of charge remaining in the dosimeter at any point is inversely proportional
to the ionization produced in the cavity.  The degree of discharge, and therefore the exposure, is measured
by attaching the dosimeter to the charger-reader.   Pocket dosimeters gradually discharge over time due to
cosmic radiation and charge leakage across the insulating material.  Because of the natural discharging and
the potential for malfunction due to dropping the device, they are typically worn in duplicate with a film
badge or TLD and are read and recharged daily (Cember 1996)
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Figure 2-6.  Geiger-Mueller Counter with an Energy-
compensated Gamma Probe.  (Photo courtesy of Ludlum
Measurements, Inc.)
Figure 2-7.  Geiger-Mueller Counter with a Beta/gamma Pancake-
type Detection Probe. (Photo courtesy of Ludlum Measurements,
Inc.)
Electronic dosimeters are now widely used.  These
dosimeters feature solid-state detectors and a
microprocessor to monitor x and gamma ray dose,
dose rate, and dose history. Also, these small,
programmable, lightweight dosimeters feature
audible and vibrating alarms and visible digital
readouts that keep the wearer informed of their
radiation dose status at all times.  Units with
telemetric capabilities can be monitored at stations
outside the work area where the dosimetry of a
number of individuals can be simultaneously viewed and assessed to facilitate a higher degree of radiological
control, such as for activities involving high intensity radiation sources.  These dosimeter can be retained
indefinitely by the individual and the person’s dose history can be accumulated remotely, stored digitally in
database fashion, and used to produce computer generated dosimetry reports on demand.  
2.5.3 Field Radiation and Contamination Surveys
Environmental radiation arises from four basic
sources: (1) natural radioactivity from uranium,
thorium, and other primordial radionuclides; (2)
cosmic rays and radionuclides produced by cosmic-
ray interactions in the atmosphere; (3) contaminants
from nuclear-weapons fallout; and (4) effluent from
nuclear and medical facilities (NCRP 1985).  Two
methods are routinely used for measuring
environmental radiation: (1) field surveys using
portable survey instruments, and (2) analysis of
samples procured in the field that are returned to the laboratory for quantification.
2.5.3.1  Field Measurements of Ionizing Radiation
External radioactivity and radiation measurements can be made with portable, hand-held survey instruments.
The primary purpose of some types of survey instruments is to measure the radiation levels to which people
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Figure 2-9. Floor Monitor System with Multi-
detector Array.  (Photo courtesy of Ludlum
Measurements, Inc.)
Figure 2-8.  Large Area Alpha Radiation Detector with Digital/Analog
 Survey Meter  (photo courtesy of Ludlum Measurements, Inc.)
are exposed, while others detect any
contamination that may be present on
an individual's skin, clothing, shoes or
in the environment.  
Various types of radiation detectors
(e.g., Geiger-Mueller or scintillation)
are coupled with a count rate meter
designed to detect alpha, beta, and
gamma radiation.  The count rate meter
has a scale with a needle indicator or
digital display that provides an immediate readout of levels of radiation or contamination that may be present
in units of milliroentgens per hour (mR/hr) (1 mR . 1 mrem = 0.01 mSv) or counts per minute (cpm).  Two
frequently used GM survey meters are the energy compensated GM detector (Figure 2-6) and the GM thin
window "pancake" type detector (Figure 2-7).  The energy compensated type of GM detector surrounds the
detector chamber with a material of density and thickness that somewhat normalizes the dose response over
a range of energies, which sacrifices some sensitivity for accuracy.  The pancake detector typically has a very
thin window and a relatively large detection area.  The typical survey meter for identifying alpha contamination
uses a zinc sulfide scintillator material that can reliably detect 200–500 dpm per 100 cm2 (DOE 1988).
Disintegrations per minute per 100 cm2 of contaminated area is the criterion that has been chosen by regulatory
agencies for control purposes.  The alpha reading may be inaccurately low if the surface is irregular, porous,
or damp since these conditions can attenuate the alpha particles.
Recent developments in large area gas and gas-flow proportional
counter technology, which have enabled these detectors to achieve
higher sensitivities than alpha scintillator detectors, have made
them acceptable for use in decommissioning operations.  Figure 2-
8 is an example of a current generation large area detector with
digital survey meter.  Figure 2-9 is a floor monitor system with
multi-detector array that covers a wide path.  The detector is
slowly moved over a building or roadway surface to locate
radioactive contamination and then held in place to quantify the
level.  Floor monitors with drive, data recording, and positioning
systems are used to develop digitized reports and plots of alpha
and beta contamination levels; these units can quantify
contamination levels while continuously moving.
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Figure 2-10.  In-Situ Gamma Ray Spectrometer 
(adapted from http://www.em.doe.gov/rainplum/fig16.html)
Field surveys can be either qualitative (to provide a go/no-go indication for excess radiation levels) or
quantitative (to provide a numerical value for the level and possible identification of the radionuclides
present).  Most field surveys involve the use of calibrated, portable, hand-held survey meters equipped with
count-rate meters or digital displays that provide an immediate reading of the radiation field strength or the
surface contamination level.
The radiation detector used in a survey must be appropriate to the type of radiation being measured. Typical
alpha radiation detectors use the alpha scintillator material ZnS, as well as gas-flow surface contamination
monitors.  Typical beta radiation detectors are pancake type GM detectors and gas-flow surface contamination
monitors.  Gamma radiation detectors include a wide range of equipment types, including the GM and sodium
iodide scintillation counters.  Counter-type survey instruments are highly sensitive and are used mainly to
search for and detect radiation.  Ion chambers are used for measuring the radiation dose rate, with pressurized
ion chambers being used for very low radiation levels.
Specialty instruments are available for more detailed field work, but their use generally requires special skills
and training.  The in-situ germanium spectrometer is a multichannel analyzer with a germanium detector that
can identify a range of γ-emitting isotopes and quantify their concentration in surface soil.  The Laser
Ablation Inductively Coupled Plasma mass spectrometer (LA-ICP-MS) can measure 0.3 pCi/g of 238U in soil.
The Long Range Alpha Detector (LRAD) can measure alpha soil contamination down to 10 pCi/g.  The Field
Instrument for Detection of Low Energy Radiation (FIDLER) is used to measure plutonium and americium
surface contamination.  The field
x ray fluorescence spectrometer
can measure the relative
concentration of metal atoms in
soil or water down to the parts per
million (ppm) range.
Field survey instruments provide
timely information on the
presence and levels of radiation
fields or radioactive materials.  
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Measurements of radiation fields or loose radioactive material can be made in the field with portable
instrumentation (Figure 2-10).  Similar surveys can also be performed on people when contamination is
suspected since both environmental surveys and personnel surveys use many of the same types of portable
instrumentation. 
Semi-permanent instruments or instruments placed in the field for extended periods of time are sometimes
used to measure ambient environmental radiation levels or to detect changes in ambient environmental
radiation levels (for example, around nuclear facilities).  Pressurized ionization chambers (PICs) are used as
a standard for measuring gamma radiation levels.  Readings are recorded on a real-time strip chart recorder
or on a magnetic card, and can be arranged to transmit these data to a central site for computer processing.
Several types of portable survey instruments using ionization chamber detectors are also available.  Ionization
chamber detectors can only be used for ambient environmental radiation monitoring, if the detection
sensitivity is several µrad/hour (Kathren 1984).  Ion chamber survey meters typically exhibit long response
times, particularly at low radiation levels, requiring up to several minutes to record a detectable measurement
above background levels at low radiation levels.  
GM counters and both plastic and NaI scintillators have also been used for field measurements of ambient
radiation.  These instruments have detection capability down to several µrad/hour (nGy/hr).  They are
rugged and have a shorter time constant than a pressurized ion chamber (PIC), making them more suitable
than PICs when numerous environmental measurements are to be made.  Counter-type survey meters,
such as GM and scintillation counters, are very energy dependent when used to measure dose.  They can
be used to reliably measure dose or dose rate only for radiation whose energy is the same as the energy of
the calibration source.  Energy flattening filters are sometimes used in GM survey meters to compensate
for the energy dependence (Kathren 1984; NCRP 1976, 1985).  The energy response problem can largely
be overcome by taking paired PIC and GM or NaI readings at several points to develop factors for
converting GM or NaI readings to true exposure levels in mR/hr (EPA 1994).
Scintillation detectors and semiconductor detectors, when used in conjunction with a multichannel
analyzer and computing capabilities, make it possible to determine whether the radiation fields originate
from terrestrial radiation, cosmic radiation, or anthropogenic radiation, or from a combination of these
sources.  These instruments are useful for environmental monitoring around reactor sites and sites
undergoing remediation for unrestricted use by the public.
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The very short range of the alpha particle makes it necessary for the distance between the α-emitting
source and the alpha detector to be very small.  It also requires that the detector window be very thin to
enable passage of the alpha particle into the detector.  A scintillation detector that is frequently used is
silver-activated ZnS.  The ZnS scintillation detector is relatively insensitive to beta or gamma radiation
and exhibits a low background count, thus permitting measurement of alphas in the presence of high beta
or gamma radiation fields.  Gas-filled proportional counters are particularly well-suited for low-level
alpha measurements due to their large counting areas and low background.  Proportional detectors can
distinguish between alpha and beta particles based on differences in the size of the output voltage pulses
from alphas and betas (NCRP 1978; Shapiro 1990).
Awareness of the need for detection of plutonium in the environment has increased due to several
accidents that have occurred in the past (see Section 3.5).  Plutonium transforms by α emission with a
small percentage of accompanying x rays with energies in the region of 17 keV from the excited 237Np
daughter.  Due to the difficulties associated with measurement of alpha particles, an instrument called a
FIDLER (Field Instrument for Detection of Low Energy Radiation) was developed.  This instrument
measures the 17 keV photons associated with the transformation of 239Pu using a 5-inch diameter crystal
of NaI, 1/16th of an inch thick.  FIDLER measurements are also made of the 60 keV photons from
americium-241 (241Am), which is often associated with plutonium as an impurity (Kathren 1984).
Large-scale environmental monitoring for contamination is sometimes carried out on roads and railroad
tracks using scintillation detectors mounted on vehicles.  The detectors are shielded on the sides and tops
and are suspended above the ground surface.  In addition, aerial surveys for radioactivity are useful for
mineral exploration, special studies of uranium fields, nuclear facilities monitoring, fallout measurements,
etc.  The detector of choice for most of these measurements is the scintillator, usually a large single
crystal (Kathren 1984) or multiple smaller detectors with summed responses.  The correlation of airborne
measurements with ground-level data indicates agreement to within about ± 20% in a strip of land
400 meters wide under the flight lines (NCRP 1976).
In addition to the use of survey instruments, environmental radiation is also measured with passive inte-
grating detectors such as film badges or TLDs.  TLDs are superior to film badges in energy dependence,
angular dependence of radiation incident upon the dosimeter, permissible time in the field, resistance to
environmental conditions, and lower limit of detection (10 mrad for film compared with 1 mrad for TLD) 
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(Kathren 1984; NCRP 1976).  Several different thermoluminescent phosphors are available for
environmental measurements, including LiF, CaF2,  CaSO4 (Kathren 1984; NCRP 1976) and Al2O3.  In
the field, TLDs do not require a great deal of protection; however, some phosphors may exhibit
sensitivity to light and humidity.  Consequently, it is useful to package the TLD in some sort of light and
water-tight material.  
A good source of information on the performance of field radiation surveys, the collection and processing
of samples and the applicability, operation, specificity, sensitivity, cost, and cost of operation of field and
laboratory equipment is the Multi-Agency Radiation Survey and Site Investigation Manual (MARSSIM)
prepared by EPA, NRC, DOD, and DOE as a consensus guide for conducting the final status survey in
releasing a radiation site for unrestricted public use (MARSSIM 1997).
2.5.3.2  Laboratory Analysis of Environmental Samples
There are standardized analytical methods for the quantification of radioactive material in air, water,
sediment, food, vegetation, and other biota (DOE 1997a); however, current philosophy supports
performance-based rather than prescriptive methods.  In many cases, particularly in occupational settings,
the radionuclide(s) are known so the analysis can be confined to that particular radionuclide(s).  If the
radioactivity in a sample is from an unknown radionuclide(s), the sample should be examined for α and
β/γ-emitting nuclides.  Environmental samples usually involve measurement of low levels of specific
radionuclides in the presence of naturally occurring radionuclides.  Consequently, the analyzing analytical
instrumentation is sensitive and the effect of natural background radiation levels on the detectors should
be minimized.  Background reductions are usually achieved mechanically by the use of shields around the
detectors and electronically by pulse size discrimination (NCRP 1978).
Preparation of various environmental media for analysis of radioactive content may require concentrating
the radioactive material from a large sample into a small volume to increase the sensitivity of the analysis
or to reduce the sample to a form more suitable for counting.  For example, solvent extraction may be
used for samples with high salt content whereas ion exchange chromatography may be used for samples
with low salt content.  However, some standardized methods for environmental sample preparation have
been developed in laboratories for analysis of radionuclides in various matrices (EPA 1984) and in
drinking water (EPA 1980).  Chemical separation techniques and nuclear instrumentation for assessment 
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of several radionuclides in various matrices can be found in the ATSDR profiles for plutonium, radium,
and uranium (ATSDR 1990c, 1990d, 1999b).
There are several methods in use for quantification of alpha particles.  If the identity of the α-emitting
radionuclide is not needed or is already known, alpha activity of samples can be quantified by gross or
"total" alpha counting (NCRP 1985).  However, the short range of alpha particles in liquid and solid
samples usually requires physical and/or chemical separation of the radionuclide from the matrix as
described by EPA procedures (EPA 1980, 1984).  Since the energies of the radiations from radionuclides
are specific for those radionuclides, alpha spectroscopy, using a high-resolution silicon diode surface
barrier detector with a resoulution of 10–20 keV, is used when it is necessary to determine both the
identity and the quantity of the α-emitting radionuclide(s) in a sample (Knoll 1989; NCRP 1985);
procedures manuals of the DOE’s Environmental Measurements Laboratory and the Los Alamos National
Laboratory contain example procedures for such analyses (DOE 1997a).
For environmental samples containing radionuclides that emit gamma rays, scintillation detectors (sodium
iodide) and semiconductor detectors (germanium) are commonly used.  These detectors, along with the
appropriate electronics, computers and software, can be used to simultaneously identify and quantify a
number of  γ-emitting radionuclides (Kathren 1984; Knoll 1989; NCRP 1985).  Germaniuim detectors
have superior resolution and are more suitable if more than a few radionuclides are present in the sample.
A number of radionuclides, including 3H, 14C, 32P, 35S, 45Ca, 89Sr, 90Sr, and 90Y, emit only beta radiation
(NCRP 1985).  Liquid scintillation counting systems are widely used for the assay of low levels of
β-emitting radionuclides and can be used to quantify all of the radionuclides listed above.  GM detectors
are also  used for quantification of beta particles; however, GM detectors are not used to quantify 3H 
because of its very low beta energy.  Another instrument used for assessment of beta particles in
environmental samples is the gas-flow proportional counter.  Gas-flow proportional counters can readily
quantify the β-emitting radionuclides identified above, as well as 3H and 14C, either when the detector
window is very thin (in the case of 14C) or when the detector is windowless (in the case of 3H).  In
general, liquid scintillation, gas-flow proportional and GM counters provide data on total beta activity,
although some liquid scintillation counters have some ability to resolve energy spectra.  Also, solid
organic scintillators, which are usually made from plastic or crystals of anthracene and trans-stilbene, may
be used to quantify and identify beta particles (Knoll 1989). 
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2.6 CONCLUSIONS
The study of the effects of radiation is a highly specialized area of toxicology that requires knowledge
and understanding of radiation physics and radioactivity, radiation dose, and biology.  Radiation interacts
in unique ways with matter to yield carcinogenic and non-carcinogenic effects after acute and chronic
exposures.  
Low levels of radiation have always been present in the environment. Only in the past 100 years have
humans discovered its ubiquitous presence.  During the 20th century, scientists and governments have
developed uses for radionuclides both for peaceful purposes, such as medical diagnosis and treatment and
electrical power generation, and for military purposes, such as weapons technology.  Much research has
been performed to define the different types of radiation, to explain how radiation interacts with matter,
and to determine how to measure both the radioactivity and the radiation dose from a given exposure. 
This and other information has been used to correlate absorbed dose (from short-term high doses to long-
term low doses) with toxicological diseases ranging from almost immediate death after an initial exposure
to the induction of carcinogenesis years after a non-lethal exposure.  This chapter summarized some of
the information about radiation and methods for measuring radiation and radiation exposure.  The
remainder of this toxicological profile discusses in more depth the biological and toxicological effects and
mechanisms of action of radiation (Chapters 3 and 5), sources of population exposure (Chapter 6), and
regulatory situation specific to ionizing radiation (Chapter 7).  Observed Health Effects from Radiation
and Radioactive Material tables for ionizing radiation are presented in Chapter 8.
2.7 OTHER SOURCES OF INFORMATION
The Internet sites listed in Table 2-8 provide  information on the general principles and health effects of
the different forms and doses of radiation. Information obtained from internet sources should not be
considered to have been peer reviewed unless separately authenticated.
Table 2-8.  Some Internet Sites Related to Ionizing Radiation
HyperText Transfer Protocol (HTTP) address Web page contents
http://www.uic.com.au/ral.htm A beginner’s reference for radiation.
http://www.dne.bnl.gov/CoN/index.html Radionuclide information on half-life, transformation
energies, etc.
http://www.nih.gov/health/chip/od/radiation Summary information on radiation and its health effects 
http://www.umich.edu/~radinfo/introduction Introduction to radiation; professional, research and
educational resources 
http://radefx.bcm.tmc.edu/ Baylor College of Medicine Radiation Effects Homepage.
Health effects documents, downloadable software,
Chernobyl information, links to other radiation-related sites. 
http://www.em.doe.gov/cgi-bin/tc/tindex.html DOE Environmental Management.  Public information
access and links to DOE research laboratories
http://www.rerf.or.jp/ Radiation Effects Research Foundation.  Human health
impact of the atomic bomb release on Hiroshima and
Nagasaki, Japan.
http://www.ohre.doe.gov/ DOE “cold war” radiation research using human subjects.
http://www.hps.org Health Physics Society.  Involved in the development,
dissemination, and application of radiation protection.
Concerned with understanding, evaluating, and controlling
the risks from radiation exposure relative to the benefits
derived. 
http://www.epa.gov/narel/index.html
http://www.epa.gov/narel/erd-online.html
Reports nationwide radionuclide concentrations in air,
drinking water, surface water, precipitation, and milk.
http://www.aapm.org American Association of Physicists in Medicine. 
Concerned with the safe use of radiation and radioactive
materials in medicine.
http://law.house.gov/4.htm U.S. House of Representatives internet law library of the
Code of Federal Regulations.  Provides CFR text.
http://www.nrc.gov/ USNRC.  Nuclear waste, nuclear reactors in operation,
and rule-making procedures.
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3.1 INTRODUCTION
Ionizing radiation is a form of radiation with sufficient energy to remove electrons from their atomic or
molecular orbital shells in the tissues they penetrate (Borek 1993).  These ionizations, received in
sufficient quantities over a period of time, can result in tissue damage and disruption of cellular function
at the molecular level.  Of particular interest is their effect on deoxyribonucleic acids (DNA).  
A special issue to consider when examining the health effects caused by ionizing radiation is the concept
of dose and dose rate.  The dose delivered to tissue from ionizing radiation can either be acute (the energy
from the radiation is absorbed over a few hours or days) or chronic (the energy is absorbed over a longer
period of months, years, or over a lifetime).  The dose becomes particularly important when the individual
is exposed is to radioactive materials inside the body.  In distinguishing between acute and chronic
exposure, both the intake rate and the physical, chemical, and biological aspects of the radionuclide
kinetics must be considered.  For radioactive materials with effective half-lives longer than a day, even if
the intake is brief (minutes to a few days), the energy is deposited in tissue where it remains over a period
longer than a few days, so that the exposure to the surrounding tissue is of a chronic duration.  Depending
on the size  of the dose and the dose rate, the effects of ionizing radiation can either be acute (occurring
within several hours to several months after exposure) or delayed (occurring several years after the
exposure).
The principles of dose are important to the interpretation of Tables 8-1 through 8-4, found in Chapter 8
(“Levels of Significant Exposure to Radiation and Radioactive Material”) in this profile.  For example,
Table 8-1 lists the observed health effects from radiation and radioactive material using inhalation as the
route of exposure.  Entry 109 shows a study in which Beagle dogs were exposed for 2 to 22 minutes to
90SrCl2.  Although these animals received the total amount of radionuclide within 2 to 22 minutes (an
acute duration of exposure), the radionuclide was absorbed and redistributed to other tissues (in this case,
bone), where it remained for a protracted period of time (chronic exposure).  Delayed effects of
osteosarcoma and other tumors were found in almost half of these animals (Gillett et al. 1987b).  Without
a clear understanding of both the dose and the toxicokinetics of the radionuclide, one might conclude
from this table that a 2- to 22-minute dose of radiation from  90SrCl2 will cause bone cancer in dogs.  The
more appropriate conclusion to draw from this study is that after a 2- to 22-minute  intake, 90SrCl2 
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appeared to have redistributed from the lungs to the bones and, given its long physical half-time (t1/2) of
28.6 years, would have irradiated the surrounding tissues for a lengthy period of time to produce a
cancerous end point.
Sources of ionizing radiation can be found at many waste sites in the United States and other countries. 
Exposure to these sources may have potential adverse health effects, depending on the isotope, the
absorbed dose, and the dose rate.  The predominant radionuclides found currently or in the past at
Department of Energy (DOE) National Priorities List (NPL) waste sites are listed in Table 3-1.
Table 3-1.  ATSDR Priority Listing of Radionuclides Present at Department of Energy 
NPL Sites
Ranking # Isotope Primary emission Physical half-life Target tissue(s) for soluble forms
1 Thorium-232 α 1.4 x 1010 years
2 Uranium-235 α 7.04 x 108 years Renal (proximal tubules)a
3 Radium-228 β 5.76 years Skeleton
4 Uranium-238 α 4.46 x 109 years Renal (proximal tubules)
5 Radium-226 α 1600 years Skeleton
6 Cobalt-60 β, γ 5.271 years Whole body
7 Krypton-85 β 10.72 years
8 Americium-241 α 432.2 years Lung
9 Uranium-234 α 2.45 x 105 years Renal (proximal tubules)
10 Potassium-40 β 1.26 x 109 years Skeleton
11 Europium-152 β 13.5 years
12 Neptunium-237 α 2.14 x 106 years
13 Cesium-137 β,γ 30 years Whole body
14 Protactinium-231 α 3.25 x 104 years
15 Strontium-90 β 28.6 years Skeleton
16 Krypton-88 β 2.84 hours
17 Thallium-208 β 3.053 minutes
18 Thorium-228 α 1.913 years
19 Protactinium-234 β 6.69 hours
20 Argon-41 β 1.82 hours
21 Plutonium-239 α 24,131 years Bone surface 
22 Krypton-87 β/γ 76.3 minutes Whole body
23 Thorium-230 α 77,000 years Bone surface
24 Uranium-236  α  2.3415 x 107 years Bone surface
25 Plutonium-238 α 87.75 years Bone surface
aRenal toxicity is more likely due its heavy metal properties rather than its radioactive properties.  
Source: Lide 1996; Schleien 1992
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The scientific literature is filled with in-depth discussions and reviews on the effects of ionizing radiation
in humans and animals, and it would be difficult, if not impractical, to summarize all of the known
information about the effects of each radionuclide in every animal.  Although the database of biological,
radiological, toxicological, and toxicokinetic information is substantial and much is known, much remains
to be learned about the specific mechanisms by which ionizing radiation produces its effects, how these
effects can be minimized in living tissues, and what the long-term effects of very low doses of ionizing
radiation are over the normal human lifespan.  In this profile, some of the information about the effects of
ionizing radiation has been obtained from human epidemiological and medical studies, but a sizable
portion has come from studies conducted in laboratory animals and then extrapolated to humans.  In
addition to data from epidemiological studies, there is a substantial human database derived from
therapeutic applications of radiation.  Because of this large database of information, and in an effort to
provide a useable overview of the health effects caused by exposure to radionuclides, this toxicological
profile will summarize the adverse effects of ionizing radiation from alpha (α), beta (β), and gamma (γ)
radiation, using representative radionuclides to illustrate the effects on specific organs and tissues.  Other
radionuclides with similar emissions and kinetics may produce similar end points.  This profile will not
provide an in-depth discussion of the more subtle points of radiation biology and toxicology.  It will,
however, provide the reader with a comprehensive and informative overview of a cross-section of the
scientific literature that pertains to the potential adverse carcinogenic and non-carcinogenic effects of  α,
β, and γ  radiation, focusing on key human and animal studies and using representative radionuclides for
illustration purposes.  Readers are  encouraged to consult both the glossary and Chapter 2 of this profile
to become familiar with the terminology used in discussing exposure to ionizing radiation and the
characteristics of these three radiations.  Several excellent texts and review papers are also available in the
open literature that provide the salient background material for many of the sections of this profile (BEIR
IV 1988; BEIR V 1990; Faw and Shultis 1993; Harley 1991; Roesch 1987; UNSCEAR 1993; Raabe
1994).
3.2 HEALTH EFFECTS FROM EXPOSURE TO IONIZING RADIATION
High doses of ionizing radiation can lead to various effects, such as skin burns, hair loss, birth defects,
illness, cancer, and death.  The basic principle of toxicology, “the dose determines poison,” applies to the
toxicology of ionizing radiation as well as to all other branches of toxicology.  In the case of threshold
effects (“deterministic effects” in the language of radiation toxicology), such as skin burns, hair loss,
sterility, nausea, and cataracts, a certain minimum dose (the threshold dose), usually on the order of
hundreds or thousands of rad, must be exceeded in order for the effect to be expressed.  An increase in the
size of the dose above the threshold dose will increase the severity of the effect.
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For cancer induction, increasing the radiation dose does not increase the severity of the cancer; instead it
increases the chance of cancer induction.  In the case of carcinogens generally, whether chemical or
radiological, safety standards are based on a postulated zero threshold (i.e., any increment of carcinogen,
no matter how small, is assumed to carry with it a corresponding increase in the chance of causing
cancer).  Increasing the size of the dose increases the probability of inducing a cancer with that
carcinogen.  Cancers that are, in fact, caused by radiation are completely indistinguishable from those that
seem to occur spontaneously or are caused by other known or suspected carcinogens.  In a given
population, such as the Japanese survivors of the atomic bombings of 1945, investigators identified the
carcinogenicity of ionizing radiation only by measuring the frequency of occurrence of cancer.  In the
case of the survivors of the atomic bombings in Japan, there was  no observed statistically significant
increase in cancer frequency among people whose radiation dose did not exceed 0.4 Gy (40 rad) and no
increase in leukemia among those whose radiation dose did not exceed 0.1 Gy (10 rad).  Because
investigators could not uniquely identify any cancer as having been caused by the radiation, and because
there was no observed increase in cancer frequency following low-level irradiation, the calculated cancer
risk coefficient (i.e., the probability of getting cancer per unit of radiation dose) is usually estimated by
extrapolation of data from observations on populations that received high doses of radiation.
For the purposes of this profile, we have divided the end points produced by ionizing radiation into
effects that were (at least initially) non-carcinogenic and carcinogenic effects.  The non-carcinogenic
effects were further subdivided by major organ systems affected plus teratogenic effects.  This was done
primarily to help the reader understand the broad scope of adverse health effects that can be produced by
ionizing radiation.  This approach was also necessary to facilitate evaluating study designs found in the
literature.  Some studies exposed laboratory animals to radiation, determined the non-cancerous end
points, and then sacrificed the animals to complete the study objectives.  These studies imply that cancer
did not or would not develop after exposure to this radiation, which certainly may not be the case.  Other
studies exposed animals to radiation, observed the non-carcinogenic end points (if any), and then allowed
the animals to live out their normal lifespans to determine if cancer would develop.  These latter studies
provided more complete information on the overall effects of exposure to ionizing radiation.  
No acute-, intermediate-, or chronic-duration inhalation, oral, or dermal Minimal Risk Levels (MRLs)
were developed for internal exposure to alpha, beta, or gamma radiation.  Radiation effect(s) on a
biological system during an acute, intermediate, or chronic duration of exposure depend on the radiation
dose; the dose, in turn, depends on several variables.  For airborne radioactivity, these include physical
form (gas versus particle), particle solubility, particle size, type of radiation (alpha, beta, gamma, or
combinations), and energy of the radiation. For oral and dermal exposure, toxicity is influenced by 
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solubility, metabolism within the body, and the type and energies of the radiation.  Since there is a
biological equivalence of internal and external dose equivalent in units of sievert and rem, an MRL for
external radiation should be appropriate for internal radiation. 
Two MRLs have been derived for exposures to ionizing radiation:
• An MRL of  0.004 Sv (0.4 rem) has been derived for acute-duration external ionizing radiation
exposure (14 days or less).
The acute MRL is based on results from two studies, one by Schull et al. (1988) and one by Burt (1966).
Schull et al. (1988) evaluated the quantitative effect of exposure to radiation on the developing fetal and
embryonic human brain.  The end point measured was change in intelligence test scores.  Broadly
speaking, a large body of literature shows the effects of radiation on the embryonic and fetal brain. 
ATSDR recognizes that there is considerable public interest in and debate about the interpretation of
intelligence scores and that government agencies have been very careful in setting health benchmarks for
chemicals whose effects are measured by intelligence testing.  ATSDR is basing the MRL on the
published results from relevant IQ studies and applies a conservative factor to account for uncertainties. 
Underlying assumptions in the MRL development are stated as clearly as possible.  
Schull et al. (1988) evaluated effects on individuals exposed in utero during the atomic bombing of
Hiroshima and Nagasaki, based on the original PE86 samples (n=1,759; data on available intelligence
testing) and the clinical sample (n=1,598).  The original PE86 sample included virtually all prenatally
exposed individuals who received tissue-absorbed doses of 0.50 Gy or more, and many more individuals
in the dose range 0–0.49 Gy than in the clinical sample.  The clinical sample does not include children
prenatally exposed at distances between 2,000–2,999 meters in Hiroshima and Nagasaki.  Children
prenatally exposed at greater distances or not present in the city were selected as controls.  In 1955–1956,
Tanaka-B (emphasis on word-sense, arithmetic abilities, and the like, which were associated with the
more subtle processing of visual clues than their simple recognition and depended more on
connectedness) and the Koga (emphasis on perception of spatial relationships) intelligence tests were
conducted in Nagasaki; the Koga test was conducted in Hiroshima.  No evidence of radiation-related
effect on intelligence was observed among individuals exposed within 0–7 weeks after fertilization or
after the 25th week. The highest risk of radiation damage to the embryonic and fetal brain occurred 8 to
15 weeks after fertilization under both T65DR and DS86 dosimetric systems (Otake and Schull 1984). 
The regression of intelligence score on estimated DS86 uterine absorbed dose is more linear than with
T65DR fetal dose, and the diminution in intelligence score under the linear model is 21–29 points at 1 
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Gy.  The regression of intelligence score on estimated fetal absorbed dose was linear for the exposed 8–15
weeks after fertilization and possibly linear for the 16–25-week group.  The cumulative distribution of
test scores suggested a progressive shift downwards in individual scores with increasing exposure in the
8–25-week exposure group.  The mean IQ scores decrease significantly and systematically with uterine or
fetal tissue dose within the groups exposed at 8–15 and 16–25 weeks.
The linearity of the response over the exposure ranges does not mean that there is no threshold for
ionizing  radiation’s neurological effects.  A threshold response (i.e., deterministic response) in the case
of ionizing radiation involves damage to brain stem cells or to cells that differentiate into brain cells.  This
threshold, however, is indeterminate and therefore, there is no readily available lowest-observed-adverse-
effect level (LOAEL).  However, a no-observed-adverse-effect level (NOAEL) is taken from a study by
Burt (1996).  Results from the Schull et al. (1998) study are used in conjunction with the Burt (1966)
study described below.  The Burt study (1996) is the basis of a population IQ differential used to establish
a NOAEL dose from the Schull et al. (1998) study.
The study by Burt (1966) determined differences in intelligence in monozygotic twins reared together
(n=95) and apart (n=53).  All tests were conducted in school and consisted of (1) a group test of
intelligence containing both non-verbal and verbal items, (2) an individual test (the London Revision of
the Terman-Binet Scale) used primarily for standardization and for doubtful cases, and (3) a set of
performance tests based on the Pitner-Paterson tests and standardization.  The methods and standard
remained much the same throughout the study.  The children were brought up by parents or foster parents
(occupation ranged from unskilled to professional).  The standard deviation of the group of separated
monozygotic twins was reported at 15.3 as compared to 15.0 of ordinary siblings.  Twins brought up in
different environments were compared with those brought up in similar circumstances.  The average IQ
scores of the twins measured on a conventional IQ scale (SD=15) was 97.8 for the separated mono-
zygotes, 98.1 for monozygotes brought up together.  The difference of 0.3 IQ point between the separated
and unseparated identical twins (97.8–98.1) is considered a NOAEL for this study.  
Husen (1959) reported a study  involving 269 pairs of Swedish monozygotic (identical) twins where the
intrapair IQ difference was 4 IQ points for a combination of twins raised together and apart.  This is
somewhat lower than the value of 7 IQ points for identical twins raised apart, and just larger than the
range of IQ scores for Washington DC children repetitively tested (Jacobi and Glauberman 1995).  
Supporting evidence for the acute MRL is provided by Jacobi and Glauberman (1995).  Children in the
1st, 3rd, and 5th grades born in Washington DC were tested, and average IQ levels of 94.2, 97.6, and 94.6 
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were reported. The differences of up to 3.4 IQ points between the grades and over time were considered
to be small and could not be tied to environmental deficiencies.  This difference is a potential LOAEL for
acute doses of ionizing radiation and would yield an MRL of 0.004 Sv (3.4 IQ points x 1 Sv/25 IQ points
÷ 30 [10 for use of a LOAEL and 3 for a sensitive human population]).
Additional supporting evidence for the acute MRL is provided by Berger et al. 1997, in a case study of
accidental radiation injury to the hand.  A Mexican engineer suffered an accidental injury to the hand
while repairing an x ray spectrometer.  The day after the accident, his symptoms included a tingling
sensation and itching in the index and middle fingers.  On days 4 and 7, a "pinching" sensation, swelling,
and slight erythema were observed.  By day 7,  the tip of his index fingers was erythematous and a large
blister developed with swelling on other fingers.  On day 10, examination by a physician showed that the
lesions had worsened and the fingers and palms were discolored.  On day 10, he was admitted to the
hospital where hyperbaric oxygen therapy was administered without success.  One month after the
accident, the patient entered the hospital again with pain, discoloration, and desquamation of his hand. 
Clinical examination showed decreased circulation in the entire hand, most notably in the index and
middle finger.  Total white blood count decreased to 3,000/µL (normal range 4,300–10,800/µL). 
Cytogenic studies of peripheral blood lymphocytes revealed four dicentrics, two rings, and eight
chromosomal fragments in the 300 metaphases studied.  The estimated whole body dose was reported to
be 0.382 Gy (38.2 rad).  This dose is a potential LOAEL for acute ionizing radiation and would yield an
MRL of 0.004 Sv (0.38 Sv ÷100 [10 for use of LOAEL and 10 for human variability]).  
The Nuclear Regulatory Commission set a radiation exposure limit of 5 mSv (500 mrem) for pregnant
working women over the full gestational period (USNRC 1991).  For the critical gestational period of 8 to
15 weeks ATSDR believes that the acute MRL of 4 mSv is consistent with the NRC limit and could be
applied to either acute (0–14 day) or intermediate (15–365 day) exposure periods.
The acute MRL is based on the finding that a 1 Gy dose (1 Sv dose equivalent) results in a 25 IQ point
reduction (range = 21–29 points; mean = 25) (Schull et al. 1988).  This assumes that the relationship
between radiation dose and IQ point reduction is linear (Schull et al 1988).  After applying an uncertainty
factor of 3 (human variability/sensitive population), this results in an MRL of 0.004 Sv (0.4 rem).
There are recognized uncertainties in the results from both the Schull et al. (1998) and the Burt (1966)
studies.  Although the linear relationship developed for data from the Japanese fetal-exposed population is
strong, it has not been established that the linear relationship holds all the way to the lowest potential
exposure levels.  Another important uncertainty is the selection of an appropriate population IQ shift that 
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could be accepted as a non-adverse effect.  A change in median population IQ test results is far different
from natural fluctuations in individual test results or from the natural variation in a population (e.g.,
standard deviation in population IQ of 15 points).  Selection of a population shift of 0.3 IQ points is an
understandably conservative, yet appropriate, approach in setting a health guideline for acute exposures to
ionizing radiation.  Though the IQ reduction end point is based on a sensitive population (8–25 week-old
fetuses), ATSDR has applied an additional uncertainty factor of 3 for human sensitivity.
Our understanding of the health hazard posed by ionizing radiation will continue to expand and,
therefore, be subject to change.  As additional new information concerning the potential public health
impact of ionizing radiation becomes available, ATSDR will evaluate that information.  ATSDR will
continue to work with our Federal partners to ensure an up-to-date assessment of all relevant biomedical
data to protect the public from exposure to harmful levels of ionizing radiation.  The acute MRL value is
supportive of the Nuclear Regulatory Commission fetal protection dose equivalent of 5 mSv (500 mrem)
during the gestation period.  EPA has derived neither an RfD nor an RfC for ionizing radiation (IRIS 1999).
• An MRL of  1.0 mSv/yr (100 mrem/yr) above background has been derived for chronic-duration
external ionizing radiation exposure (365 days or more).
No individual studies were identified that could be used to base a chronic-duration external exposure
MRL that did not result in a cancer-producing end point. However, BEIR V (1990) reports that the
average annual effective dose to the U.S. population is 3.6 mSv/yr.  A total annual effective dose
equivalent of 3.6 mSv (360 mrem)/year to members of the U.S. population is obtained mainly by
naturally occurring radiation from external sources, medical uses of radiation, and radiation from
consumer products.  Since this annual dose of 3.6 mSv/yr has not been associated with adverse health
effects or increases in the incidences of any type of cancers in humans or other animals, the 3.6 mSv/yr is
considered a NOAEL for purposes of MRL derivation.  An uncertainty factor of 3 (for human variability)
was applied to the NOAEL of 3.6 mSv/yr to derive the MRL of 1.0 mSv/yr.
The chronic MRL value is supportive of the 1 mSv/yr (100 mrem/yr) dose equivalent limit to the public
that is recommended by the International Commission on Radiological Protection and required by the
Nuclear Regulatory Commission.  The EPA has derived neither an oral RfD nor an inhalation RfC for
ionizing radiation (IRIS 1999).  EPA has derived limits for concentrations of selected radioactive
materials in drinking water under the Safe Drinking Water Act.  The population is simultaneously 
IONIZING RADIATION 89
3. SUMMARY OF HEALTH EFFECTS OF IONIZING RADIATION
exposed to radiation through oral, inhalation, and external routes of exposure, and the chronic MRL is
applicable to the cumulative exposure by all routes. 
3.2.1  Acute (Immediate and Non-Carcinogenic) Effects from Ionizing Radiation Exposure
A considerable body of information is available in the literature on the acute exposure, high-dose health
effects of ionizing radiation.  Such health effects would not be possible from levels of residual radioactive
material at NPL sites.  There are three circumstances in which a person may conceivably be exposed to
acute high-level doses of ionizing radiation that would initially result in one or many immediate non-
carcinogenic effects.  One instance would involve being in the immediate proximity of an atomic blast, as
were the Japanese populations of Hiroshima and Nagasaki in August 1945 or the Marshall Islands fallout
victims injured from fallout from an atomic weapons blast on Bikini Atoll in March 1954.  The second
instance would be a laboratory or industrial accident, where only those onsite and involved with high
intensity radioactive sources or radiation generating equipment would be affected.  The third and most
likely opportunity for exposure to high levels (or repeated doses) of ionizing radiation would involve
medical sources in the treatment of disease (protracted exposures to x rays, fluoroscopy, radioiodine
therapy, etc.) or exposure to displaced medical or industrial radiography sources.  People who volunteer
to be exposed to ionizing radiation for the purpose of medical research also fall into the third category
(see Table 3-2).  People who have a large enough area of their body exposed to high doses (>100 rad) of 
radiation in any of these situations may exhibit immediate signs known as acute radiation syndrome.  In
addition to radiation sickness, overexposure to ionizing radiation can result in lens opacities (~0.2 Gy
threshold and protracted exposure), and fetal and developmental anomalies. 
The acute and delayed effects of exposure to ionizing radiation in humans and laboratory animals have
been studied quite extensively.  Laboratory animal data have provided a large volume of information
related to the health effects of radiation; however, the most useful information related to human health
effects comes from  human exposure data.  The data collected from the larger exposed populations, such
as those from Hiroshima and Nagasaki, some medically-exposed populations, or the radium dial painters,
have provided valuable information on both the acute and the delayed (long-term) health effects in
humans exposed to radiation from certain radionuclides.  A number of studies performed on smaller
groups of people as early as the 1930s have been recently identified and made public (DOE 1995).  These
experiments will not be discussed in depth in this toxicological profile (for reasons listed below), but will
be briefly summarized.  Most of these exposures to sources of ionizing radiation were performed in small 
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groups of human volunteers at a few institutions sponsored or supported by the Department of Energy
(DOE), U.S. Energy Research and Development Administration (ERDA), the U.S. Atomic Energy
Commission (AEC), the Manhattan Engineer District (MED), and the Office of Scientific Research and
Development (OSRD).  Other studies took place at universities, private hospitals, and other institutions. 
The bulk of these human studies may be categorized as either tracer studies, metabolism studies, dose-
response studies, or as experimental treatments for disease.  Many of the studies listed in the DOE report
were done before the 1970s, so the 1995 report represents the culmination of significant efforts to
assemble the appropriate documentation to reconstruct and describe the purpose of each experiment, the
experimental designs, the dates and locations of the exposures, the doses and routes of administration, the
population size and how the populations were chosen, the use of informed consent among these
individuals, and whether any of these individuals were followed through the remainder of their life in
order to determine possible delayed effects from exposures to these radionuclides.  In spite of the
problems associated with interpreting these experiments, they yielded a useful database of information
that describes the health effects of radiation exposure in humans.  Some of these studies are summarized
in Table 3-2.  
All cells that comprise the body’s tissues and organ systems are not equally sensitive to the biological
effects of ionizing radiation; the sensitivity of cells is affected by age at the time of exposure, sex, health
status, and other factors.  Cells that are rapidly growing and dividing (such as those found in the
gastrointestinal tract, bone marrow, reproductive and lymphoid tissues, and fetal nerve cells) are more
sensitive to the cytotoxic effects of ionizing radiation.  Higher doses showed more effects in the
gastrointestinal tract than in the bone marrow.  Tissues that undergo little cell growth and mitosis under
normal conditions (such as those found in the central nervous system, the adrenal, adipose, and
connective tissues, and the kidney) are more resistant to these effects, requiring a much larger acute
absorbed dose before outward toxicological effects may be observed.  Why are these growing and
dividing cells the most sensitive to the effects of ionizing radiation?  The answer relates to the effect on
the genome of the cell.  Ionizing radiation may damage the cell’s DNA (which the cell relies on to
manufacture proteins and enzymes, perform routine cell functions, and maintain cell integrity and
homeostasis) to the point that normal cell functions are markedly decreased or stopped, resulting in cell
damage and death.  Once damaged, the cell can either repair the damage or die. Repair or misrepair may
or may not result in cell lethality.  When precursor cells in the hematopoietic system (which multiply
quite frequently to replenish aging leukocytes) are damaged or die, leukopenia may occur in the
peripheral blood, leaving the body susceptible to infections and disease.  At ~0.5 Gy (50 rad), there may
be transient changes in formed elements of the blood in some individuals.  At 1 Gy (100 rad), most
individuals express transient 
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Table 3-2.  Summary of Some Studies of Humans Exposed to Radiation and Radionuclides 
Location Year(s) Radionuclide
Purpose of
experiment
Number
of people
dosed
Dose and route of
exposure Result
ANL 1931-
1933
226Ra Determine the
retention time of
226Ra in humans
NA 70–50 µg;
injected
 Incomplete
ANL 1943-
1946
x rays;
32P
Determine effects
of radiation,
process chemicals
and toxic metals in
humans
4 x rays: 30 R
32P: route not
specified
White blood cell chemistry
was important in assessing
the radiation sensitivity of
workers exposed to
radiation
ANL 1944-
1945
32P Study the
metabolism of
hemoglobin in
cases of
polycythemia rubra
vera
7 15–40 µCi;
route not
specified
NA
ANL 1962 3H Study the uptake
of 3H thymidine in
tumors and the
effects of 3H on
tumors
4 10 µCi; injected Similar growth was noted
in both cancerous and
non-cancerous cells
treated with 3H
ANL 1943-
1944
x ray Study
hematological
changes at varying
doses of radiation
in cancer therapy
14 27–500 R;
external exposure
Reduction of white blood
cells formed in lymphoid
tissue; routine monitoring
of blood components not a
practical way of assessing
the usual occupational
radiation exposures
ANL 1948-
1953
76As Determine effects
of 76As on hemato-
poietic tissues in
leukemia patients
24 17–90 mCi;
intravenous
76As as effective as more
commonly used leukemia
therapeutic agents.
BNL 1950 131I Determine the
usefulness of 131I
to treat patients
with Grave’s
Disease and
metastatic
carcinoma of the
thyroid
12 4–360mCi or
6–20 mCi; route
not specified
NA
BNL 1951 131I Study interaction
of the thyroid and
131I in children with
nephrotic
syndrome
8 NA Maximum uptake of 131I
was 30-60% of
administered dose
(3–5 µCi); no impairment
of I uptake in children with
nephrotic syndrome.
BNL 1952-
1953
42K
38Cl
131I (1 patient)
Examine formation
and cycling of
cerebrospinal fluid
(CSF)
2 NA; injected route
not specified
The amount of CSF
produced daily is small
and fluid production is not
solely produced by the
choroid plexus
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Table 3-2.  Summary of Some Studies of Humans Exposed to Radiation 
and Radionuclides (continued)
Location Year(s) Radionuclide
Purpose of
experiment
Number
of people
dosed
Dose and route of
exposure Result
BNL 1963 59Fe Study iron
absorption in
women with
various menstrual
histories
9 1–10 µCi; oral Menstrual blood loss in
women with excessive
bleeding was 110–550 mL. 
Normal women lost 33–59
mL during menstruation. 
Heavy menstruating
women had higher
gastrointestinal tract (GIT)
absorption of iron than
normal women
BNL 1967 47Ca Study the role of
dietary Ca in
osteoporosis
7 25 µCi;
intravenous
Diets high in Ca had a
small but positive impact
on osteoporosis
BNL Early
1970s
82Br Study the kinetics
of halothane
4 2.5 µCi; inhalation Concentrations of
halothane were initially
high in upper parts of the
body and low in lower
parts of the body. 
Diffusion equilibrium
throughout the body was
achieved in about 24
minutes.
HS 1963 131I Determine uptake
kinetics of 131I in
humans
8 NA.  Dairy cows
consumed 5 mg
to 2 g/day of I. 
Volunteers
consumed milk
produced by the
cows exposed to
131I in the diet.
Uptake of 131I in humans
was characterized.
LBL 1942-
1946
x ray Determine if blood
cell changes could
be used to indicate
exposure in
workers on the
Manhattan Project.
29 5–50 R, daily
dose
100–300 R, total
dose.
Whole body
external
exposure.
Significant deviations in
white blood cell counts,
anemia formed in relation
to dose.
LBL 1948-
1949
x ray Determine the
effects of radiation
on the pituitary
gland during
treatment of
cancers of other
tissues
> 1 8,000–10,000
rad; external
exposure
Pituitary is extremely
resistant to x rays.
LBL 1949-
1950
x ray Effect of radiation
on the pituitary
gland and its effect
on advanced
melanoma and
breast cancer.
3 8,500–10,000
rad; external
exposure
Pituitary is extremely
resistant to x rays.
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Table 3-2.  Summary of Some Studies of Humans Exposed to Radiation 
and Radionuclides (continued)
Location Year(s) Radionuclide
Purpose of
experiment
Number
of people
dosed
Dose and route of
exposure Result
LBL Early
1950s
60Co Determine
feasibility of
treating bladder
cancer using
beads labeled with
60Co 
35 5,000–6,000 rad
over 7 days. 
Beads were
placed inside the
bladder cavity.
Non-infiltrating cancers
were more successfully
treated than were the
infiltrating bladder cancers.
LBL 1961 90Y Determine the
effectiveness of
90Y in the
treatment of acute
leukemia in a child
1 200 rad to
lymphatic tissue;
route not
specified.
Therapy resulted in
temporary remission of
leukemia; little effect on
peripheral blood cells and
red blood cells.
LLNL 1980s 13N
41Ar
Determine the
uptake and
clearance of
nitrogen gas in
order to better
understand
“decompression
sickness” in deep-
sea divers.
11 NA.  Inhalation
route of
exposure. Doses
in the mCi range.
 
Absorbed dose to
the lungs
estimated to be
0.3–0.5 rad.
NA
LANL 1955 NA Obtain information
needed to plan for
the safe and
effective use of
military aircraft
near “mushroom
clouds” during
combat operation 
4 #15 R;
Inhalation and
external routes
were the likely
routes of
exposure.
No significant internal
deposition of fission
products or unfissioned Pu
were detected in urine or
via whole-body counting.
LANL 1961-
1962
85Sr Determine the
cutaneous
absorption kinetics
of 85Sr through
human skin
2 70 µCi;
dermal exposure
Absorption of 85Sr across
the skin was low, and
ranged from 0.2% to 0.6%
total absorption.
OR 1956-
1973
60Co
137Cs
Study efficacy of
total-body
irradiation on the
treatment of
leukemia,
polycythemia rubra
vera, and
lymphoma
194 50–300 R, one
person received
500 R; external
exposure
Higher frequency of
remissions after 150 R
compared to 250 R.  Total
body irradiation survived
as long-but not longer-than
patients treated with non-
radiation treatments
OR 1953-
1957
233U
235U
Study the
distribution and
excretion of
uranium in humans
NS. 4–50 mg;
intravenously
99% of injected uranium
cleared the blood within 20
hrs and the remainder
either deposited in the
skeleton and kidneys or
excreted via the urine
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Table 3-2.  Summary of Some Studies of Humans Exposed to Radiation 
and Radionuclides (continued)
Location Year(s) Radionuclide
Purpose of
experiment
Number
of people
dosed
Dose and route of
exposure Result
OR 1945 32P Study effects of
beta rays on skin
10 140–1,180 rad;
external
exposure.
Threshold dose of beta
radiation that resulted in
mild tanning was about
200 rad.  Erythema
resulted after a dose of
813 rad
UC 1937-
1954
x rays Study the effect of
x rays for the
treatment of
gastric ulcers
116 1,100–2,930 rad;
external exposure
Claimed that moderate
irradiation of the stomach
reduced acid secretion and
was a valuable adjunct to
conventional gastric ulcer
therapy.  Therapy was
later discontinued due to
risks outweighing benefits 
UC 1959 51Cr Determine
feasibility of using
implanted radiation
sources in the
treatment of
cancer
24 2–5 mCi;
Implanted within
cancerous tissues
16 had good or favorable
results; the remainder of
patients had questionable
or unfavorable results. 
Implants were generally
well tolerated.
UC 1960s Various. 
Fallout contains
many alpha,
beta, and
gamma
emitting
radionuclides. 
Simulated
fallout
contained 85Sr,
133Ba, or 134Cs
Gain information in
civil defense
planning prior to
nuclear fallout
10 0.2–0.7 µCi
actual fallout;
0.4–14 µCi
simulated fallout. 
Subjects ingested 
actual fallout from
Nevada test site,
as well as
simulated fallout
particles
No gastrointestinal
symptoms were reported. 
Studies provided a basis
for estimating the systemic
uptake and internal
radiation dose that could
result from the ingestion of
fallout after nuclear bomb
detonation.
UR 1946-
1947
234U
235U
Determine dose
level at which renal
injury is first
detectable;
measure U
elimination and
excretion rates
6 6.4–70.9 µCi/kg
intravenously
U excretion occurred
mainly via the urine and
70–85% was eliminated
with 24 hrs.  Acidosis
decreased U excretion. 
Humans tolerated U at
doses as high as 70 µg/kg
UR 1956 222Rn Determine
radiation doses to
different parts of
the respiratory
tract from inhaled
222Rn
2 0.025 µCi;
inhalation
Average retention of 222Rn
and daughter products in
normal atmospheric dust 
was 25%; retention in
filtered air was 75%. 
Radiation exposure to the
lungs was due to radon
daughter products rather
than by 222Rn itself.
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Table 3-2.  Summary of Some Studies of Humans Exposed to Radiation 
and Radionuclides (continued)
Location Year(s) Radionuclide
Purpose of
experiment
Number
of people
dosed
Dose and route of
exposure Result
UR 1966-
1967
212Pb Study absorption
of lead from the
gastrointestinal
tract and
determine the
radiation hazard
and chemical
toxicity of ingested
lead.
4 1 µCi intravenous
and/or 5 µCi
orally
Lead might be released
from binding sites only
when red blood cells die.
MISC 1950s 131I Study the
transmission of 131I
in maternal breast
milk to nursing
infants
2 100 µCi; oral 131I concentration in
maternal milk was high
enough to allow significant
uptake in the thyroids of
nursing infants.  131I tracers
should be used with
caution when nursing
infants.
MISC 1953 131I Study uptake of 131I
by the thyroids of
human embryos
NA 100–200 µCi
(maternal dose);
route not
specified
Pregnant women were
scheduled for abortion
prior to receiving 131I. 
Results indicated that it
would be unwise to
administer 131I for
diagnostic or therapeutic
purposes while pregnant.
MISC 1963-
1973
x rays Determine the
effects of radiation
on human
testicular function
60 7.5–400 rad;
external exposure
Doses of 7.5 rad yielded
no adverse effect on
testicular function.  27 rad
inhibited generation of
sperm, and 75 rad
destroyed existing sperm
cells.  Doses of 100–400
rad produced temporary
sterility.  All persons
eventually recovered to
pre-exposure levels prior
to vasectomy.
Source: Human Radiation Experiments Associated with the U.S. Department of Energy and its Predecessors.  U.S.
Department of Energy, Assistant Secretary for Environment, Safety, and Health, Washington, DC, July, 1995. 
Document #DOE/EH-0491
ANL = Argonne National Laboratory; BNL = Brookhaven National Laboratory; HS = Hanford Sites; LBL = Lawrence
Berkeley Laboratory; LLNL = Lawrence Livermore National Laboratory; LANL = Los Alamos National Laboratory;
ORS = Oak Ridge Sites; UCLA = University of California, Los Angeles; UCACRH = University of Chicago Argonne
Cancer Research Hospital; UR = University of Rochester; MISC = Other miscellaneous studies performed at other
institutions; NA = information not available.
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hematopoietic manifestations.  Similarly, the cells lining the gastrointestinal tract, which normally have
high turnover rates, will fail to multiply and replace dying cells, making the body susceptible to
malabsorption syndromes,  secondary bacterial infections, fluid loss and electrolyte imbalance.  Fetal
nervous system cells go through a period of rapid development between weeks 8–15, during which time
they are more sensitive to radiation damage.  Mechanisms by which ionizing radiation affects cells are
described in greater detail in Chapter 5 of this profile.  The phases of acute toxicity of ionizing radiation
are discussed in the following section.
Acute Radiation Syndrome (ARS).    Doses of radiation below 0.15 Gy (15 rad) produce no
observable symptoms or signs.  Lifetime radiation exposure from radioactive NPL waste sites, nuclear
power plant operations, consumer products, natural background radiation, and most hospital nuclear
medical tests are in this range.  As the radiation dose increases, subclinical responses begin to occur at
0.15–1 Gy (15–100 rad), and clinical responses occur from 0.5 to 30 Gy (50 to 3,000 rad).  Acute
radiation syndrome (ARS) is seen in individuals following acute whole body doses of 100 or more rad. 
The degree of ARS in humans may be classified by the absorbed dose and the time over which the energy
from the radiation is deposited in tissue.  The clinical phase can be divided  into four overlapping phases:
(1) a mild phase (0.5–1 Gy, 50–100 rad), (2) hematopoietic syndrome (1–8 Gy, 100–800 rad), (3) the
gastrointestinal syndrome (8–30 Gy, 800–3,000 rad), and (4) central nervous system syndrome (>30 Gy,
>3,000 rad).  If the energy is deposited over more than a few days (i.e., at a lower dose rate), the severity
of the effects may be greatly reduced and time of onset delayed. Each of these syndromes and the tissues
they are most likely to affect are briefly discussed below.
Subclinical Response  (0.15 to <0.5 Gy, 15 to <50 rad).    This phase is characterized by very
few, if any, clinical or hematological manifestations of illness.  There are no visible symptoms from this
level of radiation exposure.  Chromosomal breaks may occur within this dose range.  At around 50 rad,
there may be transient changes in formed elements of the blood in sensitive individuals.  
Clinical Response (0.5 to 30 Gy, 50 to 3,000 rad).    
0.5–1 Gy, 50–100 Rad.    This phase of ARS is characterized by mild, but non-specific signs of
toxicity.  At 100 rad, most individuals express transient hematopoietic manifestations.  Acute clinical
signs of toxicity appear within  4–8 hours of receiving the dose; these initially consist of nausea and
vomiting.  Within 7–15 days after exposure, a moderate leukopenia appears; however, blood cell counts
eventually return to normal within 4–6 weeks after exposure.  There is no perceptible decrease in mental
capabilities.  Rest, extra fluids, antibiotics, and self-care are generally all that is needed for these 
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individuals to fully recover.  Any treatment which is offered could include antibiotics and supportive care,
much the same as one may treat cold or flu symptoms.
Hematopoietic Syndrome (1–8 Gy, 100–800 rad).    This form of ARS is characterized by four
phases.  The first phase, the prodromal phase, typically lasts up to 2–3 days, depending on the dose; it is
characterized by fatigue, listlessness, and lethargy that progresses to headache, anorexia, nausea, and
vomiting within approximately 8 hours after initial exposure, depending on the dose.  Laboratory findings
are limited to varying alterations in the peripheral blood, with the earliest changes demonstrated as a
marked lymphopenia about 1 day after exposure.  The second stage, the latent phase, begins on the third
to fourth day and may last up to 3 weeks from the time of initial exposure.  This phase is marked by a
progressive decrease in total blood leukocyte counts and hair loss (epilation) toward the third week.  The
third phase, the symptomatic or bone marrow depression phase, is present 18–21 days after exposure. 
Chills, fever, malaise, a swollen oropharynx (throat), gingivitis, bleeding gums, petechiae (small blood
blisters), ecchymoses (bruises), anemia, and acute infectious diseases are characteristic of persons in this
phase.  The leukopenia and thrombocytopenia due to destruction of stem cells in the red marrow
undermine the body's natural defenses against disease and hemorrhage, leaving the body susceptible to
acute infections and illnesses.  Depending on the dose and the aggressiveness of the treatment protocols,
the clinical picture can vary from serious to fatal.  The fourth phase, the recovery phase, is marked by a
general improvement of the patient over a 3–6 month period.  For doses from 1 to 6 Gy (100 to 600 rad),
the prognosis for recovery is good; for doses of 6–8 Gy (600–800 rad) the prognosis is poor, but some
victims are expected to survive if they receive aggressive medical treatment. The LD50/30 for whole body
irradiation is estimated to be between 350 and 450 rad (3.5–4.5 Gy) for those who receive minimal or no
medical treatment.
Gastrointestinal Syndrome (8–30 Gy, 800–3,000 rad).    The prodromal phase of this syndrome is
very abrupt in onset, characterized by nausea and diarrhea, which typically subsides after several days,
followed by a short latent period.  Symptoms then return, which include white blood cell depression as
seen in the hematopoietic form of ARS, nausea, vomiting, diarrhea (sometimes bloody), fever, and
massive electrolyte imbalances, which ultimately will result in death.  Treatments are palliative.  Persons
exposed to absorbed doses of 10 Gy (1,000 rad)  are expected to die, although aggressive medical
intervention may improve survival rates.  There is one exception.  If the dose is fractionated, as with bone
marrow transplant patients who receive a standard whole body dose of 15.75 Gy (1,575 rad) and are well-
managed, with fluids, antibiotics, and a sterile environment, the individual has a reasonable chance of
survival.
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Central Nervous System Syndrome (30 Gy, 3,000 rad).    Symptoms in this syndrome
classically have an immediate onset, and include violent nausea and vomiting, diarrhea, irrational
behavior, circulatory system collapse, and neuromuscular incoordination occurring within a few minutes
after irradiation.  Convulsions, coma, and death ensue within 48 hours after irradiation.
The phases of acute radiation effects discussed above are summarized in Table 3-3. 
Studies of Acute Effects.      Most studies which showed acute radiation effects were from external
radiation, indicating that internally-deposited radionuclides typically do not produce sufficient dose and
dose rate to induce acute effects.  As  Table 3-3 shows, the overt signs of radiation toxicity  follow a dose-
effect relationship as long as the radiation dose rate is high.  Individuals exposed to single acute doses of 
radiation that are less than 1 Gy (100 rad) experience few if any significant clinical signs of toxicity;
however, as the dose is doubled (2 Gy, 200 rad), some systems begin to show signs of overt toxicity.  At
this dose, the cells that multiply the most rapidly (gastrointestinal cells, blood-forming cells) are only
being mildly affected (nausea/vomiting, leukopenia).  Red blood cell precursors are also likely to be
affected at this dose; however, because of the lifespan of a peripheral red blood cell (90–120 days),
anemia may not become clinically evident for several days or weeks after exposure.  Cells that proliferate
more slowly (e.g., the cells of the central nervous system, connective tissues, etc.) are largely unaffected. 
As the absorbed dose increases to 6 Gy (600 rad), more severe changes in the hematopoietic and
gastrointestinal systems  present as more intense, quicker onset vomiting for longer durations and severe
white blood cell depression (leukopenia).  Infections are of a greater concern, since the white blood cell’s
main defenses against infectious  microorganisms (gastrointestinal cell barriers, neutrophils, lymphocytes)
are severely compromised or non-functional.  Coagulapathies begin to appear due to platelet anomalies
(pupura, hemorrhage) as well as hair follicle death (hair epilation).  Also at this dose, the first signs of
central nervous system disruption begin to appear, with short periods of decreased cognitive abilities.  As
the dose of ionizing radiation increases beyond 8 Gy (800 rad), a dose-dependent increase in the severity
of the hematological, gastrointestinal, and central nervous system toxicity occurs, and death will likely
ensue due to catastrophic multi-organ failure, including complete destruction of the blood forming cells in
the red marrow and destruction of the basement cells in the lining of the intestinal walls.
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Death has been reported soon after an individual has received a very high single or multiple external
radiation dose.  Most of these studies have in common very high doses (several hundred to several
thousands of rad) being administered over a relatively short period of time (acute exposure), usually over
the course of minutes or hours.  This was seen  in the human case report by Stavem et al. (1985) in which
a worker was exposed to 2,250 rad (22.5 Gy) within a few minutes time, resulting in death due to acute
radiation sickness (depressed leukocyte counts, vomiting, diarrhea, etc).  
There are many reports of studies in which animals inhaled large activities of soluble and insoluble
particles.  The inhalation studies pointed to a number of immediate or near-immediate causes of death,
including bone marrow hypoplasia (Gillette et al. 1987a); radiation pneumonitis and fibrosis (Brooks et
al. 1992; Hahn et al. 1981, 1987; Lundgren et al. 1991); and blood abnormalities, such as
thrombocytopenia, neutropenia, lymphopenia, and anemia (McClellan et al. 1973).  Death is most likely a
result of these systems being adversely affected by the deleterious effects that radiation has on the cell
functionality within these organ systems.  The overwhelming damage that radiation induces in rapidly
dividing (or undifferentiated) cells at these high doses (i.e., cell functional loss, necrosis, apoptosis, and
death of precursor cells) leads to decreased numbers of functional cells for an extended period of time,
leaving the body highly susceptible to systemic infections that can lead to organ failure and death.   It has
been suggested that the damage to lung tissue from radiation is principally vascular, with the sloughing of
dead and dying endothelial cells causing capillary leakage, both interstitially and onto the alveolar
surface.  Another theory suggests that the damage to type II pneumocytes causes serious alterations in the
amount of surfactant phospholipids, ultimately altering the normal functioning of the lung and leading to
lung inflammation.  A third theory suggests that type I pneumocytes necrose and slough, leaving denuded
basement membranes and alveolar debris.  Finally, a few researchers believe that the role of lymphocytes,
the immune system, and the interaction of bacteria plays a major part in the induction of radiation
pneumonitis (Coggle et al. 1986).  In the case of experimental animals given acute doses, causes of later
in life are primarily related to the cancerous effects (Boecker et al. 1988; Lloyd et al. 1994).
The clinical signs of toxicity from high radiation doses follow the classic dose-effect curve, with some
organs more severely affected at each dose than others.  A number of studies have been summarized that
describe the no-observed-adverse-effect level (NOAEL) and the lowest-observed-adverse-effect level
(LOAEL) of ionizing radiation on multiple body systems.  These data are summarized in the Levels of
Significant Exposure to Radiation and Radioactive Material tables in Chapter 8 of this profile.  More
specific information on some organ systems affected after receiving high doses of ionizing radiation is
discussed in more detail below.
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3.2.1.1 Gastrointestinal Effects 
Prominent gastrointestinal effects due to high acute doses of radiation can occur, usually after oral intakes
of radionuclides or after whole-body exposures.  Localized doses of external radiation of about 1,000 rad
(10 Gy), have been reported to cause inflammation and swelling of the oral cavity, including the cheeks,
soft and hard palate, tongue, and throat.  The large doses necessary to cause these effects and the absence
of effects following dental x rays demonstrate that salivary glands are not very sensitive to radiation.  The
structures near the stomach, which have stratified squamous epithelial coverings, seem to be much less
severely affected than the stomach, small and large intestines, and colon, largely due to the lower cell
turnover rates associated with this type of epithelium.  The gastrointestinal epithelium, which includes the
epithelium covering the stomach and intestines, is the most sensitive to the effects of radiation due to the
high cell turnover rates. Very large doses (>1,000 rad, 10 Gy) to the germinal epithelium of the stomach
and intestines damage these cells, rendering them unable to divide and replace older, more senescent cells
lining these structures.  As a result, ulceration, sloughing of cells, diarrhea, and hemorrhage may occur,
leading to the gastrointestinal syndrome described in Table 3-3 (Adams and Wilson 1993). 
Numerous laboratory animal studies identified gastrointestinal effects after exposure to high-level
radiation.  For example, male Swiss albino mice were injected with tritiated water with a specific activity
of 10 mCi/mL, followed by maintenance on tritiated drinking water at 2.5 µCi/mL for 12 days.  Mice
were estimated to have cumulative doses of 116, 440, 1,320, 2,200, and 5,280 mrad (1.2, 4.4, 13.22, and
5.3 mGy) for the 0.25, 1, 3, 5, and 12 days of treatment, respectively.  A significant decrease in the total
cell population and mitotic figure per crypt section was observed 6 hours after exposure; the decrease
continued through day 1.  After that, the total cell population stayed at a constant value for 3–5 days),
after which it showed a significant increase on day 12.  The number of mitotic figures increased slightly
on day 3 followed by a decrease on day 5, but these changes were not significant.  On day 12, the mitosis
also increased slightly.  The number of pycnotic nuclei and necrotic cells increased significantly 6 and 24
hours after exposure, and then decreased on day 3.  After that, the number of cells increased again on day
5.  The number of cells per villus column showed a significant decrease 6 hours after exposure; this
decline continued up to day 5, when the cell count was 67.5% of normal (control).  After this, the count
showed a significant increase on day 12.  The villus height was slightly reduced 6 hours after exposure,
and significantly reduced from day 1 to 5.  The height was 81% of normal at day 5, and 91.5% of normal
at day 12.  In summary, all of the parameters studied showed partial recovery towards normal on day 12
at the doses tested (Kumar et al. 1983).
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Gastrointestinal effects have also been described after inhalation exposure to radionuclides.  Gastro-
intestinal effects are most likely due to inhaled particles lodging in the nasopharyngeal mucus and in the
tracheobronchial mucus layers of the conducting airways of the lungs and then being carried up the
airways, where they enter the pharynx and are swallowed.  Several reports describe such gastrointestinal
effects after inhalation exposure.  Gillett et al. (1987a) exposed young adult Beagle dogs (12–14 months
old) once to soluble aerosols containing 90SrCl2.  Different airborne concentrations (2.16–418.5 µCi
90Sr/L) and exposure durations (2–22 minutes) were used to produce graded levels of initial lung burdens;
72 Beagle dogs were exposed, and another 25 unexposed dogs served as controls.  The long-term retained
burden ranged from 1.0 to 118.8 µCi  90Sr/kg body weight.  Clinical signs of radiation-induced illness
appeared about 2 weeks after exposure.  The first signs, fever and anorexia, including bloody diarrhea,
developed during the last 48 hours before death.  In another study, Hahn et al. (1975) studied the effects
of 90Y laden particles clearing to the gastrointestinal tract after an acute-duration inhalation exposure.  Ten
Beagle dogs were exposed by nose-only inhalation to aerosols of 90Y in fused-clay particles; three control
dogs were exposed to fused clay only.  Gastrointestinal burdens ranged from 8 to 34 mCi.  A rapid initial
decrease in body burden occurred (typical of an insoluble material deposited by inhalation), which was
largely due to the clearance of particles from the upper respiratory tract through the gastrointestinal tract
by way of mucociliary clearance mechanisms in the respiratory tract; 4 of 6 dogs with 18–34 mCi gastro-
intestinal burden developed a mucoid diarrhea.  The dog with the highest exposure developed
hemorrhagic diarrhea; 2 of 7 dogs exposed to 18–32 mCi gastrointestinal tract burden (32–50 mCi whole-
body burden) developed colitis.  At necropsy, lesions were found to be confined to the colon, except for
one dog with ulcerative esophagitis.  No gross lesions were seen in the stomachs or small intestines of any
of the dogs; no histologic lesions were found.  In the dogs with colitis, ulcerative and atrophic foci were
scattered in the terminal third of the colon.  Loss of mucosal epithelial cells and collapse of the lamina
propria were the most severe pathologic alterations in the colon.  The colon received the highest radiation
dose in the two exposed dogs, although the stomach and small intestines also received significant doses. 
Of the two dogs sacrificed at 8 days postexposure, the only lesions that were seen at necropsy were in the
colon of the dog that received an estimated 3,200–5,700 rad (32–57 Gy).  No lesions were seen in the
intestines of the dog that received 2,800 rad or less.  Lesions were most likely in response to a high dose
of ionizing radiation due to the long transit time of the radiolabeled material through the colon (increased
exposure time).
Similar effects from external gamma radiation have been reported.  In one human case report, Stavem et
al. (1985) described a 64-year-old male worker who accidentally received a large dose of gamma
radiation in a plant for sterilizing medical equipment.  He was exposed for only a few minutes and was 
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most likely exposed to a mean whole-body dose of 2,250 rad.  The worker developed ARS. 
Histologically, the mucosa of the gastrointestinal tract (and respiratory tract) showed only a few
mononuclear cells, and no granulocytes.  There was slight atrophy of glands in the stomach, marked
atrophy in the small intestine, and total atrophy of the glands in the large intestine.  As in humans,
laboratory animals exposed to extreme doses of external radiation exhibit effects on the exposed organ
systems.  A group of 12 male BALB/c mice was exposed to a single whole-body dose of 1,500 rad
gamma rays from a 60Co source.  The degree of gastrointestinal motility and the condition of the
abdominal blood vessels, spleen, and the contents of the stomach and intestine were examined 1 hour, 3
hours, 18 hours, and 3 days after irradiation.  Gastrointestinal mobility was present at all times after the
exposure. Vascular dilatation was absent at all times.  Lumial contents were present 1–3 hours after the
exposure and slightly present 18 hours to 3 days after the exposure.  The mucosal surface displayed
changes in the shape of the villi, with rudimentary villi being the most advanced type of collapse seen. 
Villus shape changes were seen at all times post-exposure.  Changes in tissue structure were seen at the
18-hour time point including less distinct crypts with disintegrating cells present (Indran et al. 1991).  Ijiri
(1989), studying the influence of circadian rhythm on apoptosis, found that gamma irradiation (from
137Cs) between 0900 and 1500 hours caused a higher incidence of apoptotic cells in the small intestine of
male C57BL/6crSlc mice than irradiation between 2100 and 0300 hours, irrespective of dose rate; similar
differences, but with lower incidences of apoptotic cells, were also noted in the descending colon.  The
mean lethal dose values for continuous irradiation with gamma rays were 21 rad (0.21 Gy) for the cells of
the small intestine and 38 rad (0.38 Gy) for the cells of the descending colon, and the respective values
for HTO (beta radiation) were 13 and 28 rad (0.13 and 0.28 Gy), indicating the high radiosensitivity of
these  cells.
In summary, higher doses, starting in the range of 200–300 rad (2–3 Gy), are required to produce effects
in the gastrointestinal tract than in bone marrow.  The severity of effects follows a typical dose-effect
relationship.  The cells responsible for lining the tract frequently undergo mitosis, leaving them
particularly susceptible to DNA damage, cell death, and altered cell kinetics that affect the cell’s ability to
proliferate.  These effects include karyorrhexis (fragmentation of a nucleus with scattering of pieces in the
cytoplasm), pyknotic nuclei (having polymerized and contracted chromosomal components), necrosis,
decreased number of cells/villi, and changes in shapes of the villi and mucosal surfaces.  The damage to
the epithelial lining cells results in the loss of the natural barrier between intestinal microbes and the
body, making it susceptible to systemic infections, fluid imbalances and losses, bloody diarrhea, colitis,
and a host of other clinical signs, depending on the radiation dose (Gillett et al. 1987a; Hahn et al. 1975;
Kumar et al. 1983).
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Data for acute gastrointestinal effects in humans and laboratory animals from large doses of radiation are
summarized in the Levels of Significant Exposure to Radiation and Radioactive Material tables in
Chapter 8 of this profile.  
3.2.1.2 Hematological and Lymphoreticular Effects
Hematological effects are one of the syndromes seen after acute doses to bone marrow (see Table 3-3) of
about 50 rad (0.5 Gy).  The magnitude of effect on hematopoiesis is dependent on the total dose absorbed,
regardless of the route of exposure.  As Table 3-3 shows, hematological symptoms begin to occur at doses
of 100–200 rad (1–2 Gy).  Like the gastrointestinal system, the hematopoietic system contains a large
population of cells that requires the frequent replacement of senescent cells.  To meet this need, a pool of
undifferentiated precursor cells called stem cells in the red marrow of many bones (e.g., ribs, pelvis,
vertebrae, skull, and ends of long bones) undergo high rates of mitotic activity and differentiate into the
various cell types to replace those that die off naturally.  This pool of cells is critical for the production of
replacement cell populations for erythrocytes, granulocytes, lymphocytes, and thrombocytes.  The dose of
radiation received by stem cells damages or kills these cells, thereby depressing the marrow activity,
resulting in anemia, leukopenia, thrombocytopenia, septicemia, infections, and death.  The severity of
these lesions depends on the depression of bone marrow activity due to the total dose absorbed, with
irreversible total destruction resulting from doses to the red marrow on the order of 800 or more rad
(8 Gy). 
As an example of hematological lesions in humans obtained after exposure to ionizing radiation, Klener et
al. (1986) reports one case in which a man was accidentally irradiated by a sealed 60Co source.  His health
status was followed for 11 years after the accident.  A film dosimeter worn during the accident indicated
an exposure of 159 rad (1.59 Gy).  Twelve to 24 hours after the accident, the worker felt general malaise
without vomiting; however, a blood count showed no marked deviations from normal.  Eight days after
the accident, he developed minor deviations in peripheral blood counts.  Leukocyte values were lowest
31–49 days after exposure.  The lymphocyte count was normal the first day after the accident, but
decreased on days 19–23 and day 49.  Neutrophils with coarse granulations and hypersegmentation of
nuclei were observed.  In another acute exposure case, Stavem et al. (1985) reported on a 64-year-old
male worker who was accidentally exposed to gamma radiation in a plant that used ionizing radiation for
sterilization purposes.  He was exposed for only a few minutes and received an estimated 2,250 rad
(22.5 Gy).  The worker developed ARS, with the leukocyte count rapidly diminished to low values. 
Extensive chromosome injuries were seen in cultured blood lymphocytes, and virtually no undamaged
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cells were found.  The worker died 13 days after exposure.  An autopsy found the bone marrow to be
markedly hypocellular with a few scattered plasma cells.
Hematological effects have been reported after inhalation exposures in laboratory animals.  The effects
depend on the dose absorbed.  Brooks et al. (1992) exposed male monkeys, divided into mature
(5.0±0.5 kg) and immature (2.1±0.3 kg) groups, to an aerosol of 239Pu (NO3)4 by nose-only inhalation to
produce projected initial lung burdens of either 1.08, 0.27, or 0.1 µCi (40, 10, or 3.7 kBq).  No significant
changes in blood lymphocyte numbers were observed.  Gillett et al. (1987a) exposed young adult Beagle
dogs (12–14 months old) to soluble aerosols containing 90SrCl2.  A review of the hematological
parameters of all dogs showed a similar, consistent, and dose-related pancytopenia in those animals
having a long-term retained burden greater than 10 µCi (370 kBq) 90Sr/kg.  A profound dose-related
depression of platelet counts was also found.  Decreases in platelet numbers were manifested by 7 days
and were maximal by 28 days.  Platelet counts were depressed in all exposed groups, compared to
controls, when evaluation was extended to 1,000 days after exposure.  Platelet counts among animals
having a long-term retained burden greater than 40.5 µCi (1,500 kBq) 90Sr/kg frequently fell to less than
10% of pre-exposure values.  Animals having slightly lower long-term retained burden also exhibited
depressed but less severe thrombocytopenia.  The degree of platelet depression was related to the degree
of long-term retained 90Sr.  The decline in platelet counts seen in dogs with a long-term retained burden of
27.0–118.8 µCi 90Sr/kg at 1,000 days was also associated with the presence of hemangiosarcomas. 
Thrombocytopenia and neutropenia persisted in all exposed dogs through 1,000 days after exposure. 
Lymphocyte numbers were also depressed in a dose-related manner at activity concentrations greater than
10 µCi (370 kBq) 90Sr/kg.  Reduced erythrocyte mass occurred in dogs having a long-term retained
burden greater than 10 µCi (370 kBq) 90Sr/kg between 14 and 21 days after exposure.  Red blood cell
counts fell to 70–80% of pre-exposure values, with maximal depression at 32 days.
Hobbs et al. (1972) also observed dose-related clinical, hematological, serum chemical, and pathological
alterations more than 1 year after intake.  Thirty-three Beagle dogs were given lung burdens of 3,600,
1,800,  1,200, 780, 400, 210, 110 and 0 µCi (133, 67, 44, 29, 15.8, and 4 MBq) 90Y/kg body weight. 
Cumulative doses between 990 and 55,000 rad (9.9–550 Gy) to the lungs through the end of the study or
the death of the animals were reported.  Dogs that had initial lung burdens of 670–760 µCi/kg
(25–28 MBq) and radiation doses to lung of 8,400 to 9,400 rad (8.4–9.4 Gy) and died within 31 days after
intake had a dose-related depression of circulating lymphocytes (lymphopenia), as well as a marked 
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marrow suppression and deletion of hemic elements.  Rib marrow was depopulated in dogs that died after
31 days. 
Exposure to primarily β and γ radiation from external sources yielded similar results.  Seed et al. (1989)
exposed male and female Beagle dogs to 7.5 rad/day (0.075 Gy/day) gamma radiation for 150–300 days
from a 60Co source.  The irradiated dogs showed a significant suppression/recovery pattern for the five
circulating types of cells studied (granulocytes, monocytes, platelets, erythrocytes, and lymphocytes),
compared with levels from the control animals.   These daily doses were high and would have likely been
fatal if the entire dose had been received within a period of a few days.
A large number of reports are available in the literature regarding immunological effects associated with
radionuclides that have been inhaled by laboratory animals.  Lymphopenia is a common sequela of
exposure to ionizing radiation affecting the immune system of both humans and animals.  Gillett et al.
(1987a) exposed young adult Beagle dogs (12–14 months old) to soluble aerosols containing 90SrCl2 and
found that lymphocyte numbers were depressed in a dose-related manner at exposures greater than 10 µCi
90Sr/kg.  Benjamin et al. (1976) exposed 6 Beagle dogs, (3 males and 3 females, 17–20 months old) by
nose-only inhalation to 90Y, 144Ce, or 90Sr in fused-clay particles.  Initial lung burdens were 560, 46, and
28 µCi/kg (21, 1.7, and 1.0 MBq/kg)  for 90Y, 144Ce, and 90Sr, respectively.  Cumulative absorbed dose at
death or at sacrifice after 44 weeks were 8,700, 42,000, and 39,000 rad (87, 420, and 390 Gy) for 90Y,
144Ce, and 90Sr exposures, respectively.  Lymphopenia was observed in dogs exposed to 90Y within several
days after intake and was statistically significantly depressed though 8 weeks but returned to control
levels by 16–20 weeks.  No change in peripheral lymphocytes was observed.  Lymphocyte counts in dogs
exposed to 144Ce were significantly lower (lymphopenia) than controls from 4 to 28 weeks after exposure. 
In a study conducted by Lundgren et al. (1976), the effect of 90Y inhaled in fused-clay particles on the
pulmonary clearance of inhaled Staphyloccus aureus in mice was investigated.  Groups of male CFW
mice were exposed to 90Y for 10–20 minutes.  Aerosol concentrations ranged from 14.5 to 428 µCi/L
(0.5–16 MBq/L) air and the activity median aerodynamic diameter (AMAD) ranged from 0.7 to 1.4 µm. 
The initial lung burden ranges of the groups were 2.5–4, 7–12, 20–47, and 50–76 µCi in experiment I and
5–7 and 8–12 µCi in experiment II.  Pulmonary clearance of inhaled S. aureus was suppressed in mice
with an initial lung burdens of 20 µCi 90Y or greater at 2, 3, and 4 weeks after exposure.  Lymphocyte
counts were suppressed in the 20–47 µCi and 50–76 µCi groups at 2 weeks postexposure and in the
50–76 µCi group at 3 weeks after intake.  Clearance of bacteria at a reduced rate was observed in
20–47 µCi mice at 2, 3, and 4 weeks and in 50–76 µCi mice at 2 and 3 weeks after intake.
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Similarly, Hobbs et al. (1972) observed dose-related pathological alterations more than 1 year post-
exposure in 33 Beagle dogs exposed to 90Y.  Of the 33 dogs exposed, 21 with initial lung burdens from
670 to 5,200 µCi/kg (25–192 MBq/kg) and radiation doses to the lungs ranging from 8,400 to 55,000 rad
(84–550 Gy) died between 7.5 and 163 days after intake.  Tracheobronchial lymph nodes (TBLNs) in the
early deaths showed marked lymphoid depletion, some sinus hemorrhage, and, later, phagocytosis of
hemosiderin pigment.  In the dogs that died 38 days or more postexposure, the nodes were enlarged and
exhibited hyperplastic repopulation of lymphocytes.  Hahn et al. (1976) also studied the effects of
exposure on TBLNs in 16 male and 14 female Beagle dogs exposed by nose-only inhalation to aerosols of
144Ce in fused-clay particles.  Between 2 and 730 days postinhalation, the 144Ce dose to TBLNs ranged
from 240 to 230,000 rad (2.4–2,300 Gy).  The concentration of 144Ce in the TBLNs increased during the
first year after exposure as a result of the translocation of 144Ce from the lungs via the lymphatics. 
Histologically, the changes were atrophic in nature.  The cortex showed progressive reduction in size with
increasing time after intake; by 730 days after intake, there was little cortex remaining.  Fibrosis was first
noted 128 days after intake and was more severe at each succeeding time period up to 730 days.  There
was also a loss in numbers of lymphocytes in the paracortical area 56 days after intake, although this loss
was not as severe as the depletion of lymphocytes from the cortex.  At later times the cortical and
paracortical areas were nearly devoid of lymphocytes and were populated mainly by macrophages. 
Particles could be seen in macrophages 2 days after inhalation exposure.  The authors note that since
lymph nodes play a key role in immunologic responses associated with humoral antibody production and
cell-mediated immunity and, in view of the severe atrophy and fibrosis in the TBLNs in the dogs in this
study, the immunologic function in the TBLNs would seem to have been severely impaired.
Lymphocytes are responsible for providing cell-mediated and humoral-mediated (antibodies) resistance to
infection.  Galvin et al. (1989) evaluated the cell-mediated and humoral immune responses to 239PuO2 in
the blood and lung lavage fluid.  Four Beagle dogs per group (8 total) were exposed to monodisperse
aerosols (0.72–1.4 µm AMAD) of 239PuO2, with initial  lung burdens ranging from 0.51 to 0.95 µCi
(0.02–0.04 MBq).  Cumulative dose ranges were 1,400–2,400 rad (14–24 Gy) to the lungs;
620,000–930,000 rad (6,200–9,300 Gy) to the TBLNs; 290,000–440,000 rad (2,900–4,400 Gy) to the
mediastinal lymph nodes; 200–300 rad to (2–3 Gy) the sternal lymph nodes; and 2–3 rad (0.02–0.03 Gy)
to the spleen.  The dog with the highest cumulative dose to the TBLNs (930,000 rad, 9,300 Gy) was the
only dog noted to have had chronic lymphopenia; blood cell counts of the other 3 dogs showed normal
lymphocyte counts.  TBLNs of all dogs displayed severe diffuse fibrosis and atrophy with elimination of
all lymphatic cells and follicles.  Lymphatic vessels were moderately to markedly distended.  The spleen 
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and other peripheral lymph nodes were histologically normal.  Systemic humoral response induced by
lung immunization was not different in the age-matched and exposed groups.  Peak humoral immune
response (lung lavage, immunoglobulin G [IgG]) measured in immunized lung lobes of exposed and
control dogs was significantly greater than saline-lavaged control lung lobes.
Leukopenia (severe lymphopenia and granulocytopenia) and splenic congestion were found in one male
worker who accidentally received  an external gamma dose of 2,250 rad (22.5 Gy) (Stavem et al. 1985). 
Mazur et al. (1991) exposed male Swiss mice to a single dose of 1,000 rad (10 Gy) whole-body
irradiation from a 60Co source.  Spleen weights were significantly lower in the irradiated group during the
24-hour period.  No statistically significant differences in acid phosphatase activity were seen in the
spleens and livers of radiation-exposed mice; however, the acid phosphatase activity in the spleen and
liver was statistically significantly higher in the irradiated rats as compared to controls.  An increased
activity of beta-glucuronidase was seen in the spleen, but the enzyme activity did not differ from controls
in the liver. 
In summary, the hematological and lymphoreticular systems are target systems susceptible to the effects
of ionizing radiation, the severity of which occurs in a dose-dependent manner.  As  with the
gastrointestinal tract, the hemopoietic system is largely composed of undifferentiated rapidly dividing
cells, making it more susceptible to the toxic effects of ionizing radiation than are the  tissues composed
of highly differentiated more slowly dividing cells (central nervous system).  In many of the studies,
pancytopenia was one of the first major peripheral blood changes to occur.  Neutrophils have a naturally
short lifespan in the peripheral blood (12–48 hours) and depend upon constant replenishment by the bone
marrow to adequately defend the body against infection.  Acute high (sublethal) radiation doses from an
external source or from inhaled or ingested radionuclides that distribute to bone and irradiate the sensitive
cells in the bone marrow will first noticeably affect the progenitor cells that produce leucocytes, since
their turnover rates for this cell type are very high.  The immediate peripheral blood counts of red blood
cells with longer lifespans in the peripheral blood and lower turnover rates will not be affected because of
their long lifetime (3–4 months).  Radionuclides that preferentially distribute to the bone for long periods
of time will, if the dose is high, cause prolonged depression of most red and white blood cell types, due to
constant irradiation of the bone marrow components.  Anemias, thrombocytopenia, and leukopenias (all
cell types) are also frequent findings in such situations (Benjamin et al. 1976, 1979; Davila et al. 1992;
Gillette et al. 1987a; Hahn et al. 1976; Hobbs et al. 1972).  Animals administered sublethal doses of
ionizing radiation have the ability to recover from these effects once the radiation source is removed
(Gidali et al. 1985; Hobbs et al. 1972; Seed et al. 1989, 1993) or its dose rate is sufficiently reduced.
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The data for hematological and lymphoreticular effects in humans and laboratory animals are summarized
in the Levels of Significant Exposure to Radiation and Radioactive Material tables in Chapter 8 of this
profile.  Because of the high threshold dose for changes in peripheral blood counts, blood counts are not
used to routinely monitor the health of radiation workers.
3.2.1.3 Reproductive Effects
Cells that reproduce frequently, such as those found in intestinal crypts, bone marrow, and the
reproductive systems of animals, are more radiosensitive than cells that are highly differentiated and
reproduce slowly.  This radiosensitivity is dependent on of the type of ionizing radiation or the source. 
Specific cells in the reproductive tract of both males and females replicate at accelerated rates, making
them more at risk to the effects of ionizing radiation.  In males, the spermatogonia are the cells most
sensitive to the effects of ionizing radiation.  These are the germ cells responsible for producing
spermatocytes and later, spermatids and mature sperm.  Spermatids and sperm are very radioresistant to
cytotoxic effects of radiation. Decreases in sperm numbers in semen do not occur immediately; in
humans, decreased sperm counts are not seen until 30–45 days after significant exposures.  Azospermia
can occur 10 weeks after exposure to absorbed doses >100 rad (1 Gy); a dose of 250 rad (2.5 Gy) may
cause sterility for 1–2 years.  An absorbed dose of 600 rad (6 Gy) can cause permanent sterility (Adams
and Wilson 1993).  In females, the mature oocyte is less sensitive than male spermatogonia cells, but it is
the most radiosensitive reproductive cell.  Absorbed doses of 65–150 rad (0.65–1.5 Gy) have been
reported to produce temporary sterility (Adams and Wilson 1993); however, a fractionated dose of
600–2,000 rad (6–20 Gy) can be tolerated (BEIR V 1990).
Several studies were found in the literature that support these findings.  In one human study, Birioukov et
al. (1993) investigated the reproductive effects of ionizing radiation in 12 men (29–78 years old) with
chronic radiation dermatitis caused by accidental exposure to beta and gamma radiation during and after
the Chernobyl nuclear reactor accident.  These men were examined for changes in sexual behavior,
hormonal status, and spermatogenesis.  All were diagnosed with ARS, which was categorized as first
degree (100–200 rad, 1–2 Gy), second degree (200–350 rad, 2–3.5 Gy, Group A), and third degree
(350–550 rad, 3.5–5.5 Gy, Group B) based on their location at the time of the incident.  Of the 12 men
evaluated, 9 reported decreased sexual potency, and 3 refused to answer the question.  Two patients
reported impotence, and seven patients had decreased libido.  The sperm of 7 patients were examined
(5 refused to give a semen sample).  All patients tested had normal semen pH values.  Other sperm 
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anomalies reported in both groups A and B included azoospermia, asthenospermia, and teratospermia. 
Others had slightly increased numbers of abnormal cells (morphological changes in the sperm head). 
Abnormal motility was present in all but one patient (in group B).  Follicle-stimulating hormone was
increased in 6 of 9 patients in group A and was normal in group B patients.  Testosterone was decreased
in 2 patients in each group.  A decrease of luteinizing hormone and an increase of prolactin were
measured only in 1 patient.
Similar reproductive effects have been noted in laboratory animals.  Ramaiya et al. (1994) performed a
comparative estimation of the frequencies of genetic disorders induced in germ cells of male mice by a
single or long-term exposure to incorporated 137Cs.  Groups of 10 male mice received a single oral
administration of 0.1, 0.5, 1.0, 2.0, and 3.0 µCi/g (3.7, 18, 37, 74, and 111 kBq/g) as 137Cs.  Groups of
10–30 males were also given daily injections of 137Cs nitrate in phosphate buffer solution for 2 weeks at
activities of 0.5, 2.0, and 5.0 µCi/g (18, 74, and 190 kBq/g)  as 137Cs.  The total absorbed dose to the
testes during the 5 weeks after the single oral exposure was 10, 50, 100, 200, and 300 rad (0.1, 0.5, 1.2,
and 3 Gy), respectively, while the total absorbed doses during the 5 weeks of multiple injections was 38,
154, and 385 rad (0.38, 1.54, and 3.85 Gy), respectively.  A decrease in the fertility of males was
observed in the 2.0 and 3.0 µCi/g (74 and 111 kBq) exposure groups, beginning from the 4th week for
radiation doses of 190–197 rad and 285–295 rad (1.90–1.97 Gy and 2.85–2.95 Gy), respectively. 
Complete, but temporary, sterility observed in animals exposed to 300 rad (3 Gy) after 6 weeks was
attributed to the death of spermatogonial cells.  There was a significant increase in post-implantation
embryo mortality and, correspondingly, in the dominant lethal mutation frequency, at a total dose of 180
rad (1.8 Gy).
Pinon-Lataillade et al. (1991) irradiated male Sprague-Dawley rats so that only the testes and surrounding
organs were exposed to a gamma-ray beam of 900 rad (9 Gy).  Groups of 6 irradiated rats and age-
matched controls were sacrificed at 7, 15, 23, 34, 50, 71, 118, and 180 days after irradiation.  Testis
weight dropped to 85% of the control by day 7, 58% of the control by day 23, and 41% by day 34. 
Epididymal weight decreased to 88% of control by day 15, 63% by day 50, and plateaued out at 55% of
the control value.  Spermatocytes were damaged, and by day 34, only elongated spermatids remained in a
few tubules and very little regeneration of the seminiferous tubule had occurred.  From day 15 after the
irradiation, the epididymal content of androgen-binding protein (ABP) value dropped to 26% of the
control and by day 34 it was back to only 14% of this value.  From day 50 to the end, the ABP value
remained below 10% of the control levels.  No significant changes were observed in the weights of the
seminal vesicles or in the concentrations of seminal vesicles.
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Another study of acute duration estimated comparative frequencies of genetic disorders induced in germ
cells of male mice by a single or long-term exposure to incorporated 137Cs or to external gamma radiation. 
Groups of 10 male mice were exposed to a 137Cs apparatus for a whole-body dose of gamma radiation of
300 rad (3 Gy) at a rate of 0.675 rad/hour.  Subsequent data on effective matings and embryo mortality
were collected.  Animals that mated and that were exposed to external gamma radiation had a significant
decrease in male fertility, and at 3 weeks the animals became sterile.  During weeks 1 and 2, there was a
significant increase in total and post-implantation embryo mortality (Ramaiya et al. 1994).
Studies of longer exposure duration have demonstrated similar results.  Searle et al. (1976) exposed 13
adult C3Hx101 hybrid male mice continuously to 1,128 rad (11.28 Gy)  60Co gamma radiation over
28 weeks at the rate of 5.8 rad/day (0.058 Gy/day).  There were significant reductions in testis mass (35%
of controls) and epididymal sperm count (15% of controls).  An increased percentage of abnormal sperm
was observed in gamma-irradiated animals (17.1% versus 3.9% controls).  The frequency of
chromosomal translocations was significantly higher than in controls.  There was also good evidence for
the induction of dominant lethal mutations, with an increase in pre-implantation loss from 16% (controls)
to 28% (radiation exposed) and in post-implantation loss from 10% (control) to 22% (radiation exposed). 
In addition, Grahn and Carnes (1988) exposed groups of 4–13 male B6CF1 mice to 60Co gamma-rays or
fission neutrons at once-weekly doses for periods up to 60 weeks (10, 25, 40, 50, or 60 weeks of exposure
and observations at 75, 90, and 99 weeks).  Doses rates were 0, 5, 7.5, and 10 rad (0, 50, 75, and 100
mSv) per week.  An increased frequency of abnormal sperm was observed at all doses and all exposure
durations.  After exposure ended, frequencies of sperm abnormalities returned to near-normal levels.
In summary, male reproductive organs are at risk for non-carcinogenic effects when exposed to high
doses of ionizing radiation due to the relative high rates of cell divisions that occur in these organs. 
Sperm anomalies, temporary impotence, decreased libido, and hormonal imbalances have been reported
in men exposed to 100–550 rad (1–5.5 Gy)  (Birioukov et al. 1993).  Similar effects in laboratory animals,
such as decreased testes weights, decreased fertility, sterility, decreased sperm counts, chromosomal
reciprocal transformations, sperm anomalies, and embryo mortality, have been reported at similar dose
levels (Grahn and Carnes 1988; Pinon-Lataillade et al. 1991; Ramaiya et al. 1994; Searle et al. 1976;
Shevchenko et al. 1992).
The data for reproductive effects in humans and laboratory animals are summarized in the Levels of
Significant Exposure to Radiation and Radioactive Material tables in Chapter 8 of this profile.  
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3.2.1.4 Teratogenic/Embryotoxic Effects
The rapidly dividing cells in the developing fetus, like those in the reproductive system, are also at a
much higher risk of radiation damage, independent of the type of ionizing radiation, or the source  or
route of exposure, than slowly dividing, differentiated cells.  The vast majority of the available literature
reported numerous toxicological end points on the developing fetus associated with external radiation
exposure.  External exposure to the fetal animal by alpha and beta radiation is of no concern because α
and β radiation cannot penetrate the mother’s body tissues and the placental sac.  Gamma radiation is very
penetrating and can expose the fetus.  The embryo/fetus is always uniformly exposed to external gamma
rays from background radiation.  There may also be partial body exposure from medical x rays or from
internal exposure to a radionuclide such as 90Sr, which results in preferential uptake during fetal bone
development.  Of most concern in cases of human exposure are the effects of embryo organogenesis and
how these changes will affect the individual as a child and an adult.
During the early days of development, the human embryo largely consists of a mass of undifferentiated
cells, which are the cells most sensitive to the effects of ionizing radiation.  These cells transform  into
more specialized (differentiated) cells at specific times during gestation and develop into the more
organized tissues seen later at maturity.  For the purposes of describing teratogenic and other effects of in
utero exposure, gestation is divided into three major periods: preimplantation, 0-2 weeks, major
organogenesis, 2–8 weeks, and the fetal period, 8–40 weeks (Brent et al. 1980).  Central nervous system
(CNS) injury of radiological importance results from exposure in the early fetal period.  CNS
development in humans can be subdivided into four basic periods of development after conception: weeks
1–7, weeks 8–15, weeks 16–25, and 25 weeks.  During weeks 1–7, the cells that will later differentiate
into neurons are steadily multiplying.  During weeks 8–15, the population of neurons rapidly increases,
and neurons migrate to their functional sites, and lose their ability to further divide.  Between weeks 16
and 25, these neurons continue to develop, but more importantly, they undergo synaptogenesis in order to
communicate.  From week 25 on, the neurons continue to differentiate into more mature neurons, with
continued growth of the cerebrum (cognitive thought and motor skills) and cerebellum (motor
coordination) (BEIR V 1990; ICRP 1986). 
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Fetal Central Nervous System Developmental Defects (Mental Retardation and Impaired
Intelligence).    Analysis of human data from fetuses exposed to very high doses of radiation during the
bombing of Hiroshima and Nagasaki suggests that the cells of the developing central nervous system are
among the cells most sensitive to the effects of ionizing radiation in the developing human fetus.  The
major clinical effects on these susceptible cells were mental retardation and IQ reduction; these effects
were observed after birth during childhood development.  Human fetuses exposed to doses of ionizing
radiation from 1 to 7 weeks after conception suffered no discernable ill effects after birth. A dose-
dependent increase in mental retardation occurred in individuals who were irradiated in utero during
weeks 8–15 after conception.  Severe mental retardation in all 30 cases in the clinical sample was
diagnosed before age 17, based on clinical impressions and not on IQ scores.  A “no effect” threshold was
seen for doses in the range of 20–40 rad (0.2–0.4 Gy); at a dose of 100 rad (1 Gy), the frequency of
observed mental retardation was 43% (BEIR V 1988; ICRP 1986; Schull et al. 1988).  Similar results
were seen in fetuses exposed from weeks 16 to 25; however, the relative risk of mental retardation was
significantly lower.  No discernable adverse effects occurred in children exposed during the period from
week 26 to birth.  Although the mothers of the retarded children had suffered very large radiation doses,
some groups have suggested that these CNS effects on their unborn children may not have been caused by
radiation but by genetic variation, nutritional variation, bacterial and viral infections during pregnancy,
and embryonic or fetal hypoxia (BEIR V 1990; ICRP 1986).
Intelligence quotient (IQ) test scores of children fetally exposed to high radiation doses during each of
these time frames support the supposition that exposure to ionizing radiation during fetal development
may cause adverse effects.  The MRL is based on a combination of two studies, one by Schull et al.
(1988) and one by Burt (1966). Schull et al. (1988) evaluated the quantitative effect of exposure to
ionizing radiation on the developing fetal and embryonic human brain.  The end point measured was
change in intelligence test scores.  The effects on individuals exposed in utero during the atomic bombing
of Hiroshima and Nagasaki were based on the original PE86 samples (n=1,759; data on available
intelligence testing) and the clinical sample (n=1,598).  The original PE86 sample included virtually all
prenatally exposed individuals who received tissue-absorbed doses of 0.50 Gy or more, and many more
individuals in the dose range 0–0.49 Gy than in the clinical sample.  The clinical sample does not include
children prenatally exposed at distances between 2,000–2,999 m in Hiroshima and Nagasaki.  Children
exposed at greater distances or not present in the city were selected as controls.  In 1955–1956, Tanaka-B
(emphasis on word-sense, arithmetic abilities, and the like, which were associated with the more subtle
processing of visual clues than their simple recognition and depended more on connectedness) and the 
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Koga (emphasis on perception of spatial relationships) intelligence tests were conducted in Nagasaki and
the Koga test in Hiroshima.  No evidence of radiation-related effect on intelligence was observed among
individuals exposed within 0–7 weeks after fertilization or in the 26th or subsequent weeks.  The highest
risk of radiation damage to the embryonic and fetal brain occurred 8–15 weeks after fertilization under
both T65DR and DS86 dosimetric systems.  These systems represent the best estimates of radiation doses
to individual Japanese survivors using the best data available through 1965 and 1986, respectively.  The
T65DR dosimetry used site-specific data along with information obtained during later atomic bomb
testing under arid conditions, whereas the DS86 dosimetry incorporated effects of high atmospheric
humidity that existed when the weapons were exploded over Japan.  The regression of intelligence score
on estimated DS86 uterine absorbed dose is more linear than with T65DR fetal dose, and the diminution
in intelligence score under the linear model is 21–29 points at 1 Gy.  The regression of intelligence score
on estimated fetal absorbed dose was linear for the exposed 8–15 weeks after fertilization and possibly
linear for the 16–25 week group.  The cumulative distribution of test scores suggested a progressive shift
downwards in individual scores with increasing exposure; the mean IQ scores decrease significantly and
systematically with uterine or fetal tissue dose within the groups exposed at 8–15 and 16–25 weeks.
In summary, analysis of intelligence test scores at 10–11 years of age of individuals exposed prenatally
showed that:
# There is no evidence of a radiation-related effect on intelligence scores among those individuals
exposed within 0–7 weeks of fertilization or in the 26th week of gestation and beyond;
# The cumulative distribution of test scores suggests a progressive shift downwards in intelligence
scores with increasing exposure to ionizing radiation (dose-response relationship);
# The most sensitive group was the 8–15 week exposure group. The regression in intelligence scores
was found to be linear, with a 1-Gy dose resulting in a 21–29 point decrease in intelligence scores.
Using the Schull et al. (1988) data in conjunction with the observations of Burt (1966), an MRL of
0.004 Sv (400 mrem) was derived for acute-duration external radiation exposures.
Embryo Organogenesis Defects and Body Weight Alterations.    Beta and gamma radiation
have been demonstrated to induce embryo/organogenic defects in laboratory animals.  As in the human
fetus, the developing central nervous system of laboratory animals during specific stages of development
is at varying degrees of risk from exposure to ionizing radiation.  In laboratory animals, effects such as
hydrocephaly, anencephaly, encephalocele, spina bifida, functional and behavioral effects, motor defects, 
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hyperactivity, and defects in learning, as well as a host of other defects have been reported (BEIR V
1990).  For example, Bruni et al. (1994) studied the effects of low levels of ionizing radiation on
embryogenesis.  Pregnant Sprague-Dawley rats were exposed for 14–17 seconds on gestational days 9.5,
15, and 18 to 50 rad (0.5 Gy) of 60Co radiation.  Irradiated rats and controls were sacrificed at prenatal
intervals of 4 hours, 48 hours, and 10 days (term) after exposure.  No statistically significant difference
was seen in the number of embryos recovered per litter for control and irradiated embryos sacrificed 4
hours after exposure.  With the exception of the neuroepithelium, no histopathological changes were
observed in embryos in this group.  In irradiated embryos, mitoses were reduced within the
neuroepithelium; pyknosis and some necrosis of cells were apparent at this gestational interval.  No
significant difference was seen in the number of embryos recovered per litter, the crown-rump length, or
the head length of irradiated embryos sacrificed 48 hours after irradiation compared to controls.  Among
the gross developmental abnormalities observed in embryos 48 hours after irradiation, excessive flexion
of the embryo (seen in 3.7%) and abnormal flexion of the head (seen in 1.2%) were the only effects that
appeared to possibly be radiation-induced.  At term, no significant differences in litter size or resorption
rates were observed in irradiated animals compared to the controls.  Mean fetal body and placental
weights were not significantly different.  There was a higher incidence of developmental abnormalities in
irradiated fetuses (9.7%) than in controls (4%), but this observation was not statistically significant.  The
most common anomalies were defects in ocular development; microphthalmia (small eyes) and
anophthalmia (absence of eyes) were seen in 3% and 1.5% of irradiated fetuses, respectively.  Scoliosis
was also significant with a prevalence of 1%. Viscerally, abnormally positioned kidneys were found in
5.8% of irradiated fetuses and 7.1% of controls. Ureteric anomalies and hemorrhagic liver lesions were
encountered in 2% and 11.5% of irradiated fetuses, respectively.  No significant developmental
differences were observed in the nervous system of irradiated versus control fetuses at term.  The authors
concluded that in utero doses of 50 rad (0.5 Gy) of gamma radiation during the period of early
organogenesis can produce some irreversible defects that are discernable at term.
External Malformations, Growth Retardation, and Death.    Many other types of birth defects in
animals have been reported.  Kusama and Hasegawa (1993) designed a study to precisely determine the
radiosensitive period in the development of mouse embryos during which external malformations and
growth retardation tended to occur.  Pregnant mice were treated at various times during the gestation
period with a single whole-body gamma radiation dose of 150 rad (1.5 Gy) delivered at a dose rate of
20 rad/minute (0.2 Gy/min) from a 137Cs source.  Death of the embryo/fetus, especially during the early
period of organogenesis, was most frequent in mice irradiated between days 6.75 and 8.25 of gestation.  
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There was no difference in radiosensitivity between male and female fetuses.  Reduction of fetal body
weight was found to be a good indicator of radiation effects.  Body weights of all irradiated fetuses were
significantly less than controls.  The reduction in fetal body weights was marked in mice irradiated 
during the intermediate stage of organogenesis (between days 9.75 and 12.75 of gestation).  The body
weights of abnormal fetuses with external malformations other than exencephalia (exposed brain) and
eventration were not significantly different from those of fetuses without external malformations. 
Exencephalia appeared most often in mice irradiated between 6.5 and 8.75 days of gestation (0.6–21.7%)
and at a low frequency between days 10.25 and 10.75 of gestation (0.5–1.5%).  Cleft palate appeared in
mice irradiated between days 8.25 and 12.75 of gestation (1.1–20.5%).  Micromelia, ectrodactyly, and
polydactyly were observed in fore- and hindpaws.  The forepaw malformations appeared in fetuses
exposed on days 10.25–12 of gestation (0.8–46.2%).  Hindpaw malformations showed two periods of
high sensitivity, from days 7.5 to 8.75 (0.6–3.8%) and from days 10.25 to 12 (0.6–28.9%) of gestation. 
Shortened and/or bent tails were observed in groups irradiated from days 7 to 11.5 of gestation
(0.7–32.5%), with the peak frequency among those irradiated on day 9.25 of gestation.
Other animal studies support the observation of increased incidences of birth defects after exposure to
ionizing radiation.  Devi et al. (1994) exposed the whole abdominal region of pregnant Swiss mice (n=25)
to 5–50 rad (0.05–0.5 Gy) of 60Co gamma radiation (at a dose rate of 83 rad/min, 0.83 Gy/min) on
postcoitus day 11.5.  Increased fetal mortality and retarded growth was seen among the 50 rad (0.5 Gy)
group.  At this level, retarded growth was observed in 12% of fetuses, with body weight and body length
decreased (7% and 3%, respectively).  A significant reduction in head length, width, and brain weight was
seen at 25 rad (0.25 Gy) and above.  A significant increase in the incidence of microphthalmia was also
observed at 25 rad (0.25 Gy) and above in 14% of fetuses.  Zaman et al. (1992) also studied the effects of
acute-duration prenatal radiation on myelination of the developing brain, as well as some physical para-
meters.  Rats were treated with a single dose of gamma radiation (6.8, 15, or 150 rad, 0.068, 0.15, or
1.5 Gy) on the 20th day of pregnancy.  At day 30, absolute brain, kidney, heart, and spleen weights of the
150 rad (1.5 Gy) treated group were significantly lower than that of any other treatment group.  Relative
brain, ovary, adrenal, kidney, liver, heart, spleen, and lung weights showed no significant differences
among  the lower treatment groups.  At postnatal day 52, brain weight of the 150 rad (1.5 Gy) treated
group was significantly lower than the other treatment groups and controls.  No significant differences
were seen in other organ weights at day 52.  The relative weight of the cerebral cortex was significantly
less than controls in the 150 and 15 rad (1.5 and 0.15 Gy) groups at day 30 and in the 150 rad (1.5 Gy)
group on day 52 (9–11%).  In addition, Reyners et al. (1992) evaluated the effects of radiation on fetal 
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brain development in pregnant Wistar rats exposed on gestation day (Gd) 15.  Protracted gamma
irradiation to total doses up to 80 rad (0.8 Gy) was performed with a 60Co source.  The dose rate varied
from 1 rad/day to 13.3 rad/day (0.01–0.133 Gy/day).  Exposure was carried out either from Gd 12 to 16
(4 days) or from Gd 14 to 20 (6 days).  60Co gamma irradiation protracted over 4 days from Gd 12 to 16
significantly reduced the brain weight in 3-month-old rats by 3%, 4%, and 13% after 160, 350, and 560
rad (16, 35, and 56 Gy) exposures.  Animals irradiated for 6 days from Gd 14 to 20 also showed a
significant reduction in the 3-month-old brain weight of 5%, 4%, and 7% after exposures to 17, 34, and
80 rad (0.17, 0.34, and 0.8 Gy), respectively.  The cingulum volume was also significantly decreased in
the 80 rad group by 19%.
Dental and Oral Cavity Development.    Ionizing radiation can also affect dental and oral cavity
development.  Lee et al. (1989) irradiated Beagle dogs in utero at 8, 28, or 55 days postcoitus or
postnatally at 2, 70, or 365 days postpartum.  Whole-body 60Co gamma radiation doses ranged from 0 to
380 rad (3.8 rad).  After a threshold effect dose of 83 rad (0.83 Gy), there was an age-dependent
dose-related increase in premolar hypodontia for dogs irradiated at 55 days postcoitus or 2 days
postpartum.  Dogs irradiated at 55 days postcoitus were the most sensitive, with fewer than 20% having
normal teeth at doses above 83 rad (0.83 Gy).  After irradiation at 28 days postcoitus, no effect was seen
below doses of 120 rad (1.2 Gy).  Similarly, Saad et al. (1991) exposed pregnant CD-1 Swiss albino mice 
on the 12th gestational day to an external gamma radiation dose of 400 rad (4 Gy).  All irradiated fetuses
presented clefts of the secondary palate but usually not cleft lip.  The development of the maxillary and
mandibular incisors was retarded in irradiated fetuses and was in early bell stage, whereas controls had
elaborated their matrices.
Fetal Blood Forming Organs.    Significant doses of ionizing radiation can also affect the fetal
blood-forming organs.  Koshimoto et al. (1994) mated female Wistar rats, and on the 13th, 14th, or 15th
day of gestation,  and then externally irradiated them with 50–800 rad (0.5–8 Gy) of  137Cs gamma
radiation.  Forty-eight hours later, the pregnant animals were sacrificed and the numbers of ovulations,
implantations, and surviving fetuses were determined.  Blood cell volume was measured, and fetal blood
was collected.  The numbers of erythrocytes and hepatocytes in the livers in the fetuses were counted. 
The number of blood cells in circulating blood after the fetuses were irradiated to 800 rad (8 Gy) on day
15 was significantly lower than the controls, and the formation of micronuclei was significantly increased
at 50 rad (0.5 Gy) and above.  The erythrocyte counts in the fetal liver were significantly lower than
controls at 400 and 800 rad (4 and 8 Gy), and the ratio of the large hematocyte count to the small
hematocyte count was significantly higher than controls at doses of 100 rad (1 Gy) and above.
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Reproductive Tract.    The in utero exposure to large doses of ionizing radiation can affect the
forming reproductive tracts of male and female embryos.  As an example, Inano et al. (1989) exposed
pregnant rats to whole-body irradiation at Gd 20, with 260 rad (2.6 Gy) gamma rays from a 60Co source. 
It was found that the seminiferous tubules of the irradiated male offspring were remarkably atrophied
with free germinal epithelium and contained only Sertoli cells.  Female offspring also had atrophied
ovaries.  The testicular and ovarian weight in irradiated offspring were 18% and 34%, respectively, of
controls.  No oocytes or Graafian follicles were found in ovaries of the irradiated rats.  Testicular tissue
obtained from control and 60Co-irradiated rats was incubated with 14C-labeled pregnenolone,
progesterone, 17-alpha-hydroxyprogesterone, and androstenedione as a substrate.  Intermediates for
androgen production and catabolic metabolites were isolated after the incubation.  The amounts of these
metabolites produced by the irradiated testes were low in comparison with the control.  The activities of
delta[5]-3-beta-hydroxysteroid dehydrogenase, 17-alpha-hydroxylase, C(17, 20)-lyase, and
delta[4]-5-alpha-reductase in the irradiated testes were 30–40% of those in nonirradiated testes.  The
activities of 17-beta- and 20-alpha-hydroxysteroid dehydrogenases were 72% and 52% of controls,
respectively.  The activity of delta[5]-3-beta-hydroxysteroid dehydrogenase of the irradiated ovary was
only 19% of the control.  The authors note that these results suggest that high-dose 60Co irradiation of the
fetus in utero markedly affects the production of steroid hormones in the testes, ovaries, and adrenal
glands after birth.
Behavioral Alterations.    Behavioral changes have also been noted in laboratory animals after birth
when exposed to certain doses of ionizing radiation during the embryo stages of development. 
Minamisawa et al. (1992) investigated social behavior, in particular aggressive behavior (AB), in mice
exposed prenatally to ionizing radiation.  Pregnant C57BL/6 mice (n=3) were exposed to whole-body
gamma radiation from a 137Cs source on Gd 14.  The dose rate to the midline of the mouse was 25 rad per
minute (0.25 Gy/min) and doses of  0, 100, and 200 rad (0, 1, and 2 Gy) were given.  AB in first-
generation (F1) hybrid male offspring was studied.  The number of instances of AB was significantly
higher in the 100-rad (1 Gy) group than in controls during the first 45 minutes of observation.  The AB of
the 200-rad (2 Gy) group was significantly more intensive than that of the control group.  There is little
information in the literature with which to compare these findings.
In a similar study, Zaman et al. (1993) treated adult female Fischer 344 rats with a single dose of total-
body gamma radiation (6.8, 15, or 150 rad [0.0068, 0.15, or 1.5 Gy]) on the 20th day of gestation (thus,
the offspring received the radiation doses on the 20th day of prenatal life).  During the 3 weeks of the
offspring’s postnatal life, changes in pivoting, crawling, negative geotaxis, cliff avoidance, hindlimb 
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support, eye opening, and tooth eruption were studied.  Pups irradiated with 150 rad (1.5 Gy) exhibited
significantly lower pivoting than any other group on days 15–16 of the observation period.  No significant
differences were observed between treatment groups for crawling, geotaxis, or hindlimb support when
suspended.  Cliff avoidance was recorded from days 3 to 10 postnatally.  Cliff avoidance was
significantly different in the 15 and 150 rad (0.15 and 1.5 Gy) groups compared to the 6.8 rad (0.068 Gy)
group and controls on day 8 only; however, the mean score was not significantly different in the 15 rad
(0.15 Gy) group. Data from this study suggest that radiation affects several of the tested locomotion
parameters.  Based on the data presented in this study, it appears that areas of cerebral cortex including
the somatosensory and sensory cortex, the primary cortex, and the premotor cortex were adversely
affected by doses of 150 rad (1.5 Gy) when delivered around gestation day 20.
Sensorimotor Effects.    Norton and Kimler (1987) also investigated the early postnatal behaviors
involving sensorimotor integration and the thickness of the sensorimotor cortex in prenatally irradiated
rats which received a dose of 100 rad (1 Gy)  from a 137Cs source.  Performance in the negative geotaxis
test was poorer in irradiated rats than in controls.  Rats irradiated on Gd 17 were unable to equal the
performance of either controls or rats irradiated on Gd 11 in the reflex suspension test.  No gait alterations
were seen in the irradiated rats.  In a later study, Norton and Kimler (1990) exposed pregnant Sprague-
Dawley rats to whole-body gamma radiation from a 137Cs source on Gd 15 to doses of 25, 50, 75, or
100 rad (0.25, 0.5, 0.75, 1.0 Gy).  The fetuses of irradiated dams were examined 24 hours after irradiation
for changes in the cells of the cerebral mantle of the developing brain.  Changes were seen in those rats
treated with 50 or more rad (0.5 Gy).  Cortical thickness of the cerebral mantle was not significantly
altered.  The number of pyknotic cells, the number of macrophages, the nuclear area, and the number of
mitotic cells were altered in a dose-related way.  The number of mitotic figures in the ventricular zone
was significantly reduced and the number of macrophages was significantly increased in fetuses from the
50-, 75- and 100 rad (0.5, 0.75, and 1 Gy) treatment groups.  The nuclear area in fetuses prenatally
exposed to 100 rad (1 Gy) was significantly increased.  In fetuses prenatally exposed to 50 rad (0.5 Gy),
the nuclear area of subventricular zone cells was significantly increased compared to controls 12 hours
postirradiation but returned to almost the control value at 24 hours postirradiation.  The number of
macrophages in the ventricle and in the cortical mantle was significantly increased at 12 and 24 hours in
fetuses prenatally exposed to 50 rad (0.5 Gy).  Several vesicles containing nuclear fragments were present
in each macrophage at these times.  The number of mitotic figures in the ventricular zones was
significantly increased at 3 and 6 hours postexposure and significantly decreased at 12 and 24 hours
postexposure in fetuses prenatally exposed to 50 rad (0.5 Gy) compared to controls.  Pyknotic cells 
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developed rapidly after irradiation with 50 rad (0.5 Gy).  At 3 hours postirradiation, the total number of
pyknotic cells in the cortical mantle had increased from nearly 0 to 166.  This number increased slightly
from 3 to 6 hours and then declined from 12 to 24 hours.  The number of pyknotic cells in the ventricular
and subventricular zones decreased while the proportion in the intermediate and cortical plate zones
increased.  Both the percentage and number of pyknotic cells increased with time in the two latter zones. 
A positive correlation between the number of pyknotic cells and the number of macrophages developed
with time.  At 3 hours after irradiation, about 60% of pyknotic cells were found in the subventricular zone
and about 25% in the intermediate zone and cortical plate.  The number of such cells in the upper layers
of the cortex steadily increased up to 24 hours, at which time about 70% of pyknotic cells were in these
two layers.
In summary, the developing fetus, with its rapidly dividing cell characteristics, has been an area of intense
study relating to the effects of radiation, particularly for large gamma radiation doses.  Laboratory animal
models have been used to delineate many of these effects.  Radiation, above a threshold dose of about 25
rad (0.25 Gy) can impair development of embryonic structures, in particular the structures of the central
nervous system when delivered during a sensitive period.  Radiation affects specific cells of the
developing nervous system at specific times during its developmental process, although the exact
mechanisms behind these alterations are not known.  Many of these reports include descriptions of
decreased fetal body weights (Devi et al. 1994; Minamisawa et al. 1990; Norton and Kimler 1987; Zaman
et al. 1992) and developmental anomalies, such as necrosis of neuroepithelial cells, microphthalmia,
anophthalmia, scoliosis, decreased myelination of the brain, hypodontia, cleft palate, micromelia,
ectrodactyly, polydactyly, as well as many more defects (Bruni et al. 1994; Kusama and Hasegawa 1993;
Lee et al. 1989; Reyners et al. 1992; Saad et al. 1991; Zaman et al. 1992) at doses of <300 rad (3 Gy). 
Social behavior changes have also been reported in male mice at doses of 100 rad (1 Gy) and higher
(Minamisawa et al. 1992).  Locomotor difficulties have also been reported (Norton and Kimler 1987,
1988; Zaman et al. 1993) as well as reproductive organ anomalies (Inano et al. 1989).  From these animal
studies, it is clear that the developing embryo and fetus are subject to damage from radiation at doses
greater than 25–50 rad (0.25– 0.5 Gy).
Data for developmental effects in humans and laboratory animals are summarized in the Levels of
Significant Exposure to Radiation and Radioactive Material tables in Chapter 8 of this profile.  
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3.2.1.5 Central Nervous System (CNS) Effects
As a whole, the central nervous system of the adult human and laboratory animal is extremely resistant to
the effects of radiation (see Table 3-2).  In contrast to the rapidly dividing cells of the gastrointestinal and
hematopoietic systems, the central nervous system has a relatively static population of cells, with cell
mitosis occurring between long intervals of latency, if at all.  This allows cells to be exposed to much
larger doses of radiation because the cells have much more time to repair themselves before they multiply. 
The brain appears to be sensitive to ionizing radiation only at extremely large doses; a dose of
approximately 1,500 rad (1.5 Gy)  was necessary to produce discernable deterministic effects.  Necrosis
of the brain (associated with demyelination and cerebral vascular damage) may occur within 3 years after
a 5,500 rad (55 Gy) dose received over a 6-week time frame. Demyelination and necrosis of neurons in
the white matter of the spinal cord can also develop within 6 months after exposure to high doses (>6,000
rad or 60 Gy) of radiation.  These are very large doses of radiation.
Birioukov et al. (1993) reported that one man exposed to 200–350 rad (2–3.5 Gy) had clinical symptoms
such as permanent headache and vision impairment after accidental exposure to gamma radiation during
and after the Chernobyl atomic power plant accident.  Reports are available that describe the effects that
radiation has on the nervous system of the developing embryo in laboratory animals (Minamisawa et al.
1992; Norton and Kimler 1987, 1990).  Harmful effects have been found from extremely high doses of
radiation to adult animals.  Cockerham et al. (1986) explored the effects of radiation on early transient
incapacitation (ETI) and performance decrement (PD) in support of nuclear warfare research efforts. 
Rhesus monkeys (n=6) were exposed to a lethal whole-body total dose of 10,000 rad (1,000 Gy) from a
60Co source.  Autopsy findings included destroyed nerve cells (neurons), supporting tissue in the brain
(glial cells), and lining cells (endothelium) of the capillaries in the brain.  
Bassant and Court (1978) exposed rabbits to a 60Co gamma ray source, with a mean absorbed dose of
450 rad (4.5 Gy).  According to the authors, the LD50/30 for rabbits ranges from 600 to 650 rad (6–6.5 Gy). 
Following irradiation, the hippocampal cellular activity was highly disturbed, as described by the EEG
activity.
Data for neurological effects in humans and laboratory animals are summarized in the Levels of
Significant Exposure to Radiation and Radioactive Material tables in Chapter 8 of this profile.  
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3.2.1.6 Respiratory and Cardiovascular Effects
The respiratory tract has long been known to be a target organ of both internal and external radiation. 
Respiratory effects have been reported in humans (Stavem et al. 1985) who had received radiotherapy for
breast cancer and those who had been accidentally overexposed, as well as in laboratory animals (Rezvani
et al. 1989; Salovsky and Shopova 1992).  No harmful effects have been seen in the millions of people
who  receive occasional diagnostic x rays of the chest. Local injury is tolerated much more than diffuse
injuries.  Irradiation of large portions of one or both lungs initially results in alterations in blood flow,
initially manifested as edema, and later as pneumonitis and pulmonary fibrosis, depending on the total
dose received.  Radiation pneumonitis, followed by pulmonary fibrosis (i.e., fibrosis of alveolar structures
involving changes in the ratios of some pulmonary collagens), are two of the most commonly reported
aberrations in laboratory animals following an inhalation of large activities of radioactive material
(Benjamin et al. 1978, 1979; Brooks et al. 1992; Hahn et al. 1975, 1981; Lundgren et al. 1980a, 1991).  
The mechanism behind the induction of radiation pneumonitis is not completely understood; however, a
vascular component (comprised of sloughing and of dead and dying endothelial cells that may lead to
capillary leakage) has been suggested.  Damage to type II pneumocytes, which can lead to serious
alterations in the amount of surfactant phospholipids and to lung inflammation, has also been considered. 
The role of type I pneumocytes, which by necrosing and sloughing leave denuded basement membranes
and alveolar debris, may also be significant.  Any one or all of these mechanisms may be involved in the
development of pneumonitis.  Fibrosis, a serious sequela of pulmonary inflammation due to large popula-
tions of cells dying and not being replaced, is seen in the lungs after exposure to ionizing radiation at
moderate to high doses or to fibrogenic dusts, such as quartz and asbestos or even aluminum (ATSDR
1999a).  A more in-depth discussion of radiation pneumonitis and subsequent fibrosis after exposure to
ionizing radiation is available in a report by Coggle et al. (1986).
Most respiratory studies have focused on the effects of ionizing radiation on the lungs when associated
with inhaled insoluble (and, to a lesser degree, soluble) particles.  Most of these studies looked at acute
inhalations of large quantities of radioactive material resulting in high initial lung burdens and cumulative
radiation doses on the order of hundreds of rad (several Gy).  After the radioactive material was inhaled,
clinical signs were related to the organ system which received the major radiation dose during and after
redistribution of these particles had occurred.  Important aspects of this redistribution related to whether
these radionuclides were in a soluble or insoluble form and to the size of the inhaled particle.  Soluble 
IONIZING RADIATION 123
3. SUMMARY OF HEALTH EFFECTS OF IONIZING RADIATION
particles tended to dissolve in the lung matrix and redistribute based on chemical mechanisms; then they
had the potential to affect other organ systems.  These soluble particles tended to deliver a higher dose
rate to the lungs shortly after inhalation; the rate tended to decrease rapidly as the material was dissolved
and the radionuclide redistributed to other organs via the normal lung clearance mechanisms.  Soluble
particles deposited in the respiratory tract tended to result in lower overall lung dose and higher overall
distal organ dose over time when compared to insoluble particles because they exposed the lung tissue for
a shorter period of time.
Unlike the soluble particles, the bulk of the inhaled insoluble particles tended to remain for long periods
of time in the lungs (several days to several years), irradiating the tissues and depositing large radiation
doses to the tissue immediately around the particles.  Some fraction of these particles would initially be
coughed up or removed  by the ciliary clearance mechanism and then swallowed during the first few days
after exposure, thereby exposing the gastrointestinal tract as the particles passed through and cleared the
body.  In addition, smaller particles (1–3 µm) tended to penetrate to the deeper regions of the lungs
(terminal bronchioles and alveoli); larger (>6 µm) particles were deposited in the upper respiratory tract
(trachea, conducting airways).  The effect of inhaled radioactive particles, therefore, varied with the size
distribution and solubility of the inhaled particles, as well as the type and quantity of the inhaled
radioactivity. 
Respiratory insufficiency was a common finding in many studies following high radiation doses to the
lungs.  This was manifested clinically as increased respiratory rates, increased abnormal lung sounds and
cyanosis, decreased lung volumes, and total lung capacity, and compliance (common but not pathoneu-
monic symptoms of pneumonia).  These clinical symptoms were most likely related to inflammatory and
fibrotic changes occurring within the lungs.  This observation is supported by radiographic, gross, and
histopathological evidence, such as increased radiographic focal or diffuse lung-field densities, and by
interstitial, perivascular, peribronchial, and pleural fibrosis; emphysema; inflammation; vascular damage;
fibrin exudation; congestion; and hemorrhage (Benjamin et al. 1976; Hahn et al. 1976; Lundgren et al.
1991).
Numerous assessments of human exposure to inhaled radionuclides (with no dermal or oral component)
have been identified in the open literature.  A group of 26 workers inhaled quantities of 239Pu dust that
were many times larger than acceptable occupational standards.  These workers have been followed
medically since the inhalation in 1944.  To date, one person has died from heart disease and one from
bone cancer.  Another  report involved a U.S. military airplane crash near Palomares, Spain, in January 
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1966.  The aircraft was carrying four thermonuclear weapons containing 239Pu.  Two of the devices were
recovered, and the other two devices detonated their conventional explosives and released fissile material
upon ground impact.  Partial ignition (chemical burning) of the fissile material resulted in a cloud
formation that contaminated approximately 2.25 km2 of farmland.  The deposition density of alpha
emitters  was 32.4 µCi/m2  (1.2 MBq/m2); estimates of the inhaled and ingested dose from 239Pu and 240Pu
were derived.  Of the 714 people examined through 1988, 124 had urine concentrations of Pu greater than
the minimum detection limits.  An estimate from Iranzo et al. (1987) states that the 70-year committed
effective dose for 55 of those 124 people, due to inhalation of radioactive particles, was 2–20 rem
(0.02–0.2 Sv); however, no acute respiratory effects were reported and there has apparently been no long-
term follow-up of these individuals.  
There is a considerable database available on the effects seen from inhaled radionuclides in laboratory
animals.  For example, Hobbs et al. (1972) exposed Beagle dogs to initial lung burdens of 3,600, 1,800,
1,200, 780, 400, 210, and 110 µCi (133, 67, 44, 29, 15.8, and 4 MBq) 90Y/kg body weight.  The AMADs
of the aerosols used ranged from 0.8 to 1.2 µm.  Death was reported in 21 of 33 dogs exposed within 7.5
and 163 days postexposure, with their initial lung burdens ranging from 670 to 5,200 µCi/kg causing
cumulative radiation doses through time of death of  8,400 to 55,000 rad (84–550 Gy).  Clinical signs in
the dogs that died included progressive increase of respiratory rates, abnormal lung sounds on
auscultation, anorexia, progressive weight loss, and eventual cyanosis of the mucous membrane. 
Additionally, thoracic radiographs showed marked, generally diffuse nodular increases in density of lung
fields.  The authors note that clinical signs did not differ from high to low doses; however, the time to the
onset and the duration of the illness varied considerably.  A dose response could be demonstrated with
these exposures: “acute symptoms” occurring 7–10 days after inhalation, with initial lung burdens of
1,700–5,200 µCi/kg (62–190 MBq/kg) and doses to the lungs of 21,000–55,000 rad (210–550 Gy);
“subacute symptoms” with signs of respiratory insufficiency 3–4 weeks postexposure, initial lung burdens
of 1,000–2,400 µCi/kg (37–89 MBq/kg) and doses to the lungs of 13,000–29,000 rad (130–290 Gy);
“subacute to chronic symptoms” appearing at 6–8 weeks, which included a gradual deterioration in the
animals' condition.  Animals in this group had initial lung burdens of 670–760 µCi/kg (25–28 MBq/kg)
and cumulative radiation doses to the lungs of 8,400–9,400 rad (84–94 Gy).  Pathological findings at
necropsy included pulmonary and pleural fibrosis, occlusive pulmonary vascular lesions, metaplasia
and/or hyperplasia of terminal bronchiole and alveolar epithelium, right heart dilation, and hypertrophy. 
Small indurated hemorrhagic areas near the ventricular junction were present in the right atria of the
hearts of 7 of the 12 dogs that died 64–92 days postexposure.  Infarctions of the right atria were found in
some animals.  
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Similarly, Muggenburg et al. (1988) exposed 216 Beagle dogs by inhalation to initial lung burdens of
3–54 µCi (0.1–2 MBq) 239Pu/kg monodisperse 239PuO2 aerosols with AMADs of 0.75, 1.5, or 3.0 µm,
which produced a protracted alpha irradiation dose to the lungs.  From the group of 78 dogs which
survived to 7.1 years post-inhalation, 20 were selected for cardiorespiratory function tests and further
clinical evaluation.  Of these 20 dogs, 10 were selected because they had persistent respiratory
frequencies of 40 breaths/min for more than 1 year (group I).  The second 10 dogs were selected because
they had similar or slightly lower plutonium lung burdens at the time of inhalation as the dogs in group I,
but had normal respiratory frequencies (group II).  Ten controls were used (group III).  The average dose
to the lungs through 2,600 days after inhalation for the dogs in group I ranged from 230 to 3,200 rad (2.3
to 32 Gy) and for the dogs in group II, from 80 to 1,570 rad (0.8 to 15.7 Gy).  Respiratory tract injury was
again first observed as an increased respiratory frequency on average 3.4 years after inhalation; this
change in breathing pattern persisted for at least 1 year.  Only the dogs in group I with signs of lung
injury had a mild respiratory function disorder consisting of smaller lung volumes, decreased total lung
capacity, vital capacity, functional residual capacity, reduced dynamic and quasistatic compliance, and
increased respiratory frequency and minute volume.  Carbon monoxide diffusing capacity was
significantly reduced in both groups I and II.  These findings indicate that alpha irradiation of the lungs of
humans could produce restrictive lung disease at long times after initial inhalation.
In addition to alterations in respiratory rates and respiratory function, pneumonitis and pulmonary fibrosis
are two of the most commonly reported respiratory effects in animals (and humans) after lung exposure to
large activities of inhaled radionuclides (Coggle et al. 1986).  Hahn et al. (1975) studied the radiation
dose of 90Y to the upper respiratory tract in Beagles exposed by nose-only inhalation to aerosols of 90Y in
fused clay.  Initial whole-body burdens ranged from 23 to 65 mCi (850–2,400 MBq), with initial lung
burdens ranging from 9 to 35 mCi (520–1,300 MBq).  A rapid initial decrease in body burden, typical of
an insoluble material deposited by inhalation, was due to the clearance of particles from the upper
respiratory tract entering the gastrointestinal tract.  Of the 7 dogs surviving 27–29 days, 6 dogs exposed to
14–35 mCi initial lung burden developed radiation pneumonitis.  Radiation pneumonitis was
characterized by accumulations of alveolar macrophages, bizarre alveolar lining cells, and alveolar
hemorrhage; vasculitis was the most consistent histopathologic finding.  Benjamin et al. (1976) exposed
6 Beagle dogs to a nose-only inhalation of 90Y, 144Ce, or 90Sr in fused aluminosilicate particles (FAP). 
The initial lung burdens  were 560, 46, and 28 µCi/kg (21, 1.7, and 1 MBq/kg) for 90Y, 144Ce, and 90Sr,
respectively.  Deterioration in the health of the dogs exposed to 90Sr included an increased respiratory
rate, dyspnea, cyanosis, and dry and moist rales.  Increased radiographic focal or diffuse lung-field 
IONIZING RADIATION 126
3. SUMMARY OF HEALTH EFFECTS OF IONIZING RADIATION
densities, with clear evidence of ventricular enlargement, was apparent.  The lungs of dogs exposed to 90Y
and 144Ce showed radiation pneumonitis characterized by interstitial, perivascular, peribronchial, and
pleural fibrosis, focal emphysema, and acute and chronic inflammation with increased numbers of
alveolar macrophages.  Vascular damage included congestion, hemorrhage, fibrin exudation, and
occasional vessels with fibrinoid necrosis or proliferation.  Epithelial changes included denudation of
terminal bronchioles and alveolar ducts, with regeneration of bizarre lining cells and proliferation of
bizarre, hypertrophied alveolar lining cells.  Adenomatous epithelial proliferation and squamous
metaplasia were common findings in the 90Y dogs.
Later, Benjamin et al. (1978) again exposed Beagles to 144Ce in FAP by nose-only inhalation using
particle sizes 1.4–2.7 µm.  Initial lung burden ranges were around 25–35 µCi/kg body weight in dogs
sacrificed or those that died between 1.4 and 4.1 years postexposure.  The  cumulative absorbed lung
doses to death for these groups of dogs ranged from 27,000 to 47,000 rad (270–470 Gy).  Dogs were
sacrificed at half- to full-year intervals from 1.5 to 4 years.  By 2 years after exposure, more than 90% of
the radiation dose had been delivered.  Beyond that time, radiation pneumonitis and pulmonary fibrosis
were evident in approximately 80% of the dogs.  Other reports of radiation pneumonitis and/or pulmonary
fibrosis have been described in dogs (Benjamin et al. 1979; Hahn et al. 1976), monkeys (Brooks et al.
1992; Hahn et al. 1987; LaBauve et al. 1980), mice (Lundgren et al. 1980a, 1981, 1991), and hamsters
(Lundgren et al. 1983).
Some laboratory animal studies were found that dealt with the effects of external  radiation on the
respiratory tract.  In one study, Rezvani et al. (1989) determined the effects of external  radiation on the
diaphragmatic lobe of the left lung in female large white pigs irradiated with single doses of
900–1,470 rad (9–14.7 Gy) of 60Co gamma rays at a dose rate of 80 rad/min (0.8 Gy/min).  Standard lung
function tests were performed prior to irradiation and at 4 and 13 weeks after irradiation, then at 13 week
intervals up to 104 weeks.  At 104 weeks after irradiation, the animals were sacrificed and the lungs were
excised and examined for gross changes.  A marked impairment in the ventilation capacity of the lungs
4 weeks after irradiation was seen, but was not considered to be dose-dependent.  After a dose of 900 rad
(9 Gy), the initial impairment in lung function was resolved within 13 weeks, while at 1,470 rad (14.7
Gy) damage persisted.  There was an elevation in the breathing rate at 4 weeks after irradiation, which
was most marked in animals irradiated with the highest doses; however, the breathing rate returned to
normal within 13 weeks  at all dose levels.  At 104 weeks after irradiation, postmortem examination
revealed only one case of adhesion between the lung and chest wall.  In animals irradiated with
1,090 rad (10.9 Gy), atrophy of the irradiated left lobe of the left lung was seen.  This was particularly 
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characteristic in all lungs irradiated with 1,470 rad (14.7 Gy) in which the lungs showed severe atrophy. 
At 1,280 rad (12.8 Gy), a general and severe thickening of the interlobular septa was seen in some
animals.  The authors calculated a 50% effective dose (ED50) value for pathological changes (fibrosis and
focal scarring) in the lungs of 1,112 rad (11 Gy).
With regard to external exposure to radiation, Salovsky and Shopova (1992) exposed male Wistar rats to
0, 400, 800, or 1,500 rad in a single whole-body dose in order to study the changes present in broncheo-
alveolar tissue after exposure to ionizing radiation.  Eight animals of each group were sacrificed on days
1, 5, and 15.  Prior to sacrifice, a broncheoalveolar lavage was performed.  The lavage fluid was analyzed
for lactase dehydrogenase (LDH), alkaline phosphatase (APH), acid phosphatase (AcPH), angiotensin
converting enzyme (ACE), and protein content.  LDH activity was decreased on day 1 in the 1,500 rad
(15 Gy) group.  At day 5, the 400 and 800 rad (4 and 8 Gy) groups LDH levels were significantly
decreased by 30% and 49%, respectively.  No significant difference was observed at day 15.  Both APH
(31–41%) and AcPH (40–67%) were significantly decreased on day 1 in all irradiated groups.  In the
800 rad (8 Gy) group, APH was significantly increased on day 15 (203%).  ACE activity was examined
only on day 1, with a significant increase in ACE in the 800 rad (8 Gy) (190%) and 1,500 rad (15 Gy) 
(187%) groups.  Protein content decreased significantly only in the 1,500 rad (15 Gy) group, measured
only on day 1.  ACE is normally bound to lung endothelial cell surfaces, with increased concentrations
suggesting endothelial cell injury.  Increased protein content in the broncheoalveolar lavage fluid (BALF)
indicates vascular permeability changes due to adverse events in the endothelial cells lining the
capillaries.  LDH, APH, and AcPH are normally intracellular enzymes, and their release into the
extracellular domain indicates lung cellular membrane damage.  From these data, it appears that LDH
decrease may provide a non-specific biomarker of exposure to ionizing radiation at 1 week after exposure
has occurred, whereas APH increase would be a non-specific biomarker of exposure at 2 weeks after
exposure, to higher doses of ionizing radiation. 
No harmful radiation effects on the heart have been seen at dose levels below hundreds of rad (tens of
Gy).  However, cardiovascular effects have been reported after exposure to inhaled radioactive material
that led to very high radiation doses to the heart.  The study described earlier by Muggenburg et al. (1988)
noted no abnormal cardiac function parameters in any of the dogs studied; however, Hobbs et al. (1972)
reported cardiac lesions in 33 Beagle dogs exposed in groups to mean initial lung burdens of 3,600,
1,800, 1,200, 780, 400, 210, and 110, µCi (133, 67, 44, 29, 15, 8, and 4 MBq) of 90Y/kg body weight. 
Electrocardiogram changes, consistent with the right heart enlargement and/or conduction defect, were 
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observed in 5 of the animals that died 64–92 days postexposure after receiving a dose of 8,400 rad (84
Gy).  Pathological cardiac findings included right heart dilation and hypertrophy.  Small indurated
hemorrhagic areas near the ventricular junction were present in the right atria of the hearts of 7 of the 12
dogs that died 64–92 days postexposure.  Infarcts of the right atria were also found in some animals. 
ECG changes occurred in 5 of 12 and hemorrhagic areas were found near the ventricular junction in the
right atria of 7 of 12 dogs that died 64–92 days after exposure. 
Durakovic (1986a) studied cardiac function in male Beagle dogs that received 3,000, 6,000, or 10,000 rad
(30, 60, or 100 Gy) of gamma radiation applied bilaterally to the precordium.  The electrocardiograms
remained normal after irradiation at all dose levels.  The atrium, right and left ventricle, and papillary
muscle of every dog all showed focal areas of perivasculitis.  No evidence of focal necrosis was observed. 
The left ventricular ejection fraction (LVEF) did not show statistically significant decreases until
58–70 days after the irradiation, when a marked impairment of heart function was finally observed.
With regard to cardiovascular effects and external exposure to ionizing radiation, Stavem et al. (1985)
reported a case of a 64-year-old male worker who accidentally received a large dose of gamma radiation
in a facility that used ionizing radiation for sterilization.  He was exposed for only a few minutes.  From
spectroscopic analyses of electron-spin resonance in irradiated material, the following mean doses were
estimated: whole body, 2,250 rad (22.5 Gy); bone marrow, 2,100 rad (21 Gy); and brain, 1,400 rad
(14 Gy).  The dose to nitroglycerin tablets that were in the worker's pocket at the time was 4,000 rad
(40 Gy).  The worker developed an ARS and an autopsy was performed after death.  The left ventricle of
the heart was hypertrophic and the anterior descending ramus of the coronary artery was markedly
stenotic; however, it was not clear whether this was an age-related effect or directly related to the effects
of the radiation since much larger doses to animals are needed to produce such effects.
In summary, respiratory effects have been reported in humans (Stavem et al. 1985) as well as in
laboratory animals (Rezvani et al. 1989; Salovsky and Shopova 1992) exposed to very high doses from
internal and external sources of radiation because the respiratory system appears to be resistant to high
doses of radiation.  Most research has focused on radiation effects  on the lungs when associated with
inhaled insoluble (and, to a lesser degree, soluble) particles.  These studies were acute, high-dose
exposures resulting in high initial lung burdens on the order of several millicuries (tens of thousands of
Bq), which resulted in cumulative doses in the thousands of rad (tens of Gy).  After the radioactive
material was inhaled, clinical signs were related to the organ system that received the major radiation 
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dose.  Soluble particles dissolved in the lung and redistributed, depending on the radionuclide, to the liver
or bone to induce toxic effects in those organ systems.  After an initial clearance phase from the lungs,
from which a portion of the initial lung burden was transferred to the gastrointestinal tract, the balance of
the insoluble particles remained for long periods of time in the lung (days to years), irradiating the tissues
closest to their immediate lung location and leaving the lungs very slowly.  The effect of ionizing
radiation on the lungs varied with the dose and length of exposure of the lung tissue.  Respiratory
insufficiency, manifested clinically as increased respiratory rates, increased abnormal lung sounds, and
cyanosis, was a common finding in these studies (Hobbs et al. 1972; Muggenburg et al. 1988), in
association with decreased lung volumes, total lung capacity, and compliance (common but not
pathognomonic of pneumonia) (Muggenburg et al. 1988).  These clinical signs are most likely related to
inflammatory and fibrotic changes occurring within the lungs.  This observation is supported by
radiographic, gross, and histopathological evidence, such as increased focal or diffuse radiographic lung-
field densities, and by interstitial, perivascular, peribronchial, and pleural fibrosis; emphysema;
inflammation; vascular damage; fibrin exudation; congestion; and hemorrhage (Benjamin et al. 1976;
Hahn et al. 1976; Lundgren et al. 1991).  Radiation pneumonitis, followed by pulmonary fibrosis (fibrosis
of alveolar structures involving changes in the ratios of some pulmonary collagens), are two of the most
commonly reported aberrations in laboratory animals following the inhalation of radioactive substances
(Benjamin et al. 1978, 1979; Brooks et al. 1992; Hahn et al. 1975, 1981; Lundgren et al. 1980a, 1991). 
Radiation pneumonitis is characterized by sloughing of dead and dying endothelial cells that may lead to
capillary leakage.  Damage to type II pneumocytes, which can lead to serious alterations in the amount of
surfactant phospholipids and lung inflammation, has also been considered.  The role of type I
pneumocytes, that by necrosing and sloughing leave denuded basement membranes and alveolar debris,
may also be significant.  Alterations in cardiovascular functions could not be definitively linked to
ionizing radiation after inhalation or external ionizing radiation exposures in laboratory animals
(Durakovic 1986a; Hobbs et al. 1972; Muggenburg et al. 1988) or in one man exposed to external
ionizing radiation (Stavem et al. 1985); however, some changes in regional cerebral blood flow were
noted in one study (Cockerham et al. 1986) that used Rhesus monkeys as a model and these were
probably linked to histamine release.  However, all of these effects are due to very high radiation doses,
which are extremely unlikely at radioactive waste sites.
Data for respiratory and cardiovascular effects in humans and laboratory animals are summarized in the
Levels of Significant Exposure to Radiation and Radioactive Material tables in Chapter 8 of this profile.
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3.2.1.7 Ocular  Effects
The lens of the eye is not among the most radiosensitive tissues in the body, but it has less efficient repair
capabilities than many other tissues.  This allows radiation damage to build up with less repair, even when
doses are fractionated or delivered at low dose rates.  Exposure of the lens to sufficient doses of ionizing
radiation results in cataract formation, which can range from minimally detectable opacities that do not
impair vision to blindness.  The target cells in the lens are the epithelial cells on the interior surface of the
anterior capsule of the lens.  These cells differentiate into lens fibers, which are normally transparent. 
The function of the lens is to focus the light entering the pupil onto the retina.  After exposure to ionizing
radiation, these cells fail to divide to produce lens fibers of the appropriate length or transparency.  These
defective fibers then tend to migrate to the posterior pole of the lens, where they can be seen ophthalmo-
logically as a small, opaque dot.  The appearance of the opacities can appear anytime between 0.5 and
35 years postexposure.  Occurrence is affected by the dose, dose rate, and the type and energy of the
radiation.  Cataracts can be induced with as little as 2 Gy (200 Gy) of x ray irradiation (Adams and
Wilson 1993).  Data from those victims exposed to large doses of ionizing radiation after the bombings of
Hiroshima and Nagasaki show a threshold of 0.6–1.5 Gy (60-150 rad) of low LET radiation.  However,
typical human exposures over a long period of time are thought to have a vision impairing threshold
greater than 8 Gy (800 rad)  (BEIR V 1990).
The effects of ionizing radiation on the eye have been reported in some human exposure cases.  Ham
(1953) described the radiogenic cataracts in cyclotron physicists from mixed gamma-neutron doses of
700–1,000 rad (70–100 Gy) to the lens.  Klener et al. (1986) reported on a human case study in which a
male technician was accidentally irradiated by a sealed 60Co source he had been installing.  His health
status was followed for 11 years after the accident.  A film dosimeter worn during the accident indicated
it received an exposure of 159 rad (1.59 Gy), but the dose to his eye was not reported.  Changes in the
lens of the left eye began to appear gradually, leading to the deterioration of visual acuity.  Later,
opacities of the lens of the right eye were also found. 
Schweitzer et al. (1987) exposed Beagle dogs to single, bilateral, whole-body exposures to 60Co gamma
radiation at various stages during fetal ocular development.  Dogs were irradiated during middle or late
pregnancy at 28 or 55 days postcoitus (dpc) or as neonates on the second postpartum day (ppd), with
mean whole-body doses ranging from 100 to 386 rad (1–3.86 Gy).  The dose to the eyes was essentially
equivalent to the whole-body dose.  For dogs exposed on ppd 2, the most prominent fundic alteration on 
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or before 70 days of age was a reduction in arterioles and a narrowing of the venules.  The venules were
dull, the tapetal fundus mottled in appearance, the nontapetal fundus lighter in color than controls, the
optic disc paler, and the eyes characterized by a generalized slight haziness of the ocular media.  Dogs
sacrificed at 2–4 years of age had more marked reductions in arterioles and attenuation of the venules. 
Hyperreflectivity from the eye was found, and homogeneity was often lost in affected eyes.  General and
focal degenerative lesions were evident as were color changes.  Partial tapetal atrophy with increased
pigmentation in the area previously occupied by tapetum was noted in some eyes.  Loss of color and
hyperreflectivity were related to focal loss of pigment and thinning of atrophic retinal foci.  With severe
retinal atrophy or degeneration, choroidal circulation was seen in the nontapetal fundus.  Retinal lesions
were progressive in severity and extent, and the degree of injury was similar for both eyes.  A correlation
was seen between lesions (mostly in the retina and lens) and radiation treatment, with respect to both age
at exposure and radiation dose.  Due to fixation and sectioning artifacts, most lenses couldn't be
adequately evaluated histopathologically.  Retinal dysplasias and atrophy were the most striking lesions
seen.  The stage of development at exposure had a marked effect on the distribution of retinal lesions. 
The most severe changes were seen in the portion of the retina undergoing differentiation at the time of
the insult.  In dogs sacrificed at 70 days of age, the lesions were primarily dysplasias, consisting of
ectopic nuclear aggregates in the photoreceptor layer, retinal folds, and retinal rosettes.  With increasing
age, there appeared to be progression of the extent of the clinically evident lesions, and there was a
change in the nature of the lesions from dysplasia to atrophy.  This was accompanied by marked
attenuation of the retinal vasculature.  In dogs exposed on ppd 2, retinal degeneration was evident in all
dogs sacrificed at 70 days, 2 years, or 4 years of age.  Retinal dysplasias were evident in all dogs
sacrificed at 70 days of age and in 4 of the 13 dogs sacrificed at 2 years.  Retinal dysplasia was not
evident in dogs sacrificed at 4 years.  Atrophy in dogs exposed on ppd 2 was evident in 19 of the 20 dogs
sacrificed at 70 days of age and in all dogs sacrificed at 2 and 4 years of age.  Dysplasias included focal
aggregates of nuclei in the rod and cone layer, retinal folds, and retinal rosettes.  Atrophic changes
included altered rosettes, as well as the rest of the retina, loss of rods and cones, and/or thinning of inner
and outer nuclear layers.  These lesions were bilateral and focal-to-diffuse in nature.  They increased in
severity with increasing radiation dose.  In dogs exposed on ppd 2, central retinal lesions only were seen
in 1 of the 20 dogs sacrificed at 70 days of age.  No lesions were seen in dogs sacrificed at 2 or 4 years. 
Central and peripheral retinal lesions were seen in 19 of the 20 dogs and in all dogs sacrificed at 70 days
and at 2 or 4 years, respectively.
In summary, ocular effects have been reported in both humans and laboratory animals after radiation
doses exceeding 0.6 Gy (60 rad).  These effects range from mild opacities of the lens to cataract formation
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and alterations in both the posterior chamber of the eye and of the retinal structures.  The effects are not
immediate, and in people may occur several years after the initial exposure.
3.2.1.8 Dermal Effects
Clinically observable dermal radiation effects ranging from erythema (skin reddening) to necrosis have
been observed following external beta, gamma and x ray exposure above threshold doses at high dose
rates.  A transient erythema, the earliest sign of overexposure of the skin, occurs after a dose of about 300
rad (3 Gy), and was once used by physicians to calibrate x ray machines.  The erythema appears several
hours after exposure, and disappears within a day.  Much greater radiation doses lead to a second
erythema several weeks later, which lasts for about a month.  Greater doses lead to loss of hair, peeling of
the skin (dry desquamation), blistering (wet desquamation), ulceration, and necrosis (Potten 1985).  The
USNRC limit for occupational exposure of the skin is 50 rem (0.5 Sv) per year is protective for such
effects.  The skin has a susceptible cell population sensitive to the effects of ionizing radiation.  The target
cells are those comprising the germinal cells of the skin (stratum germinativum), also known as the basal
cell layer, which is itself affected by the thickness of the various skin layers of the epidermis.  Normally,
the basal cells give rise to the outer layers of the skin (stratum granulosum, stratum lucidum, etc.) and
finally form the outmost protective dead layer of the skin, the stratum corneum.  
Radiation effects on the skin are  proportional to the dose received by this germinal cell layer and to the
type of radiation received.  Alpha particles with energies greater than 7.5 MeV (8.8 MeV 212Po in the
232Th series, 8.8 MeV 213Po in the 241Pu series, 7.7 MeV 214Po in the 238U series and possibly 7.4 MeV 215Po
in the 235U series) can penetrate the stratum corneum; therefore, there could be an alpha skin dose in these
situations, but much of their energy will be expended in the epidermis, leaving only a small portion for
dermal exposure.  In general, alpha particles with energies less than 7.5 MeV that deposit on the skin
surface (stratum corneum) have little effect, given the short penetration range of this type of radiation. 
The bulk of the dose is absorbed by the stratum corneum, comprised of dead cells, phospholipids, waxes,
and other large complex molecules (Riviere and Spoo 1995).  Beta and gamma radiation, which can
penetrate deeper to live cell layers, can produce erythema, indicating a vascular component manifested by
vasodilation and probably mediated by histamine or other inflammatory mediators.  As the dose increases,
epilation, dry and/or moist desquamation, and necrosis can occur.  The threshold dose of gamma radiation
in humans required to produce skin erythema over an area of 10 cm2 is  600–800 rad (6–8 Gy) for single
doses and 3,000 rad (30 Gy) for multiple (fractionated) doses (Adams and Wilson 1993).  The threshold 
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dose increases with decreasing area of the irradiated skin.  The dermis is less severely affected, given its
population of less active cells, connective tissue, sebaceous glands, and nerve fibers.  However, the endo-
thelial cells associated with the dermal blood vessels are somewhat more susceptible and may play a role
in the production of erythema after receiving doses of ionizing radiation.  The long-term effects on the
skin after receiving over 1,000 rad (10 Gy) of ionizing radiation include pigmentation, epidermal atrophy,
dermal fibrosis, and atrophy of several dermal and epidermal structures, such as sweat and sebaceous
glands and hair follicles.
Hahn et al. (1975) reported the effects of ionizing radiation on the skin of Beagle dogs after inhalation
exposure to 90Y in FAP.  Four of the 7 dogs exposed to 14–22 mCi (520–814 MBq) initial lung burden
(32–40 mCi [1,200–1,500 MBq] whole-body burden) developed a nasal dermatitis.  Hobbs et al. (1972)
exposed 33 Beagle dogs to initial lung burdens of 3,600, 1,800, 1,200, 780, 400, 210, 110, and 0 µCi
(133, 67, 44, 29, 15, 8, 4, and 0 MBq) 90Y/kg body weight.  Patches of radiation alopecia were found on
the dorsum of the nose of four animals that died 70–91 days postexposure.  These patches were character-
ized by a thinning of the outer epidermal layer of the skin, atrophy, and loss of hair follicles and hair
shafts.  Dermal collagen seemed unaffected.  Nasal dermatitis, however, is unlikely to occur in humans
for two reasons: (1) these animals were exposed to very high activities of 90Y that are essentially out of
the realm of possibility for humans, and (2) these effects are likely to occur in animals with long snouts or
muzzles.
Syrian golden (23) and white (24) hamsters (8 weeks of age) were exposed to a 85Kr source that was in
direct contact with the skin.  Skin-absorbed doses ranged from 2,000 to 10,000 rad (20–100 Gy) and were
delivered at the rate of 495 rad/min (4.95 Gy/min).  Within 24 hours after radiation, erythematous
reactions developed and persisted for several days postexposure.  At sites where larger doses were
applied, severe radiation dermatitis developed and sometimes resulted in ulcerative changes in the
epidermis.  Permanent epilation resulted at doses of 10,000 rad (100 Gy), and doses of 4,000 rad (40 Gy)
induced temporary epilation up to the 17th week in all males and most of the females.  Growth of grey
hair was subsequently observed in the exposed areas of all animals in the 4,000 rad (40 Gy) dose group. 
Females receiving 2,000 rad (20 Gy) showed about 12 weeks of epilation followed by growth of grey hair
in most of them.  Some males showed epilation for a short period of time, and the rest of the males
showed initial and transient periods of epilation followed by growth of normal hair.  Complete epilation
occurred in white hamsters receiving 4,000 and 10,000 rad (40 and 100 Gy) and recuperation of hair
growth in these animals was not observed.  A short period of epilation was observed, followed by growth 
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of normal hair in animals exposed at the 2,000-rad (20 Gy) level.  Few animals showed complete
epilation preceded or interrupted by periods of growth of normal hair.  No spreading of the hair-greying
effect of beta particles was observed in this experiment (Garcia and Shubik 1971).
Similar results were found in pigs, whose skin is considered to be most like that of humans.  Hopewell et
al. (1986) studied the dose-effect relationship as a function of an irradiated area of the skin by irradiating
an area of skin in 3–4 month old large white pigs with 90Sr, 170Tm, or 147Pm disk sources of different
diameters.  These radionuclides emit beta particles with energies of 0.55, 0.97, and 0.22 MeV that can
penetrate 2, 4, and 0.5 mm of tissue, respectively, compared with 0.007 mm for the stratum corneum.  The 
diameter of the sources varied from 1 to 40 mm for 90Sr, from 0.1 to 19 mm for 170Tm, and from 2 to
15 mm for 147Pm.  In the porcine model, the ED50 values for moist desquamation for 90Sr varied from
2,750 rad (27.5 Gy) for the 22.5-mm diameter source to 7,500 rad (75 Gy) for the 5-mm source.  An
increase in source diameter to 40 mm did not significantly change the ED50 value from that obtained with
a 22.5-mm source. 170Tm irradiation in the pig produced no distinct area effect for sources 5–19 mm in
diameter (ED50 for moist desquamation ~8,000 rad [~80 Gy]).  Acute tissue necrosis was only achieved in
pig skin by very high doses (ED50 14,000 rad [140 Gy]) from sources #2 mm in diameter.  Irradiation
of pig skin with 147Pm produced acute epithelial breakdown but only after high skin-surface doses (ED50
55,000–72,500 rad [550–725 Gy] for 15–2 mm sources).  In a similar experiment, Hopewell et al. (1986)
exposed SAS/4 randomly-bred male mice, 11–12 weeks old to 90Sr, 170Tm, and 147Pm, again with the
sources varying in diameter.  90Sr and 170Tm exposure in the mouse resulted in a distinct field-size effect
for sources 5–22.5 mm in diameter; the ED50 values for moist desquamation were 2,200–2,750 rad
(22–27.5 Gy) for the 22.5-mm source and 7,500–9,000 rad for the 5-mm source.  There was a distinct
source  area effect; the ED50 values decreased as the source diameter increased.  Acute tissue breakdown
was only achieved in mouse skin by very high doses (ED50 14,000 rad) from sources of #2 mm in
diameter from both types of beta emitters.  The large differences in doses required to produce the same
effect, with higher energy beta particles producing a greater effect from the same size source by these
three radionuclides, may be due to differences in penetrating power.  The lower energy beta particles
deposit a larger portion of their energy in the dead layers of the stratum corneum, compared with live
tissue, so the actual live tissue doses may be larger for the higher energy beta emitters.
A study by Song et al. (1968) examined the efficacy of several anti-inflammatory agents on the
suppression of the early increase in radiation-induced vascular permeability to plasma protein in guinea 
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pigs (radiodermatitis is one limiting factor in radiation therapy because the skin is the first in line for
exposure to absorb the energy).  Albino male guinea pigs were exposed to 3,000 rep (1 rep1 rad) of β
particles (750 rad/min [7.5 Gy/min]) from a 90Sr /90Y source.  Immediately after irradiation, 125I-labeled
guinea pig serum albumin (15 µCi [0.56 MBq] in 0.15–0.20 mL of saline) was injected into the blood. 
The peak increase in accumulation of vascular permeability as measured by plasma protein between the
control and the 3,000-rad (30 Gy) beta-irradiated skin was determined to occur at 18 hours.  A significant
increase in vascular permeability occurred in the control group receiving no anti-inflammatory drug, as
demonstrated by an approximately 3- and 1.6-fold increase in the 18-hour accumulation of plasma protein
in the irradiated epidermis and dermis, respectively.
External radiation exposure  shows similar results in humans.  Birioukov et al. (1993) reported on a case
study in which 12 men developed different forms and stages of chronic radiation dermatitis caused by
accidental exposure to beta and gamma radiation during and after the Chernobyl nuclear power plant
accident.  Nine of the men were close enough to the accident to receive doses ranging from 350–550 rad
(3.5–5.5 Gy).  Three men received doses ranging from 200–350 rad (2–3.5 Gy): two had worked in the
contaminated zone for 2 months to 3 years and one was inside the power plant during the accident.  All
the men were diagnosed with ARS of varying severity after the accident.  All the men except one had
chronic radiation dermatitis on the upper and lower extremities.  The other patient had slight radiation
dermatitis on the neck.  
Klener et al. (1986) reported another human case study in which a male technician was accidentally
irradiated by a sealed 3,000 Ci (110 TBq) 60Co telotherapy source that he had been installing.  A film
dosimeter worn during the accident indicated a dose of 159 rad (1.59 Gy); however, his whole body was
highly non-uniformly irradiated.  His health status was followed for 11 years after the accident. 
Eight days after the accident, he developed severe skin changes on the left hand (reddening and painful
inflammation) that would result from doses much greater than 159 rad (1.59 Gy).  Clearly, his left hand
suffered a very much greater dose than that shown on his film badge.  Since he was left-handed, it seems
likely that his left hand was closer to the radioactive source and received a much larger dose than his film
badge.  Apparently, he severely overexposed his left hand during his several unsuccessful attempts and
his final successful attempt to place the source back into the container using improvised tools.  He also
suffered epilation in a small area of the left temporal region, with minor deviations in peripheral blood
counts.  In the following year, repeated surgery due to secondary skin defects of the left hand resulted in 
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the loss of the second through fifth fingers; effects included serious trophic changes characterized by a
smoothed discolored skin, hard swelling of deep skin layers, and disturbed local blood flow.
In laboratory animal studies, Hulse (1966) exposed albino hairless mice to 750–1,500 rad (7.5–15 Gy) of
204Tl radiation (0.77 MeV beta particles) to determine if a nonepilating dose produced skin erythema.  No
visible changes in the skin of albino hairless mice were observed with a 750-rad (7.5 Gy) exposure.  Only
slight erythema was noted in the 1,500-rad (15 Gy) animal groups.  Using slightly higher doses, Etoh et
al. (1977) irradiated male albino guinea pigs at a total of 6 sites per animal.  Maximum cell loss of
recognizable basal cells of 20% on day 8, 60% on day 12, and 75% on day 15 occurred after irradiation
with 1,000, 2,200, and 3,000 rad (10, 22, and 30 Gy), respectively.  The data for the 5,000-rad (50 Gy)
exposure were similar to data for 3,000 rad (30 Gy).  Regeneration occurred from survivors within the
irradiated area after 1,000 and 2,200 rad (10 and 22 Gy), and was completed in 5 days.  No hyperplasia
was seen at 1,000 rad (10 Gy), but a long-lived hyperplastic epidermis resulted after the higher doses. 
Lefaix et al. (1993) exposed large white pigs to a single dose of 12,000, 16,000, or 25,600 rad (120, 160,
or 256 Gy) applied to the outer side of the right thigh; in another group, some animals were given single
doses of 1,600, 3,200, 4,800, 6,400, 8,000, and 9,600 rad (16, 32, 48, 64, 80, and 96 Gy) applied to the
back skin.  Data were collected 30 weeks after exposure.  No change in the skin surface was observed
following a dose of 1,600 rad (16 Gy).  After a 3,200-rad (32 Gy) dose, erythema was observed.  After
4,800 rad (48 Gy), desquamation of the epidermis developed at the 12th week post-irradiation.  At 6,400,
8,000, and 9,600 rad (64, 80, and 96 Gy) all showed a moderate erythema in the first 3–4 days, a distinct
erythema after 3–5 weeks, and moist desquamation after 7–12 weeks.  Skin necrosis was observed during
the 5th week following doses to 12,000 and 16,000 rad (120 and 160 Gy), and cutaneous and muscular
ulceration during the 6th week.  The highest dose of 25,600 rad (256 Gy) caused skin necrosis at the end
of the second week and well-delimited ulceration by the third week.  After doses of 12,000, 16,000, and
25,600 rad (120, 160, and 256 Gy), which all induced skin and skeletal muscle ulceration, and 6,400,
8,000, and 9,600 rad doses, which induced dried exudate crusts, damaged skeletal muscles healed by
replacement fibrosis and scar formation.  It should be noted that the 0.77 MeV 204Tl beta particles can
penetrate 300 mg/cm2 of material, or approximately 0.3 cm of tissue, which is enough to penetrate all
layers of the skin and continue to penetrate into the skeletal muscle.
In summary, the skin is resistant to the deterministic effects of radiation until a threshold of 200–300 rad
(2–3 Gy) is reached, after which the effects  appear to follow a dose-effect relationship  (Etoh et al. 1977; 
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Hulse 1966; Lefaix et al. 1993).  Ionizing radiation affects the deep, rapidly multiplying cells of the
epidermis (basal cells), which are at a mean depth of 0.007 cm below the outer surface layer of dead cells
and which are responsible for the production of the more superficial layers of the epidermis.  Other cells
within the epidermis that multiply rapidly, such as cells that surround the hair follicle, can also be affected
by ionizing radiation, resulting in epilation.  Dermal radiation effects seem to be most common after
either a direct dermal exposure to a beta or gamma emitter or after external exposure scenarios; alpha
emitters, due to their short penetration range, do not penetrate the upper, dead layers of the epidermis
(stratum corneum).  A clear dose-effect relationship between radiation and  skin damage as a whole was
demonstrated in humans and in animals.  In humans, the earliest response is a mild, transitory erythema
that appears several hours after a dose of about 300 rad (3 Gy).  Responses ranged from mild epilation
that led to the return of normal hair growth at a dose of 2,000 rad (20 Gy), to ulcerative dermatitis and
permanent epilation at doses up to 10,000 rad (100 Gy) (Garcia and Shubik 1971).  Moist desquamation
occurred in pigs at 2,250–7,500 rad (22.5-5.75 Gy) and acute tissue necrosis occurred at doses of 14,000
rad (140 Gy) and above (Hopewell et al. 1986).  Erythema and epilation, followed by serious trophic
changes and altered skin blood flow, have also been reported in a man whose film badge showed a dose
of 159 rad (1.59 Gy); however, the affected areas on the hand received a much higher dose than that
reported on the film dosimeter (Klener et al. 1986).  Men exposed to external radiation (200–550 rad
[2–5.5 Gy]) from the Chernobyl reactor accident also developed chronic dermatitis as a result of the
exposures.
Data for dermal and ocular effects in humans and laboratory animals are summarized in the Levels of
Significant Exposure to Radiation and Radioactive Material tables in Chapter 8 of this profile.
3.2.1.9 Genotoxic Effects
The scientific literature contains abundant information on the genotoxic effects of all forms of ionizing
radiation from multiple routes of exposure.  Tables 3-4 and 3-5 summarize several representative studies
that demonstrate the genotoxic end points that can be caused by radiation using in vivo and in vitro testing
systems.  However, genetic effects of radiation have never been seen in any human population exposed to
any level of radiation.
The data presented in Tables 3-4 and 3-5 show that genotoxicity is a major toxicological end point for
exposure to ionizing radiation; specific end points consist of chromosomal aberrations and breaks, 
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reciprocal translocations, deletions, sister chromatid exchanges, dominant lethal mutations, sperm
anomalies, and mutations.  DNA is a major target molecule during exposure to radiation (see Chapter 5). 
Other macromolecules, such as lipids and proteins, are also at risk of damage when exposed to ionizing
radiation.  The genotoxicity of ionizing radiation is an area of intense study, as damage to the DNA is
ultimately responsible for many of the adverse toxicological effects described so far in this chapter.  Cells
depend on their DNA for coding information to make specific enzymes, proteins, hormones, vasoactive
substances, and a host of other essential chemicals.  When the genetic information containing the
“blueprint” for these substances is disturbed, cellular homeostasis is disrupted, resulting in a wide-range
of immediate and/or delayed toxicological effects in a number of organ systems, as described earlier in
this chapter.  Disruptions and changes of the cellular genome are also thought to be responsible for the
formation of cancer in both humans and laboratory animals.  
Radiation can interact either directly or indirectly with the cellular DNA to produce the effects seen in
Tables 3-4 and 3-5.  These interactions can be classified as direct and indirect interactions.  In direct
interactions with DNA (as well as other macromolecules), an alpha particle, beta particle, or gamma ray
knocks an electron out of the DNA molecule through an ionizing collision.  This can break the
intramolecular chemical bond that contains the vital information that must be transmitted to the daughter
cells.  Complete repair is normally expected, but if the damage goes unrepaired, the information encoded
in the DNA structure is distorted, and faulty information is transmitted to the daughter cells during
mitosis, or else the cell dies and terminates the genetic defect.  These effects can result in the genetic
effects listed in Tables 3-4 and 3-5.  In indirect interactions of with DNA, radiation has no direct contact
with the DNA; instead it interacts with smaller molecules, especially water, surrounding the DNA to
produce highly reactive radicals and ions like those produced in normal metabolic processes, and the end-
products of this reaction diffuse away from the site of interaction with the radiation and interact with the
DNA, breaking its molecular bonds just as with direct radiation.  Misrepair and replication can then
produce the adverse effects listed in Tables 3-4 and 3-5.  More specific information about how radiation
produces its effects on DNA and other macromolecules is presented in Chapter 5 of this profile.
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The structure of the DNA molecule is damaged after direct or indirect interactions by radiation. 
Significant amounts of damage to the DNA lead to errors for gene coding of essential enzymes, proteins,
and other essential molecules.  DNA base-pair damage is the  predominant type of DNA damage,
followed (in decreasing order of incidence) by single strand breaks (which are four times less prevalent
than base-pair lesions), DNA-protein cross-linkages, and double-strand breaks.  At the molecular level, an
important type of change to DNA that is frequently produced by radiation is the removal of a base,
forming an apurinic or apyrimidinic site.  The deletion or total destruction of DNA bases, destruction of
deoxyribose residues, and deamination of cytosine or adenine are only a few of the many ways radiation
can alter the DNA at a molecular level.  Minor damage left unrepaired or damage that was not completely
or correctly repaired can result in mutations.  A more in-depth discussion of the alterations at the DNA
level by radiation, including some DNA repair mechanisms, is presented in BEIR V (1990) and in
Chapter 5.
Damage to genetic material in an organism may have one of several outcomes.  First, enough damage can
cause cell death.  Second, the genetic material may be repaired by the cell’s native DNA repair
mechanisms.  If the damage is small and the DNA can be repaired correctly prior to cell division, no
adverse effects are likely to come from the genetic damage.  Chromosomal repair mechanisms have likely
existed since life began and our knowledge of these mechanisms has existed for many years.  Without
these repair mechanisms, the normal damage that occurs to the entire organisms's DNA every day
spontaneously, and from other sources such as normal metabolic products, mutagenic chemicals and
background radiation, could be lethal.  Chromosomal repair mechanisms are a method of minimizing
damage, including radiation damage to DNA, providing that the dose of radiation is not so large as to
overwhelm them.  If the damage is reparable and the cell divides prior to repair, or if the damage is so
extensive it cannot be repaired by the normal mechanisms, the cell may die.  The results range from no
apparent effect on the organs if few or scattered cells die to damaged tissues at higher doses.  Another
alternative is that the DNA damage is not repaired, the cell lives and carries out its normal functions, and
then divides to produce progeny cells.  If the progeny cells die, then the mutational event is considered a
lethal mutation with no consequences.  If the progeny cells live, then the cells will likely carry these
genetic mutations forward into all future daughter cells.  In-depth reviews of these mutation processes and
their impact on the induction of cancer in animals and humans are available (Hoffman 1996; Pitot III and
Dragan 1996; Sanders 1983; Sanders and Kathren 1983).
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If the cell survives the radiation-induced genetic damage and carries the mutations into future cell
populations, two events can take place.  First, the cell may carry the DNA defect and express an adverse
event, such as altered protein and enzyme synthesis and defects in cellular metabolism.  These defects can
be numerous, depending largely on where on the genome the mutation takes place and how critical the
normal gene is to normal cell function.  The second event is multi-stage carcinogenesis, which is
discussed in more detail later in Chapter 5.
Both somatic and reproductive cell chromosomes can sustain damage after exposure to radiation. 
Damage to the human genome in exposed populations of humans has potentially serious implications.  If
genetic damage occurs in the reproductive cells (sperm and ova), this may result in decreased fertility,
malformed fetuses, and certain hereditary diseases.  These effects have been observed in animal studies,
but long-term follow-up of radiation-exposed human populations has not identified any genetic effects.
Estimates of spontaneous genetic diseases vary.  Table 3-6 shows that genetic diseases occur
spontaneously (naturally) in approximately 5% of the population (excluding genetic contributions to
heart, cancer, and other selected human diseases).  UNSCEAR (1993) reported that about 8% of liveborn
humans will have a hereditary disease that leads to a serious handicap manifested before 25 years of age.
This 8% figure includes all serious congenital anomalies, some of which may be only slightly influenced
by transmitted mutations.  Before one begins to determine whether human genetic damage can be caused
by exposure to increasing doses of radiation, it is necessary to know what the normal, spontaneous, or
“background” rates of genetic diseases are in the human population exposed to ambient levels.  Several
investigators have performed work to measure the spontaneous frequencies of genetic anomalies and
spontaneous mutation rates of many genetic traits in humans throughout the world (Childs 1981; Czeizel
and Sankaranarayanan 1984; Stevenson 1959, 1961; Stevenson and Kerr 1967).  Difficulties are clearly
inherent in such comprehensive studies.  As an example, as our knowledge of human and animal genetics
increases, discrepancies in the data may arise from changes in the classification of some genetic disorders. 
For example, Stevenson (1959) estimated that 30.7/1000 live births were due to autosomal dominant
genetic disorders, while in a study 15 years later by Trimble and Doughty (1974) estimated that only 
0.8/1000 live births for the same class of genetic disorders.  The data from the Stevenson (1959) data 
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Table 3-6.  Estimated Genetic Effects of 1 Rem (0.01 Sv) of  Radiation per Generationa
 
Type of disorder
Spontaneous/
not irradiated
Irradiated
Additional cases/106 liveborn offspring/rem
(0.01 Sv)/generation
Current incidence per million
liveborn offspring First generation Equilibrium
Autosomal dominant b
   Clinically severe
   Clinically mild
2,500c
7,500g
 
  5–20d
  1–15d
25e
75e 
X-linked 400 <1 <5
Recessive 2,500 <1 Very slow increase
Chromosomal
   Unbalanced  translocation
   Trisomies
600h
3,800i
<5
<1
Very little increase 
<1
Congenital abnormalities 20,000–30,000 10j 10–100k
Other disorders of organs l
   Heart m
   Cancer
   Selected others
600,000
300,000
300,000
Not estimated Not estimated
aRisks pertain to average population exposure of 1 rem per generation to a population with the spontaneous genetic
burden of humans and a doubling dose for chronic exposure of 100 rem (1 Sv)
bAssumes that survival and reproduction are reduced by 20-80% relative to normal (s=0.2-0.8), which is consistent
with the range of values in Table 2.2 in BEIR (1990).
CApproximates incidence of severe dominant traits in Table 2-2 in BEIR (1990).
DCalculated using Equations (2-7) in BEIR (1990) with s=0.2-0.8 for clinically severe and s = 0.01-0.2 for clinically
mild.
eCalculated using Equations (2-1) in BEIR (1990), with the mutational component = 1.
fAssumes that survival and reproduction are reduced by 1-20 percent relative to normal (s=0.01-0.02).
gObtained by subtracting an estimated 2,500 clinically severe dominant traits from an estimated total incidence of
dominant traits of 10,000.
hEstimated frequency from UNSCEAR (1982, 1986).
iMost frequent result of chromosomal nondisjunction among liveborn children.  Estimated frequency from UNSCEAR
(1982, 1986).
jBased on  worse-case assumption that mutational component results from dominant genes with an average s of 0.1:
hence, using Equation 2.3 in BEIR (1990), excess cases <30,000 x 0.35 x 100-1 x 0.1 = 10.
kCalculated using Equation 2-1 in BEIR (1990), with the mutational component 5-35%.
lLifetime prevalence estimates may vary according to diagnostic criteria and other factors.  The values given for heart
disease and cancer are round-number approximations for all varieties of the diseases, and the value for other
selected traits approximates that for the tabulation in Table 2-4 of BEIR (1990).
mNo implication is made that any form of heart disease is caused by radiation among exposed individuals.  The effect,
if any, results from mutations that may be induced by radiation and expressed in later generations, which contribute,
along with other genes, to the genetic component of susceptibility.  This is analogous to environmental risk factors
that contribute to the environmental component of susceptibility.  The magnitude of the genetic component in
susceptibility to heart disease and other disorders with complex etiologies is unknown.
Source: adapted from  BEIR V 1990
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set included disorders now known to not be of an autosomal dominant mechanism, resulting in an
artificially high estimate in the 1959 report.  Definitions of serious and mild genetic disease, size of the
population sampled and the specific world location sampled, in addition to the frequencies of some
genetic diseases tending to wax and wane over a number of years, will all significantly contribute to the
problem of obtaining stable and accurate estimates of background genetic disease burdens in humans.
Table 3-6 summarizes the current incidence of some generalized genetic anomalies (background levels of
genetic disease) and the estimated genetic effects of 1 rem (0.01 Sv)/year/generation of radiation on the
genome of humans based on an assumed doubling dose of 100 rem (1 Sv) (BEIR V 1990).
Determining the genotoxic effects of ionizing radiation in a population of humans is difficult.  Several
factors complicate making such predictions of genotoxic effects in humans.  First, the genotoxic effects of
radiation in humans must be detected in the offspring from the parent(s) that were irradiated. 
Given the normally long life cycle of humans compared to laboratory animal models, it may be a
few weeks to many years before any genetic effects induced by radiation express themselves in the
offspring of an exposed human population.  The epidemiologic studies that are needed to accumulate a
sufficient database of information after such an exposure would be both time consuming and expensive,
with the final results most likely not being available for years after exposure.  In addition, radiation
effects in an exposed population may vary significantly by exposure location:  all of the population may
not have received a uniform whole body dose, and different individuals would have received different
radiation doses, thus complicating the data collection process.  Distance-from-exposure source and total
organ dose received are only estimates and not a precise measurement.  Age and sex distribution of the
exposed population and their normal probabilities of producing children must also be accounted for and
determined using relevant control populations.  
A major problem with the genetic studies on humans relates to the many remaining uncertainties about
dosimetry.  Many of the difficulties described above were encountered with the data collected from the
exposures to radiation resulting from the atomic bombing at Hiroshima and Nagasaki, Japan; these
exposures consisted primarily of external gamma radiation.  The original dosimetry measurements from
that exposure (T65D) have been revised (DS86) and are still undergoing revision to more accurately ]
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determine the actual doses of radiation received by individuals who survived the atomic bomb explosions
in August 1945.  Although no increased incidence of hereditary effects among the children and
grandchildren of the atomic bombing survivors has been seen, certain authors and committees made
certain assumptions about the induction of radiation-induced hereditary effects and have calculated the
chances of the occurrence of these effects; the results and assumptions are presented and discussed in
other texts (BEIR IV 1988; BEIR V 1990; UNSCEAR 1993). Another major problem in quantifying
genetic effects is the wide spectrum of possible health outcomes that may be attributable to genotoxic
events.  The total genetic detriment includes health effects that may have minor or insignificant impact,
major genetic diseases, and death.  Some of these outcomes may be very difficult to measure.
Today, two basic models are used to estimate the risk for radiation-induced hereditary disease for low
doses of radiation.  These models are the Direct Method and the Doubling Dose Method. Both models are
linear, no-threshold models for dose response.  
In the Direct Method, the dose-related rate of hereditary effects in mice is extrapolated to humans. 
However, because of the many uncertainties in this extrapolation, this method is not favored for
estimating the chances of a radiation-based hereditary effect in humans.
The Doubling Dose Method requires fewer assumptions and estimates than the direct method.  The
"doubling dose"  of radiation is defined as the dose that induces a mutation frequency equal to the total
spontaneous mutation frequency per generation.  Hence, the doubling dose of radiation doubles the total
mutation frequency per generation.  In other words, the dose of radiation to the gonads (testes or ovaries)
that, if delivered per generation to all members of a population would, at equilibrium after many
generations, doubles the spontaneous burden that existed before exposure began (BEIR V 1990; Faw and
Shultis 1993).  This method uses the natural frequency of human hereditary disease in determining an
estimate of the increased frequency of genetic alterations as a result of a sudden increase in radiation
exposure to the general public.  Compared to the direct method, the doubling dose method directly takes
into account the effect of a genetic anomaly on all generations beyond the first generation.  The problem
of species extrapolation from animal to human is also somewhat circumvented; in theory, this method
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relies entirely on a known estimate of a specific genetic mutation frequency in the human, although some
of the doubling-dose estimates originate from data collected in the mouse animal model.  Risk estimates
of genetic disease using the doubling dose method have been adopted by the latest BEIR committee;
however, UNSCEAR still relies on the direct method of risk estimation.
Risk estimates have been reported for humans exposed to  radiation, despite the difficulties with the
availability of data.  Using the epidemiological data gathered after the atomic bombing of Hiroshima and
Nagasaki in August 1945, which encompasses nearly 50 years of data, together with data from studies
with mice, some estimates of genetic disease risk using the doubling dose method can be derived for
human exposures to radiation.  These estimates are presented in Table 3-7.  
Table 3-7.  Estimated Lower 95% Confidence Limits of Doubling Dose (in rem) from Chronic
Radiation Exposure for Malformations, Stillbirths, Neonatal Deaths, and All Untoward Pregnancy
Outcomes (Based on the Hiroshima and Nagasaki Atomic Bombing Data)
Group Malformations  Stillbirths Neonatal death
All untoward
outcomes
All groups 96 124 90 60
Only mother
exposed 277 32 23 29
Only father
exposed 65 344 56 41
Combined 119 64 35 36
Both mother
and father exposed 41 73
  
75 37
Source: adapted from BEIR V 1990 and Schull et al. 1981
NOTE:  Data are the lower 95% confident limits of the doubling dose adjusted for concomitant sources of variation. 
For acute doubling doses, divide by  3.  For all estimates adjusted for concomitant  sources of variation, the range of
the doubling dose is 23–344 rem (0.23–3.44 Sv), the median is 62 rem (0.62 Sv), and the mean is 86 rem (0.86 Sv).
Table 3-7 provides the lower 95% confidence limits of the minimum doubling dose estimates (in rem) on
adjusted data from those individuals that survived the atomic blasts of 1945, and are for chronic radiation
exposures only.  The human data set closely approximates the median values obtained in mice (data not
shown), and overall may suggest that humans are somewhat more radioresistant than mice, implying
lower risk.  Due to the data restrictions in this human population (discussed previously in this section), the
human data may be biased in such a way as to yield an artificially lower number than that obtained using 
IONIZING RADIATION 151
3. SUMMARY OF HEALTH EFFECTS OF IONIZING RADIATION
the mouse data.  The numbers in Table 3-6 are based on the application of actual doses to models derived
from animal experiments.  In the case of the survivors of the atomic bombing, Dr. J.V. Neel, who had
been studying the genetic effects of these bombings since 1946, concluded that “the children of the most
highly irradiated population in the world’s history provide no statistically significant evidence that
mutations were produced in their parents. . . . In particular, the studies should prove reassurance to that
considerable group of exposed Japanese and their children, without whose magnificent cooperation these
studies would have been impossible and who over the years have been subject to a barrage of
exaggerations concerning the genetic risks involved” (Neel et al. 1990).  In short, Neel and others believe
that  humans may be less sensitive to induction of mutations than mice. The data of Neel and colleagues
indicated that mice may be much less sensitive than has been thought, however, to reach this conclusion
they had to disregard the genes that have been studied the most (the specific-locus data), based on the
argument that those genes might be atypically mutable.
In summary, the intracellular genetic materials in humans and in animals may be damaged by radiation. 
The severity of these lesions depends on the dose and type of ionizing radiation received and the extent to
which these lesions can be repaired by the resident cellular repair systems.  These lesions range from
point mutations, which cause serious hereditary diseases, and chromosomal aberrations and breaks to
lethal  mutations of the genetic material, which lead to cellular death.  
The amount of radiation needed to cause hereditary effects is not known, because hereditary effects have
not been detected in humans.  As stated in the UNSCEAR (1993) report, “Epidemiology has not detected
hereditary effects of radiation in humans with a statistically significant degree of confidence.  The risk
estimate based on animals is so small that it would have been surprising to find a statistically significant
effect in the end-points studied in Hiroshima and Nagasaki. . . .  Risk estimation therefore rests on genetic
experimentation with a wide range of organisms and on cellular studies, with limited support from the
negative human findings.”  The two models that currently exist for making these determinations have
both strengths and weaknesses.  One of the weaknesses is the high rate of spontaneous chromosomal
breaks; about 200,000 broken chromosomes are repaired per hour. The main difficultly with estimating
genetic effects of radiation is that the frequency of the postulated effects, even for high radiation doses, is
less than the annual statistical variability in the number of these that occur spontaneously.
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3.2.2 Children’s Susceptibility
This section discusses potential health effects from exposures during the period from conception to
maturity at 18 years of age in humans, when all biological systems will have fully developed.  Potential
effects on offspring resulting from exposures of parental germ cells are considered, as well as any indirect
effects on the fetus and neonate due to maternal exposure during gestation and lactation.  Relevant animal
and in vitro models are also discussed.
  
Children are not small adults.  They differ from adults in their exposures and may differ in their
susceptibility to hazardous chemicals.  Children’s unique physiology and behavior can influence the
extent of their exposure.
With respect to chemical toxicity, children sometimes differ from adults in their susceptibility to
hazardous chemicals, but whether there is a difference depends on the chemical (Guzelian et al. 1992;
NRC 1993).  Children may be more or less susceptible than adults to health effects from environmental
insults, and the relationship may change with developmental age (Guzelian et al. 1992; NRC 1993). 
Vulnerability often depends on developmental stage. There are critical periods of structural and functional
development during both pre-natal and post-natal life and a particular structure or function will be most
sensitive to disruption during its critical period(s).  Damage may not be evident until a later stage of
development. There are often differences in pharmacokinetics and metabolism between children and
adults.  For example, absorption may be different in neonates because of the immaturity of their
gastrointestinal tract and their larger skin surface area in proportion to body weight (Morselli et al. 1980;
NRC 1993); the gastrointestinal absorption of lead is greatest in infants and young children (Ziegler et al.
1978).  Distribution of xenobiotics may be different; for example, infants have a larger proportion of their
bodies as extracellular water and their brains and livers are proportionately larger (Altman and Dittmer
1974; Fomon 1966; Fomon et al. 1982; Owen and Brozek 1966; Widdowson and Dickerson 1964).  The
infant also has an immature blood-brain barrier (Adinolfi 1985; Johanson 1980) and probably an
immature blood-testis barrier (Setchell and Waites 1975).   Many xenobiotic metabolizing enzymes have
distinctive developmental patterns and at various stages of growth and development, levels of particular 
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enzymes may be higher or lower than those of adults and sometimes unique enzymes may exist at
particular developmental stages (Komori 1990; Leeder and Kearns 1997; NRC 1993; Vieira et al. 1996).
According to the Law of Bergonie and Tribondeau, rapidly dividing and undifferentiated cells are more
sensitive to radiation damage than slowly dividing and highly differentiated cells.  This applies to fetal
cells as their sensitivity changes with level of activity during the different stages of development, and to
all types of radiation whether the dose is delivered internally or externally.  Gamma and x rays from
sources such as 60Co and x ray machines are the radiation types with enough penetrating power to
externally expose the fetus while in utero; alpha and beta emitters, such as 239Pu and 90Sr which
preferentially distribute to fetal bone, must be internalized by the fetus to cause a radiation dose.  The
specific organ systems are expected to be the most sensitive to radiation damage during that system’s
primary period(s) of organogenesis.  Prenatally injured cells that replicate while damaged may affect the
individual as a child and as an adult.  Exposure to radiation after birth results in similar effects in children
and adults.
Radiation damage to the fetus thus depends on the dose and type of radiation that delivered it, and the
sensitivities of the various organ systems during exposure.  The expression of that damage will depend on
the efficiency of the fetal repair system that all humans use for protection against low-level radiation to
which all life is exposed.  External radiation dose depends on the radiation dose rate which would exist if
the mother and fetus were not present, the time of exposure, and the shielding which the mother’s body
and fluids provide the fetus.  Natural terrestrial, cosmic, and internal radiation will normally represent the
largest radiation dose to the fetus.  This can be supplemented by external radiation doses from x ray and
nuclear medicine procedures to the mother and any gamma radiation field from sources around the
mother, such as radioactive fallout and any nearby radioactive sources.  Terrestrial and cosmic radiation
doses are affected by the concentrations of various radioactive materials in the surrounding environment,
such as soil and construction material, and the altitude, which affects cosmic ray intensity.  Internal
radiation dose depends on the combination of gamma dose rate to the fetus from radionuclides inside the
mother, plus the dose equivalent rate from alpha, beta, and gamma emitting radioactive materials which
have entered and distributed within the fetus.  Potassium-40, which is the inseparable radioactive
component of natural, biologically important potassium, will probably cause the largest portion of the
internal dose, but the dose from radon transformation products which cause the largest adult dose will be 
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minimally important in the fetus because it doesn’t breathe. Absorption, distribution, metabolism (if any),
and excretion of radionuclides depend largely on the pharmaco/toxicokinetics for both mother and fetus. 
If the mother can metabolize and excrete the radioactive compound prior to distribution to the fetal
compartment, the dose to the fetus is minimized.  Those compounds that are easily absorbed and freely
distributed to the fetal and/or placental compartments may give a larger dose than those that have low
absorption coefficients or those that never leave the maternal blood supply to penetrate peripheral tissues. 
Compounds that distribute to the fetal compartment and undergo little metabolism and excretion (i.e.,
extended fetal compartment residence times) are also more likely to cause damage to fetal tissues.  The
overall dose equivalent, which considers all radiation doses and the quality factors of the radiation, and
the dose rate are the major players in predicting fetal toxicity. 
Some of the fetal effects which have been observed in humans include mental retardation, IQ reduction,
and microencephaly.  The pivotal study that links the effects of external radiation to defects in child
development is the study conducted by Schull et al. (1988) that describes decreases in IQ scores with
increasing maternal doses of ionizing radiation.  That study evaluated the quantitative effect of exposure
to ionizing radiation on the developing fetal and embryonic human brain after the Hiroshima/Nagasaki
atomic bombings of 1945.  The sample included virtually all prenatally exposed individuals who received
tissue-absorbed doses of 0.50 Gy (50 rad) or more, and many more individuals in the dose range 0–0.49
Gy (0–49 rad) than in the clinical sample.  The clinical sample does not include children prenatally
exposed at distances between 2,000–2,999 m in Hiroshima and Nagasaki.  No evidence of
radiation-related effect on intelligence was observed among individuals exposed within 0–7 weeks after
fertilization or in the 26th or subsequent weeks. The highest risk of radiation damage to the embryonic
and fetal brain occurs 8–15 weeks after fertilization under both the T65D individual specific dosimetric
system, developed using data accumulated through 1965 and atomic bomb radiation data from tests in
arid climates, and the DS86 system, which accounts for neutron dose reduction from the high ambient
relative humidity in Japan during the 1945 blasts.  The regression of intelligence score on estimated fetal
absorbed dose was linear or linear-quadratic for the group exposed 8–15 weeks after fertilization and
possibly linear for the 16–25 week group.  The cumulative distribution of test scores suggested a
progressive shift downwards in individual scores with increasing dose.  The mean IQ scores decreased 
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significantly and systematically with uterine or fetal tissue dose within the groups exposed during 8–15
and 16–25 weeks postgestation.  This effect was not reversible and was the basis for the acute duration MRL.
3.2.3 Carcinogenic Effects from Ionizing Radiation Exposure
3.2.3.1 Introduction
Cancer is the major latent harmful effect produced by ionizing radiation and the one that most people
exposed to radiation are concerned about.  The ability of alpha, beta, and gamma radiation to produce
cancer in virtually every tissue and organ in laboratory animals has been well-demonstrated.  There is also
a large database that exists for people exposed to radiation for diagnostic purposes, those treated for
disease with radiation, occupational exposure populations, people that live in high background  regions,
survivors of radiation accidents, and nuclear bombing survivors.  It is presently not clear whether humans
are more or less sensitive to the adverse effects of low-levels of radiation than are the laboratory animal
models.
The development of cancer is not an immediate effect.  It may take several years to develop (referred to as
the latent period or latency), if it develops at all. Radiation-induced cancers are the same types that are
normally found in an unexposed individual.  However, after exposure to radiation, these cancer types may
occur with some increasing frequency and therefore can be detected only by epidemiological means. 
Most of these cancers occur only when those individuals reach an age when these cancers would normally
be expected to develop (except for leukemia).  For example, a female #10 years of age who was exposed
to external  radiation from the atomic blast, who survived the acute effects of the initial radiation
exposure, would have an increased probability of developing breast cancer as a result of that exposure,
but not before the end of the latent period for this specific cancer.  The same would be true for the other
types of cancers.  Radiation-induced leukemia has the shortest latent period at 2 years, while other
radiation induced cancers have latent periods >20 years.  Radiation carcinogenesis has not been demon-
strated in several types of human cells, possibly because the latent period exceeds the human lifespan. 
Raabe (1994) has developed two- and three-dimensional models of risk of developing cancer as a
function of isotope and dose rate.  The typical plot of lifespan vs. daily dose rate has three portions based
on the cause of death, natural life-span, cancer, and acute radiation syndrome.  According to Raabe, at
low dose rates the animal’s natural life-span is the cause of death before cancer can develop.  As the daily 
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dose rate increases, a threshold is reached where cancer deaths dominate in a dose-responsive manner. 
Similarly, at high dose rates, a threshold is reached where acute radiation syndrome is the cause of death. 
These are lifetime studies involving a wide range of dose rates from very high down toward levels that
humans may normally experience.  
The mechanism by which cancer is induced in living cells is complex and is a topic of  intense study.  The
accepted theory states that the induction of cancer by exposure to radiation takes place in three steps.  The
first step is initiation, which is a mutational event caused by the effect of the radiation interacting with the
cellular genome.  This may involve a single gene or multiple genes on one or many chromosomes, and
may involve the activation of an oncogene or the mutation and subsequent inactivation of tumor
suppressor genes.  The mechanism may stall at this point, with the gene(s) either undergoing repair or
remaining mutated and dormant.  If repair fails to take place at all, if the repair is unsuccessful, or if cell
division occurs before repair is complete, and  the cell remains viable through future cell generations, the
gene(s) appear in the progeny cells and will then enter into the stage of promotion.  The second step,
promotion, is generally thought to be unrelated to the dose of radiation (initiation step) received, even
though thyroid cancer in children from 131I or external exposure may suggest otherwise; therefore, the
latent period is clearly independent of the initial dose of radiation received.  This would be a reasonable
explanation of why cancers develop at the ages that they would normally develop in unexposed
populations, with the increased incidence of cancer related to the increased number of cell insults/injuries
in the genome of the damaged cells.  Several promotor agents have been identified, with some acting as
both initiators and promotors.  In the third step, cell transformation and proliferation, neoplasic cells are
produced.  More information on how radiation interacts with the genome and on the mechanisms by
which it induces cancer is presented in Chapter 5 of this profile.
A few human studies are available that describe the incidences and types of cancers produced by some
radionuclides.  Osteogenic sarcomas were found in people whose average skeletal doses exceeded 1,380
rad (13.8 Gy) of alpha radiation following exposure to 226Ra and 228Ra via several routes of exposure (Aub
et al. 1952; Evans 1966; Martland 1931; Rowland et al. 1978; Woodard 1980).  224Ra, used in the
treatment of ankylosing spondylitis, has also been implicated in producing osteosarcomas (Chemelevsky
1986; Mays 1988; Spiess and Mays 1970, 1973; Wick et al. 1986).  One of the largest cohort of humans
available for studying the effects of external radiation and cancer is the group of people exposed to the
varying doses of radiation produced by the two atomic bombs detonated in Japan in August 1945.  In this 
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population, an increase in leukemia incidence rate was seen only in those persons whose dose exceeded
10 rad (0.1 Gy).  An increased incidence of solid tumors was seen only in those whose dose exceeded
40 rad (0.4 Gy). 
Exposure to radiation can produce cancer at any site within the body; however, some sites appear to be
more common than others.  The BEIR V (1990) committee report came to some conclusions about which
sites are more at risk than others in humans, and these data are summarized in Table 3-8.  The relative risk
of death normalized to a dose of 100 rad (1 Gy) from several types of cancer among 75, 991 atomic bomb
survivors whose radiation doses are known are given in Table 3-9.
The conclusions of the BEIR V (1990) report were based on many human epidemiological studies over
the past 70–80 years.  Laboratory animal data have also proven useful for understanding human risks
from radiation, particularly to the respiratory tract of humans, and were included when relevant.  The use
of human epidemiological data is certainly a valuable tool in determining the long-term carcinogenic
effects from radiation.  The BEIR V (1990) committee used human epidemiological data whenever
possible; however, it also recognized its many limitations when attempting to draw conclusions about the
carcinogenic effects of low doses of radiation.  No increase in cancer has been observed at low doses. 
Therefore, for purposes of setting safety standards and public policy, we resort to mathematical models
with a postulated zero threshold.
Most of the literature examined reported the effects of radiation in laboratory animal species, such as
monkeys, dogs, rats, pigs, mice, and guinea pigs.  The short- and long-term effects of radiation in these
animals as a result of this research have been studied.  When the laboratory animal data are examined
more closely, the researcher and risk assessor are faced with a difficult and complex question: “Is this
what happens when humans are exposed to this dose of ionizing radiation?”  The answer will likely
depend on a number of variables, including the toxicological end point being examined (in this case,
cancer).  The use of human subjects in scientific research is a highly regulated area and, for obvious moral
reasons, is not an acceptable practice in the area of radiation biology unless there is full informed consent
and the radiation doses are low.  This normally leaves radiation biology risk assessors with  the following
sources of information from which to determine the risks associated with radiation exposure in humans:
(1) extrapolation of data from laboratory animal models (which is associated with many uncertainty 
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Table 3-8.  Summary of Risks of Developing Cancer After Exposure to Ionizing Radiation
Organ or system BEIR Committee conclusions about risk
Cancer Relative Risk (RR)
Factors (low dose/low dose
rate) per 106 rad (104 Gy) a
Mammary/breast 1. The development of cancer from susceptible mammary
cells due to exposure to ionizing radiation depends on
the hormonal status of these cells.
2. The age-distribution of radiogenic breast cancers and
those breast cancers from unknown causes is similar.
3.  Women irradiated at #20 years of age are at higher risk
than those irradiated later in life.
4. There is no evidence to suggest that radiogenic breast
cancer will appear during the first 10 years after
exposure to ionizing radiation.  Peak incidences occur
15 to 20 years after exposure.
5. The data show little if any decrease in the yield of
tumors when multiple radiation doses are compared to
single, brief exposures to ionizing radiation.
92.5
Lung 1. Absolute risk of lung cancer from exposure to ionizing
radiation is similar for both males and females.
2. The data suggest that smoking has a “greater than
additive” effect on the development of lung cancer after
exposure to ionizing radiation.
75.4
Stomach/digestive
system
1. The incidence of stomach cancers increases with
increased exposure to ionizing radiation.
2. Females are at greater risk for developing cancers than
are males
3. The relative risk for developing cancer is higher for
those exposed when 30 years of age or younger.
4. The baseline risk for digestive cancers increases with
age; most of the excess cancers occur after middle age.
49.3
Thyroid 1. Susceptibility to radiation-induced thyroid cancer is
greater in childhood.
2. Development of thyroid cancer is dependant on the
hormonal status of the individual; sustained levels of
TSH increase the risk of developing thyroid cancer.
3. For those exposed before puberty, the tumors do not
appear until after sexual maturation.  The risk is
greatest for children exposed within the first 5 years of
life.
4. Females are 2–3 times more susceptible than males to
radiogenic (and spontaneous) thyroid cancer.
5. Radiogenic cancer of the thyroid is usually preceded by
benign thyroid nodules and the frequency of
hypothyroidism and goiter is increased in those exposed
to large doses when very young.
32.1
Esophagus 1. Increased incidences of cancer of the esophagus have
been observed to occur in humans receiving doses of
ionizing radiation.
2. Little human data are available to make strong
conclusions about the risk of developing esophageal
cancer after exposure to ionizing radiation, although a
risk estimate is available.
9.5
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Table 3-8.  Summary of Risks of Developing Cancer After Exposure to 
Ionizing Radiation (continued)
Organ or system BEIR Committee conclusions about risk
Cancer Relative Risk (RR)
Factors (low dose/low dose
rate) per 106 rad (104 Gy) a
Small intestine
(duodenum,
jejunum, ileum)
1. Cancers of the small intestine have been produced in
laboratory animals exposed to large doses of ionizing
radiation.
2. None of the human epidemiological studies have
conclusively demonstrated an increased risk of
developing cancers of the small intestine after exposure
to ionizing radiation.
NR
Large intestine
(colon/rectum)
1. Data imply that there is an increased risk of developing
either colon or rectal cancer after exposure to ionizing
radiation
2. Based on human exposure data, the development of
colon or rectal cancer is not apparent until 15 years
after exposure or longer.
178.5
Skeleton 1. Large doses of low-LET ionizing radiation can result in
the development of bone cancers.
2. The data suggest a threshold of between 4 Gy of low-
LET or 13.8 Gy of high-LET radiation before increased
bone cancers begin to occur.
1.3
Brain/central
nervous system
(CNS)
1. Increased incidences of CNS tumors have been
observed in both humans and laboratory animals
exposed to ionizing radiation.
2. Tumors are both malignant and benign.
3. The brain is considered to be relatively sensitive to
developing cancer after exposure to ionizing radiation.
4. Increases have been reported when irradiated during
childhood at doses less than 1–2 Gy.
NR
Ovary and uterus 1. There is no clear relationship between exposure to
ionizing radiation and the development of uterine or
ovarian cancers
23.8
Testis 1. There are few  human data available for studying the
relationship between exposure to ionizing radiation and
testicular cancer.
2. The existing data suggest that the testis is relatively
insensitive to the carcinogenic effects of ionizing
radiation.
NR
Prostate 1. There is a weak association between cancer of the
prostate and exposure to ionizing radiation.
2. The relative risk of cancer of the prostate due to
exposure to ionizing radiation is small.
NR
Urinary tract 1. Exposure to ionizing radiation can cause cancer of the
bladder, as well as cancers of the kidney and other
urinary structures.
2. Women < 55 years old at the time of exposure are at
greater  risk than older women, with this risk increasing
with time after exposure.
3. Gender appears to have little effect on the incidence of
bladder cancer mortality.
49.7
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Table 3-8.  Summary of Risks of Developing Cancer After Exposure to 
Ionizing Radiation (continued)
Organ or system BEIR Committee conclusions about risk
Cancer Relative Risk (RR)
Factors (low dose/low dose
rate) per 106 rad (104 Gy) a
Parathyroid
glands
1. Increased incidences of hyperparathyroidism,
parathyroid hyperplasia and parathyroid adenoma occur
after exposure to ionizing radiation.
2. The data suggest that the incidences of
hyperparathyroidism and parathyroid neoplasia increase
with increasing doses of ionizing radiation.
3. Time to diagnosis normally is 30 years.
NR
Nasal cavity and
sinuses
1. Little human data is available for analysis.  Nasal and
sinus tumors have been noted after human exposure to
internally deposited 226Ra and 232Th.
2. The latency of these tumors is  at least 10 years.
3. The risk of developing nasal and sinus cavity tumors
from routes other than from internalized sources of
alpha ion radiation are extremely low.
NR
Skin 1. Increased incidences of basal cell and squamous cell
carcinomas of the skin have been reported after
occupational and therapeutic exposures to ionizing
radiation.
2. Incidence from radiation exposure may be 5 times
greater if the skin is also exposed to sunlight 
1.0
Bone marrow
(leukemia,
lymphoma, and
multiple myeloma)
1. Examples include multiple myeloma, non-Hodgkins
lymphoma, and chronic lymphocytic leukemia.
2. Multiple myelomas are observed to form after irradiation
of the bone marrow.
3. The latent period for multiple myeloma is considerably
longer than that of leukemia.
4. In Japanese A-bomb survivors, an excess of multiple
myeloma cases did not appear until 20 years after
exposure.
5. Excess mortality from multiple myelomas has been
observed at doses as low as 0.5-0.99 Gy
6. No other form for lymphoma has been consistently
observed in human populations exposed to excess
amounts of ionizing radiation.
NR
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Table 3-8.  Summary of Risks of Developing Cancer After Exposure to 
Ionizing Radiation (continued)
Organ or system BEIR Committee conclusions about risk
Cancer Relative Risk (RR)
Factors (low dose/low dose
rate) per 106 rad (104 Gy) a
Pharynx,
hypopharynx, and
larynx
1. Increased incidences of cancer do arise in these tissues
after therapeutic radiation (i.e., ankylosing spondylitis) in
the 30–60 Gy range.  Increases in these cancers were
not statistically significant at the p<0.05 level.
2. There were no increases in the incidences of these
cancers in the Japanese A-bomb survivors exposed to
<1 Gy.
3. The risk of developing cancers of these tissues after
exposure to ionizing radiation appears to be very low.
NR 
Salivary gland 1. The incidence of salivary gland tumors was increased in
the Japanese A-bomb survivors, patients treated with
x rays to the head and neck during childhood, and
women treated with 131I when middle-aged.
2. Increases in salivary gland neoplasia are dose-
dependent in the Japanese A-bomb survivors, but with
no detectable increases in excess mortality.
3. The salivary gland appears to be particularly susceptible
to the development of cancer after exposure to ionizing
radiation.
NR
Pancreas 1. An association between cancer of the pancreas and
exposure to ionizing radiation has been suggested in
some literature reports.
2. Pancreatic cancer has been found in occupationally
exposed thorium workers. b
2. The existing data suggest that the pancreas is relatively
insensitive to the carcinogenic effects of ionizing
radiation.
NR
a Values from EPA Report 402-R-96-016, Radiation Exposure and Risk Assessment Manual, June 1996.
  Sum of all values = 760.6, including a remainder incidence risk of 173.4 for all other organs, including those listed   
in column 3 as NR.
b  Polednak et al. (1980), Health Physics 44 (Suppl 1): 239-251.
Source: summarized from BEIR V 1990
LET = linear energy transport; NR = RR factor not reported.
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Table 3-9.  Summary of Radiation Dose Response for Cancer Mortality by Sitea,b 
Site of cancer
Number
of deaths
Statistical
p testc
Estimated relative
risk at 1 Gy
 (100 rad)
Excess risk per 104
person-year Gy
(PY Gy)
(per 106 PY-rad)
Attributable risk
(%)d
All malignant
neoplasms
5936 0.0000 1.39 (1.23, 1.46) 10.0 (8.36, 11.8) 10.2 (8.50, 12.0)
Leukemia 202 0.0000 4.92 (3.89, 6.40) 2.29 (1.89, 2.73) 55.4 (45.7, 66.3)
All cancers except
leukemia
5734 0.0000 1.29 (1.23, 1.36) 7.41 (5.83, 9.08) 7.86 (6.19, 9.64)
Digestive organs and
peritoneum
3129 0.0000 1.24 (1.16, 1.33) 3.39 (2.27, 4.59) 6.58 (4.41, 8.91)
Esophagus 176 0.02 1.43 (1.09, 1.91) 0.34 (0.08, 0.67) 12.7 (2.92, 25.0)
Stomach 2007 0.0000 1.23 (1.13, 1.34) 2.07 (1.19, 3.05) 6.26 (3.61, 9.23)
Colon 232 0.0000 1.56 (1.25, 1.98) 0.56 (0.26, 0.91) 15.1 (6.96, 24.7)
Rectum 216 0.67 0.93 ( , 1.27)† -0.07 ( , 0.25)† -1.93 ( , 7.12)†
Liver (primary) 77 0.57 1.12 (0.87, 1.70) 0.05 (-0.05, 0.25) 3.90 (-4.38, 20.5)
Gallbladder and bile
ducts
149 0.13 1.37 (0.98, 1.96) 0.22 (-0.01, 0.53) 8.24 (-0.55, 19.5)
Pancreas 191 0.53 0.89 ( , 1.23)† -0.10 ( , 0.20)† -3.01 ( , 6.21)†
Other (unspecified) 81 0.29 1.32 (0.87, 2.14) 0.11 (-0.05, 0.35) 7.73 (-3.29, 24.2)
Respiratory system 747 0.0000 1.40 (1.21, 1.63) 1.29 (0.71, 1.96) 10.1 (5.50, 15.3)
Lung 638 0.0000 1.46 (1.25, 1.72) 1.25 (0.70, 1.89) 11.4 (6.36, 17.1)
Breast (female) 155 0.0000 2.00 (1.48, 2.75) 1.02 (0.53, 1.60) 22.1 (11.4, 34.8)
Cervix uteri and
uterus (female)
382 0.08 1.22 (1.01, 1.50) 0.60 (0.04, 1.29) 5.30 (0.34, 11.5)
Cervix uteri (female) 90 0.17 1.43 (0.93, 2.30) 0.26 (-0.04, 0.70) 10.0 (-1.68, 26.9)
Ovary (female) 82 0.03 1.81 (1.16, 2.89) 0.45 (0.10, 0.90) 18.7 (3.97, 37.7)
Prostate (male) 52 0.85 1.05 ( , 1.73)† 0.03 ( , 0.40)† 1.89 ( , 24.8)†
Urinary tract 133 0.0000 2.02 (1.45, 2.87) 0.55 (0.26, 0.89) 22.7 (10.8, 37.1)
Malignant lymphoma 110 0.81 1.92 ( , 1.40)† -0.02 ( , 0.18)† -1.75 ( , 13.6)†
Multiple myeloma 36 0.002 2.86 (1.55, 5.41) 0.21 (0.07, 0.39) 32.5 (11.3, 59.5)
Liver (including not
specified as primary)
590 0.02 1.24 (1.06, 1.47) 0.63 (0.07, 1.18) 7.02 (1.87, 13.2)
Kidney 38 0.18 1.58 (0.91, 2.94) 0.09 (-0.02, 0.26) 15.7 (-2.77, 43.3)
Bladder 90 0.003 2.13 (1.40, 3.28) 0.41 (0.16, 0.70) 23.6 (9.31, 40.8)
Tongue 26 0.40 0.83 ( , 1.49)† -0.02 ( , 0.06)† -5.35 ( , 14.1)†
Pharynx 23 0.61 0.83 ( , 2.04)† -0.02 ( , 0.09)† -6.14 ( , 31.6)†
Nose 44 0.58 0.84 ( , 1.67)† -0.03 ( , 0.12)† -4.04 ( , 14.5)†
Larynx 46 0.16 1.51 (0.95, 2.68) 0.10 (-0.01, 0.29) 13.4 (-1.47, 37.1)
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Table 3-9.  Summary of Radiation Dose Response for Cancer Mortality 
by Sitea,b (continued)
Site of cancer
Number
of deaths
Statistical
p testc
Estimated relative
risk at 1 Gy
(100 rad)
Excess risk per 104
person-year Gy
(PY Gy)
(per 106 PY-rad)
Attributable risk
(%)d
Skin (except
melanoma)
21 0.69 1.17 ( , 2.47)† 0.02 ( , 0.12)† 5.60 ( , 38.7)†
Bone 27 0.65 1.22 ( , 2.79)† 0.02 ( , 0.16)† 6.56 ( , 42.9)†
Brain tumors 47 0.97 1.03 (0.51, 2.09) 0.01 (-0.12, 0.20) 1.0 (-13.0, 22.5)
Tumors of central
nervous system
(except brain)
14 0.08 3.09 (1.06, 9.74) 0.10 (0.00, 0.24) 35.9 (1.4, 82.2)
Other 907 0.03 1.20 (1.05, 1.38) 0.77 (0.19, 1.44) 5.65 (1.37, 10.5)
a  Adapted from Shimizu et al. 1988.  Number in parentheses indicate 90% confidence intervals.
b  Data includes Hiroshima and Nagasaki, Japan, both sexes (unless specifically otherwise stated), all ages at time of
bombing (ATB), from 1950 to 1985.
c p-value based on the test for increasing trend in radiation dose.
d Based on 41,719 human subjects exposed to 1 rad (average = 29.5 rad).
† Lower confidence limit not reported by study authors.
 
factors), (2) epidemiological studies of populations that live in high and low background areas, and of
populations of accidentally or occupational exposed persons, and (3) data from patients who have
received diagnostic radiation  and radiotherapy.
The use of human data pools theoretically provides the most direct and informative approach to assessing
the toxicity of radiation in humans.  This would likely be the case in laboratories using controlled
exposure scenarios.  Much of the information regarding exposures to radiation does not use a controlled
exposure situation.  Most of the human information comes from epidemiological studies following the
detonation of nuclear bombs (Hiroshima, Nagasaki, Bikini Atoll, etc.), from accidents involving the
release of radionuclides (Palomares, Spain; Thule, Greenland; Rocky Flats, Colorado; Hanford,
Washington and others), or from exposed radiation workers or patients.
Epidemiology is the study of the incidence of disease in groups of people.  Epidemiologists attempt to
determine the risk factors that may cause health effects by comparing the rate of occurrence of a disease
among exposed and non-exposed populations with similar attributes.  Epidemiologists prefer to compare
the rate of occurrence of the effects under consideration.  The major questions asked are: (1) Do the rates
of occurrence differ between populations?  (2) Are any noted differences a real effect or are they merely
due to chance? and (3) Is there a relationship between an agent or other risk factor (such as radiation) and
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the effect?  In studying populations, epidemiologists must characterize the subjects based upon both the
risk factor and the disease status.  There are three main types of observational epidemiological studies:
 cohort, case-control, and prevalence (cross-sectional).  Prevalence studies measure the presence or
absence of a disease in a particular population at a particular time.  Cohort (or incidence) is a prospective
study that looks at the development of a disease in an initially disease free cohort in the context of
postulated risk factors.  Case-control studies compare a population with an existing disease to a sex- and
age-matched disease-free population.
Prevalence, cohort, and case-control studies are the most likely types of epidemiological studies to be
conducted in the case of exposure to ionizing radiation.  Cohort studies follow a group of initially healthy
persons with differing levels of exposure or risk factors and compare the rate of occurrence of disease in
each population over time.  Because exposure is assessed prior to development of the effect, there is less
chance for bias; in addition, the relationship of other disease outcomes to the pre-assessed risk factors
may also be studied.  In case-control studies, a population with a particular disease and a matched (except
for the disease) disease-free population are assessed for exposure or risk factors in order to determine
whether a causal relationship exists.  By studying populations after the development of the disease, the
causes of relatively rare diseases can be assessed without following thousands of people; thus, a case-
control study is a quicker and less expensive study than a cohort study.  However, there is more
opportunity for bias due to the fact that the disease has already occurred prior to determining exposure or
risk factors.  Also, only one disease may be investigated per study. 
All epidemiological studies have inherent weaknesses due to the potential for bias in the experimental
design or implementation.  Common forms of bias include selection bias, recall bias, misclassification,
and confounding factors.
Selection bias occurs when subjects are not recruited uniformly.  When information about health and
exposure status is not collected consistently or reliably, this will also artificially affect the outcome of the
study.  Recall bias occurs when subjects do not uniformly report the incidence or severity of exposures or
health effects.  Misclassification refers to mislabeling or incorrectly characterizing a study participant
with regard to the toxic end point or outcome (disease).  A common type of misclassification occurs in
patients with cancer; the cause of death in these subjects may be complicated and classified as the result 
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of a secondary illness.  Even when death is attributed to cancer(s), the specific cancer listed on the death
certificate may be a secondary metastatic cancer.  Exposure may also be misclassified, particularly when
study subjects are aware that they are practicing risky behavior.  Confounding refers to the interaction of
multiple factors on a given effect and the possibility of attributing risk to an inappropriate factor.  For
example, when assessing the risk of a disease due to a factor such as the wire code of high power lines
(involving non-ionizing radiation), one must consider that the wire code of power lines may be highly
correlated with urbanization, heavy traffic, and increased pollution, and not associated with the actual
electric and magnetic field strengths to which individuals are exposed.  In such a case, an association
between power lines and disease must be investigated while taking these other factors into account; other-
wise, the results and any statistical correlation found may not be interpretable or appropriate.
Epidemiological studies should be carefully crafted to identify and account for appropriate confounders,
and their unique data interpreted objectively.  The  following pages contain a synopsis of some of the
more important human radiation epidemiological studies.
3.2.3.2 Nuclear Detonations of 1945 in Hiroshima and Nagasaki, Japan
The first atomic device was exploded in a test on July 16, 1945, in Alamogordo, New Mexico.  The U.S.
military, in an effort to bring a swifter end to the war and to avoid the casualties of a ground invasion of
Japan (actually planned for November 1945), detonated a 235U atomic bomb over the city of Hiroshima,
Japan, on August 6, 1945.  Three days later, another atomic bomb using 239Pu was detonated over the city
of Nagasaki, Japan.  In both Hiroshima and Nagasaki, a total of 64,000 people within 1 km of the air
detonation site (the air detonation side is designated as the "epicenter" and the point on the ground below
the epicenter is designated as the "hypocenter" or "ground zero) were killed by a combination of the blast,
intense heat, and to a much lesser extent gamma and neutron radiation emitted by these bombs.  Blast,
heat and light, and ionizing radiation accounted for 50%, 35%, and 15%, respectively, of the energy
released by the bombs (Glasstone and Dolan 1977; Zajtchuk 1989).  Survivors 1–2 kilometers away from
the hypocenter received up to several hundreds of rad (several gray) of radiation and suffered the ill
effects of  ARS.  The doses dropped off fairly rapidly with distance.  In Hiroshima, the dose at 1 km was
on the order of 100 rad (1 Gy), dropping to approximately 1 rad (0.01 Gy) at 2 km.  For Nagasaki, the
doses were on the order of 1,000 rad (10 Gy) and 10 rad (0.1 Gy), respectively.  Those who survived the
immediate effects, including those who were far enough away or shielded from a portion of the radiation, 
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were potential candidates for the latent effects of radiation.  A more in-depth discussion of the events
surrounding the creation of the atomic devices appears in Chapter 2 of this toxicological profile.
A few years after the atomic bombs were detonated, an effort was begun to study the effects that the
different doses of ionizing radiation had on the surviving populations of Hiroshima and Nagasaki.  This
study was instituted by the Atomic Bomb Casualty Commission (ABCC) in 1950; the effects continue to
be monitored today by the Radiation Effects Research Foundation (RERF).  Periodic reports are
published on the effects of ionizing radiation in the human populations of these cities in the main study,
called the Lifespan Study (LSS).  The LSS includes 120,321 individuals living in Hiroshima and
Nagasaki in 1950; of these, 91,228 were exposed at the time of the bombing (BEIR V 1990). 
At the time of the bombing of both cities, it was not possible to determine the exact doses of ionizing
radiation each person had received; therefore, estimates were made as to the dose of radiation received by
persons located at different distances from the hypocenter.  The dose estimates, called the Tentative 1965
Dose (T65D), used the air dose (gamma ray + neutron  kerma in air) adjusted for shielding by structures
and natural terrain based on data obtained at the Nevada test sites, the Bare Reactor Experiment Nevada
(BREN) experiment, and from large-scale shielding experiments.  The accuracy of this computational
system was questioned in 1978.  After re-examining the available data, a new system of dose estimation,
the Dosimetry System 1986 (DS86), was created and is available in its final format (Roesch 1987).  The
DS86 system provides more accurate radiation dose estimates than the T65D estimates because of
improvements in assessing shielding of building materials, in verifying the gamma-ray component of the
radiation doses to survivors using thermoluminescence of quartz crystals in roof tiles, and in considering
the reduction in the neutron component of the radiation dose caused by the high humidity in Japan as
compared to the Nevada desert.  The DS86 data are currently being reevaluated, largely because of 
differing opinions on the magnitude of  the Hiroshima neutron doses, which could produce small changes
in the individual dose estimates, and because these doses directly affect the risk estimates  
Based on the new dosimetry system, there are sufficient data from these large-scale human exposures to
derive some conclusions about the cancer-inducing effects of external  radiation.  A report by Shimizu et
al. (1988) used the exposure data from 75,991 survivors of the atomic bombs at Hiroshima and Nagasaki
(based on the DS86 dosimetry) to estimate the risk of developing cancer when humans are exposed to 
radiation.  Of these 75,991 exposed persons, 59,784 were distally exposed and 16,207 were proximally 
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exposed to the explosions.  These persons are being followed to their time of death from 1950, with the
specific types of cancers found through 1985 in these deceased individuals summarized in Table 3-9. The
Radiation Effects Research Foundation (RERF) plans to continue studying the survivors and their
offspring throughout the survivor lifespan in order to further refine the risk estimates. 
As shown in Table 3-9, external  radiation induces site-specific cancers in some organs but not in others. 
This extensive data set indicates that leukemia (acute and chronic myeloid and acute lymphocytic, but not
chronic lymphocytic), cancers of the esophagus, stomach, colon, lung, female breast, ovary, and bladder,
and multiple myelomas have statistically significant increases in incidences after exposure to  radiation. 
The incidence of these types of cancer increases with the dose (as measured by estimated relative risk at
100 rad [1 Gy] and excess risk per 10,000 individuals each exposed to 100 rad [1 Gy] [104 person-
year Gy]).  Conversely, incidences of cancers of the rectum, gallbladder, pancreas, uterus, brain, and
prostate, and incidences of malignant lymphoma do not appear to increase after exposure to ionizing
radiation.
A number of other conclusions can be drawn from the data sets that are presented in many extensive
tables in the Shimizu et al. (1988) report.  Due to the size of these data sets, much of the raw data has
been omitted from this toxicological profile.
Table 3-9 shows the risks associated with certain types of cancers over all age groups;  when cancers are
further classified by age at the time of death (ATD) and age at the time of the bombing (ATB), other
trends are  seen.  For ATB <10 years, the risk of stomach cancer appears to be greater for those younger
ATD groups (as observed for all cancers), but this trend is not statistically significant.  No definable
trends are observed for breast, lung, and colon cancers;  this is most likely  because in 1985, this age
group had not yet reached the age where expression is likely.  However, the relative risk of leukemia
peaked at 6–8 years after the bombing and tends to decrease every year thereafter.
In humans, cancers do not begin to appear immediately after exposure to radiation; it is only after some
minimum latent period (defined in this study as the time from exposure to the time of observation) that
cancers induced by the effects of radiation will occur.  This is the case with leukemia and with solid 
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tumors shown in Table 3-9.  The incidence of radiation-induced leukemia began to occur 2–3 years after
the detonation occurred, reached a peak within 6–8 years, and has been steadily declining ever since.  A
small (yet significant) excess in leukemia mortality still existed as of the writing of the Shimizu et al.
(1988) report.  This study also  suggested that the incidence rate of radiation-induced cancers increases
significantly only when the survivors reach those ages at which cancers normally develop.  Thus, the
minimum latent period is longer for the younger irradiated groups.  These data also have demonstrated
that the latent period for all the cancers shown in Table 3-9 (except for leukemia) appears not to be dose-
dependent; the latency period is not affected by the dose.  The latency period, however, is shorter among
the young who were exposed to higher doses within the first 10 years of life.  For the solid tumors (all but
leukemia), the data from this study suggest that the minimum latent period is 15–19 years for stomach
cancer, 20–24 years for lung and breast cancers, 25–29 years for ovarian cancer, and 30–34 years for
cancers of the colon and urinary tract and for multiple myeloma.  Some benefits of following this group
until the last individual dies are (1) the improvement of radiogenic cancer risk estimates and (2) the
possibility of verifying that certain cancer types whose incidence rates have not increased may have very
long latency periods.
Other factors were examined in this cohort that may affect cancer rates.  The relative risk of developing
leukemia was not significantly different for males and females.  For cancers other than leukemia,
particularly those of the esophagus and lung, the relative risk is higher for females than for males.  As for
the effect of smoking on the rate of development of lung cancers, the relative risk of lung cancer at
100 rad (1 Gy) is greater for females than males.  Adjusting for the effects of smoking in both males and
females, the relative risk differences no longer are statistically significant.  Also, no shortening of the lung
cancer latency period was noted in male or female smokers.
The Shimizu et al. (1988) report addressed the occurrence of leukemia in the populations of Nagasaki and
Hiroshima;  the report did not elaborate on the specific types of leukemia found in those populations as a
result of age and dose.  Tomonaga et al. (1993) reported on the differential effects of radiation in inducing
major leukemia types in these two cities using the DS86 dosimetry system.  That study included
766 leukemia cases (249 among LSS subjects) occurring as of the end of 1980 in people who were
exposed within a 9-kilometer radius of the detonation hypocenter.  Bone marrow and blood specimens of 
IONIZING RADIATION 169
3. SUMMARY OF HEALTH EFFECTS OF IONIZING RADIATION
the registered cases were reassembled and re-examined for 493 of the 766 leukemia-diagnosed cases,
including 177 of the 249 LSS cases, using the French-American-British classification system of leukemia
diagnosis.  Leukemias were further subclassified into a specific type of leukemia:  acute lymphocytic
leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and other leukemias
(OTHER, including adult T-cell leukemia and other specifically diagnosed leukemias).  Once a diagnosis
was ascertained, the type of leukemia was correlated with the total body kerma received by that person,
the city the dose was received in, and the elapsed time since exposure.  Incidence estimates for each type
of leukemia by exposure category and time period were determined (see Table 3-8) as well as incidence
estimates for each type of leukemia by exposure category (see Table 3-9).
Meaningful statistical analysis on the leukemia data set could not be performed and should be taken as
descriptive only.  For the three lowest exposure categories, incidence rates were either similar or slightly
increased over time; the two highest dose categories had incidence rates for all types of leukemias
declining over time.  CML and OTHER leukemia incidence rates returned to background levels during
the late 1970s, while at the highest exposure levels (150 rad [1.5 Gy]), the overall incidence rates of
ALL and AML were 4–5 times higher than background levels from 1976 to 1980.  The age at time of
bombing seemed not to modify the temporal trends of leukemia in the three lowest exposure groups. 
Tomonaga et al. (1993) states in regard to this data,  "In the two highest exposure groups, type-specific
incidence rates declined with time in the youngest age-ATB group (0–15 years) for all types.  In the
young adult age-ATB group (16–35 years), however, this pattern held for ALL and CML in the two
highest exposure categories and for OTHER in the 50–149.9 rad (0.5–1.499 Gy) group.  The incidences
of OTHER among those exposed to 1.5 Gy (150 rad) and of AML among those exposed to 50–149.9 rad
(0.5–1.499 Gy) held nearly constant in time and that of AML among those exposed to >150 rad (1.5 Gy)
increased.  Among older adults (i.e., 36 years old ATB), there was either no change or an increase in
incidence over time for AML and OTHER in the two highest exposure categories.  CML and OTHER
rates declined with time in the 50–149.9 rad (0.5–1.499 Gy) group, and CML and CML and ALL
declined with time in the 150 rad (1.5 Gy) group.  There was an increase over time in the excess rates of
AML among those exposed to very high radiation levels (150 rad [1.5 Gy]) at adult ages ATB.  Thus
age ATB appears to moderate the temporal patterns of incidence in the highest exposure groups."  The 
incidence estimates for these types of leukemias suggest that the incidences for ALL, AML, CML, and
OTHER were all greater in the higher dose categories.  In the highest dose group, the estimated incidence 
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of ALL decreased with increasing age ATB, while those of ALL, CML, and OTHER were less dependent
on age ATB.  The risks of ALL and CML increased more rapidly with an increasing dose than did those
of AML and OTHER.  These findings suggest that ALL and CML leukemogeneses are more affected by
atomic bomb radiation production than AML.
3.2.3.3 Human Exposures to 226Ra and 228Ra: The Radium Dial Painters
Radium was one of the first radioactive isotopes discovered (see Chapter 2).  It was used in medicines and
concoctions around 1900; however, the highest exposures to radium involved its use in dial paint.
Martland (1931) reported that approximately 800 females employed in a factory in New Jersey painted
the dials of watches and clocks with special luminous paint.  The paint consisted of a crystalline,
phosphorescent zinc sulfide, with the addition of varying amounts of radium and its progeny containing
primarily 226Ra, 228Ra, and 228Th, all in the form of insoluble sulfates in the paint.  These young women 
“tipped” or pointed the end of the paint brush with their mouth and lips whenever needed to restore a
sharp painting point.  This resulted in oral ingestion of small amounts of radium, mainly 226Ra (t1/2 =
1,600 years) and 228Ra (t1/2 = 5.75 years).  In the women who died, deposits of these isotopes were found
over the entire skeleton, and in particular in the cortical bone surface.  Martland also estimated the total
lifetime body burden of radium to be between 2 and 20 µg Ra in those exhibiting clinical signs of
“radium poisoning.”  Radiation toxicity seemed more evident in those individuals who worked at the
factory for >1–2 years or who had swallowed the paint for >1–4 years.
One of the main findings in this study was the increased incidence of death in some of the exposed
women.  Death was noted in 18 women in the study.  Thirteen of the women who died also had jaw
necrosis and anemias that developed within 4–6 years after they left the factory for other employment. 
The other eight deaths occurred at a later date.  Jaw necrosis and anemia occurred with less severity and at
lower levels;  these individuals developed bone lesions which were characterized as radiation osteitis. 
Osteogenic sarcomas (scapula, knee, pelvis, femur, orbit) also developed in this study population.
A study by Evans et al. (1966) at the Massachusetts Institute of Technology (MIT) reported on the
incidence of tumors in individuals exposed to 226Ra and 228Ra in both the radium dial painter population
and other populations exposed to alpha emitters.  The study included approximately 5,000 or more
persons, including chemists who inhaled or ingested radioactive compounds, patients receiving 
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intravenous injections of 224RaCl, those who ingested water containing 224Ra, and the female radium dial
painters.  As a group, the total duration of exposure was usually less than 1 year but in some cases was as
long as 20 years.  The  conclusion from this study confirmed the study findings of both Martland (1931)
and Rowland et al. (1978)— people who inhale or ingest radium (224Ra, 226Ra, 228Ra) have an increased
chance of developing tumors of the bone or of the paranasal sinuses but little, if any, chance of
developing leukemia from any of the doses studied.  The data also supported the conclusion that the time
required to develop these sarcomas or carcinomas tended to increase as the total activity of radium
decreased.  When all measured cases were included, the skeletal dose at which tumors began to be
observed was 1,200 rad (12 Gy) of alpha radiation.  No tumors were observed in the population that
received less than 1,200 rad (12 Gy), the “practical threshold”;  the tumor incidences began to climb in a 
linear dose-response manner from 1,200 to 50,000 rad (12–500 Gy) skeletal dose.  Not all persons
receiving a >1,200 rad (12 Gy) skeletal dose developed sarcomas or carcinomas; the tumor incidence at
>1,200 rad (12 Gy) skeletal dose was placed at 40% at the time the study ended.   Rowland et al. (1978)
conducted a follow-up study on the incidences of osteosarcoma and “head carcinomas” (carcinomas
originating in the mastoid air cells or paranasal sinuses) on this population of female dial painters.  The
data sets are shown in Tables 3-10 and 3-11.
Using statistics from the U.S. Department of Labor (DOL), it was estimated that approximately 2,000
individuals had been employed in the radium dial painting industry prior to 1929, with 1,474 workers
identified who worked in the industry prior to 1930.  Most of the dial workers were not located until as
late as the 1960s.  For the osteosarcoma analysis, the combined  intake of radium (226Ra + 228 Ra) ranged
from <0.5 to 2,500 µCi (0.02–92 MBq), with the time-weighted average ranging from 0.74 to 3,602 µCi
(0.03–133 MBq).  The average age at first exposure to these two isotopes ranged from 18.4 to 19.8 years. 
For the head carcinomas, the intake of 226 Ra ranged from <0.5 to 1,000 µCi, with the time-weighted
average ranging from 0.71 to 1,577 µCi.  The average age at first exposure ranged from 17.8 to
22.3 years.  The increased incidence of osteosarcoma in this exposed population can be attributed in part
to radium’s distribution and elimination kinetics.  Radium has distribution patterns similar to those of
calcium.  Once ingested, radium distributes primarily to the bone surfaces and within about 10 µm from
the osteogenic cells (the target cells for radium toxicity).  The range of alpha particles in soft tissue is
estimated to be approximately 30–70 µm (see Chapter 2), well within the range of these  radiosensitive 
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Table 3-10.  Distribution of Osteosarcomas in a Population of Female Dial Painters 
Exposed to 226Ra and 228Ra
Systemic intakea
(226Ra + 2.5 228Ra)b
 Activity range
(µCi)
 Activity
weighted
average (µCi)
Number
of cases
Average age at
first exposure
(years)
Number of
bone
sarcomas
Person-
years
Person-
years at
risk
Sarcomas per 1,000
person-years at risk
(10-3 years -1)
2500 3602 16 18.5 4 299 219 18.3
1000–2499 1675 22 19.2 15 529 419 36.8
500–999 675 18 19.7 8 700 610 13.1
250–499 375 32 19.8 9 1409 1249 7.21
100–249 171 27 18.4 2 1299 1164 1.72
50–99 68.0 21 18.6 0 1082 977 0.00
25–49.9 35.2 45 19.5 0 2331 2106 0.00
10–24.9 16.3 71 19.2 0 3642 3287 0.00
5–9.9 7.04 66 19.1 0 3378 3048 0.00
2.5–4.9 3.63 83 18.8 0 4217 3802 0.00
1.0–2.49 1.56 101 18.9 0 5240 4735 0.00
0.5–0.99 0.74 52 18.4 0 2731 2471 0.00
<0.5 –- 205 19.0 0 10535 9510 0.00
aestimated amount that entered the blood after oral exposure
bdose adjustment factor for 226Ra (and daughters) energy (29.4 MeV) and t1/2 (1600 years), in relation to 228Ra (and
daughters) energy (10.6 MeV) and t1/2 (5.75 years)
Source: Rowland et al. 1978
cells but outside the range of red marrow cells from which leukemias would originate.  The osteogenic
cells initially receive a large radiation dose after each intake of 226Ra and/or 228Ra.  Owing to the long
physical t1/2 of both 226Ra (1,600 years) and 228Ra (5.75 years), both radionuclides will eventually
redistribute throughout the bone matrix over time, moving out of range of the osteogenic cells but
continuing to irradiate other less sensitive cells and tissues within a 70-µm radius of each atom of radium.
A similar proximity of exposure scenario is likely true for the development of the head carcinomas in this
population of exposed workers.  The most likely explanation for the head carcinomas is that they are due
to accumulation of 222Rn gas and radon daughters in the mastoid air spaces of the sinus cavities.  This
explains the lack of effect of 224Ra and 228Ra, which transform through 220Rn by short half-life transitions,
and which produce much lower doses in the parasinal cavities than from 222Rn (Rowland 1994).
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Table 3-11.  Distribution of Head Carcinomas in a Population of 
Female Dial Painters Exposed to 226Ra
Systemic intakea
(226Ra)
 Activity
range (µCi)
 Activity
weighted
average
(µCi)
Number
of cases
Average age at
first exposure
(years)
Number of
head 
carcinomas
Person-
years
Person-
years at
risk
Carcinomas per
1,000 person-
years at risk
(10-3 years -1)
1000 1577 10 17.8 3 264 164 18.3
500–999 584 11 22.3 2 385 275 7.27
250–499 366 25 20.1 5 1062 812 6.16
100–249 176 31 18.3 5 1255 945 5.29
50–99 68.3 23 18.2 1 1123 893 1.12
25–49 35.5 34 18.8 1 1666 1326 0.75
10–24.9 15.9 59 19  0 3025 2435  0
5–9.9 6.99 41 18.4 0 2114 1704  0
2.5–4.9 3.52 70 19.6 0 3558 2858  0
1.0–2.49 1.55 145 19.3 0 7531 6081  0
0.5–0.99 0.71 73 18.7 0 3799 3069  0
<0.5 – 227 18.9 0 11624 9354  0
a estimated amount that entered the blood after ingestion
Source: Rowland et al. 1978
The data presented in both tables show that a dose response is present when comparing the weighted-
average dose to the number of osteosarcomas or head carcinomas observed throughout the lifespan of
these exposed individuals.  In addition, a dose-squared-exponential function most closely described the
bone sarcomas induced by these two radionuclides.  In contrast, a linear dose-response function was
found to best describe the head carcinoma data.
3.2.3.4 Human Exposures to 224Ra via Injection
During 1944–1951, injections of 224Ra were administered to approximately 2,000 German adults and
children as a treatment modality for several debilitating diseases, including tuberculosis and ankylosing
spondylitis.  A report by Spiess and Mays (1970) summarized the health effects of 925 humans (708
adults and 217 children) injected with 224Ra who received alpha doses of up to 5,750 rad (57.7 Gy).  The
duration of treatment ranged from a few weeks to a few years, depending on the disease being treated. 
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For this study, treated individuals were  classified by age and dose received during the treatment
period(s).  These subpopulations are shown in Tables 3-12 and 3-13.
As was the case with 226Ra and 228Ra, the critical organ  for 224Ra was bone tissue, with an overall
increased incidence of osteosarcoma in the exposed population.  Tables 3-12 and 3-13 report the dose
parameters and incidences of osteosarcomas induced by 224Ra by age distribution. These data show that
the lowest dose that resulted in a detectable osteosarcoma was 90 rad (in an adult).  The incidence of
osteosarcoma in this population increased in a dose-responsive fashion, with a 0.7% rise in incidence of
osteosarcomas per 100 rad (1 Gy) skeletal dose from  224Ra  in adults and a rise of 1.4% per 100 rad
(1 Gy) in  children (see Table 3-13).  The ability of 224Ra to induce bone tumors in males and females,
with or without pre-existing bone disease, was equal in all instances.  At the time of publication of the
Speiss and Mays (1970) report, no head carcinomas or leukemias attributable to 224Ra exposure had been
observed.
The lowest alpha dose to induce osteosarcoma in this population exposed to 224Ra was 90 rad (0.9 Gy),
significantly lower than the 1,200 rad (12 Gy) (skeletal dose at death) required to induce osteosarcoma in
the radium dial painters (226Ra and 228Ra).  The answer lies in the physical half-life of 224Ra,  and the total
dose to the critical tissue.  224Ra distributes in an identical fashion within the bone matrix as does 226Ra
and 228Ra, with the initial deposition of each of these isotopes within 10 µm from the osteogenic cells on
the bone surface.  In cases of 226Ra and 228Ra exposure, the dose of radiation was initially received by the
osteogenic cells; however, as time progressed, natural bone formation (remodeling) resulted in the
redeposition of these isotopes (and other minerals) away from these target cells and into the mineral
volume of the bone, out of the range of the alpha particles (50–70 µm) emitted by these isotopes.  These
longer-lived isotopes continued to transform for several years; however, many of the radium atoms were
out of range of the target tissues (osteogenic cells) and not likely to cause bone cancer.  This was not the
case with those exposed to 224Ra.  224Ra deposits initially on bone surfaces as does 226Ra and 228Ra;
however, the half-life of 224Ra is 3.62 days and the dosimetery is quite different from other radium
isotopes.  The local dose to the skeleton of 224Ra within 0–10 µm is estimated to be nine times the average
skeletal dose of 226Ra (because the radiation dose is almost exclusively delivered to the osteogenic cells
during 224Ra’s short half-life).  However, the dose from 226Ra to the critical osteogenic cells is only
0.63 times the average skeletal dose, which is randomly distributed throughout the bone matrix.    
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Table 3-12.  Alpha Doses from Injected 224Ra (in rad) by Age Group, Number, and 
Percentage of Subpopulation Developing Osteosarcoma
Age at first injection of 224Ra
Dose range
(rad) Parameters 
1–5 
years
6–10 
years
11–15 
years
16–20 
years
All children
(1–20 years)
Adults
(>20 years)
0–89 Average rad dose 46 ND 24 55 47 53
No. of persons 1 ND 1 3 5 210
% Bone sarcomasa 0.00 ND 0.00 0.00 0.00 0.00
90–199 Average rad dose 152 126 ND 148 146 139
No. of persons 2 1 ND 4 7 229
% Bone sarcomas 0.00 0.00 ND 0.00 0.00 1.3
200–499 Average rad dose 446 397 344 342 363 306
No. of persons 2 9 7 17 35 214
% Bone sarcomas 0.00 0.00 29 0.00 5.7 1.9
500–999 Average rad dose 860 703 727 719 727 650
No. of persons 7 30 22 17 76 55
% Bone sarcomas 0.00 10 5 0.00 5.3 5.5
1000–1999 Average rad dose 1426 1381 1340 1246 1345 ND
No. of persons 16 19 18 19 72 ND
% Bone sarcomas 38 26 22 21 26.4 ND
2000–5750 Average rad dose 3491 3451 2550 3100 3329 ND
No. of persons 9 9 3 1 22 ND
% Bone sarcomas 22 67 0.00 0.00 36.4 ND
All persons
with a known
dose of 224Ra
Average rad dose 1662 1207 984 747 1103 204
No. of persons 37 68 51 61 217 708
% Bone sarcomas 22 21 14 7 15.2 1.4
a % of bone sarcomas as of 1969     ND = No data available
Source: adapted from Speiss and Mays 1970  
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Table 3-13.  Age Distribution, Alpha Dose (in rad), and % Incidence of Osteosarcomas 
Induced by 224Ra Injection
Age (years)
Exposed
patients Sarcoma cases % Incidence
Average dose
(rad)
% Incidence per
100 rad
1–5 37 8 21.6 1662 1.30
6–10 68 14 20.6 1207 1.70
11–15 51 7 13.7 984 1.39
16–20 61 4 6.6 747 0.88
All children 217 33 15.2 1103 1.38
Adults 708 10 1.4 204 0.69
Source:  adapted from Speiss and Mays 1970  
Other similar studies  include those involving tinea capitis treatment (Albert et al. 1986; Harley et al.
1983; Ron and Modan 1984), uranium miners (NIH 1994), and iron miners (Radford and Renard 1984).
3.2.3.5 Other Human Cancer Studies
Cancer data from other sources are available in the open literature.  Sorahan and Roberts (1993)
performed a case-control study examining the association between childhood cancer and the occupational
exposure of the child’s father to radiation.  Data from the Oxford Survey of Childhood Cancers collected
from 1953 to 1981 were used.  There was a total of 15,279 cases and the same number of matched
controls (matched for sex, date of birth, and local area).  Estimates of exposure were completed based on
job descriptions.  Dose groups were:  not exposed (<0.1 rem, 0.001 Sv), 0.1–0.4 rem (0.001–0.004 Sv),
0.5–0.9 rem (0.005–0.009 Sv), and 1 rem (0.01 Sv).  There were also 27 case fathers and 10 control
fathers who had been exposed to radionuclides.  Based on the information gathered, it was determined
that 67 fathers of children with cancer and 50 fathers of controls were exposed to external radiation within
6 months of conception of their children.  Relative risks for estimated external radiation doses  and all
childhood cancers were near one, and none of the specific types was statistically significant.  Among
fathers with likely exposure to radionuclides (from unsealed radioactive material), the relative risk for all
childhood cancers was statistically significant at 2.87 (95% CI 1.15–7.13).  There is considerable
uncertainty associated with this value, and the findings are not supported by those in the studies of the
survivors of the atomic bombings in Japan.  Cancer incidence during the first 20 years of life among the
children of parents who suffered a mean gonadal dose of 43 rem (0.43 Sv) was 43 cases in 31,150
offspring, and there were 49 cases among 41,066 offspring from the control population.  For leukemia,
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there were 16 cases among 31,150 children of exposed parents and 21 cases among the 41,066 children
from the unexposed controls (Yashimoto et al. 1991).
In 1991, Matanoski (1991) reported on the health effects of low-level radiation exposure to shipyard
workers.  Many of the earlier human radiation studies had been of groups exposed to large doses of
radiation where there was a clear dose response for cancer induction.  The typical dose response curve
assumes a linear no-threshold shape that starts with zero effect at zero dose and extends linearly upward
to intersect the measured effect at doses above 10–40 rad (0.1–0.4 Gy).  Previous attempts to demonstrate
the shape of the curve at low and occupational doses had not produced a clear result.  The purpose of the
Matinoski study was to better define the upper and lower bounds of risk associated with radiation
exposure using a relatively large population group whose radiation doses had been measured carefully,
many of which were elevated above ambient levels, and for which there was an adequate control
population.  The selected group was workers in public and private U.S. shipyards involved in the
overhaul and refueling of nuclear-powered warships.  Concern over the risk to these workers had been
raised earlier in a limited study of deaths among Portsmouth, New Hampshire, shipyard workers
(Najarian 1978).  Also, a report had been released on an apparent leukemia excess among U.S. military
veterans (Caldwell 1980).  However, a subsequent cohort study by Rinsky (1981) did not observe a
relationship between exposures and leukemia.  These groups had received approximately the same
radiation dose.  The Matinoski study group involved workers at eight nuclear facilities throughout the
United States, who had been occupationally exposed from 1957 through 1981.  The study group was
divided into dose groups and exposures were lagged by 2 years for leukemia and lymphoma, and 5 years
for lung cancer to account for disease latency.  The numbers in each of the three major dose groups were:
32,510 non-radiation workers, 10,348 radiation workers whose doses were below 0.5 rem (0.005 Sv), and
27,872 radiation workers whose doses were over 0.5 rem (0.005 Sv).  The data were analyzed statistically 
using methods suggested by Gilbert (1983).  In this manner it was estimated that the statistical power had
a 79% probability of finding a risk of leukemia from cancer if the risks were as large as five times the
linear model estimates in BEIR III (1980).  For those whose doses exceeded 0.5 rem (0.005 Sv), the death
rate from leukemia was only 91% of the normally expected death rates from that disease (95% confidence
interval = 56–139%), and the death rate from lymphatic and hemopoietic cancers was 82% (95%
confidence interval = 61–108%) of the normally expected death rates from those diseases.  The death
rates from these diseases in the less than 0.5 rem (0.005 Sv) group were similar to those in the above 0.5
rem (0.005 Sv) group. Standard mortality ratios (SMRs) for the lower-dose group were similar.  This 
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indicates the risks of these diseases is lower among shipyard workers than in the general population.  The
risk of lung cancer, however, was significantly higher (p<0.05) in the non-nuclear work group and
slightly higher in the nuclear work groups than for the public.  Mesothelioma was selected as a biological
marker for the presence of asbestos exposure in the population, and a high SMR for mesothelioma (>5 for
radiation workers and 2.4 for non-radiation workers) suggests that the excess is due to asbestos exposure
and not to radiation.  The radiation worker population did not show a significant increase in the risk of
any of the cancers studied, except for mesothelioma which was attributed to asbestos.  The data suggest
that there is a threshold greater than 0.5 rem (0.005 Sv) for leukemia, and lymphatic and hemopoietic
cancers.
In another human study, Checkoway et al. (1988) used a historical cohort mortality study of 8,375
workers at the Y-12 plant at Oak Ridge who were exposed to gamma radiation and/or alpha radiation by
inhaling uranium compounds.  The population studied included employees who had worked for at least
30 days between May 1947 and December 1974.  The median duration of exposure in that study was
9.2 years.  There were 862 deaths in the cohort, which was composed of 6,781 white males.  The majority
of the cohort was followed for 10 years.  Exposure from gamma radiation was measured with dosimeters
or film badges, and internal alpha contamination was estimated with urinalysis for uranium (reported as
cumulative radiation dose).  Mortality was compared with both U.S. and Tennessee rates.  For all causes
there were fewer deaths than expected (Standardized Mortality Ratio [SMR] 0.89, 95% CI 0.84–0.96). 
These findings are consistent with the healthy worker effect.  There were a total of 196 cancer deaths in
the population compared to 193 expected, (SMR 1.01).  Relative to U.S. white males, there were
statistically significant excesses of lung cancer (SMR 1.36, 95% CI 1.09–1.67) and possibly cancers of
the and central nervous system (SMR 1.8, 95% CI 0.98–3.02).  Cancer SMRs for Tennessee white males
were lower than those for the U.S. white male referent population.  A trend was observed for increasing
lung cancer deaths with increasing radiation dose, although the trend was greater with a zero-year latency
assumption than for a 10-year latency assumption.  Mortality for brain and central nervous system cancers
was unrelated to either the alpha or gamma dose.  The authors point out that the dose-response trend for
lung cancer mortality should be viewed with some caution because the rate ratio estimates are imprecise,
as reflected by the wide confidence limits because of small numbers.  Also, the dose-response gradients
are reduced considerably when a 10-year latency is assumed.  No data on cigarette smoking were
included in the study.  Other studies have also shown that the lung is the primary target organ of airborne
radon when mixed with diesel fumes, cigarette smoke and silica dust related to uranium mining, but not
from uranium itself (BEIR IV 1988), which was the most important airborne radioactive material at this
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plant.  Readers are referred to the effects of cancer induced by the chemical and radiological effects of
uranium mining in the ATSDR Toxicologic Profile for Uranium (ATSDR 1999b).
In a later related report, Kneale et al. (1981) responded to criticism of previous reports of a study of
cancer risks from radiation to workers at Hanford using the method of regression models in life-tables. 
The population included employees up to 1975 who wore film badges for their external dosimetry record
and included deaths through 1977.  Some internal monitoring was also completed:  individuals for whom
internal monitoring was completed tended to have higher external exposures.  Cause of deaths was
classified into three categories: (1) cancers of radiosensitive tissues (stomach, large intestine, pancreas,
other intestinal, pharynx, lung, breast, lymphoma, myeloma, myeloid leukemia, other reticuloendothelial
system cancers, and thyroid); (2) other cancers; and (3) non-cancer.  The reported risk per unit of
radiation dose for cancers of radiosensitive tissues was much greater than the generally accepted risk
based on other studies which had been used in setting safety levels for exposure to low-level ionizing
radiation.  The estimated risk calculated from this study was about 10–20 times greater than would have
been expected by extrapolating downward from higher doses analyzed in previous studies, notably studies
of the atomic bomb survivors.  The authors suggested that after statistically controlling for a wide range
of possible interfering factors, there was a significant downward curve at about 10 rem (0.1 Sv) in the
dose-response relationship.  Therefore, the agreement with other studies, conducted at higher doses, may
be stronger than is widely assumed.  The authors also point out that the findings on cancer latency (about
25 years) and the effect of exposure age (increasing risk with age) are in general agreement with other
studies.  The unexplained finding is a significantly higher dose for all workers than for workers who
developed cancers in tissues that are supposed to have low sensitivity to cancer induction by radiation. 
The “healthy worker effect” was very large in this study—the SMR for all causes of death was 75. 
Therefore, the fact that living workers at Hanford in Washington State have higher radiation doses than
workers who died could reflect a healthy worker effect.  Using a model that allowed for cancer latency
and variation in sensitivity to radiation with age of exposure, investigators estimated a doubling dose for
cancer of 15 rad (0.15 Gy) with a 95% CI of 2–150 rad.  The interval between cancer induction and death
was estimated (maximum likelihood estimate) to be 25 years.  The investigators also discuss the fact that
Japanese bomb survivor data and ankylosing spondylitis data indicate that the doubling dose is about 200
rem (2 Sv).  No records of smoking were available for the Hanford population.  Internal monitoring
showed evidence of internal exposure in only 225 of the Hanford workers; the investigators indicate that 
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the effects were a result of external rather than internal radiation.  The authors pointed out that the
Hanford study could not distinguish between effects of neutron and gamma radiation. 
3.2.3.6 Laboratory Animal Reports
Cancer is a major latent biological effect of inhaling many of the various isotopes and chemical forms of
radioactive materials.  The literature contains many studies describing the onset and specific types of
cancers that occur after inhalation exposure(s) (see the ATSDR profiles on uranium and radon for more
complete information).  The vast majority of reports concerning the inhalation of radionuclides with the
subsequent development of cancer dealt with alpha and beta particle emitters incorporated into soluble or
insoluble particles of varying sizes for an acute duration of delivery (usually only a few minutes to
achieve the desired initial lung burdens) followed by a long-term exposure of the tissues.  Due to the large
database describing the neoplasia associated with exposure to ionizing radiation, only a cross-section of
these reports will be discussed in some detail here.
Cancer has been reported in  laboratory animals after inhalation of different radionuclides (see Table 3-1). 
For example, isotopes of strontium (85Sr and 90Sr) have strong affinities for bone; therefore, it is
reasonable to expect that the initial site of neoplasia formation will be in bone tissues.  Metastases may
occur to more distant organs at a later time, depending on the type of tumor induced.  For example, Gillett
et al. (1987b) studied the late-occurring biologic effects in Beagle dogs given graded levels of 90SrCl2 via
single brief inhalation exposures and then observed for their lifespans.  The cumulative absorbed beta
dose to bone ranged from 12 to 1,200 rad (0.012–12 Gy) at 30 days and from 200 to 170,000 rad
(92–1,700 Gy) at 1,000 days after exposure.  The most frequent cause of death in exposed dogs was
primary bone cancer (30 of the 66 exposed dogs).  Bone-tumor-related deaths occurred from 759 to
3,472 days after exposure.  Four additional animals developed carcinomas in soft tissues adjacent to the
bones of the skull (invasive baso-squamous carcinoma, transitional carcinomas of the nasal cavity, and an
adenocarcinoma in the maxilloturbinate region).  The remaining exposed and control dogs died from a
variety of other causes not related to 90Sr exposure.  Radiation-induced lesions were confined to the bone,
bone marrow, and adjacent soft tissue.  Forty-five primary bone tumors occurred in 31 of the 66 exposed
dogs (47%).  Metastasis occurred from 21 tumors, with the lungs being the most frequent site of
metastasis (76%).  Twenty-seven tumors were classified as different subtypes of osteosarcoma, 14 as
hemangiosarcomas, 3 as fibrosarcomas, and 1 as a myxosarcoma.
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Using 241Am, Gillette et al. (1985) determined the retention, translocation, and excretion of inhaled mono-
disperse (1.8 µm AMAD) or polydisperse aerosols (AMAD 0.75, 1.5, 3.0 µm) and explored the develop-
ment of osteosarcomas in dogs.  241Am was soluble and transported in blood and deposited in the liver and
skeleton.  Two years after exposure, 0.5–3.0% of the initial lung burden was present in the lung, 10–47%
was in the liver, and 10–36% in the skeleton.  Four of 15 dogs developed osteoblastic osteosarcomas
#1,000 days after exposure to 241Am.  Three of these were in the 1.8-µm AMAD group and one was in the
3.0-µm AMAD group.  Initial lung burdens for all 15 ranged from 1.0 to 6.2 µCi (0.04–0.2 MBq). 
Radiation doses to 1,000 days for dogs ranged from 185 to 1,260 rad (1.85–12.6 Gy) to the lungs, 180 to
1,070 rad (1.8–10.7 Gy) to the liver, and 67 to 410 rad (0.67–41 Gy) to the skeleton, while the skeletal
doses to death for the 4 dogs developing osteosarcoma were 500, 300, 240, and 180 rad (5, 3, 2.4, and
1.8 Gy).  Metastasis was evident in only 1 of the 4 dogs.
Neoplastic formation after exposure to 238Pu and 239Pu has been extensively studied in Beagles.  Hahn et
al. (1981) exposed 72 Beagle dogs by inhalation to monodisperse aerosols of 238PuO2 measuring 1.5 µm
and another 72 dogs to particles measuring 3.0 µm.  Twenty-four control dogs inhaled an aerosol
produced from a diluent solution.  Equal numbers of males and females were used.  Groups of 12 dogs
were exposed to concentrations expected to produce initial lung burdens of 0.56, 0.28, 0.14, 0.07, 0.029,
0.01, and 0 µCi/kg (0.021, 0.010, 0.0052, 0.0826, 0.0011, 0.00037, and 0 MBq/kg).  However, mean
actual initial lung burdens were 0.97, 0.43, 0.26, 0.11, 0.055, 0.017, and 0 µCi/kg (0.0359, 0.0159,
0.0096, 0.0041, 0.0020, and 0 MBq/kg), respectively, for 1.5 µm particles, and 1.2, 0.57, 0.30, 0.14,
0.069, 0.024, or 0 µCi/kg (0.044, 0.021, 0.011, 0.0052, 0.0026, 0.00089, or 0 MBq/kg), respectively, for
3.0 µm particles.  Necropsy and histopathological examinations were performed at death.  Primary bone
cancers developed in Beagle dogs briefly exposed by inhalation to aerosols of 238PuO2.  238PuO2 was
initially deposited in the respiratory tract where it was retained with a half-time greater than 100 days.  A
portion of the 238Pu was solubilized and translocated to the liver and skeleton; 46 of 144 exposed dogs and
2 of 24 control dogs died (as of date of publication).  Deaths unrelated to bone tumors are as follows:  7 of
the 144 dogs died from severe radiation pneumonitis and pulmonary fibrosis 536–1,213 days after
exposure (3,700–8,600 rad [37–86 Gy] to lungs) and 4 of the 144 dogs died of pulmonary carcinomas
1,319–2,143 days after exposure (2,100–5,900 rad [21–59 Gy] to lungs).  Five years after exposure, 46
osteosarcomas developed in 35 of 144 exposed dogs.  The cumulative absorbed radiation doses to the
skeleton for these dogs ranged from 210 to 830 rad (21-83 Gy), and time from inhalation exposure to
death ranged from 1,125 to 2,078 days.  Of the 46 bone tumors, 22 originated in the vertebrae (49%), 
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12 in the humeri (26%), 6 in the pelvis (13%), and 6 in miscellaneous long and flat bones (13%).  Most of
the tumors were well differentiated sarcomas.  Only 10 of the tumors metastasized; the lung was the organ
most often invaded.  Bone tumors were associated with lesions of radiation osteodysplasia.  The number
of bone tumors found in this study indicated that inhaled 238PuO2 was an effective skeletal carcinogen. 
The authors noted that the rate of solubilization in the lungs and translocation to the bone may be factors
in the radiation dose pattern and the type and location of bone tumors that developed after inhalation of
238PuO2.
In another study, Muggenburg et al. (1994) exposed 144 Beagle dogs to 238PuO2 aerosols; 72 of these
dogs inhaled monodisperse aerosols of 238PuO2 with AMADs of 1.5 µm, and 72 dogs inhaled 3.0-µm
AMAD particles.  For each particle size, dogs were exposed to achieve one of the following six graded
activity levels of initial lung burden:  0.57, 0.27, 0.14, 0.08, 0.03, or 0.01 µCi of 238PuO2/kg.  These dogs
were observed for biological effects (cancerous and non-cancerous effects) over their natural lifespan. 
The 238PuO2 aerosol exposures resulted in initial lung burden ranging from 37 to 0.11µCi and from 1.50 to
0.01 µCi (1.4–0.004 and 0.06–0.0004 MBq) of 238PuO2/kg of body mass for the 1.5- and 3.0-µm particles,
respectively.  The particles were found to dissolve slowly, resulting in translocation of the Pu to liver,
bone, and other tissue sites.  The principal late-occurring effects were tumors of the lung, skeleton, and
liver.  Lung tumors were detected in 47 of the exposed dogs; within this group, lung tumors were the
primary cause of death in 8 dogs that died from 3.6 to 12.3 years after exposure.  Twenty-seven dogs that
died from bone tumors also had lung tumors.  Lung tumors were primarily bronchoalveolar carcinomas
and papillary adenocarcinomas.  Skeletal tumors were detected in 92 dogs; of this group, bone tumors
were the primary cause of death in 89 dogs that died from 3.1 to 13.2 years after exposure.  These tumors
were primarily osteosarcomas that occurred in the axial skeleton and head of the humerus.  Liver tumors
were detected in 19 dogs and caused the death of 2 dogs that died from 6.6 to 13.2 years after exposure. 
Thirteen of these dogs had a variety of malignant liver tumors and 6 had only benign liver tumors.  Risk
factors estimated for these cancers were 2.8 lung cancers per 106 dog-rad, 8.0 liver cancers per 106  dog-
rad, and 6.2 bone cancers per 106 dog-rad. 
Using a different isotope of Pu, Muggenburg et al. (1988) exposed 216 Beagle dogs to 239PuO2 aerosols. 
The 239PuO2 aerosols were monodisperse with AMADs of 0.75, 1.5, or 3.0 µm.  After  the inhalation was
completed, all animals were matched by age and sex (6 males and 4 females in each group).  Group I dogs
had initial pulmonary burdens (IPBs) of 8.91–109.9 µCi (0.3–4 MBq) of 239PuO2/kg of body mass with a
mean of 42.9 µCi/kg (1.6 MBq/kg).  Group II dogs had IPBs of 2.97–52.9 µCi (0.1–2 MBq) of 239PuO2/kg 
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of body mass with a mean of 15.9 µCi/kg (0.6 MBq/kg).  The plutonium particles produced protracted
alpha irradiation of the lungs over the course of several years.  The average alpha dose to the lungs to
2,600 days after exposure for the dogs in group I ranged from 230 to 3,200 rad and for the dogs in group
II, 80 to 1,570 rad.  Five dogs died within 1 year of exposure.  Lung carcinomas were observed in 3 dogs
(2 males and 1 female) from group I (2,900–3,200 rad) and in 1 dog (male) from group II (1,000 rad). 
These 3 dogs from group I had the highest doses and had many small, dense, parenchymal scars and small
foci of alveolar septal fibrosis scattered throughout the lungs.  Alveolar epithelial hyperplasia was
associated with many of the fibrotic foci.  Oral melanoma was found in one dog (male) from group II that
died (190 rad).The authors note that these findings indicate that alpha irradiation of the lungs of humans
could produce restrictive lung disease at long times after initial exposure.  Other studies in dogs have
demonstrated that exposure to 239Pu can induce lung cancer (Boecker et al. 1988; Galvin et al. 1989).
In addition to Pu, other radionuclides have been shown to induce cancer in dogs.  Hahn et al. (1977)
reported on a series of lifespan studies initiated to study the biological effects of beta emitters using
aerosols of insoluble fused-clay particles containing 90Y, 91Y, 144Ce, or 90Sr.  AMADs ranged from 0.8 to
2.7 µm and the duration of exposure was 2–48 minutes.  90Y exposures resulted in a range of initial lung
burdens of 0 or 80–5,200 µCi/kg body weight; 91Y exposures resulted in a range of initial lung burdens of
0 or 11–360 µCi/kg; 144Ce exposures resulted in a range of initial lung burdens of 0 or
0.0024–210 µCi/kg; and 90Sr exposures resulted in a range of initial lung burdens of 0 or 3.7–94 µCi/kg. 
The approximate effective half-lives in the lungs of insoluble 90Y, 91Y, 144Ce, and 90Sr are 2.6, 50, 180, and
400 days, respectively.  Dogs exposed to 144Ce or 90Sr generally had more active inflammation and
pulmonary fibrosis than dogs exposed to 90Y or 91Y, perhaps due to their longer average survival time
after inhalation exposure and the influence of the continuous irradiation.  Primary malignant lung tumors
were found in 5 of the 91Y exposed dogs (cumulative lung doses to death of 16,000–25,000 rad), 9 of the
144Ce exposed dogs (22,000–61,000 rad), and 14 of the 90Sr exposed dogs (34,000–68,000 rad).  Several
dogs died with primary hemangiosarcomas of the heart or mediastinum, and several died with primary
bone tumors or epithelial tumors associated with the nasal cavity.  Exposure to 144Ce or 90Sr, with dose
rates that decreased slowly, induced pulmonary hemangiosarcomas.  Pulmonary irradiation from 91Y, with
a rapidly decreasing dose rate, resulted in bronchoalveolar carcinomas.  Benjamin et al. (1978) exposed
dogs to 144Ce in fused aluminosilicate particles with particle sizes ranging from 1.4 to 2.7 µm.  Radiation
pneumonitis and pulmonary fibrosis were evident in 13 of 14 dogs that died.  Additionally, there was one
bronchoalveolar-squamous carcinoma and four pulmonary hemangiosarcomas.  The  tumors observed 
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developed within a time period when the dogs showed severe lymphopenia and also were likely to have
immune suppression.  These studies  suggest that chronic pulmonary irradiation from internally deposited
radionuclides may have a dual effect in terms of combined carcinogenic and immunosuppressive effects.
Other species exposed to Pu isotopes show similar results.  Brooks et al. (1992) exposed male monkeys
by nose-only inhalation to an aerosol of soluble 239Pu (NO3)4 to produce projected initial lung burdens of
either 1.08, 0.27, or 0.1 µCi (0.04, 0.01, or 0.004 MBq).  Total skeletal  plutonium activity was nearly
constant for the first year after  exposure; however, the skeletal burden at sacrifice increased with time up
to 99 months after exposure to 1.08 µCi (0.04 MBq) because of transfer from other organs.  239Pu in the
liver peaked at 1 year and then decreased to about 10% of the peak value at 99 months postexposure.  In
the testes, Pu was localized in the interstitial tissue with only 0.01–0.002% of the projected lung burden
remaining in the testes at 99 months after inhalation.  Animals exposed to 1.08 µCi (0.04 MBq) died (3 of
the 8) of radiation-related pulmonary pneumonitis and fibrosis, and a primary papillary adenocarcinoma
of the lung was identified in one animal in that group.  Of 2 animals exposed  to 0.27 µCi (0.01 MBq),
1 developed fibrosis and 1 developed fibrosis and pneumonitis.  Of those exposed  to 1.08 µCi
(0.04 MBq), 6 developed pneumonitis, 9 developed fibrosis, 7 developed alveolar epithelial proliferation,
and 1 developed lung cancer.  Overall, results of this study indicate that the lungs, the bone, and the liver
are the major sites of deposition following inhalation of soluble plutonium in monkeys.  The primary
biological effects, pneumonitis and pulmonary fibrosis, were seen in monkeys with large initial plutonium
burdens.  There was little indication of chromosome damage at levels of plutonium at which there were
no major histological changes in the lungs.
 Hahn et al. (1987) exposed 16 male Rhesus monkeys to particles laden with 239PuO2 via inhalation
(AMAD 1.6 µm).  Initial lung burdens ranged from 0.0018 to 1.8 µCi (0.00007–0.07 MBq).  A
pulmonary fibrosarcoma of bronchial origin was discovered in  one monkey that died of pulmonary
fibrosis after 9 years (3,277 days) with a radiation dose to the lungs of 1,400 rad (14 Gy).  The
fibrosarcoma proliferated around the major bronchus of the right cardiac lung lobe and extended into the
bronchial lumen and surrounding pulmonary parenchyma.  The time-dose relationship for survival is
consistent with that of dogs and baboons that inhaled plutonium dioxide and died with lung tumors.
In addition to dogs and monkeys, induction of cancers in rats irradiated with different radionuclides has
also been studied.  A lifespan study was conducted by Lundgren et al. (1981) in CFW random-bred male 
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mice for the toxicity of 90Y (AMAD 0.7–1.4 µm) inhaled in insoluble fused aluminosilicate particles. 
Groups of 25–393 mice were exposed to achieve initial lung burdens of 1–10, 11–20, 21–30, 31–40,
41–50, 51–60, and 61–140 µCi (0.04–0.4, 0.4–0.7, 0.8–1.1, 1.2–1.5, 1.5–1.8, 1.9–2.2, and 2.3–5.2 MBq). 
Exposures were 10–20 minutes.  Control mice (n=763) were either unexposed, sham exposed, or exposed
to nonradioactive Y in fused aluminosilicate particles.  At death, animals were necropsied and major
organs examined.  Mean absorbed dose to the lungs to death were 1,100, 2,300, 3,800, 6,000, 7,200,
8,800, and 14,000 rad (11, 23, 38, 60, 72, 88, and 140 Gy) for initial lung burdens of 1–10, 11–20, 21–30,
31–40, 41–50, 51–60, and 61–140 µCi (0.04–0.4, 0.4–0.7, 0.8–1.1, 1.2–1.5, 1.5–1.8, 1.9–2.2, and 2.3–5.2
MBq), respectively.  The cumulative survival rates of mice in groups with initial lung burdens  up to 20
µCi (0.7 MBq) that produced lung doses as large as 2,300 rad (23 Gy) were not significantly different
from that of controls.  Larger lung burdens caused lung doses >3,000 rad (30 Gy) and resulted in radiation
pneumonitis and a significant shortening of the lifespan (p<0.05).  Median survival time ranged from 12%
to 2.1% of controls at initial lung burdens of more than 20 µCi, and median time of survival after
exposure ranged from 66 to 12 days for these dose levels.  Radiation pneumonitis was observed in
75–100% of mice at these dose levels.  The incidences of all lung tumors and other lesions in exposed
mice were similar to those of controls, except for pulmonary adenomas, which were found more
frequently in groups of mice with initial lung burdens of  as large as 20 µCi (0.7 MBq).  The  early
occurring biological effects observed in mice in this study were similar to those observed in Beagle dogs
exposed to 90Y.
Hahn and Lundgren (1992) also studied lung cancers induced in rats by inhaled 144CeO2.  Rats were
exposed once or repeatedly by inhaling 144CeO2 and observed over their natural lifespan.  Three groups (a
total of 314 rats) were exposed once, briefly, to 144CeO2 to achieve lung burdens of 0.06, 0.32, 1.16, or
6.48 µCi (0.002, 0.01, 0.04, and 0.24 MBq).  Another group of 201 rats was repeatedly exposed briefly
once every other month for 1 year (7 exposures) to initially establish and subsequently re-establish
desired lung burdens in groups of 18–38 males and 19–38 females of 0.35, 1.30, 5.67, or 32.4 µCi (0.01,
0.05, 0.2, and 1.2 MBq).  There was significant life shortening only in those rats exposed repeatedly at the
highest radioactivity level (32.4 µCi, 1.2 MBq).  In these rats, there was a high percentage of squamous
cell carcinomas of the lungs, as well as much lower percentages of adenocarcinomas of the lungs,
hemangiosarcomas of the lungs, and pleural mesotheliomas.  At lower doses, adenocarcinomas were the 
predominant tumor, with alveolar, papillary, tubular, or undifferentiated adenocarcinomas most
commonly observed histologically.  The lung neoplasms induced by this beta-emitting radionuclide are 
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similar in nature to those induced by alpha-emitting radionuclides deposited in the lung in rats.  However,
the radiation-induced squamous cell carcinomas of the lungs differed from those induced by 
nonradioactive compounds.
Many other studies also confirm the formation of cancers of the respiratory tract in laboratory animals
(Benjamin et al. 1975, 1978, 1979; Boecker et al. 1988; Gillette et al. 1992; Hahn et al. 1976, 1980, 1988;
Lundgren et al. 1974, 1980a, 1983, 1991; McClellan et al. 1973).
Skin and bone cancer have been demonstrated after external exposure to radionuclides, particularly those
that are beta and gamma emitters.  Ootsuyama and Tanooka (1989) exposed female mice to beta
irradiation from 40,000 µCi (1,500 MBq) of 90Sr and 90Y which delivered a surface dose rate of 228
rad/minute (2.28 Gy/min) and a 20–80% lower dose rate to the top of the vertebrae.  Mice were irradiated
three times weekly at skin entrance doses per exposure of 135, 150, 250, 350, 470, and 1,180 rad (1.35,
1.5, 2.5, 3.5, 4.7, and 11.8 Gy), respectively, and irradiation was continued until a palpable tumor
appeared (up to 86 weeks).  Tumors that formed in the irradiated area were of skin and bone origin.  Most
mice had either an osteosarcoma or a skin tumor, while some mice had both osteosarcomas and skin
tumors.  Osteosarcomas were induced most frequently with skin surface doses of 250–350 rad (2.5–3.5
Gy) per exposure.  These doses were 20–80% lower at the depth of the bone.  The skin is incidentally
irradiated in the radiotherapy of deep tumors.  Repetitive irradiation  was essential, or at least more
effective, for induction of osteosarcomas, as well as for skin tumors, and the carcinogenic dose for
osteosarcoma was less than that for skin tumors.  
Hulse (1966) irradiated female mice with 204Tl and then allowed them to live out their natural life (unless
they were moribund or sacrifice was deemed necessary).  Nominal doses ranged from 750 to 12,000 rad
(7.5–120 Gy).  204Tl beta particles have a low energy (mean 0.24 MeV) and a maximum range in soft
tissue of 3 mm.  Doses to the dermis and epidermis were 69–72% and 40–70%, respectively, of the
epidermal entrance dose.  Mice were irradiated on one or two zones.  The single-zone exposure included
the middle of the trunk, and the two-zone exposure included the thorax (with proximal forelimbs) and
pelvis (with hindlimbs), with an intervening unirradiated gap of about 1 cm.  In one group, two zones
were arranged to be immediately adjacent (thorax-midtrunk, midtrunk-pelvis) with the potential for slight
overlap due to the movement of the mice.  The percentage of mice irradiated on one zone only and dying
with skin tumors was 7, 25, 42, and 57 for the 1,500-, 3,000-, 6,000-, and 12,000-rad (15, 30, 60, and 120 
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Gy) dose groups, respectively.  In mice exposed to two separate zones, the percentage dying of skin
tumors was 3, 17, and 50 for the 750-, 1,500-, and 3,000-rad (7.5, 15, and 30 Gy) dose groups,
respectively.  Mice that were irradiated on two adjacent zones received 1,500 rad (15 Gy) only.  Twenty
percent of these mice died with skin tumors.  A total of 133 tumors arose in tissues which were affected
by the irradiation, and 7 tumors arose in similar tissues outside the irradiated zones.  There were 20
epidermal tumors: 2 benign and 18 squamous cell carcinomas, which were situated on the torso.  There
were 96 dermal tumors; 77 of those were malignant and of those 74 were fibrosarcomas.  Five
fibrosarcomas occurred beneath the irradiated skin and 12 breast tumors occurred.  No tumors of the
epidermis or dermis were seen in the unirradiated control mice.  The maximum incidence of dermal
tumors in all dose groups occurred during the third year after irradiation.  Increasing the number of
irradiated zones from one to two zones, which doubled the exposed skin area, essentially doubled the
animal’s chance of dying from skin cancer.
In summary, cancer is the major latent biological effect in several studies identified in this profile after
inhalation, ingestion, or external exposure.  Reports of cancer induction after ingestion and the more
unconventional exposure routes are numerous (Evans et al. 1966; Martland 1931; Raabe 1994; Rowland
et al. 1978; Speiss and Mays 1970). Excess cancer has been reported in humans after exposure to varying
amounts of radiation during the Hiroshima and Nagasaki atomic blasts (Shimizu et al. 1988), which has
provided risk assessors a unique data set to determine the short- and long-term biological effects of
radiation in humans.  Several other studies that monitored cancer death rates from radiation exposure in
humans were also located (Checkoway et al. 1988; Kneale et al. 1981; Sorahan and Roberts 1993). 
Reports of humans receiving an acute inhalation, oral, dermal, or external dose of radiation  under
controlled conditions were not identified in the open literature.  Levels of Significant Exposure to
Radiation and Radioactive Material tables that describe Cancer Effect Levels (CELs) from exposure to
radiation in humans and laboratory animals are provided in Chapter 8 of this profile.
Many laboratory animal inhalation exposure studies were identified that described increased incidences of
cancer developing in a variety of species after exposure to alpha, beta, and gamma radiation.  Many of
these studies were selected for discussion in this profile because they were lifespan studies, concentrating
on the effects of alpha (238Pu, 239Pu) and beta (90Sr, 144Ce, 91Y, 137Cs) emitters.  The main animal model, the
Beagle dog, has lungs that are similar anatomically, physiologically, and morphologically to human
lungs, making them an ideal lung model to study the potential effects of inhaled nuclides in humans. The
nasopharageal structure of the Beagle is significantly different from a human’s; therefore, comparisons of
nasal tissue and bone cancers between the species are not practical at this time.  These studies provide
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valuable data on the long-term toxicity of many radionuclides that would be likely to be inhaled in
soluble and insoluble forms during a nuclear fallout or an acute exposure event, as well as low-level
radionuclide exposure from fallout and  natural in the atmosphere.  Biennial reports of these lifespan
studies that summarize the most recent findings from these laboratory animal studies are available.
These animal studies, especially the Beagle dog studies, clearly demonstrate that the inhalation of very
large amounts of radionuclides in soluble or insoluble forms, which results in very high absorbed doses to
the lungs, has the potential to produce lung cancer and to induce cancers in other organs.  These cancers
are the same cancers that would normally appear with a lower frequency in an unexposed animal
population. After exposure(s) to one or to a combination of radionuclides, the incidence of these naturally
occurring cancers tend to increase, though the latent periods do not change.  This observation was
demonstrated by the studies performed by many investigators in which 238PuO2 and 239PuO2 exposed dogs
had increases in lung, skeletal and liver tumors after exposures to varying doses of these nuclides
(Boecker et al. 1988; Brooks et al. 1992; Gillett et al. 1985; Hahn et al. 1987, 1981; Muggenburg et al.
1994).  This trend, also noted with the cancers that were produced in those individuals exposed to external
sources of ionizing radiation after the atomic blasts in Hiroshima and Nagasaki, Japan, in August 1945, is
discussed in more detail below (Shimizu et al. 1988).
The sites where these cancers occurred in exposed laboratory animals depended largely on (1) the dose,
which depends on the quantity of radioactive material, (2) the physical properties of the particle (or
vapor) they were incorporated into, (3) the solubility of the particle, (4) the particle size, and (5) the
radiological and biological properties of the material.  For example, for dogs exposed to insoluble
aerosols of 238Pu (1.5 and 3.0 µm), it may be reasonably surmised that these animals would develop lung
tumors based on the physical half-life of the radionuclide, the insoluble nature of the particle, the small
particle size (long retention times), the dose, and the tissues at risk of receiving large doses of radiation
within a short distance of the particle retention site.  Lung tumors did in fact develop in these animals at
an increased incidence rate many years after the initial exposure.  Liver and bone tumors also developed
in conjunction with some of these lung tumors.  Over a period of time, the particles slowly dissolved and
the 239Pu was  transferred to the hepatic and skeletal tissues, subsequently irradiating other susceptible
tissues and inducing cancers of the liver and osteosarcomas of the bone (Muggenburg et al. 1994). 
Metastasis also is a factor in the appearance of cancer in some organs.
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External exposure  has also been found to induce cancers in both humans and laboratory animals.  A few
human studies that involved external exposures to radiation and resulted in cancer were identified, but the
best study available to date is the Life Span Study (LSS) currently being conducted by the Radiation
Effects Research Foundation (RERF) with the survivors of the atomic bombings of Japan in 1945.  A
large database is available from the persons exposed to radiation from the atomic bombing of Hiroshima
and Nagasaki.  According to DS86 doses, the major type of radiation was gamma emissions, with lesser
amounts of neutron radiation than originally anticipated using T65D dosimetry assumptions; the estimates
of doses to these individuals are still being refined today.  Exposures are considered to be mostly from
external radiation, with much smaller amounts of internal radiation from inhalation and oral exposure
routes, due to relatively little fallout from those atomic blasts.  In Nagasaki, however, survivors were
exposed to the “Black Rain,” which is fallout radioactivity mixed in a rain shower.  Many of these
individuals received high doses to their unprotected skin and even to skin under water-saturated clothing
due to the high-activity, beta and gamma-emitting fission products.  This ongoing epidemiologic study
provides an excellent source of data for use in studying the delayed effects of radiation in humans.
As with cancers induced after inhalation of radioactive material by laboratory animals, cancers in humans
or animals exposed to external radiation do not appear immediately after the initial exposure.  In the
Hiroshima and Nagasaki atomic bombing survivors, and in the dog studies discussed above, there was no
dose-dependent shortening of the latent periods for cancer induction, except possibly for those individuals
exposed to radiation within the first 10 years of life (which was dose-dependent).  This observation may
reflect a higher sensitivity to the effects of radiation in very young humans.  Cancers were also of the type
that are normally found in unexposed individuals, but they occurred with some increasing frequency. 
These cancers occur only when those individuals reach an age when these cancers normally would be
expected to develop (except for leukemia).  For example, a female #10 years of age who was exposed to
external gamma  radiation from the atomic blast and survived the acute effects of the initial radiation
exposure would have an increased probability of developing (and dying from) breast cancer as a result of
the latent radiation effects, but not before she reached the age at which the majority of unexposed women
would be expected to start developing this specific cancer.  The same would be true for the other types of
cancers as well, except for leukemias.  Deaths due to leukemia did exhibit a minimum latent period
(2–3 years).  The incidence of the cancer increased to a peak at 6–8 years after exposure and the incidence 
declined after that.  A slightly significant increase in deaths due to leukemia existed at least through 1980 
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(the cut-off date for much of the DS86 dosimetry system data), some 35 years after the initial exposure;
this increase  was independent of the age at which the initial exposure had occurred.
In another report by Upton (1991) and in the report by Shimizu et al. (1988), the same cohort was
reported to show linear dose-mortality relationship responses for cancers (other than leukemia) ranging
from 40 to 300 rad (0.4–3 Gy).  In the most recent report on this cohort, solid cancer excess deaths
increased greatly in the last 5-year study period, 1986–1990; for those exposed as children, 50% of the
excess deaths occurred during this period (Pierce et al. 1996).  For all cancers, most of the excess deaths
were due to leukemia and most leukemias occurred in the 15 years following exposure.  Though excess
relative risk for those exposed as children declined over the recent years, the excess absolute risk
increased rapidly and excess absolute risk is seen to be an important measure of radiation’s population
impact.  Solid cancer excess lifetime risk per sievert was estimated at 0.10 for males (10 cancers per 100
people) and 0.14 for females, and still shows a linearity up to about 3 Sv (Pierce et al. 1996).  However,
leukemia showed nonlinearity of risks: risk at 0.1 Sv was 1/20 of the risk at 1 Sv. 
Cancer mortality due to ionizing radiation has been evaluated extensively (BEIR V 1990; Shimizu et al.
1988; Upton 1991).  In summary, for the Japanese atomic bomb survivors, the relative risk for the whole
exposed population (all ages and both sexes) for malignant neoplasms (including leukemia) for the years
1950–1985 has been estimated to be 1.39 (range 1.32–1.46) per 100 rad (1 Gy), corresponding to an
absolute risk of 13.1 (10.1–15.9) excess deaths per million person rad (104 person-Gy)/year.  When
leukemia is excluded from the previous estimates, the relative risk for the whole exposed population (all
ages and both sexes) for solid cancers is estimated to be 0.41 (0.32–0.51) per 100 rad (per Gy) organ-
absorbed dose, corresponding to a lower absolute risk of 10.13 excess cancer deaths per million person
rad (104 person-Gy)/year organ-absorbed dose.  When total cancer mortality (including leukemia) is
reexamined on the basis of sex, sex ratios of radiation-induced cancers at specific sites are not
significantly different from those of the unexposed general population.  The relative risk for some
epithelial tumors tends to be somewhat higher in females than in males (Upton 1991).  Finally, when the
data are re-examined as to cancer mortality and age at exposure, the current data suggest that the lifetime
risk of developing radiation-induced cancer is substantially lower in those persons exposed during their
adult years than in those exposed during childhood or adolescence, a conclusion supported by BEIR V
(1990).  Several types of 
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cancer were observed with increased frequencies in this exposed population and are summarized in     
Table 3-8.
CELs from exposure to ionizing radiation in humans and laboratory animals are summarized in the Levels
of Significant Exposure to Radiation and Radioactive Material tables in Chapter 8 of this profile.
3.3 IDENTIFICATION OF DATA NEEDS
The database appears to have a sufficient volume of information for regulators to allow workers to work
safely with radiation sources.  This is verified by the fact that the nuclear power industry has the best
overall safety record of all industries.  This good safety record, with a Standardized Mortality Ratio
(SMR) of less than 100 is usually attributed to the “Healthy Worker Effect.”  However, for scientific
reasons, the following have been identified as potential data needs regarding health effects that may be
associated with exposure to ionizing radiation:
• Since somatic and reproductive cell chromosomes are radiosensitive tissues that can sustain
damage after exposure to ionizing radiation, damage to the  chromosomes and the genes on them
in exposed populations has potentially serious implications.  Better methods are needed by
which to estimate the levels of exposure to ionizing radiation that may result in an increased risk
of hereditary disease.
• Important gaps in knowledge should be filled to permit more reliable estimation of genetic and
hereditary risks.  In some cases this might include collection of new data that could remove or
refine assumptions needed in the direct and indirect (doubling-dose) methods of hereditary risk
estimation.  In other cases, gaps in knowledge could be filled by the reevaluation of the masses
of data collected in the past (for example, specific-locus experiments) in the light of new
understandings about hereditary risk.  In addition, information gathered as part of the Human
Genome Project may lead to improvements in the existing methods or to entirely new methods
of estimating hereditary risk.
• The largest group of workers that receive elevated doses of ionizing radiation are airline air
crews.  Assuming a dose of 1 mrem/hr (0.01 mSv/hr) and 72–100 hours/month airtime for 11
months, this leads to an approximate dose of 800–1,100 mrem/year (8–11 mSv/year), about
twice the annual dose of an average nuclear power plant worker.  There is a need to determine
whether or not this long-term, continuing, low-level radiation dose rate leads to harmful effects.
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• The mechanisms by which cancer is induced in living cells are complex and an area under
intense study.  More research is required to better understand the mechanisms by which cancer is
induced after exposure to chemical carcinogens and to ionizing radiation.  This would include
the identification of unique biomarkers and biochemical pathways at the cellular and tissue level,
and the study of radiological and chemical mixtures.
• Regarding radon exposure, several studies involving underground-miner surveys need to be 
completed and the data analyzed for the interaction between radon and smoking.  These studies
should also provide more information on radon dosimetry and narrow some uncertainties in
applying the lung-cancer risk data derived from the miner data sets to estimation of risk of radon
exposure in the general population.
• Epidemiological studies need to continue in order to more firmly describe the risks of lung
cancer in underground miners and the risks of indoor home radon exposure to those potentially
exposed to radon and radon progeny.  In addition, adding a thoron (220Rn- and 220Rn- plus decay
products) study to the radon studies would be of benefit, because thoron is hard to get into the
home.  If it does, the decay products are long-lived; there are limited data on in-home thoron and
thoron decay product levels.
• Further modeling of the indoor air environment is needed to assess potential health
consequences of indoor radon exposure.
• The role of  210Po in tobacco smoke and lung cancer should continue to be evaluated; this 
includes bronchial and lung dosimetry, identification and characterization of target cells, and the
role of cofactors in the carcinogenic response.
• The deterministic acute and delayed health effects from 210Po,  particularly those affecting the
renal, cardiovascular, and reproductive systems, should continue to be investigated.
• More quantitative information regarding the 224Ra, 226Ra, and 228Ra human exposures is needed
to more adequately evaluate the magnitude of some dosimetric uncertainties and what impact these
uncertainties have on quantitative risk estimation.
• The bone cancer information from all of the human 224Ra, 226Ra, and 228Ra exposures should be 
integrated and more adequately analyzed.
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• Research should continue on identifying the cells at risk after exposure to radium.  This should 
include cell behavior over time, changes in cell behavior, location of cells in relation to the
microenvironment of the radiation field, responses of the cell to the radiation, and the time
course and distribution of radioactivity in the bone.
• The dosimetry of the mastoids should be examined in order to calculate the risk per unit of 
epithelial tissue and per unit of cell dose.
• Data should be obtained from the five major epidemiological studies of Thorotrast-exposed
patients and the data analyzed to develop risk models for liver and other cancers.
• The dosimetry of the thorium isotopes at the cellular level in target organs should be closely 
examined.
• The mechanism of uranium deposition and redistribution in bone should be further investigated
in order to more accurately define the potential carcinogenic effect of natural uranium based on
results obtained from enriched uranium or other alpha particle emitters.
• The current epidemiological studies of worker populations exposed to transuranic elements
should be continued.
• The current lifespan studies with dogs should be completed and the results reported.
• The current lifespan studies of the Japanese atomic bomb survivors should be continued and the 
results reported regularly every 5 years.
• Studies should continue regarding the genetic effects of low-level exposure to ionizing radiation,
particularly in the second generation offspring of the Japanese atomic bomb survivors.  Better
methods for extrapolating data from animal studies for applications in human genetic risk
assessment are also needed.
• It would be useful to have some information on induced dominant damage in female mice for
use in the direct method of hereditary risk estimation, as none has been known to have been
collected.  Presently the application of the direct method to females assumes that the relative
risks of the sexes are the same for serious dominant mutations as they are for specific-locus
mutations, which are recessives.
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• Efforts to assess the carcinogenic risks of exposure to low levels of ionizing radiation, for both
single dose and protracted and fractioned doses, should continue.
• The carcinogenicity of neutron radiation exposure in human populations should continue to be 
examined.  Similarly, the mutagenicity of low doses of neutron radiation should continued to be
investigated in order to more comfortably predict the potential genetic risks observed in
laboratory animals and extrapolate those findings to human populations.
3.4 CONCLUSIONS
This chapter has provided an overview of the health effects related to ionizing radiation exposure in
humans and laboratory animals.  These effects can be both non-carcinogenic and carcinogenic in nature. 
Non-carcinogenic effects primarily result in immediate effects, mainly to organs with rapidly dividing
cells, which include the hematopoietic system, gastrointestinal tract, and skin, or delayed effects such as
cataracts and embryo/fetal development problems.  Carcinogenic effects also may occur in any number of
organ systems.  This end point may not be expressed for several years after the initial exposure.  The
dose-response relationships for these effects are known from the massive amount of data from studies on
both humans and animals.  Epidemiology studies are not likely to provide significant refinement of
radiation risk estimates.  The most fruitful approach to further understanding risk from exposure to
ionizing radiation is through molecular studies, including the identification of unique biomarkers and
pathogenic pathways at the cellular and tissue levels.
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Radiation accidents may be viewed as unusual exposure events which provide possible high exposures to
a few people and, in the case of nuclear plant events, low exposures to large populations.  A number of
radiation accidents have occurred over the past 50 years involving radiation producing machines, radio-
active materials, and uncontrolled nuclear reactors.  These accidents have resulted in a number of people
being exposed to a range of internal and external radiation doses, and those involving radioactive
materials have involved multiple routes of exposure.  Some of the more important accidents involving
significant radiation doses or releases of radioactive material, including any known health effects, are
discussed below.  It is important to carefully and critically assess each individual accident in order to
identify the causes and then to implement indicated corrective measures that will prevent a recurrence. 
An analysis of the common characteristics of accidents is useful in resolving overarching issues, as has
been done following nuclear power, industrial radiography, and medical accidents.  Success in avoiding
accidents and responding when they do occur requires planning in order to have adequately trained and
prepared health physics organization; well-defined dose limits and action levels; a well-developed
instrument program; close cooperation among radiation protection, experts, local and state authorities,
and emergency responders; and solid communication among response groups, the medical community,
the media, and the public (Morgan and Turner 1973).  Focus is given to the successful avoidance of
accidents and the response in the event they do occur.  Examples of some accidents are discussed below.
4.1 PALOMARES, SPAIN
From the 1950s through the late 1960s, the Strategic Air Command (SAC) conducted Operation Chrome
Dome which, in the interest of national defense,  required the Air Force to fly aircraft carrying nuclear
weapons around the world 24 hours a day.  On January 16, 1966, two B-52 airplanes, each carrying four
thermonuclear weapons containing 239Pu, flew to the southern fringes of the former Soviet Union.  On
their return trip to the United States, one collided in mid-air with a KC-135 tanker aircraft during a
refueling operation over Spain.  After fire erupted on the planes, the B-52 broke apart and scattered all
four nuclear weapons.  The weapons were dispersed over Palomares, a town located in a remote area of
Spain.  Two weapons landed without incident, one in the water and the other on the beach near
Palomares, and both were recovered.  The third weapon landed in low mountains west of the town, and
the fourth landed on agricultural land to the east.  The high explosives in these last two weapons 
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detonated and burned, causing some of the plutonium inside to also burn and spread plutonium
contamination throughout the area.  There were chemical but no nuclear explosions (Civil Defense
Technology Workshop 1995).
Partial chemical burning of the fissile material from the two bombs that had been blown apart by their
high explosive charges resulted in a cloud formation which was dispersed by a 35-mph wind. 
Approximately 2.25 km2 of farmland was contaminated with plutonium at levels of 50–500 µg/m2
(3–32 µCi/m2), and low levels of plutonium were detectable for a distance of 2 miles.  Initially, 630 acres
of land were reported to be contaminated; however, an additional 20 acres were subsequently classified as
contaminated due to resuspension by the wind.  The primary form of income for the citizens of Palomares
was their tomato crop.  The U.S. government purchased the tomato crop for a total of $250,000.  These
mildly contaminated tomatoes were washed free of contamination and were considered safe to eat.  Crops
in highly contaminated fields where levels exceeded 5 µg/m2 (0.3 µCi/m2) were dug up and burned in
open-pit fires, which further spread the contamination.  
An agreement between the United States and Spain called for removing the top 10 cm (4 inches) of soil in
areas contaminated with more than 32 µCi/m2 (500 µg/m2).  This resulted in the removal of 1,100 m3 of
soil.  The decontamination procedure required 747 people and 8 weeks of labor and resulted in the filling
of 4,879 metal 55-gallon drums with contaminated soil.  Soil with surface contamination levels between
approximately 5 and 500 µg/m2 was mixed with petroleum oil, plowed under to a depth of 8 inches, and
then covered over with another layer of top soil.  Following this decontamination, the concentration of
activity in surface soil averaged 1 µg/g, with a maximum of 40 µg/g.  The plutonium concentration in
plants ranged from uncontaminated to 30 times the ambient level in Spain. The Air Force contracted 140
trucks to move 3,400 truck loads of replacement soil from a dry river bed.  These actions essentially
destroyed all of the indigenous population’s crop lands.  All soil levels greater than 462 µg/m2, together
with other contaminated materials, were transferred to the United States for burial.  All but two of the
barrels were shipped to the Savannah Naval Storage Facility in Aiken, South Carolina.  The other two
barrels were sent to Los Alamos National Laboratories in New Mexico, where they are still being
monitored and tested (Civil Defense Technology Workshop 1995; Shapiro 1990; UNSCEAR 1993).  No
plutonium was found in the 100 residents of Palomares who were the most likely to have been exposed. 
The potential dose to the lungs, bone surface, and bone marrow of the local residents has been estimated
to be much less than the ICRP recommended limits (Iranzo et al. 1987).  Follow-up studies on this group 
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of exposed individuals are not likely to provide useful information on the long-term effects of plutonium
exposure in humans.
The Spanish government, concerned about public perception and panic, prohibited the U.S. Air Force
cleanup crews from wearing anti-contamination suits or full face masks.  Only uniforms, hats, and
surgical gloves with tape over the openings between gloves and clothing were permitted.  This resulted in
internal contamination of some service members, who were monitored by urinalysis for plutonium
content.  Data indicate that a small number registered readily measurable levels, and some of those levels
decreased to below detection limits in a few months.  Long-term monitoring of the others was eventually
discontinued. Counter to U.S. recommendations, civilians were not restricted in their movements in or
around the area.  In the hilly, rocky area surrounding the impact site of the fourth weapon, it proved
impossible to reach the initial cleanup standards set by the Spanish Government, so the limits for this area
were adjusted to meet the conditions, with the agreement that the area would not be used for agriculture. 
Where the soil could not be removed, the workers soaked it with water to force the contamination into the
soil.  This area has never been restricted by local authorities, and, although the local population was
warned that the area was contaminated, Spanish citizens eventually began to farm some of this land (Civil
Defense Technology Workshop 1995).  Six years after the incident, follow-up studies found that there
was little change in the community and in exposed persons (Shapiro 1990).  Of the 714 people examined
through 1988, 124 had urine concentrations of plutonium greater than the minimum detection limits
(MDLs).  
4.2.  GOIANIA, BRAZIL
On September 13, 1987, two scavengers found an abandoned teletherapy device in an abandoned medical
clinic in Goiania, Brazil.  The machine contained a radioactive 137Cs source with an activity of 1,375 Ci
(50.9 TBq) in the form of powdered and soluble 137CsCl.  After removing the source from its shield, they
took it home and, in a crude attempt to break it apart, managed to rupture the source and spread pieces
about the property.  Both became ill within hours.  Either 1 or 5 days later, according to various versions
of the story, the device became the property of a junk dealer.  This dealer noticed a luminescence
emanating from the unit and used tools to cut the unit apart to gain access to the material inside.  The
rupture allowed the 137CsCl powder to disperse easily and be further distributed by wind suspension and
rainwater runoff.  Several land areas and 129 people were significantly contaminated, resulting in four
deaths and one forearm amputation (Amaral et al. 1991; Rosenthal et al. 1991).
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Initial External Response.    On September 29, 1987, the Secretary of Health for the State of Goiania
allowed a local physicist to notify the Department of Nuclear Installations (DNI) which, in turn, notified
the National Nuclear Energy Commission (CNEN) in Rio de Janeiro.  The Director of DNI and
technicians from the Institute of Nuclear Energy research (IPEN) left that day and arrived in Goiania the
next morning (Moreira 1991).  The abandoned hospital was searched first, but there was no source of
contamination.  Next, the houses of presumably contaminated patients were checked and contamination
was found.  A detailed search found 7 highly contaminated areas that included 2 houses, 4 lots, and the
Public Hygiene Control Unit.  Part of the original source was found at this unit.  Testing showed
maximum radiation readings of 1,000 rem/hr (10 Sv/hr) on contact and 40 rem/hr (0.4 Sv/hr) at 1 meter. 
The source was shielded with concrete for personnel protection.  That night the Goiania task force
developed its site action plan. 
Initial Patient Management.    The accident primarily exposed or contaminated about 80 people, who
were all related, and an additional 170 were later contaminated to much lower levels.  Initially, 11
individuals who had handled the source and who were the most highly contaminated were taken to the
Hospital of Tropical Diseases or to the Santa Maria Hospital.  The most highly contaminated of these
were then transported to the Marcilio Dias Naval Hospital in Rio de Janeiro.  People from the primary
contamination zones were assessed and, based on clinical findings, sent to Goiania Hospital, FEBEM, or
the House of the Good Shepherd.  Twenty-two people who were evacuated from contaminated homes
were taken to Olympic Stadium, and others who were in the vicinity were encouraged to go there.  In a
prioritized manner, the contaminated victims were provided with medical care, clean clothing,
nourishment and orientation, and contamination monitoring; the public was informed.  Because of
exaggerated claims of water contamination by the press, an additional 112,000 unaffected individuals
went to Olympic Stadium for monitoring.  A total of 249 were found to be contaminated.  About half had
shoe and clothing contamination, that could have been picked up from walking in the stadium.  Of the
other 129, who were both internally and externally contaminated, 21 required intense medical treatment. 
Ten of these were seriously compromised, four died, and one required forearm amputation (Brandao-
Mello et al. 1991; Oliveira et al. 1991a, 1991b).
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Contamination Spread.    The 137Cs contamination was spread by social contacts, the sale of
contaminated material, the movement of pieces of the source, and wind and rain dispersal (Amaral et al.
1991; Becker et al. 1991; da Silva et al. 1991; Godoy et al. 1991).  Contamination was found on 7 major
properties; in 42 residences, including 22 homes of family and friends who were evacuated and 20 others
where radiation levels ranged from 0.1 to 1 rem/hr (1–10 mSv/hr); and on 68 of the more than 10 million
currency bills tested.  The population was internally exposed by inhalation and the ingestion of fruits and
vegetables, and externally exposed to the penetrating 137Cs gamma radiation, but the drinking water
supply was found to be clean.
Contaminated materials in the environment were removed from the various sites and loaded into
containers, with liquids being immobilized in concrete.  Decontamination limits for solids were set by the
national standard.  Anything contaminated below 74 kBq/kg was considered to be clean and unaffected
by the accident.  Contamination level was characterized by the contact radiation level, with values of 0.2
and 2 rem/hr (2 and 20 mSv/hr) being the respective limits for low- and medium-level contamination.  An
estimated 1,200 Ci (44 TBq) of 137Cs was recaptured during the decontamination effort, which left the
area with no significant residual hazard (Rosenthal et al. 1991).
The type of media coverage of this accident caused a psychological impact on a community with recent
memories of the Chernobyl reactor accident in the former Soviet Union.  The situation improved when
the news media refocused their efforts toward balanced reporting and public education.
4.3 THULE, GREENLAND
In January 1968, a U.S. Air Force plane experienced an on-board fire and subsequently crashed while
attempting an emergency landing near Thule, Greenland.  The plane was carrying four unarmed
1.1-megaton nuclear weapons; although the nuclear weapons did not detonate, the conventional
explosives of the weapons exploded on impact, depositing an inventory of 1 TBq (27 Ci) combined 239Pu
and 240Pu, 0.02 TBq (0.54 Ci) 238Pu, and 0.1 TBq (0.27 Ci) 241Am; igniting fuel; and creating an intense
fire that burned for almost 4 hours.  The force of the crash and explosions resulted in the spread of
plutonium-laden debris over an area approximately 100 m by 700 m.  The burning plutonium was
converted mainly into insoluble oxides and dispersed as fine particles.  Measurements of  239Pu and 240Pu 
IONIZING RADIATION 200
4.  RADIATION ACCIDENTS
indicated that the radionuclides preferentially deposited in the fine-grained bottom sediments covering the
basins in the vicinity of the crash site.  Follow-up investigations found that plutonium levels in bivalves
and crustacea to be increased by a factor of 10–1,000 over pre-accident levels (Aarkrog 1971, 1994;
Handler 1992; Shapiro 1990; Smith et al. 1994).
The cleanup effort, called project Crested Ice, lasted 8 months and resulted in the shipping of almost
240,000 tons of contaminated ice and snow to the United States.  About 99% of the plutonium was
contained in the blackened ice at the crash site; this was recovered by road graders and mechanized
loaders scraping away the affected ice.  A total of sixty-seven 25,000-gallon fuel tanks were filled with
debris and four additional containers were used for storing contaminated recovery equipment and gear. 
The materials were shipped to the United States for disposal.  Although low-level contamination was
detected on land close to the crash site, it is believed that minimal amounts of plutonium escaped from the
crash site.  No significant radionuclide exposure and no long-term effects to neighboring populations
were expected (Handler 1992; Shapiro 1990).
4.4 ROCKY FLATS, COLORADO
The Rocky Flats Nuclear Weapons Plant, located approximately 15 miles from Denver, Colorado,
occupies approximately 2 square miles of federally owned land.  Approximately 2.2 million people from
the 8-county Denver metropolitan area live within a 52-mile radius of the facility.  As of December 1995,
there were approximately 4,700 employees at the Rocky Flats facility.  Since beginning operations in
1953, the plant has been a major processor of plutonium.  During the Cold War, Rocky Flats was
responsible for the fabrication of the hollow plutonium sphere, or "pit," that serves as nuclear fuel for
nuclear warheads.  Rocky Flats also was responsible for recycling plutonium retrieved from retired
nuclear warheads.  A high-tech machine shop produced other weapons parts from stainless steel,
beryllium, depleted uranium, and other metals.
Due to its proximity to an urban area (Denver, Colorado) and because its property boundaries border two
creeks feeding public waters, there is a potential for public exposure to radioactive material following an
accident at this plant.  Several significant incidents have occurred at this plant: two fires in 1957 and 1969
and leakage of plutonium-contaminated cutting oils from storage drums (Rocky Flats Citizens Advisory
Board 1995; Shapiro 1990).
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Probably no individual location at the Rocky Flats site has achieved more attention than the site known as
the 903 Pad.  In the late 1950s and early 1960s, Rocky Flats stored barrels at this location which were
filled with plutonium-contaminated oil left over from the pit manufacturing operations.  Over time, many
of the oil barrels had corroded, allowing the contaminated oil to spill out onto the ground.  The leakage
was first detected in 1964, and efforts to prevent the spread of leakage were initiated the same year. 
Managers at the site attempted to solve the problem by removing all of the barrels and cleaning up the
storage area.  However, the cleanup effort resulted in the disturbance of the contaminated soil, and the
radioactive dust was picked up and spread further by the high winds that are common at Rocky Flats. 
The Health Advisory Panel overseeing the Dose Reconstruction Project for the Colorado Department of
Public Health and Environment lists the 903 Pad as one of the major contributors to off-site
contamination from Rocky Flats (Rocky Flats Citizens Advisory Board 1995; Shapiro 1990).  
The first of two major fires at the Rocky Flats facility occurred on the evening of September 11, 1957,
when some of the plutonium on the glove box line spontaneously ignited.  Although the area was
designed to be fireproof, it was soon engulfed in flames.  Firemen switched on ventilating fans, which
ultimately spread the flames to contact more plutonium.  Attempts to quench the fire with carbon dioxide
also failed.  Meanwhile, the filters designed to trap plutonium escaping up the stacks caught fire.  The
shift captain and other observers reported a billowing black cloud pouring some 80–160 feet into the air
above the 150-foot-high stack.  When the carbon dioxide gas failed to extinguish the fire, the firefighters
began pouring water into the blaze.  The fire was extinguished roughly 13 hours after it began.  Some
14–20 kg of plutonium were estimated to have burned in the fire, not including plutonium liberated from
the burning filters.  In addition, the water used to extinguish the fire became contaminated with
radioactive material, and approximately 30,000 gallons of it escaped unfiltered, spreading contamination
into local streams and into the water table.  Although some of the buildings were heavily contaminated,
plutonium pit production was back under way within a few days (Wasserman et al. 1982).
The fire in 1969 also started with the spontaneous ignition of plutonium metal.  Several kilograms of
plutonium burned and the resulting smoke plume spread to surrounding areas.  Soil samples collected
from 15 locations ranged from background levels of 20 pCi/kg (0.7 Bq/kg) of material to 6,000 pCi/kg
(220 Bq/kg) in the top centimeter; 7 water samples ranged from 0.001 to 0.2 pCi/L (10-5 to 10-2 Bq/L. 
Another study in 1970 of soil samples to a depth of 20 cm found levels up to 2 Ci/km2 (70,000 MBq/km2)
at sites adjacent to the property boundaries (Shapiro 1990).
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Figure 4-1.  Schematic of Three Mile Island Unit 2 
Nuclear Reactor (adapted from PSU 1999)
Johnson (1981) examined the relation between cancer rates and plutonium exposures using cancer
diagnosis data for 1969–1971 and plutonium exposures estimated from an analysis of soil samples
collected near Rocky Flats in 1970.  Johnson claimed to have found increases in many cancer types for
persons in exposed areas, as compared with those for unexposed areas.  However, a feasibility study for
an epidemiologic study of persons who lived near the plant concluded that exposures were not high
enough to be evaluated statistically (Dreyer et al. 1982).  Cobb et al. (1982) compared plutonium
concentrations in autopsy samples from persons who lived near Rocky Flats with those who lived far
from the plant.  A weak relation between plutonium concentrations in autopsy samples and distance from
Rocky Flats was detected; however, these authors did not believe that the elevated concentrations could
be conclusively linked to emissions from Rocky Flats.  Crump et al. (1987) re-evaluated cancer diagnosis
data for 1969–1971 and for 1979–1981 using the study designed by Johnson (1981).  For both study
periods, the authors found no increase in cancer rates for combined cancers, for radiation-sensitive
cancers, or for cancers of the respiratory system in those living within 10 miles of Rocky Flats.  A
National Cancer Institute (NCI) study of cancer incidence and mortality around nuclear facilities in the
United States found slight elevations for some cancers in some age groups among those living near the
Rocky Flats facility; however, the study should be interpreted with caution because county-by-county
cancer mortality data were used and because of limited information on potential confounding factors
(Jablon et al. 1990), and because it appears that plutonium exposures were not detectable.
4.5 THREE MILE ISLAND, PENNSYLVANIA
On March 28, 1979, an accident occurred at the unit 2
civilian nuclear power reactor at Three Mile Island
(TMI).  Figure 4-1 is a simplified diagram of the TMI
pressurized water nuclear reactor design.  Under
normal operating conditions, the control rods are
withdrawn from the reactor core to produce power,
and water from the principal source (#1) circulates
through the core and a primary heat exchange loop.
A secondary water source (#2) is in standby.  To
prevent a major accident, it is imperative that the
reactor core be submerged in water at all times.  Although the water should never be allowed to boil inside
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the pressure vessel, a pressure safety relief valve exists to release steam to an alternate collection location in
the event of inadvertent boiling; during normal operation, this valve is closed.  During shutdown, there is no
chain reaction, but the cooling water continues to circulate through the core to remove the heat generated by
the decay of the radioactive fission products in the fuel rods.
In the TMI incident, water from supply #1, which returns condensed steam from the steam generators,
was interrupted because the feed water pumps that pumped water from the reactor to the reactor’s steam
generators stopped.  The loss of water flow resulted in a loss of cooling of the reactor core.  The operators
immediately switched on the emergency feedwater pumps.  However, the water did not enter into the
cooling loop because the valve was accidentally left closed the previous day following a scheduled
maintenance activity (the reactor operators didn't realize this).  Emergency water injection pumps started
automatically, but an operator misinterpreted the gauge readings and reduced the flow.  The water
overheated and steam bubbles began forming.  The operators responded improperly, draining water out of
the system, exacerbating the coolant problems.  The fuel heated up and partially melted, releasing
radioactive material into the remaining coolant, which continued flowing out of the reactor through the
relief valve and onto the containment room floor (Eisenbud 1987; PSU 1999; Shapiro 1990).
The cleanup is still in progress at a cost that has already exceeded 1 billion dollars.  The high cost is not
only due to the cleanup itself, but to the research into the materials and their behavior during the accident. 
This has made the cleanup a huge research project.  However, very little radioactivity was released to the
environment.  The main contaminants reaching the environment were 133Xe and 131I, with total releases of
approximately 370 PBq (10 MCi) and 550 GBq (14.85 Ci), respectively.  The actual quantity of 131I
released was much smaller than the overconservative models of the time projected.  Subsequent research
confirmed previous scientific studies which showed that hot iodine is very reactive; during the accident,
much of the iodine plated out on the concrete and structural metal components inside the containment
dome, greatly limiting the quantity released.  The average dose to the general public within 80 km was
estimated to be 0.0015 rem (0.000015 Sv), and the highest dose was estimated to be 0.085 rem
(0.00085 Sv), mainly in the form of external gamma radiation.  In contrast, the average annual radiation
dose from natural radiation is approximately 0.3 rem (0.003 Sv), of which 0.036 rem (0.00036 Sv) is from
radioactive material naturally inside the human body (PSU 1999; UNSCEAR 1993).  No radiation effects
have been reported among the surrounding population because population exposures were small relative
to normal background radiation. Psychological effects have been documented at TMI.  One cause was the
very large 131I release estimates that were projected using models known to be overconservative, and 
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Figure 4-2.  Aerial View of the Damaged Chernobyl Reactor Facility
(adapted from http://193.125.172.36/www-klae/POLYN/history.html)
another was the emotional political response and media coverage which projected fetal health outcomes
based on those projected releases and uninformed reporting.  Public panic ensued despite the small
radiation doses.  Research in the aftermath led regulators to accept more realistic radionuclide release
models on which to base emergency response recommendations.  Lessons learned from this event include
the need to accurately project releases of radioactive material and to keep the news media accurately
informed of the situation and response actions.  The media must then make the decision to provide fair
and balanced coverage in the public interest.
4.6 CHERNOBYL, UKRAINE
In April 1986, an accident at the civilian nuclear reactor facility at Chernobyl in the former USSR,
resulted in the largest accidental release of radioactive material to date.  The RBMK-1000 reactors
utilized at Chernobyl have a design flaw that makes their operation at low power unstable.  In this mode
of operation, any increase in the production of steam can boost the rate of energy production in the
reactor.  If that extra energy generates still more steam, the result can be a runaway power surge.  While
performing an unauthorized engineering test on a generator, instabilities developed in the reactor system
which could not be controlled; the operators had deliberately disabled safety systems that could have
averted the reactor's loss of control because the safety systems might have interfered with the
performance of the test.  At 1:23 a.m, an operator pressed a button to activate the automatic protection
system, but by this time it was too late. 
Within 3 seconds, the fission rate in
the reactor dramatically increased to
hundreds of times the normal operating
level. The fuel temperature consequently
rose within seconds to beyond the melting
point of uranium dioxide (2,760 EC;
5,000 EF).  The resulting steam explosion
lifted the 90-ton covering of the reactor,
destroyed the roof, and ejected fuel debris
from the facility (Figure 4-2).  Molten
nuclear fuel and graphite from the reactor
core caused fires in and around the reactor
that burned for 10 days.  
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Figure 4-3.  Hot Spots of Radioactivity in  Regions
Surrounding the Chernobyl Facility  (BRAMA 1996) 
Efforts to quench the flames included dumping 5,000
tons of various materials (boron carbide, dolomite,
sand-clay mixture, and lead) by helicopter.   By the
time the fires were extinguished, 250 tons of graphite
had been consumed by the fires (Shapiro 1990;
Shcherbak 1996). The total release of radioactive
material from Chernobyl was estimated to be
1–2 EBq (27–54 MCi). The major radionuclides
released were 131I (630 PBq; 17.0 MCi), 134Cs
(35 PBq; 0.95 MCi), and 137Cs (70 PBq; 1.9 MCi).  A
plume containing these radionuclides moved with the
prevailing winds to the north and west, and then east
around the world, transporting the radioactive
material thousands of miles (Figure 4-3).  
The deposition on the ground varied considerably during the accident due to variations in temperature and
other  atmospheric conditions during the release.  137Cs was the main contributor to the radiation doses
received by the population once the short-lived 131I had decayed.   The three main areas of 137Cs
contamination resulting from the Chernobyl accident were identified as the Central, Bryansk-Belarus, and
Kaluga-Tula-Orel spots.  The central spot, formed during the initial, active stage of the release, had
ground depositions of 137Cs of more than 40 kBq/m2 (1.1 µCi/m2) over large areas of Northern Ukraine
and Southern Belarus.  The most highly contaminated area was the 30-km zone surrounding the reactor,
where 137Cs ground depositions exceeded 1,500 kBq/m2 (40.5 µCi/m2).  The Bryansk-Belarus spot,
centered 200 km to the north-northeast of the reactor, was formed as a result of rainfall on the region. 
The ground depositions of 137Cs in the most highly contaminated areas reached 5,000 kBq/m2
(135.1 µCi/m2) in some villages.  The Kaluga-Tula-Orel spot, approximately 500 km northeast of the
reactor in Russia, was also formed as a result of rainfall; the levels of 137Cs deposition in this area were
usually less than 600 kBq/m2  (16.2 µCi/m2).  Outside the three main hot spots there were many areas in
the European territory of the former Soviet Union contaminated with 137Cs at levels ranging from 40 to 
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200 kBq/m2 (1.1–5.4 µCi/m2).  Overall, the territory of the former Soviet Union initially contained
approximately 3,100 km2 contaminated by 137Cs at levels exceeding 1,500 kBq/m2 (40.5 µCi/m2);
7,200 km2 with levels of 600–1,500 kBq/m2 (16.2–40.5 µCi/m2); and 103,000 km2 with levels of 
40–200 kBq/m2 (1.1–5.4 µCi/m2) (NEA 1995).  The regions affected included not only the Ukraine,
Belarus, and Russia, but also Georgia, Finland, Poland, Sweden, Germany, Turkey, and other countries. 
Even such distant lands as the United States and Japan received measurable amounts of radioactive
material.  In Poland, Germany, Austria, and Hungary as well as in the Ukraine, some crops and milk were
contaminated and had to be destroyed, while others were destroyed out of panic.  In Finland, Sweden, and
Norway, carcasses of reindeer that had grazed on contaminated vegetation were destroyed (Shcherbak
1996;  UNSCEAR 1993).
A total of 237 plant workers and firefighters suffered from ARS (Shapiro 1990).  Within 3 months, the
death toll from the incident was 30 persons; all of the deceased were either plant operators or firefighters
(UNSCEAR 1993).  Approximately 15,000 persons from the plant or surrounding communities were
reported to have lost their ability to work as a result of diseases which they claimed could be attributed to
radiation exposure including: gastrointestinal (inflammatory immediately after the accident and ulcerative
in later years); immunological; metabolic (5–6 year latency period); respiratory (chronic obstructive
bronchitis); hemopoietic (increase or decrease in white blood cell numbers); and neuropathologies
(reduced mental capacity, inability to estimate one’s own abilities).  In addition, 12,000 children received
large doses to the thyroid, and 9,000 persons were exposed in utero.  An increase in thyroid cancer among
those who had been exposed as children is the only major public health effect documented and
authenticated to date.  An investigation of brain damage in utero, performed by the International
Programme on the Health Effects of the Chernobyl Accident (IPHECA), found some evidence of retarded
mental development and deviations in behavioral and emotional reactions in exposed children; however,
the extent to which radiation contributed to these problems could not be determined due to the lack of
individual dosimetry data (Bebeshko 1995; WHO 1995).  By 1992, the frequency of occurrence of
thyroid cancer had increased dramatically in the children of Belarus, but these data may be difficult to
interpret because of endemic goiter in the population. The pattern of the increases was not uniform but
was correlated with those areas in the direct path of the radioactive fallout (Kazakov et al. 1992).  Other
health-related side effects of the accident included: radiophobia, an increase in stress-related illnesses due
to both fear of radiation and to the dislocation of people; poor diets due to stringent safeguards against
potentially contaminated food, that may have led to vitamin deficiencies; the aborting of as many as
200,000 healthy fetuses because of concern that they might have been damaged in the womb by minor
radiation exposures; and an increase in alcoholism following the accident (Atomic Energy Insights 1996).
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Figure 4-4.   A View of the Sarcophagus Covering the 
Chernobyl Reactor Facility 
 (adapted from http://193.125.172.36/www-kiae/POLYN/history.html) 
About 200,000 people involved in the initial cleanup received an average whole-body dose on the order
of 10 rem (0.1 Sv).  An exclusion zone (within 30 km [18.6 mi] of the reactor) was established that
required the evacuation of 116,000 of the surrounding residents.  Fewer than 10% of these people
received doses greater than 5 rem (0.05 Sv), and the dose to more than 95% of these was less than
10 rem (0.10 Sv), but exceeded 30–40 rem (0.3–0.4 Sv) in some cases.  In contrast, the average annual
radiation dose from background radiation is approximately 0.36 rem (0.0036 Sv).  A total of 786
settlements in Belarus, the Russian Federation, and the Ukraine were declared strict control zones.  In the
settlements, food consumption was restricted as a protective measure.  The average dose during the first
year to persons in these settlements was 3.7 rem (0.037 Sv); in 2 subsequent years, average annual doses
were approximately 2.3 rem (0.023 Sv) (UNSCEAR 1993).  
The collective dose (the sum of all individual
doses) from the Chernobyl accident has been
estimated to be 600,000 man•Sv.  The majority
of this dose is expected to be received by the
population in the former USSR (40%)
and Europe (57%).  The remainder (3%) is
expected to  be dispersed over other countries
of the northern hemisphere (UNSCEAR 1993).
Direct costs of the accident, due to loss of the
facility, firefighting, and relocating citizens,
approached $7 billion (Shapiro 1990).  This
figure does not include current or predicted
future medical expenses.  The explosion left
approximately 180 metric tons of fuel exposed to the atmosphere.  In an attempt to prevent the further escape
of radiation, the Ukrainian government built a concrete covering over the entire facility, referred to as the
sarcophagus (Figure 4-4), beginning in May 1986 and completed in November of that year.  However, the
sarcophagus is not leak-tight. There is concern that rainwater and wind might enter the structure and disperse
some of the residual contamination to the environment (NEI 1995). 
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4.7 KYSHTYM
In September 1957, a major accident occurred at the Chelyabinsk-40 military plutonium production
facility near Kyshtym in the southern Ural mountains of the former Soviet Union.  The facility, built in
1953, had a number of underground steel storage tanks equipped with cooling systems to store high-level
waste so that it would not be dumped in the River Techna.  These high-level wastes overheated when the
cooling system failed.  The heat buildup resulted in evaporation of the coolant water, which allowed the
sediment to heat further and dry.  The chemicals in the tank exploded on September 29, 1957, with an
explosive power of 70–100 tons of TNT, which hurled the 2.5-m-thick concrete lid 25–30 m away.  The
radioactive cloud from the explosion reached about 1 km.  Due to calm wind conditions, about 90% of the
materials deposited locally, while 100 PBq (2.7 MCi) was dispersed away from the plant in an oblong
fallout pattern about 300 km in length,  including parts of Chelyabinsk, Sverdlovsk, and Tyumen
counties.  Almost all of the radioactive fallout occurred within the first 11 hours (UNSCEAR 1993;
Wasserman et al. 1982).  
The major contaminants released were 144Ce, 95Zr, 95Nb, and 90Sr.  Most fission products deposited on the
ground, allowing the strontium isotopes to enter the food chain.  A ban on food containing 90Sr at
concentrations greater than 2.4 Bq/g (64.8 pCi/g) resulted in the destruction of 10,000 tons of agricultural
produce in the first 2 years.  All stores in Kamensk-Uralskiy which sold milk, meat, and other foodstuffs
were closed as a precaution against consuming radioactive material, and new supplies were brought in
2 days later by train and truck.  Approximately 10,000 people were evacuated from the high-
contamination area, while approximately 260,000 people remained in less contaminated areas.  The
highest individual doses were experienced by those evacuated within a few days of the accident.  These
individuals received an average external dose of 17 rem (0.17 Sv) and an average internal
(gastrointestinal) dose of 150 rem (1.5 Sv); the average effective dose equivalent was approximately
52 rem (0.52 Sv).  The average 30-year committed dose for persons living in areas with a 90Sr surface
contamination level of 40–70 kBq/m2 (1.1–1.9 µCi/km2) was estimated to be 2 rem (0.02 Sv) (CIA 1959;
UNSCEAR 1993).
4.8 WINDSCALE, U.K.
In October 1957, the first substantially publicized release of radioactive material from a nuclear reactor
accident occurred at the Windscale nuclear weapons plant at Sellafield in the United Kingdom.  During a
routine release of stored energy from the graphite core of a carbon dioxide-cooled, graphite-moderated
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reactor, operator error allowed the fuel to overheat.  This led to uranium oxidation and a subsequent
graphite fire.  Attempts to extinguish the fire with carbon dioxide were ineffective.  In the end, water was
applied directly to the fuel channels but not before the fire had burned for 3 days, resulting in the release
of 131I (740 TBq; 20 kCi), 137Cs (22 TBq; 0.6 kCi), 210Po (8.8 TBq;  0.2 kCi), 106Ru (3 TBq; 0.08 kCi), and
133Xe (1.2 PBq; 32.4 kCi).  The fire consumed much of the uranium fuel, and some of the resulting fallout
was in the form of flake-like uranium oxide varying in size from 1 to 25 cm (Schultz 1996; UNSCEAR
1993).
The contamination of pastureland was widespread; for those in close proximity to the accident, the
greatest threat of exposure was considered to be from 131I via contaminated cow’s milk.  Those living
farther from the accident were exposed to significant amounts of 131I via milk consumption and air
inhalation.  The consumption of cow’s milk was quickly banned; this lessened the exposure to 131I.  The
highest individual doses (approximately 100 mGy) were to the thyroids of children living near the
accident site.  The collective dose equivalent received in the United Kingdom and the rest of Europe was
estimated to be 2,000 man•Sv, of which 900 man•Sv was from inhalation, 800 man•Sv was from
ingestion, and 300 man•Sv was from external exposure.  The main radionuclides contributing to the
exposures were 131I (37%), 210Po (37%), and 137Cs (15%) (UNSCEAR 1993).  There has been no detected
impact on the health of the public from this accident.
4.9 TOMSK
An incident occurred at a plant near Tomsk in the Russian federation in 1993 in which individual
exposures were low and few in number.  The Tomsk site featured one of Russia's three operating
plutonium production reactors.  The Tomsk reactors were built to produce plutonium and to supply steam
for the city's district heating plant.  Reprocessing, which involves the use of chemical processes to
separate uranium and plutonium from spent nuclear fuel, occurs at the plant.  Under certain conditions,
the chemical solutions can cause an explosion.  In April 1993, a tank containing a blend of paraffin and
tributyl phosphate chemically exploded, resulting in the involuntary release of uranium, plutonium,
niobium, zirconium and ruthenium.  The tank had a volume of 34.1 m3, and held 25 m3 of solution.  The
solution contained 8,773 kg of uranium, and about 310 kg of plutonium. The total amount of radioactivity
in the solution was approximately 20.7 TBq (559.3 Ci).  The explosion caused substantial damage to the
facility and contaminated a largely unpopulated area of about 123 km2.  The release from the tank was
estimated to be 4.3 TBq (115 Ci) of long-lived isotopes. Radioactive material spread to the north-east and 
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fallout was detected over an area of 120 km3.  Gamma radiation 20 times higher than the norm was
measured in the area that received the most fallout. The personnel who assisted in putting out the flames
received the maximum radiation dose of 2 mSv (200 mrem).   The accident could have had more serious
local consequences if the wind had carried the contamination to two large nearby cities.  In June 1993,
DOE officials visited Tomsk to investigate the accident.  Although they were not permitted to view the
chemical tank that had exploded, they did see other parts of the facility.  Several operational errors, such
as improper mixing of chemicals in the reprocessing tank, and possible design flaws, such as inadequate
tank ventilation, were identified as contributors to the accident (GAO 1995; Nilsen 1997; OTA 1994;
UNSCEAR 1993).
4.10 LOST INDUSTRIAL OR MEDICAL SOURCES
Four incidents in which sealed sources of radiation intended for industrial or medical use were lost or
damaged have occurred since 1982.  
In 1983, an obsolete teletherapy machine from a hospital in Ciudad Juarez, Mexico, containing 16.7 TBq
of  60Co was sold as scrap metal.  As a result, thousands of tons of steel products sold in Mexico and the
United States, as well as several foundries and streets and hundreds of houses, were contaminated and
approximately 1,000 people were exposed to an approximate dose of 0.025 rem (0.25 mSv).  About 80
people received doses of 0.25–3 Sv (25–300 rem), and 700 people received doses of 0.005–0.25 Sv
(0.5–25 rem) (UNSCEAR 1993).  No deaths resulted from this exposure.
In 1984, a family in Morocco found and kept within their house a sealed radiography source containing
192Ir.  The source was used to radiograph (make x-ray-like pictures) to noninvasively check the integrity
of metal welds at construction sites.  The capsule holding the source became disconnected from the
restraint system inside the source shield and fell out of the shield.  A passer-by found the source and took
it home, consequently exposing himself and his family.  The resultant effective doses were estimated to
be 800–2,500 rem (8–25 Sv); 8 members of the family died (UNSCEAR 1993).  A poorly designed
source- capsule-locking device along with personnel error on the part of the contractor led to these deaths
and injuries.  Radiography source-locking mechanisms have been redesigned to help prevent such
accidents from occurring. 
In Goiania, Brazil, in 1987, 54 people were hospitalized and 4 died after removing a teletherapy source
containing 137Cs from its enclosure.  Individual doses were estimated to range up to 500 rad (5 Gy)
(UNSCEAR 1993).  This accident is described in more detail in Section 4.2.
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In 1992, in the Shanxi province of China, three people in one family died after a member found a 60Co
source.  The U.S. Nuclear Regulatory Commission has published a safety document that describes the
acute health effects of these types of radiation accidents (USNRC 1982).
4.11 IDENTIFICATION OF DATA NEEDS
The following has been identified as a potential data need regarding health effects associated with
exposure to ionizing radiation.
A number of people have been exposed to a range of radiation doses as a result of the accidents discussed
in this chapter.  Some human data do exist on the health effects associated with acute exposure to ionizing
radiation (see Chapters 3 and 5); however, most of the radiological effects have been derived from
laboratory animal data.  It would be helpful to estimate the dose of radiation each of these individuals was
exposed to and monitor these people over the long term to determine what health effects (if any) these
doses of ionizing radiation had on lifespan, cancer rates, and reproductive effects.  There is ongoing
research in these areas, mainly the observation of the survivors of the nuclear bombings in Japan and their
children and grandchildren by the Radiation Effects Research Foundation (RERF).  The RERF is a
binational agency that is supported by the United States and Japan.
4.12 CONCLUSIONS
Although most radiation to which the public is exposed is of natural origin, that portion arising from
human activities, particularly accidental releases, is perceived by the public to be a very serious threat to
health.  For the majority of the world’s population, less than 1% of radiation exposure arises from nuclear
weapons testing fallout and the generation of electricity in nuclear, coal (many coal-fired electric
generating stations emit more radioactivity than do nuclear stations), and geothermal power plants. 
Selected military and civilian accidents have resulted in the exposure of certain populations to substantial
amounts of radiation.  Few exposures of general populations have been of sufficient size to produce
quantifiable deleterious effects.  The thyroid cancer rates (the only type of excess cancer seen to date)
associated with the Chernobyl accident have begun to rise.  After the Hiroshima and Nagasaki bombings,
there was a surge of childhood leukemia cases into the 1950s (Pierce et al. 1996).  There are also elevated
incidence rates for  some cancers in the population exposed by the Hiroshima and Nagasaki bombings. 
To date, there have been about 500 excess deaths from cancer among the survivors of the bombings.  The
circumstances and results of nuclear power plant accidents indicate that rapid mobilization of clean-up
efforts, imposed dietary restrictions, and evacuation of residents (especially pregnant women) minimizes
IONIZING RADIATION 212
4.  RADIATION ACCIDENTS
the public risk.  Three-Mile Island and Chernobyl are cases in which the evacuations caused a health
detriment and a health benefit, respectively.
4.13 OTHER SOURCES OF INFORMATION
This chapter provided a brief synopsis of population exposures to ionizing radiation.  Readers are
encouraged to read Chapters 2 through 6 of this toxicological profile for more in-depth information on the
basic principles of ionizing radiation, the health effects of ionizing radiation, and the sources of
population exposure to ionizing radiation.  Further scientific information can be obtained from the United
Nations specialized agencies, such as the World Health Organization (WHO), Geneva, Switzerland, and
the International Atomic Energy Agency (IAEA), Vienna, Austria.  Readers are also referred to the
Internet sites listed in Table 4-1 for further information on the general principles and health effect issues
involving the different types and doses of ionizing radiation.  These sites are sponsored by scientific,
government, and academic organizations.
Table 4-1.  Internet Sites Pertaining to Population 
Exposures to Ionizing Radiation
HyperText Transfer Protocol (HTTP) Address Web Page Contents 
http://www.hps.org The Health Physics Society, a scientific organization
dealing with radiation safety
http://www.rerf.or.jp Atomic bomb survivor studies provide by Radiation
Effects Research Foundation, a joint Japanese-U.S.
sponsored research organization
http://www.sandia.gov/LabNews/LN01-19-96/palo.html A newspaper for the employees of Sandia National
Laboratories and recounts the Palomares incident
http://fema.gov/home/fema/radiolo.htm Federal Emergency Management Agency information
on how to prepare for an emergency and what to do if
an accident occurs
http://www.radres.org/intro.htm The Radiation Research Society
http://www.afrri.usuhs.mil/www/index.html The Armed Forces Radiobiology Research Institute
http://cedr.lbl.gov Comprehensive epidemiologic data resource related
to radiological releases from sites
http://radefx.bcm.tmc.edu/ Radiation Health Effects Research Resource page. 
A comprehensive page on radiation and health
effects, including extensive literature searches on
Chernobyl health effects
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  5.  MECHANISMS OF BIOLOGICAL EFFECTS
5.1 INTRODUCTION
Radiation ionizes cellular atoms and molecules; if immediate recombination does not occur, these can
manifest as some type of molecular, cellular, or organic system alteration.  An ionizing event can cause a
variety of damage scenarios: (1) no damage if the ionized molecule reforms immediately; (2) repairable
damage that causes no clinical effects if repaired; (3) repairable damage to DNA, which can be
tumoriginic or carcinogenic if not repaired prior to cell division; (4) irreparable small-scale damage which
causes cell death to a small population of cells that is insignificant and produces no clinical effects; and
(5) irreparable large-scale damage that kills enough cells within an organ system to produce deterministic
threshold effects such as cataracts and acute radiation syndrome
A very large radiation dose received in a short enough period of time to preclude significant repair can
cause cellular walls to collapse and disrupt organ systems, producing deterministic effects such as acute
radiation syndrome, cataracts, and teratogenesis (mental retardation, IQ reduction, microencephaly,
stunted growth).  These effects can be caused by acute exposure to sources of high intensity radiation,
such as can be found in hospitals, government, and industry.  Overexposure events which have caused
such effects are not applicable to NPL site residual radioactive contamination.  The discussion below
largely relates to lower radiation doses and dose rates which can cause non-deterministic effects and
which are more relatable to radiation exposure from NPL sites.
A number of direct and indirect radiation interaction pathways can produce damage to the DNA of
irradiated cells.  DNA damage occurs by indirect action (mediated through radiolytic products in water)
or direct ionization.  Cells depend on their DNA for coding information to make various classes of
proteins that include enzymes, certain hormones, transport proteins, and structural proteins that support
life.  When the genetic information containing the “blueprint” for these substances is disrupted, cell
homeostasis is disrupted, resulting in a wide-range of immediate and/or delayed toxicological effects. 
Direct and indirect ionization of DNA is ultimately responsible for the DNA alterations that adversely
affect the structural and genetic integrity of the system.  These alterations can be repaired, or can result in
mutations in the genetic coding that can be passed on to daughter somatic cells or to progeny offspring
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from reproductive cells.  These alterations can result in the wide range of somatic and reproductive effects
described in greater detail in Chapter 3.
The human body has nearly 1013 cells.  Each somatic cell (cells other than sperm and eggs) contains
23 pairs of chromosomes.  Each cell (except for red blood cells) contains a nucleus that houses these
chromosomes.  The total chromosomal content of a cell involves approximately 105 genes in a specialized
macromolecule of deoxyribonucleic acid (DNA).  DNA is composed of alternating sugar and phosphate
groups, with the sugar attached to 1 of 4 possible nucleotide bases (adenosine, cytosine, guanine,
thymidine).  These bases attach to each other in a specific pattern: adenosine:thymidine and
cytosine:guanine.  Genetic sequences of the bases are read in groups of three (called a triplet), with a
possibility of 64 configurations or “words” in which to code information.  
Specialized cell structures called  ribosomes are the cellular organelles that actually synthesize the
proteins (RNA transcription).  RNA polymerases read the codes from specific areas of the DNA and
transcribe the information into a mRNA copy of the DNA.  At the ribosome, the processed mRNA is
translated to produce proteins from amino acid units.  When the genetic information containing the
“blueprint” for these substances is disrupted, cell homeostasis is disrupted, with a wide range of possible
non-carcinogenic and carcinogenic toxicological effects.  These effects were described in some detail in
Chapter 3.  Radiation can disrupt the structure of the DNA (and other macromolecules), thereby
disrupting normal cell and organ functions.  
Direct macromolecule damage by radiation involves partial or complete energy transfer to one or more
electrons on the molecule.  Each electron that is given enough energy to overcome the attractive forces of
the nucleus escapes from the DNA or other macromolecule and leaves it in the form of a charged ion; this
process, called “ionization,” is the source of the term “ionizing radiation” (see Chapter 2).  Unlike non-
ionizing radiation (such as microwaves and ultraviolet radiation), which has insufficient energy to eject
molecular electrons, ionizing radiation deposits sufficient energy to remove electrons from atomic orbits
and create molecular ion pairs along particle tracks.
Ionizing radiation can exert a number of adverse toxicological effects on many tissues in the body by
ionizing and subsequently altering the DNA in the nucleus and other macromolecules of the irradiated 
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cell and possibly even the cytoplasm itself.  This radiological toxicity occurs independently of, and in
addition to, whatever chemical toxicological effects are produced by internally deposited radionuclides. 
Chapter 3 describes in some detail the biological effects of radiation in different organ systems in humans
and laboratory animals and demonstrates that some systems or tissues are more sensitive to the effects of
radiation than others.  Chapter 3 also provides some general explanation for the presence of marked
toxicity differences.  DNA damage and cell wall destruction are the likely bases for lethality due to
radiation; however, other molecules and cellular organelles may be damaged by radiation.  These other
molecular alterations may also result in adverse cellular activity and may be responsible for some of the
biological responses observed after exposure to radiation.  This chapter is an overview of the specific
mechanisms that result in the non-carcinogenic and carcinogenic biological effects.
5.2 EVIDENCE OF THE EFFECTS ON DNA
 
Before any mechanism of action of ionizing radiation on DNA can be presented, it is necessary to
demonstrate that DNA is indeed the critical molecule after exposure to radiation.  Indirect evidence comes
from studies which show that cells that divide frequently (undergo mitosis or meiosis in the case of
spermatogonia) are the most sensitive to the effects of radiation.  This phenomenon is described in
Table 5-1.  Conversely, structures that undergo less frequent mitotic cycles (myocytes, connective tissue,
nervous tissue) are relatively more resistant to the effects of radiation.  Early experiments, in which either
the cytoplasm of the cell (not the nuclear material) or the nucleus only were irradiated with alpha
radiation, demonstrated that the DNA is the most critical cellular component in radiation toxicology
(Munro 1970).  Those experiments showed that, although some minor effects could be induced after
exposing the cytoplasm to alpha radiation, the nucleus (and the genome) were many times more sensitive
to the effects of ionizing radiation.  Recently developed research techniques, which allow precise
irradiation of individual cell components with a predetermined number of alpha particles, have also
concluded that cellular cytoplasm is less radiosensitive than DNA (Miller et al. 1999; Wu et al. 1999). 
These alterations are what ultimately gives rise to lethal or phenotypic genetic alterations of the DNA and
may lead to the induction of many types of cancers in the irradiated individual (see Chapter 3 of this
profile).
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Table 5-1.  Relative Sensitivities of Major Organs and Tissues to the 
Effects of Ionizing Radiation
Radiosensitivity category Organ system General cell type affected Frequency of mitosis
High Lymphoreticular Lymphocytes Very frequent
Hematological Immature hematopoietic cells
Reproductive Spermatogonia
Ovarian follicular cells
Gastrointestinal Intestinal epithelium
Esophageal epithelium Frequent
Gastric mucosa
Renal Urinary bladder epithelium
Dermal Epidermal epithelial cells
Mucous membranes
Ocular Epithelium of optic lens
Medium  Circulatory system Endothelium
Musculoskeletal Growing bone and
cartilaginous tissues
Moderately frequently
Brain/CNS Glial cells
Dermal Glandular epithelium of the
breast
Respiratory Pulmonary epithelium,
tracheobronchial epithelium
Renal Renal epithelium
Hepatic Hepatic epithelium
Endocrine Pancreatic epithelium
Thyroid epithelium
Adrenal epithelium
Low Hematological Mature hematopoietic cells
(erythrocytes, neutrophils,
eosinophils, basophils,
macrophages)
Infrequently/rarely
Musculoskeletal Myocytes, osteocytes
Mature connective tissues
Mature bone and cartilage
Brain and peripheral
nervous system
Ganglion cells
Other evidence exists to support the thesis that radiation's toxicological effects are intimately related to
nuclear DNA damage.  For example, when non-radioactive thymidine is incorporated into the DNA of a
cell, no change in the cell's lifespan is encountered; however, when the same thymidine is labeled with
radioactive tritium (3H), which emits short-range beta particles (see Chapter 2), cell lethality dramatically
increases.  Coupled with the other indirect evidence, this suggests that the low-energy beta particles are 
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ionizing the nuclear DNA, resulting in increased incidences of cellular death.  Additionally, work
involving radioactive material in viruses and plants has shown a strong correlation between the
chromosome volume of a cell with radiosensitivity—the larger the volume of chromosomal material, the
greater the relative radiosensitivity of the cell.  Radiosensitivity is relative to a specific biological end
point.  For instance, sperm have a high radiosensitivity with respect to mutation induction but a very low
sensitivity with respect to cell killing.  A direct correlation has been demonstrated between aberrant
chromosome formation at the first cell division after irradiating hamster cells.  These and many other
studies provide strong evidence that exposure to radiation has detrimental effects on cellular DNA (Hall
1988).  
5.3 INTERACTIONS OF IONIZING RADIATION WITH DNA
Chapter 2 provides an overview of the types of radiation and their ability to transfer energy when ionizing
biological matrices. The interaction of radiation with all molecules (including DNA and other cellular
components) may be classified as either direct or indirect interactions.  Each produces damage by a
specific pathway (or mechanism) that is described in more detail in this section. 
Depending on the energy of alpha and beta particles when they are formed, the initial velocity of an alpha
particle can be a few tenths the speed of light and that of a beta particle can approach the speed of light;
however, these velocities reduce toward zero as they interact with the medium through which they pass,
losing energy as they excite and ionize molecules along their paths.  Since gamma rays are
electomagnetic radiation, they travel at the speed of light even as their energy is transferred to the
medium.  As described above, a direct interaction occurs when an alpha particle, beta particle, or gamma
ray hits and ionizes an atom or molecule. Both high and low LET radiation can directly ionize a molecule
at the point of impact, producing two adjacent pieces which are chemically reactive.  If the two pieces
immediately recombine to reproduce the same original molecule, no damage results. Alternately, the
pieces may drift apart, engaging neighboring atoms and molecules in any stabilizing chemical reactions
that are thermodynamically feasible.  Each chemical reaction produces a different molecular species. In
the case of high LET radiation or high intensities of low LET radiation, the distance between ionizing
events is short enough that the radiation can ionize adjacent molecules or even multiple bonds on the
same molecule. For a large macromolecule such as DNA with its multistrand arrangement in
chromosomes, these actions can damage the molecular structure in a number of ways.  Radiation can
remove large or small pieces of the molecules, and can open purine rings (leading to depurination) and
break phosphodiester bonds.  This action may result in the genetic effects listed in Tables 3-4 and 3-5. 
IONIZING RADIATION 218
5.  MECHANISMS OF BIOLOGICAL EFFECTS
Genotoxic effects are a major toxicological end point for exposure to ionizing radiation and are likely
involved in the induction of cancer in humans.  The data from Tables 3-4 and 3-5 demonstrate that the
typical genotoxic effects associated with radiation exposure of genetic material primarily consist of
deletions, mutations, chromosomal aberrations, and breaks, resulting in reciprocal translocations, sister
chromatid exchanges, dominant lethal mutations, and sperm anomalies.  When the cell enters a mitotic
cycle, these damaged chromosomal units have an increased probability of failing to replicate properly due
to structural damage unless chromosomal repair mechanisms repair the damage prior to entering mitosis. 
If the repair mechanisms fail to perfectly and seamlessly repair the damage to the chromosome, restoring
it to its original preionized structure, or do not repair the damage at all, the chromosome may not replicate
properly.  This results in critical portions of that chromosome being deleted during the replication cycle,
resulting in cell death (which equates to no damage at low doses) or genetic mutations in cell progeny. 
Table 5-1 shows that those cells that undergo rapid mitotic cycles (intestinal crypt cells, fetal cells, and
other rapidly dividing cells) have less time for repair mechanisms to reverse the radiation damage to the
nuclear DNA, making chromosomal anomalies more likely to be present during subsequent mitotic cycles
and increasing the chances for cell death, genetic mutations, and abnormal cell functions in cell progeny. 
Ionizing radiation can affect other macromolecules in a similar fashion; these effects are discussed in
Section 5.4.
Indirect interactions are molecular disruptions occurring at distances from the radiation’s direct
interaction site.  Indirect interactions are mediated by radiation-produced chemical species (free radicals
and  oxidizers) with sufficient life-times and reactivity to diffuse away from the primary site and disrupt
molecules with which they collide.  Some of the radiation degradation (radiolysis) products of water,
including the hydrogen and hydroxyl radicals produced by the reactions below, are recognized cytotoxins,
and oxygen enhances these effects.  Thus, oxygenated tissue is more radiosensitive than anoxic tissue. 
Water comprises approximately 60% of the total body mass of humans and laboratory animals, and
75–80% of the chemical composition of the living cell.  When radiation interacts with water molecules
surrounding DNA, the end products diffuse away and react with any DNA that is in their paths. 
Biological material that has a low water content, such as spores, exhibits a greater resistance to radiation
effects.
Radiolysis of water
H2O + IR v e– + H2O+ 
e– + H2O v H2O– vOH– + H• 
H2O+ v H+ + OH•
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In  the first reaction, radiation interacts with free cellular water to produce one free electron (e–) and one
ionized water molecule (H2O+), a reaction commonly known as radiolysis.  This free electron is highly
reactive and interacts with another un-ionized water molecule to produce a negatively charged and highly
unstable water molecule.  This molecule quickly decomposes to form the OH– ion and the H• free radical;
the H• radical is reactive, but the OH– ion is more stable and can then diffuse out into the cellular fluid and
interact with any number of macromolecules it encounters in its path, such as molecules of DNA.  The
remaining H2O+ molecule can also transform into a free and ionized hydrogen ion (potentially affecting
intracellular or extracellular pH) and the hydroxyl radical.  From these reactions, four products of
radiolysis can occur after ionizing radiation interacts with a water molecule:  H•, OH•, H+, and OH–.
Of the radiolysis products, 55% are either H• or OH– and are the most important species biologically;
however, they have lifetimes of approximately 10–11 seconds, which is long enough to produce damage to
DNA and other macromolecules.  These ionized particles will react with DNA, resulting in the addition of
atoms or loss of atoms or pieces of the molecule; this will ultimately result in structural degradation,
cross-linking, breakage of chemical bonds, and a host of other adverse effects.  H• or OH– may also
interact with each other, to form an innocuous water molecule.
In the presence of water and oxygen, radiation can produce another set of reactions that have more
potentially destructive capabilities within the cell.  The radiolysis reaction, in the presence of molecular
oxygen, results in the formation of three chemical entities: hydrogen peroxide (H2O2), hydroperoxy
radicals (HO2•), and hydroperoxy ions (HO2–).  All have potent oxidizing potential and lifetimes of
approximately 10–11 seconds.  With an extended lifetime (when compared to the 10–11 second half-lives of
H•, OH•, H+, and OH–), there is a greater diffusion length and potential for interacting with and inducing
more damage to the DNA.  Oxygen is, therefore, considered a radiosensitizing agent, associated with the
production of relatively longer-lived and more potent by-products than in tissues containing less oxygen. 
The oxygen-water-ionizing radiation interactions have practical applications in clinical medicine. 
Radiotherapy is often used to treat large cancerous tumors in humans.  Oxygen tension is lowest at the
center of these large cancers, due to an inadequate blood supply to the cancer, compression from
surrounding cells, or altered aerobic metabolism in these cancerous cells.  Many of these masses may
have liquified and necrotic centers as well.  Low oxygen tension in these cancers may not result in the
production of significant amounts of hydrogen peroxide and hydroperoxy ions/radicals to damage
macromolecules within these abnormal cells and, therefore, may limit the efficacy of radiotherapy in
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these patients. The use of oxygenating chemicals to offset this oxygen deficit and enhance the oxygen
tension can make cancer tissue more radiosensitive than the surrounding healthy tissue.
Radiation frequently produces an important type of change to DNA at the molecular level by removing a
base to form an apurinic or apyrimidinic site. The deletion or total destruction of DNA bases, destruction
of deoxyribose residues, and deamination of cytosine or adenine are a few of the many ways radiation can
alter the DNA at a molecular level.  The attack by direct and indirect radiation action results in the
degradation of bases and sugars, breakage of the hydrogen and sugar-phosphate bonds, and cross-
linkages, all of which are deleterious to the structural integrity of the DNA macromolecule.  Significant
amounts of damage make the DNA unable to successfully replicate during mitosis and/or unusable for
transcription into RNA.  The magnitude of the damage is dose-dependant.  A more in-depth discussion of
the alterations at the DNA level by radiation, including a few of the known DNA repair mechanisms, is
presented in BEIR V (1990). 
DNA base damage is the most predominant type of DNA damage, followed (in decreasing order of
incidence) by single-strand breaks, DNA-protein cross-linkages, and double-strand breaks.  In base
damage, thymidine appears to be the most radiosensitive base, followed by cytosine, adenine, and
guanine.  A 100-rad (1 Gy) dose of low LET radiation can produce 63–70 double-strand breaks per cell
and 1,000 single-strand breaks (Cockerham et al. 1994).  In addition, it was noted that there were 440
sites of multiple DNA strand lesions that are in close proximity to each other that interact in such a way to
cause cell death (called Locally Multiple Damaged Sites [LMDS]).  It would appear that simple single- or
double-strand breakage is responsible for cell death; however, in cases of genotoxicity after chemical
exposure, single-strand breakages have numbered into the hundreds of thousands, suggesting that the
relatively low number of single-strand breaks after exposure to radiation is not likely to be the primary
cause of cell toxicity, probably because of the presence of repair systems.  Double-strand breaks are likely
too few to be of consequence for cell death, but they are critically important in cancer initiation.  Given
that there are only three types of damage to the DNA that could be responsible for cell death, this leaves
LMDS as the primary cause for cell death (Faw and Shultis 1993).  
Strand breakage is also responsible for chromosomal anomalies, some of which were listed  in Tables 3-4
and 3-5.  DNA strand damage is a serious cellular event; however, the cell comes equipped with chromo-
somal repair mechanisms.  Without them, the damage that occurs to the entire organisms's DNA every
day could prove lethal.  Chromosomal repair mechanisms provide a mechanism for minimizing the 
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adverse DNA effects of radiation on the genome, providing that the dose is not so large as to overwhelm
the inherent repair mechanisms.  However, like many other biological functions, they are not always
100% efficient at performing this task.  Single-strand breaks stand a better chance for repair by the
cellular DNA repair enzymes (DNA ligase) than do double-strand breaks.  First, with single-strand
breaks, only one strand of the double-stranded DNA is broken, whereas both strands are broken with
double-strand DNA damage.  Because one strand is still intact, single-strand breaks are usually stable and
within a reasonable distance from each other for repair enzymes to function; however, this is not always
the case with double-strand DNA breaks.  Secondly, there is a template on the adjacent strand in single-
strand DNA breaks to determine where various bases go on the missing strand. The ionizing event that
produces a double-strand break may leave the displaced sections close enough together to rejoin with
minimal repair, or it may displace large sections, leaving no template for repair enzymes to follow in
order to replace the missing segments.  Because single-strand breaks in DNA are more easily repaired,
cells can tolerate much more of this type of strand breakage before the repair mechanisms are
overwhelmed.
Chromosomal aberrations and chromatid aberrations are the two most common types of chromosomal
anomalies that can be visibly observed during the metaphase or anaphase stages of the cycle.  Chromo-
somal aberrations are a result of a cell that was irradiated early in the interphase cell cycle (G1 or early S
phase), prior to the chromosome being duplicated.  Chromatid aberrations are commonly observed when
the damage was received in the later stages of interphase (late S or G2 phase) after the chromosome has
duplicated and consists of two strands of chromatin.  Specific radiation-induced aberrations in
chromosome and chromatid structure have been discussed in more depth by Hall (1988).  These
aberrations may or may not result in the disruption of normal cellular functions, depending on which
chromosome the breakage occurred in and where on the chromosome the damage occurred.  When
examined more closely, the broken ends of the chromosomes appear "sticky" and  may fail to mitotically
separate with the proper chromatid (Hall 1988).  However, when the cell enters a mitotic cycle, these
damaged chromosomal units will ultimately fail to replicate properly unless chromosomal repair
mechanisms can repair the damage prior to entering mitosis/meiosis.  If the repair mechanisms fail, cell
death or genetically deficient progeny cells result.  Of the single and multiple gene mutations that result,
point mutations and small deletions usually involve a small number of bases (~20 to 60), whereas large
base deletions or base rearrangements may involve several hundred or many thousands of bases.  The 
mutation frequency increases with the radiation dose (Borek 1993).  The cells that undergo more frequent
mitotic cycles (intestinal crypt cells, fetal cells, and other rapidly dividing cells) have less repair time, and
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a resulting increase in sensitivity to radiation induces genetic mutations and abnormal cell functionality.
Cells with less frequent mitotic activity (nerve, lens, musculoskeletal) are conversely less radiosensitive. 
The types of genetic damage described above for radiation exposure are also caused by other
environmental agents, and their rates are in addition to a high rate of spontaneous production. An average
of 200,000 repairs per hour are made to spontaneously occurring damage to DNA in humans. Actually,
the damage occurs at a much greater rate than can be observed because the damage is simultaneously
being repaired by many physiological mechanisms.  Damage is expressed when the rate at which the
damage is produced exceeds the body’s natural repair mechanisms or when those mechanisms fail. 
5.4 EFFECTS ON OTHER CELLULAR MACROMOLECULES
DNA is the most critical molecule for damage from radiation.  A number of other critical cellular
components have been reported; some effects on these molecules are outlined in Table 5-2.
Table 5-2 shows that a wide range of molecules, varying in both size and molecular weight, can be
adversely affected by exposure to radiation.  The mechanisms by which each is affected are the direct and
indirect effects of radiation discussed for DNA.  The end results are broken chemical bonds, cross-
linkages, and conformational changes.  These changes may affect the molecule’s biological function; for
example, a conformation change in the structure of an enzyme or protein could affect its ability to
perform a critical function in a metabolic pathway and thereby halt a certain function.
Amino acids and their larger counterparts, peptides, polypeptides, and proteins, are also susceptible to
radiation damage.  Irradiation of these molecules frequently results in breakage of hydrogen bonds,
disulfide bridges, and cross-linking with DNA or with other proteins.  All of these effects can result in
conformation changes and alterations in function.  Radiation causes the depolymerization of glycogen and
cleavage of α-glycosidic bonds within glycogen and other molecules containing α-glycosidic bonds. 
Glycogenesis and gluconeogenesis pathways within the cell are activated; insulin and blood glucose
levels also rise due to increased release of insulin and adrenocorticoid release.  By comparison, radiation
doses that are orders of magnitude larger than required to produce these effects are used in industry to
polymerize monomers to produce hard plastics and bond materials.  Even larger doses are required to
inactivate bacteria and viruses during sterilization of medical equipment, spices, vegetables, and meat.
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Table 5-2.  Some Effects of Ionizing Radiation on Molecules in Animal Tissues
Molecule General effects
Amino acids Production of ammonia, H2S, pyruvic acid, CO2, hydrogen molecules
Carbohydrates Cleavage of glycosidic bonds, depolymerization of monomers, oxidation of
terminal alcohols to aldehydes
Deoxyribonucleic acid (DNA) Degradation from base loss and modification, breakage of hydrogen bonds
and sugar-phosphate bonds; DNA-DNA and/or DNA-protein cross-linking;
single- or double-strand breakage; formation of guanyl, thymidyl and sugar
radicals 
Lipids Peroxidation and carbon bond rearrangement: conjugated diene formation,
aldehyde formation, β-scission, lipid cross-linking, increased microviscosity,
cell membrane rupture 
Proteins Degradation and modification of amino acids, chain scission, cross-linkage;
denaturation, molecular weight modifications, changes in solubility 
Thiols Redox reactions, radical formation, cross-linkages, inhibit thiol from
mediating damage to lipids 
Source: adapted from Cockerham et al. 1994.
Lipids are ubiquitous macromolecules that participate in a number of cell process.  They comprise cell
membranes, disruption of which leads to disruptions of homeostasis, cellular dysfunction, and death. 
Lipids are also involved in the production of prostaglandins, which modulate a number of biological
functions, including digestion, reproduction, and neural function.  Lipid peroxidation occurs primarily
through free-radical attacks at double-bond sites and at carbonyl groups, and starts a chain reaction within
cells.  When a lipid radical interacts with another organic molecule, that molecule is transformed to a free-
radical state which then interacts with another molecule.  Given this chain of events, the damage induced
after lipid peroxidation can be formidable.  Fortunately, animals have several mechanisms by which to
slow or stop this chain reaction.  A number of free-radical scavengers such as vitamin A, vitamin E, and
thiols are available to inhibit the chain reactions.  Other detoxification systems that can inhibit the effects
of lipid peroxidation include metallothionine, glutathione transferase, reduced NADPH-dependent
glutathione reductase, selenium-dependant glutathione peroxidase, ferric manganese and copper-zinc
superoxidase dismutases, and catalase.  A more in-depth discussion on the specific mechanisms by which
each system functions is available (Cockerham et al. 1994).  Several of these systems and a number of
chemicals have been more closely studied in order to potentially decrease the harmful effects of moderate
to high doses of radiation in humans and animals, but results have been mixed (Biambarresi and Walter
1989).
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5.5 MECHANISMS OF CARCINOGENESIS
The exact mechanism(s) by which cancer is produced are not clearly understood, but over the years,
several theories and models have been developed that describe the events that scientists suggest must take
place in order for cancer to occur.  Some of the more traditional carcinogenesis models are briefly
summarized in Table 5-3.  A number of factors have been identified (such as diet; hormonal status;
genetics; and exposure to some solvents, chemicals, and ionizing radiation) that appear to predispose
some individuals to developing cancer.  Both chemicals and ionizing radiation are known to induce many
types of cancer and much of the evidence for this observation was discussed in Chapter 3 of this profile. 
Cancer is the major latent effect after exposure to radiation, with the critical molecule being the DNA. 
Cells depend on their DNA for coding information to make very specific enzymes, proteins, hormones,
vasoactive substances, and a host of other chemicals in order to live.  When the genetic information
containing the “blueprint” for these substances is disrupted, cell homeostasis is disrupted, with a wide
range of carcinogenic and non-carcinogenic toxicological effects that have been described in Chapter 3.
Not all alterations in the genome will result in the expression of immediate adverse events.  Radiation
may cause genetic damage, which includes gene deletions, point mutations, frameshift mutations, and
“nonsense” coding of some genes on one or many chromosomes.  These alterations occur by the same
direct and/or indirect mechanisms outlined in Section 5.3.  If these genes are not used by the cell or if
their mutation or total absence is of little consequence to normal cell function, no immediate effects may
be incurred.  Cell function and homeostasis is not disrupted.  These seemingly inconsequential genetic
effects may initially be of minimal importance.  However, with spontaneous changes in the genetic
apparatus of somatic cells continuing over time and with further exposure to environmental carcinogens,
the amount of misinformation in the genetic apparatus continues to increase within the cell’s DNA.  If this
misinformation affects the DNA coding that either controls or suppresses an oncogene, then oncogenic
lesions may be initiated.
The formation of cancer has been an area of intense research in the scientific community for centuries.  In
1775, Percival Pott was the first to report that cancer could be caused by environmental factors.  Pott
described a number of cases of cancer in men employed as chimney sweeps sometime during their life. 
Pott concluded from his observations that their exposure to soot was in some way related to their
developing 
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Table 5-3.  Some Models That Describe the Induction of Cancer in Animals
Model Model type and premise Model characteristics
Single Hit a Mechanistic model:  One “hit” is
sufficient for a cell to mutate and then
transform into a neoplastic cell.
Tumor development depends only on the total dose
received and not on the pattern of exposure; yields high
estimations of risk compared to other models
Multi-Hit Mechanistic model:  A critical number
of hits must occur before the cell
becomes neoplastic.
May produce very high or very low “safe-dose” estimates;
doesn’t easily account for dose-response relationships that
are linear at low doses; begins to curve as dose increases
Multistage/
Linearized
Multistage
(LMS)
Mechanistic model (based on the
model of Armitage and Doll 1957): A
progression of orderly events must
occur in a cell in order for cancer to
occur.
Use of upper bounds results in a model less sensitive to
changes in data; multi-degree polynomials are fitted using
only 2 or 3 dose levels; a constant dose rate is assumed
(which is not always the case); does provide conservative
risk estimates
MVK Mechanistic model; Two-stage
model:  Similar to the LMS, but it
assumes that altered cells have a
selective advantage over normal
cells.
Assumes tumors come from mutations of anti-oncogenes;
assumes 2 events must occur for malignant
transformation;
allows for cell kinetic information and mutations to be
incorporated into the model
Probit Statistical model Estimates probability of a response at a given dose; may
not reflect scientific observations of dose-response when
extrapolating from a 50% response dose to a 1/1,000,000
risk estimate
Logit Statistical model Derived from chemical kinetic data; used to derive “virtually
safe doses” by some government agencies until the late
1970's; similar to Probit model
Weibull Statistical model Used to derive “virtually safe doses” by some government
agencies until the late 1970s; uses power transformations
to describe the data; greater flexibility than either the Probit
or Logit models; risk estimates range between the LMS
and multihit mechanistic models; dose and time
relationship are described
a A “hit” is defined as a critical cellular interaction, such as a gene mutation, that alters the cell’s DNA (Faustman and
Omenn 1996).
Source: summarized from Faustman and Omenn 1996 and Rees and Hattis 1994
cancer of the scrotum.  Since that time, a number of chemical, environmental, and lifestyle factors have
been identified as either be directly or indirectly implicated in producing different types of cancer.  Many
of these chemicals have similar physico-chemical and structural characteristics.
Today, the induction of cancer from exposure to some chemicals is believed to be a multi-stage process
that involves at least three distinct phases and multiple steps.  Some chemicals or agents may be capable
of inciting one, two, or all three of these steps.  It is believed that exposure to ionizing radiation involves
the same multi-step process as does the chemical carcinogen exposure, and that radiation can induce each
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step.  The first stage is initiation, which is characterized by the fixation of a somatic mutational event in
the cell’s DNA.  This damage may occur by direct, indirect, or a combination of the events described in
Sections 5.2 and 5.3.  This initiation may occur at one or multiple sites within the genome and may affect
any gene on any chromosome in any exposed cell.  Once exposed, certain outcomes are possible.  In cases
of high doses of radiation, the cell may sustain such extensive genetic damage that the cell is unable to
perform its functions or sustain itself metabolically, in which case it simply dies.  High doses may kill so
many cells that the organism shows  signs and symptoms, but lower doses can kill few enough cells that
effects are not readily observed.  The cell may attempt to repair the damage using alkyltransferases, base
excision repair, nucleotide excision repair, mismatch repair, or other innate repair mechanisms inherent to
that cell.  If all of the damage is repaired correctly, the cell is considered normal and not at risk for
developing cancer.  However, repair mechanisms are not always 100% effective and may result in
incorrect repair or no repair at all.  In this case, the cell may either live and tolerate the damage to the
genetic material or undergo apoptosis (programmed cell death).  Only the cells that continue to live and
reproduce can potentially produce cancer.  Exposure to ionizing radiation can result in changes to a cell’s
genetic apparatus and can act as an initiating agent in the development of cancer.  Additional information
about the ability of radiation to inflict damage on the DNA structure is presented in Chapters 2, 3, and
earlier in this chapter.  
Initiation requires at least a partial failure of gene repair mechanisms and one or more cell mitotic cycles
before the genetic alteration can be “fixed” into place.  Initiation is an irreversible process once this
fixation occurs.  Whatever the mechanism, the end product is a mutation of the cell’s DNA that the cell’s
innate repair systems failed to restore to the normal genetic state.  This mutation is considered an adverse
event; however, the initiation or “genetic recoding” alone is not sufficient to produce cancer.
The initiation step must be followed by the second stage, promotion.  A promoting agent is one which
stimulates the initiated (or pre-neoplastic) cell to divide or otherwise provides certain conditions that
allow the preferential selection of mutated cells to survive over unmutated cells in the tissue.  In contrast
to initiation, the promotion step is a reversible step both at the DNA and cellular level, and depends on
continuous exposure to the promoting agent.  This reversibility is a  characteristic of the promotion stage
of carcinogenesis.  For promoting agents, there is no evidence to suggest that these chemicals or other
factors must interact directly with the DNA to affect cell proliferation.  Promoters need not necessarily be
carcinogenic agents themselves.  Many chemicals (phenobarbital, dioxins, cholic acid), as well as some
hormones (estrogen and thyroid-stimulating hormone) are not carcinogenic themselves, but have been 
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found to promote carcinogenesis after certain cells have undergone the initiation process in some species
of animals.  Promoting agents may also be species specific.  A promoting agent for cancer in laboratory
animals may not necessarily be a promoting agent in humans.  Although some promoters are actually
non-carcinogenic when administered by themselves, other promoters can act as both initiators and
promoting agents.  Radiation is an excellent example of an agent that can act as both an initiator
(producing gene mutations and chromosomal alterations) and as a promoting agent by stimulating cell
division after exposure.
The last stage of carcinogenesis is called progression.  Progression agents cause uncontrolled and
extensive proliferation of abnormal cell types.  During this stage, a specific phenotype of mutated cells is
selected that effectively evades the host defense mechanisms and then undergoes massive proliferation. 
Arsenic salts, asbestos fibers, benzene, benzoyl peroxide, and hydroxyurea have all been identified as
proliferation agents associated with cancer formation.  This uncontrolled and extensive proliferation of
abnormal cell types leads to the formation of solid tumors (adenomas, squamous cell carcinoma,
adenocarcinomas, etc.) or non-solid tumors (leukemia, lymphoma, etc.) at one or multiple locations
throughout the body.  How locally invasive the tumor is (aggressiveness) or the ability of the tumor to
relocate to sites distant from the site of initial formation (metastasis) depends on the type of tumor
formed.  If the  progression becomes widespread throughout the body or causes severe harm to vital organ
functions, the organism will eventually succumb to organ failure and die.  Radiation is capable of acting
as a proliferation agent in the formation of cancer in the skin of mice.
Gene mutation is a key step in the formation of cancer.  Any gene or any locus on the DNA can be
affected by a genotoxic agent and undergo.  Certain gene mutations and chromosomal irregularities are
associated with specific cancers in humans and laboratory animals.  These genes are called proto-
oncogenes, oncogenes, and tumor suppressor genes.  Proto-oncogenes are similar to viral oncogenes. 
Proto-oncogenes are considered normal genes.  When mutated, proto-oncogenes become oncogenes,
which, in turn, initiate carcinogenesis.  Both proto-oncogenes and oncogenes are dominant genes that
normally function to regulate cell growth, signal transduction, and nuclear transcription (Pitot III and
Dragan 1996).  Mutations in these genes result in the activation and subsequent neoplastic transformation
of cells containing these mutated genes.  Conversely, tumor suppressor genes are recessive genes which
normally function to slow cell growth.  When these genes mutate, cells lose this capacity to down-
regulate cell growth, which results in the activation and subsequent neoplastic transformation of the
mutated cells.  Radiation may cause mutations in proto-oncogenes, oncogenes, and tumor suppressor
genes.
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Environmental factors have also been shown to play a role in lung carcinogenesis, particularly in the
promotion stage.  These environmental factors include tobacco, silicon dust, diesel fumes, and possibly
other toxicants found in the breathable air of mines.  Other factors that have been related to chemically-
induced cancers include alcohol use, food additives, diet, sexual behavior, occupation, air and water
pollution, pharmaceuticals, and bacterial and viral infections.  
5.6 IDENTIFICATION OF DATA NEEDS
The following has been identified as a potential data need regarding health effects associated with
exposure to ionizing radiation.
Environmental factors, such as tobacco, silicon dust, diesel fumes, and possibly other toxicants found in
the breathable air of mines, together with radiation, have been shown to play a role in the development of
lung cancer.  More research is needed on biomarkers as identifiers of unique DNA and cellular changes
associated with exposure to radiation.  More research is also needed to determine possible interactions
between other carcinogens and ionizing radiation.
Human epidemiological studies have clear limitations in the low-dose range, and mechanistic studies may
be important in further clarifying the true effects at low doses.  In this regard, there is a need to more fully
understand the role of DNA repair at low dose, gene expression in carcinogenesis, and the role of
radiation in cancer promotion and progression.  Mechanistic studies should be considered for non-
carcinogenic effects such as human developmental radiobiology, particularly for internal emitters.
5.7 SUMMARY
This chapter summarized the major mechanisms by which ionizing radiation exerts it toxic effects on cell
structure.  Macromolecules, in particular DNA, are the critical molecules for damage from  radiation.  The
method by which  radiation interacts with a biological medium may be direct or indirect.  Damage can
occur due to direct ionization of the DNA molecule itself or indirectly through the formation of toxic
products, such as free radicals, hydrogen peroxide, hydroperoxy radicals, and hydroperoxy ions, that
diffuse from the site of formation and interact with any molecules in their path.  Since cells rely heavily
on their DNA for instruction information, when the genetic information containing the “blueprint” for this
information is disrupted, cell homeostasis is disrupted, and a wide range of biological responses is 
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encountered.  These responses include non-carcinogenic and carcinogenic end points.  Other molecules,
such as lipids, proteins, thiols, amino acids, and carbohydrates, can also be damaged when irradiated.  A
number of models were presented that reflect possible mechanisms of cancer induction, as well as a brief
discussion of the three steps of cancer formation.  By knowing the specific mechanisms by which
radiation produces carcinogenic and non-carcinogenic end points, research can focus on identifying
biomarkers of effect with which to better assess the effects of low-level radiation exposure.
.
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Figure 6-1.  Radiation Exposure to the Average U.S. Citizen
adapted from (NCRP1987a)
6.  SOURCES OF POPULATION EXPOSURE TO IONIZING RADIATION
6.1 OVERVIEW
All organisms (e.g., bacteria, plants, or
animals, including humans) are exposed
everyday to varying amounts of ionizing
radiation. Figure 6-1 shows average
contributions from various sources of
radiation to which the average U.S.
citizen is exposed during his or her
lifetime. Approximately 82% of the
radiation dose is from natural sources:
55% from radon (see Figure 1-3), 8%
from cosmic radiation (from the sun and
stars), another 8% from terrestrial
sources (radioactive material in rocks and soil), and 11% from internal sources (radioactive materials,
primarily potassium-40, from food and water consumed in the daily diet).
The remaining 18% of the dose comes from anthropogenic (man-made) sources such as medical x ray
exposure (11%), nuclear medicine procedures exposure (4%), consumer products (3%), and other sources
(<1%).  These other sources include occupational exposure, nuclear fallout, and the nuclear fuel cycle. 
The total average annual effective dose equivalent for the population of the United States, natural and
anthropogenic, is approximately 360 mrem (3.6 mSv) and is described further in Chapter 1 of this profile
(BEIR V 1990).
The majority of exposure to radiation comes from natural sources.  With the exception of indoor radon
exposure (and to some extent exposure from terrestrial sources), exposure to natural radiation is only
moderately controllable.  Controllability in relation to radon refers to mitigation of radon concentrations
in buildings and homes.  The average annual effective dose equivalent from all natural sources combined
is approximately 3 mSv (300 mrem).  Of this amount, approximately 98 mrem (98 mSv) is due to 
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background radiation; this includes cosmic rays, 29 mrem (0.29 mSv); terrestrial gamma rays, 29 mrem
(0.29 mSv); and naturally existing radionuclides within the body, 40 mrem (0.40 mSv).  Individual doses
from natural sources may be much greater.  The magnitude of natural exposures depends upon numerous
factors such as geographic location, height above sea level, and the construction and ventilation of
buildings.  For instance, the average annual radiation dose received by a person living in Boston,
Massachusetts, is approximately 300 mrem (3 mSv), while people living in Denver, Colorado, and
Kerala, India, receive average annual doses of approximately 600 mrem and 1500 mrem, respectively. 
The difference in these doses is due mainly to greater concentrations of radioactive materials found in the
soils of the Colorado and Kerala areas and to a smaller extent the increase in cosmic radiation at higher
altitudes in these areas (BEIR V 1990; Eisenbud 1987;  Harvard Medical School 1996; UNSCEAR 1993).
Commonly used terms and scientific unit symbols and abbreviations used in this chapter are defined in
Table 6-1 and Table 6-2, respectively.  These and other terms may also be found in the glossary in
Chapter 9 or in the index at the end of this toxicologic profile.  The following sections discuss natural
external exposures (Sections 6.2 and 6.3), natural internal exposures (Section 6.4), and internal and
external man-made/industrial exposures (Sections 6.5, 6.6, and 6.7).
6.2 COSMIC RADIATION EXPOSURE
Cosmic radiation contributes an estimated 8% to the average population radiation dose.  It is primarily
composed of galactic radiation originating outside the solar system in addition to a varying degree of
solar radiation.  The primary cosmic rays that arrive in the upper atmosphere are high-energy subatomic
particles—primarily protons, but also nuclei and electrons— moving almost at the speed of light; these
primary rays create secondary rays that bathe the atmosphere in radiation.  Austrian physicist Victor Hess
discovered cosmic rays in 1912 when he and two assistants flew a balloon to an altitude of 16,000 ft
(4,877 meters).  Hess proved that the source of a mysterious radiation previously detected over the ocean,
where terrestrial radiation levels were expected to be very low, was actually coming from outside the
atmosphere; he also found that the rate of decline in radiation as the balloon ascended over land was
slower than would be expected if the radiation emanated from the earth.  The difference is caused by the
cosmic rays.  Only a small fraction of cosmic radiation originates from the sun; however, the proportion
of cosmic radiation contributed by the sun increases during periods of increased sunspot and solar flare
activity, which run in 
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Table 6-1.  Common Terms and Abbreviations
becquerel (Bq) SI unit for quantity of radioactive material; 1 Bq equals that quantity of
radioactive material in which there is 1 transformation or disintegration per
second (dps).
curie (Ci) Conventional unit for quantity of radioactive material.  One Ci is the quantity
of any radionuclide in which there are 37 billion transformations or
disintegrations in 1 second.  This is the activity of 1 gram of 226Ra. 
rad The unit of absorbed dose equal to 0.01 Joule/kg in any medium.
gray (Gy) SI unit of absorbed dose.
rem Conventional unit for dose equivalent.  The dose equivalent in rem is
numerically equal to the absorbed dose in rad multiplied by the quality
factor.
roentgen (R) A unit of x ray and gamma ray exposure.  It is measured by the amount of
ionization in air produced by x ray and gamma radiation.  One R equals
2.58x10-4 coulomb per kg of air.
sievert (Sv) The SI unit of dose equivalent. It is equal to the dose in grays times a
quality factor; 1 Sv equals 100 rem.
quality factor (Q) The linear-energy-transfer-dependent factor by which absorbed doses are
multiplied to obtain (for radiation protection purposes) a quantity that
expresses the effectiveness of the absorbed dose on a common scale for all
ionizing radiation.
Table 6-2.  Scientific Units
Prefix (symbol) Power of 10 Decimal Equivalent
atto 10-18 0.000000000000000001
femto (f) 10-15 0.000000000000001
pico (p) 10-12 0.000000000001
nano (n) 10-9 0.000000001
micro (µ) 10-6 0.000001
milli (m) 10-3 0.001
centi (c) 10-2 0.01
deci (d) 10-1 0.1
kilo (k) 103 1,000
mega (M) 106 1,000,000
giga (G) 109 1,000,000,000
tera (T) 1012 1,000,000,000,000
peta (P) 1015 1,000,000,000,000,000
exa (E) 1018 1,000,000,000,000,000,000
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11-year cycles.  Cosmic rays bombard the periphery of the earth’s atmosphere at a rate of 2x1018 particles
per second, at a density of about 4 rays/cm2-sec, and at an energy flux of 2,000 MeV/cm2•sec.  These
rays, referred to as “primary cosmic rays,” are deflected and slowed by particles in the earth’s
atmosphere, creating “secondary cosmic rays” that often reach and even penetrate the earth’s surface. 
The interaction of cosmic rays with the atmosphere leads to the production of several cosmogenic
radionuclides, notably carbon-14 (14C), tritium (3H) and beryllium-7 (7Be).  Because of the shielding
effect of the atmosphere and the earth’s geomagnetic fields, which tend to deflect charged cosmic ray
particles towards the magnetic poles, the cosmic ray dose rate increases with altitude and latitude.  The
average annual dose from cosmic radiation in the United States is 29 mrem (0.29 mSv), but this value
doubles for every 6,000-foot (1,828 meters) increase in altitude.  Thus, the dose from cosmic rays
received in Denver, Colorado, and Leadville, Colorado (altitudes of 1,600 m and 3,200 m, respectively),
is approximately two and four times that received at sea level, respectively (Eisenbud 1987; Korff 1964;
NASA 1995; Shapiro 1990; UNSCEAR 1993).  At altitudes of 30,000 to 40,000 feet (9144 to 12192
meters), where most jet aircraft fly, the cosmic ray dose rate is about 1 mrem per hour (0.01 mSv/hr).
6.3 TERRESTRIAL RADIATION EXPOSURE
Cosmic radiation contributes approximately the same amount of background radiation as terrestrial
radiation (8%), which is emitted by naturally occurring radioactive materials found in the earth’s crust,
such as 40K, uranium and its progeny, and thorium and its progeny (see Figure 6-1).  Uranium, for
example, is found in all types of soil and rock at concentrations ranging from 0.003 ppm in meteorites to
120 ppm in phosphate rock from Florida.  Exposure to radioactive materials in the soil and earthen
products occurs continuously since we are surrounded by these sources.  The radiation dose varies
tremendously and is affected by such factors as geographic location, concentration of natural radioactive
materials in the soil and building materials, and the types of materials used in building structures.
Some communities situated on soil with high concentrations of granite or mineral sand receive doses
many times the average.  Examples include coastal areas in Espiritos Santos and Rio de Janeiro in Brazil;
Kerala, on the southwest coast of India; and the Guangdong province in China.  In Brazil, the black sand
beaches are composed of monazite, a rare earth mineral containing 9% radioactive thorium.  External
radiation dose rates from these sands may be as high as 5 mrem/hr (0.05 mSv/hr); permanent residents
experience an average annual dose equivalent of approximately 500 mrem (5 mSv).  In Kerala, on the 
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west coast of India, residents receive 1,300–1,500 mrem (13–15 mSv) annually, due to the presence of
monazite sand.  Some dose rates are as high as 3,000 mrem/yr (Eisenbud and Gesell 1997).
Apart from radiation exposures due to living in close proximity to the earth’s crust, people are also
exposed to additional radiation when earth crust products (oil, coal, coal ash, minerals) are extracted,
refined, and used.  The naturally occurring radioactive materials in these products are concentrated into
what is called technologically enhanced naturally-occurring radioactive materials (TENORM).  In
general, the hazards of exposure to TENORM during the extraction and processing of earth materials are
relatively small compared to the hazards of exposure to other chemicals.  As a result, radiation exposure
from these sources, with the exception of uranium mining, milling, and processing, is not routinely
monitored (Eisenbud 1987; UNSCEAR 1993).  The radiation hazards associated with the mining of coal,
oil, natural gas, phosphate rock products, and sand are discussed below.
Radon exposure makes up the largest fraction of total radiation dose and contributes to both internal and
external radiation exposures.  The following subsections discuss various radioactive materials primarily
associated with external radiation exposures from various terrestrial activities.  Radon is inherent in these
terrestrial sources, as well, and is discussed because of its association, but with the understanding that it is
a major internal radiation exposure source.
6.3.1 Coal Production
Exposure to radionuclides occurs during the mining and use of coal and coal ash.  The methods of coal
usage vary considerably among countries; on average worldwide, about 40% of coal is burned in electric
power stations, 10% in dwellings, and 50% in other industries.  Based on samples from 15 countries, the
average concentrations of 40K, 238U, and 232Th in coal are 50, 20, and 20 Bq/kg (1.35, 0.54, and
0.54 nCi/kg), respectively.  These concentrations may vary considerably, depending upon the mine
location.  For example, concentrations of these radionuclides in China are 104, 36, and 30 Bq/kg (2.81,
0.97, and 0.81 nCi/kg), respectively.  Coal mine exhaust typically contains radon; the estimated annual
per person dose from radon in coal mine dust is 0.1–2 nSv.  The average annual per person doses of
radiation from coal-fired power plants and from domestic cooking with coal are about 0.2 mrem (2 µSv)
and 0.04–0.8 mrem (0.4–8 µSv), respectively.
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About 280 million tons of coal ash are produced by power plants each year.  Potential uses for the ash
include fertilizers and building materials for roads and dwellings.  Most U.S. power plants recover fly ash
exhaust using scrubbers, electrostatic precipitators, or bag houses.  The radioactive content of coal tends
to concentrate in the ash, resulting in 5- to 10-fold increases in the  concentration of lead-210 (210Pb) and
polonium-210 (210Po) as compared to unburned coal.  When fly ash is used in building materials, the
degree of external exposure to radiation and the inhalation of radon gas increases directly with the amount
of ash incorporated into these materials, and, for radon, the porosity of the materials.  The average annual
exposure associated with living in concrete and wooden houses is 7 mrem (70 µSv) and 3 mrem (30 µSv),
respectively.  An EPA report published in 1979 estimated that the exposure to radioactive materials
emitted from all 250 coal-fired power plants resulted in an additional 1.5 cancers per year
(Eisenbud 1987; EPA 1979 as cited by Eisenbud; UNSCEAR 1982, 1988).
6.3.2 Crude Oil and Natural Gas Production
About 3x1012 kg of crude oil and 1012 m3 of natural gas are produced worldwide annually.  Oil-fired
power plants use about 15% of all oil.  Gas-fired power plants are estimated to use about 15% of all gas. 
Radon is present in natural gas; concentrations of radon in gas at well heads average approximately
40 pCi/L (1.5 Bq/L).  The processing and blending of liquefied petroleum gas (LPG) tends to enhance
radon concentrations, and the long-lived radon daughters (210Pb and 210Po) tend to accumulate on LPG
processing machinery, resulting in low level exposure to maintenance workers.  The annual per person
doses from crude oil and gas are estimated to be 0.001 mrem (10 nSv) and 0.0001 mrem (1 nSv),
respectively.  The estimated doses are small and result from inhalation of radioactive particles and radon
gas (Eisenbud 1987; UNSCEAR 1993).
6.3.3 Phosphate Rock Products
Phosphate rock, the precursor of all phosphorous products including fertilizer, is mined at a rate of
130 million tons per year worldwide.  The worldwide use of fertilizer, estimated to be 30 million tons,
constitutes the greatest source of 40K and 226Ra mobility.  In the United States, the application rate for
fertilizers ranges from 30 kg of phosphate per hectare (barley) to 150 kg/hectare (potatoes and tobacco)
for commercial agricultural application, and possibly less for residential applications.  Concentrations of
40K and 232Th in phosphate rock are similar to those in soil (a few grams per hundred grams of soil and a
few grams per million grams of soil, respectively).  Levels of 238U and its transformation products are 
IONIZING RADIATION 237
6.  SOURCES OF POPULATION EXPOSURE TO IONIZING RADIATION
much higher in phosphate rock than in soil.  Concentrations of 238U in phosphate deposits are typically
about 1,500 Bq/kg (40.5 nCi/kg).  The practice of using phosphate fertilizers has resulted in uranium
concentrations in food at levels up to 8 ng/g (0.005 pCi/g).  Exposure to the general public occurs near
areas of mining and processing through waste effluent.  Several end-products of phosphate processing,
phosphogypsum and calcium silicate, are used for fertilizer, for back-fill and road-base material, in
additives to concrete, in mine reclamation, and in the recovery of sulphur.  Phosphogypsum is also used
as a substitute for natural gypsum in the manufacture of cement, wallboard and plaster.  The primary
radioactive material in phosphogypsum is 226Ra, which is found at concentrations of 900 Bq/kg
(24.3 nCi/kg).
Exposure to phosphate-borne radioactivity also occurs as a result of discharges into surface waters.  The
primary pathway of exposure to radioactivity in humans is through the consumption of fish and shellfish. 
Elevated concentrations of radon have been detected in structures built over reclaimed phosphate mines,
and over unmined mineral deposits.  Maximum annual individual doses near phosphate facilities range
from 4 mrem (40 µSv) in the Netherlands to 600 mrem (6 mSv) in the United States.  The average annual
per person dose of 40K derived from fertilizers is approximately 0.2 mrem (2 µSv); while the average per
person dose from potassium in the body is about 20 mrem (0.2 mSv) per year, maximum annual
individual doses, from consumption of seafood, have been estimated at 15 mrem (150 µSv), with 210Po as
the main contributor.  The annual per person radiation dose from 226Ra-laden phosphogypsum in building
materials is estimated to be about 1 mrem (0.01 mSv) (Eisenbud 1987; Shapiro 1990; UNSCEAR 1982,
1988, 1993).  The use and disposal of phosphogypsum is regulated by the EPA, and these regulations are
intended to ensure that the public is not exposed to unsafe levels of radionuclides from this material.
6.3.4 Sand
Mineral sands, defined as sands with a specific gravity of more than 2.9, originate from eroded rock. 
These sands are mined in Australia, Bangladesh, Indonesia, Malaysia, Thailand, and Vietnam.  The heavy
mineral is extracted from the sand and is processed into, among other items, paint pigment, titanium
metals, catalysts, and structural materials.  The sand itself is used as abrasive material for sandblasting. 
The principal radioactive components are 232Th and 238U.  Exposure is mainly external through minerals
spilled at the processing plants.  Although information on exposures is scant, annual levels are estimated
to be in the low µSv range (UNSCEAR 1993).
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6.3.5 Hot Springs and Caves 
Geothermal energy, produced in Iceland, Italy, Japan, New Zealand, Russia, and the United States, is
produced from steam or water from high-temperature areas within the earth’s crust.  Mineral springs and
spas, which are found in South America, Europe, Japan, and the United States, are also clustered around
these high-temperature areas of the earth’s crust.  The primary radionuclides in this source are those of the
uranium transformation chain.  Of these, 226Ra and 222Rn are considered to be the most important to public
health.
The diffusion of radon from ordinary rock and soils and from radon-rich water can cause notably elevated
radon concentrations in tunnels, caves, and spas.  In Bad Gastein, Austria, approximately 5 million
gallons of mineral water are distributed to hotels and spas daily, allowing the release of about 58 Ci (2
Mbq) of radon per year into the environment.  In comparison with levels in outdoor air, the concentrations
of radon and its transformation products in confined air spaces such as mines and caves are elevated.  The
average annual per person radiation dose from this source is estimated to be 0.0001 mrem (1 nSv);
however, the doses received by those intentionally spending time in these environs (e.g., tourists,
workers, miners) are much greater than this amount (Eisenbud 1987; IARC 1988; UNSCEAR 1993).
6.4 NATURAL INTERNAL EXPOSURE 
Natural internal radionuclides contribute an estimated 11% to the average population radiation dose.  
Radioactive materials enter the body by inhalation, ingestion, or dermal absorption.  Although radioactive
materials may also enter the body through punctures (either wounds or injections), this route of exposure
will not be addressed in this toxicological profile.
The effects induced by internally deposited nuclides or external radiation are classified as either "acute"
(early-occurring effects of radiation, which appear within days or weeks after exposure) or "latent"
(chronic or late-occurring effects of radiation, which appear months or years after exposure).  Acute
effects are not expected for natural sources of radiation because they are not capable of producing high
dose rates in a short period of time.  However, they may cause latent effects.  The most common latent
radiation effect is an increased probability of certain types of cancer.  More information on the health
effects of ionizing radiation can be found in Chapter 3 of this toxicological profile.
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6.4.1 Inhalation
The sources of inhaled radioactive materials include debris from atmospheric nuclear testing; nuclear
reactor and medical gaseous waste; radioactive materials manufacturing; diagnostic medical radionuclide
use; coal- and gas-burning power plants; airborne soil; and naturally emanating gases.  The radionuclides
(and their average concentrations) commonly found in the atmosphere include: 222Rn and 220Rn
(270 pCi/m3 [10 MBq/m3] each);  210Pb (0.01 pCi/m3);  210Po (0.001 pCi/m3);  238U (12x10-5 pCi/m3);  232Th
(3x10-5 pCi/m3); 230Th; (4.5x10-5 pCi/m3); and 228Th (3x10-5 pCi/m3), 14C and 3H.  In addition, smokers are
exposed to radiation from the radionuclide 210Po, which is found in tobacco; the resulting dose to the
bronchial epithelium can be as high as 20 mrem (0.2 mSv) per year (NCRP 1984; Shapiro 1990;
UNSCEAR 1993).
The largest dose of radiation from natural sources comes from the inhalation of 222Rn and 220Rn (thoron)
gases.  These colorless and odorless gases, which are in the uranium and thorium transformation chains,
respectively, are continuously released from the soil.  Worldwide, the total emanation rate of radon is
estimated to be 50 Ci/sec (2 TBq/sec); the total atmospheric content is estimated to be 25 MCi (1 EBq). 
The main factors controlling the rate of radon release and subsequent exposure are:  ground porosity,
ground cover, temperature, meteorological conditions, and the type of construction and ventilation
properties of dwellings.  The rate of radon emanation from soil is thought to increase with diminished
atmospheric pressure and to decrease during periods of, or in areas of, elevated moisture, while the
atmospheric concentration of radon tends to increase during temperature inversions and as the humidity
decreases.  
The health hazards of radon exposure were first recognized in the 1930s when radium miners in Scheen-
burg, Germany, and Joachimstal, Czechoslovakia, were found to have a high incidence of lung cancer. 
Over half of all miner deaths were attributed to lung cancer, and most of the miners were less than 50
years of age when they died.  In the general U.S. population, the EPA estimated that radon exposure
accounts for approximately 10% (17,000) of all lung cancers, while smoking accounts for approximately
85% (144,500) of all lung cancers.  The average annual effective dose equivalent from radon is about
200 mrem (2 mSv), but individual doses may be much higher.  It is estimated that 1–3% of all homes
have radon levels in excess of 8 pCi/L, which is twice the EPA recommended residential limit of 4 pCi/L. 
Approximately 50,000 to 100,000 homes in the U.S. have radon concentrations exceeding 20 pCi/L,
which results in exposures equal to or exceeding the limit for occupational exposure.  The 220Rn doses are
considerably lower than those of 222Rn, due to its short half-life (55 sec for 220Rn versus 3.8 days for
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222Rn).  Both 220Rn and 222Rn have several short-lived progeny in their transformation chains (see Table 6-
3), and radiation from these daughter products constitutes the hazard from radon.  Thus, in assessing the
effects associated with radon exposure, one must consider the simultaneous and cumulative effect of the
entire radon series (BEIR V 1990; Eisenbud 1987; LBL 1993;  NCI 1996; Shapiro 1990; UNSCEAR
1993).
Table 6-3.  Radioactive Properties of 222Radon and its Daughter Products
Radiation energies (MeV)
Radionuclide Half-life α β γ
222Radon 3.8 days 5.49 — —
218Polonium 3.1 minutes 6.00 — —
214Lead 26.8 minutes — 0.67
0.73
0.30
0.35
214Bismuth 19.9 minutes — 1.51
1.54
3.27
0.61
1.12
1.76
214Polonium 164 µseconds 7.60 — 0.8
210Lead 22.3 years — 0.016
0.06
0.05
210Bismuth 5 days — 1.16 —
210Polonium 138 days 5.31 — —
206Lead No half-life; stable element
Source: adapted from Schleien 1992 (includes radiations over 10% intensity)
Coal mine exhaust and the combustion products from the use of coal and oil typically contain radon and
daughter products, which contribute doses of 0.001 mrem (10 nSv) or less.  The average annual per
person doses from radiation from coal- and oil-fired power plants are about 0.2 mrem (2 µSv) and
0.001 mrem (10 nSv), respectively.  The average annual per person dose from radiation from domestic
cooking and heating with coal is about 0.04–0.8 mrem (0.4–8 µSv); this dose originates primarily from
radon and its daughter products (UNSCEAR 1993).
Several radioactive by-products of the nuclear power industry may be inhaled and result in internal
exposure.  During uranium fuel fabrication, uranium hexafluoride gas is enriched to increase the
percentage of 235U and then converted into uranium oxide or metal.  Depending upon the type of reactor 
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fuel or nuclear weapons material being produced, uranium must be enriched to a minimum of 3% 235U for
fuel and 93.5% for nuclear weapons.  Emissions from fabrication facilities usually consist of the long-
lived isotopes 234U, 235U, and 238U, and the short-lived isotopes 234Th, and protactinium-234m (234mPa). 
The major route of exposure from this source is inhalation.  More information about uranium is available
in the ATSDR Toxicological Profile for Uranium (ATSDR 1999).
6.4.2 Ingestion
The sources of radionuclides that contribute to radiation exposure by ingestion include nuclear weapons
testing, the accidental or intentional release of radioactivity from nuclear reactors, the release of medical
or experimental radionuclides into sanitary sewers, and naturally occurring radionuclides (which normally
represent the source of highest oral dose).  For most radionuclides present at waste sites containing low
levels of radioactive nuclides, oral exposure is not a major route of exposure.  There is a small probability
of radionuclide ingestion because of the potential for surface water and groundwater contamination and
uptake by plants and animals following erosion of ground cover from a contaminated site.
Among the naturally occurring radionuclides, uranium, 40K, and 226Ra are found in soils and fertilizers; as
a result, they are incorporated into foods consumed by animals and humans.  The practice of using
phosphate fertilizers has resulted in uranium concentrations in food at levels up to 8 ng/g, resulting in an
estimated average annual intake of uranium from dietary sources of 10 Bq; as a result, the average
skeletal content of uranium is estimated to be 25 µg, which is equivalent to approximately 17 pCi
(Eisenbud 1987; UNSCEAR 1993).  
The most important radionuclides that are ingested are 40K, 226Ra, and the transformation products of
226Ra.  However, wherever it is found, all potassium is radioactive because its natural isotope, 40K, is
radioactive. The body content of potassium is under strict homeostatic control and is maintained at a
relatively constant level of about 140 g/70 kg.  This amount of potassium contains approximately 0.1 µCi
(4,000 Bq) of 40K.  Because the body controls the potassium balance, environmental variations have little
effect on the 40K content in the body (Eisenbud 1987; Shapiro 1990).  This natural 40K delivers a dose of
20 mrem/year (0.2 mSv/year) to the gonads and other soft tissues and 15 mrem/year (0.15 mSv/year) to
bone.
FDA has developed guidelines for radionuclide levels in food for individuals from 3 months to adult that
are summarized in Chapter 7 (Regulations), Table 7-4, FDA Derived Intervention Levels (FDA 1998).
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6.4.3 Dermal
For the purposes of this profile, dermal exposure to radionuclides refers to exposures from a radionuclide
placed in direct contact with skin surface.  Dermal exposure is typically a minor route of internal and
external exposure.  In general, depending on the specific physical properties of the radionuclide that may
reside on the skin, the percutaneous absorption of radionuclides from particles is negligible, especially if
the skin is thoroughly washed immediately after exposure.  The long-term biological effects of dermally
absorbed radionuclides are limited to the level of the epidermis and dermis (and its vasculature).  More
soluble forms of the radionuclides may result in a small percentage of the nuclide being absorbed if it is
not removed from the skin's surface, for example tritium, as tritiated water or vapor, is readily absorbed
into the body through the skin.  Generally, the skin is an effective barrier against absorption of
radionuclides (except for tritiated water)  into the body.  The dermal exposure pathway is, therefore, a
minor route of exposure at low-level radioactive waste sites.
6.5 X RAY AND NUCLEAR MEDICINE EXPOSURES
Radioactive materials and other sources of ionizing radiation are widely used in the diagnosis and
treatment of some diseases in human and veterinary medicine (NCRP 1989a; 1996). They represent 15%
of the average population dose, 11% for x rays and 4% for nuclear medicine.  In 1989, the estimated
number of x ray machines used in the US was 109,000 for medical diagnosis, 143,000 for dental
diagnosis, and 1,300 for therapy: 3 million diagnostic examinations were made which produced a
collective US dose of 92,000 man•Sv (9,200,000 man-rem).  Typical effective dose equivalents for
various procedures are 0.14 mSv (14 mrem) for a chest x ray, 1.0 mSv (100 mrem) for mammography,
and 7.2 mSv (720 mrem) for an upper GI tract evaluation. Due to the usefulness of nuclear medicine,
radioactive drugs and diagnostic compounds have become significant contributors to internal radiation
dose from man-made sources today.  The average U.S. nuclear medicine examination gives an effective
dose equivalent of 5 mSv (500 mrem) with individual prodedured delivering 2.5 mSv (250 mrem) for a
thyroid uptake, 6.3 mSv (630 mrem) for a bone scan, and 14 mSv (1,400 mrem) for a cardiovascular
screen.  Each year in the US, the collective effective dose from nuclear medicine procedures is 32,000
man•Sv (3,200,000 man-rem).  Therapeutic doses are much larger to the individual but many fewer
individuals are exposed.  After many millions of diagnostic radionuclide procedures, we have found no
increase in cancers from these procedures.
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The common sources of radiation exposure associated with radiotherapy and diagnosis include x rays,
thallium-201 (201Tl), technetium-99m (99mTc), 125I, and 131I.  More exposures are related to diagnosis than
to therapy, and the average number of treatments per person increases as the level of health care
improves.  Also, the average dose per individual treatment tends to decrease as techniques and equipment
improve.  Overall, x ray treatments deliver a higher average per person dose in industrialized nations
(average of 0.3–2.2 mSv) than in countries with less developed health care (average exposure
0.02–0.2 mSv).  On an individual basis, the average dose increases with age, from 52 mrem/year in
adolescents to 151 mrem/year in persons over 65 years of age.  Exposures are usually lower for
examinations of the extremities and skull and higher for examination of the gastrointestinal (GI) tract.  In
the United States, the average annual dose to the bone marrow from this source increased from 83 mrem
in 1964 to 103 mrem in 1970.  A person receiving a full set of dental x rays would add approximately
40 mrem to his or her annual dose.   On the other hand, the average annual dose per patient from the
diagnostic use of radionuclides is lower in industrialized nations, largely because of greater use of 99mTc. 
This radionuclide is preferred over 131I because its shorter half-life (6 hours versus 8 days) gives a much
lower patient dose.  There is currently no radioiodine in the atmosphere due to atmospheric testing
because of the 8-day half-life of  131I.  The shorter half-life and higher cost of 99mTc make it more available
in developed than in developing nations, where 131I has frequent use.  While the average dose (per
individual) in patients undergoing radiotherapy is much greater than in patients undergoing diagnosis, the
exposure group is much smaller, resulting in a lower overall population-at-risk.  Unfortunately, serious
exposures resulting from failures of equipment, procedures, or personnel errors (usually a result of not
following procedures) sometimes occur, with several hundred failures out of several hundred million
procedures per year worldwide.
There are several emerging trends in diagnostic nuclear medicine.  Some of these trends include: the
introduction of radiolabeled monoclonal antibodies for imaging and treatment; the emergence of new
compounds used in positron emission tomography (PET) and single-photon emission computed
tomography (SPECT) studies; and the use of computed x ray tomography (CAT scans).  Radiolabeled
monoclonal antibodies have proven useful in the localization of tumors and metastases. Common
radionuclides associated with these antibodies include indium-111 (111In), 131I,   and 99mTc.  SPECT is used
for tumor localization, brain and cardiac studies, and bone or abdominal imaging.  PET, which uses
nuclides such as 11C and 18F, can gather anatomical and physiological information that would otherwise be
difficult to collect.  Whole-body imaging using radiolabeled compounds (e.g., anticancer drugs) is
becoming a common PET application (DOE 1996; Eisenbud 1987; Shapiro 1990; UNSCEAR 1993).
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The use of radiopharmaceuticals has stabilized in industrialized countries but is increasing in developing
countries.  Long-lived radionuclides are used more frequently in developing countries, while
industrialized countries tend to use short-lived radionuclides.  This results in increased exposures per
examination among developing country patients compared to those of industrialized nations.  For
example, a typical thyroid scintigraphy with 99mTc can give an effective dose of less than 0.1 rem (1 mSv),
while the same procedure using 131I gives 10 rem (100 mSv); however, 99mTc is less readily available in
developing countries.  Although the average per patient dose equivalent is lower in developed (2–5 mSv
[200-500 mrem]) than in less developed countries (20 mSv [2,000 mrem]), an apparently larger fraction
of individuals in developed nations receive nuclear medicine treatment, so the average per capita annual
dose from radiopharmaceuticals in developed countries (0.07 mSv [7 mrem]) is an order of magnitude
more than that of developing nations (0.004 mSv [4mrem]) (UNSCEAR 1993).
Radionuclides are frequently produced and used in industry, medicine, and research.  The number of
users and frequency of radionuclide use are both steadily increasing.  The number of establishments in
Japan that generate and/or use radionuclides has increased from 100 in 1960 to 5,000 in 1990.  The public
may be exposed to radionuclides from these sources as a result of routine use or from being near someone
who has recently received a nuclear medicine procedure, as well as improper handling, use, or disposal. 
In Japan, the usage of 14C, 125I, 3H, and 131I has been estimated to be 5.2, 6.1, 14, and 34 GBq (0.14, 0.16,
0.38, and 0.92 Ci) per million persons, respectively.  In contrast, the production of 14C in the United
States and Britain has been estimated to be 30 and 55 GBq (0.81 and 1.49 Ci) per million, respectively. 
The annual global production and usage of 14C has been estimated to be 30 GBq (810 mCi) per million
persons, or a total of 0.05 PBq (1.5 kCi).  The total amount of 131I produced in Sweden for medical
purposes was estimated to be 0.9 TBq (110 GBq [2.97 Ci] per million) in 1986, while the amount of 131I
discharged from Australian hospitals in 1988 and 1989 was estimated to be 2.9 TBq
(190 GBq [5.13 Ci] per million) (UNSCEAR 1993).  Information about some radionuclides used for
medical applications is shown in Table 6-4.
3H and noble gases are released to the air, while 14C release is through airborne and fluid effluents.  The
isotopes 131I and 125I are primarily released through liquid effluent.  The annual collective dose from
medical and radiopharmaceutical wastes to local populations is thought to be in the range of 
10,000 man•rem (100 man•Sv).  This level of exposure is relatively unimportant compared to that from
other sources (Eisenbud 1987; UNSCEAR 1993).
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine
Radionuclide Preparation Use Properties
99mTc Albumin Reduce pertechnetate 99mTc
in the presence of human
albumin, ascorbic acid,
FeCl2, and SnCl2. 
Primarily used for lung imaging. 
Also used for imaging of coronary,
urogenital, liver, gastrointestinal,
lymphatic, and peripheral
circulation.
The biological clearance half-
life from the lungs of 14 to
15 hours.  
111In Albumin Incubate 111In with human
albumin in phosphate at
pH 3; adjust pH to 11 and
heat.
Primarily used for lung imaging. 
Also used for imaging of coronary,
urogenital, liver, gastrointestinal,
lymphatic, and peripheral
circulation.
The biological clearance half-
life from the lungs of 14 to
15 hours.  
113mIn Albumin Incubate 113mIn with human
albumin in phosphate at
pH 3; adjust pH to 11 and
heat.
Primarily used for lung imaging. 
Also used for imaging of coronary,
urogenital, liver, gastrointestinal,
lymphatic, and peripheral
circulation.
The biological clearance half-
life from the lungs of 14 to
15 hours.  
203Pb Albumin Incubate ionic 203Pb with
human albumin at pH 10
with heat.
Primarily used for lung imaging. 
Also used for imaging of coronary,
urogenital, liver, gastrointestinal,
lymphatic, and peripheral
circulation.
The biological clearance half-
life from the lungs of 14 to
15 hours.  
51Cr Albumin Incubate 51CrCl3 with human
albumin
Detection and quantitation of
gastrointestinal protein loss and
placental localization
Cr (III) has strong affinity for
plasma proteins without
affecting (binding to) red
blood cells.
125I Albumin Mild iodination of human
albumin at 10 EC in slightly
alkaline medium
Diagnostic aid in determining total
blood and plasma volumes
Longer shelf life than 131I;
emits no beta radiation (all
gamma emissions); lower
doses needed  to obtain
greater  resolution compared
to 131I
131I Albumin Mild iodination of human
albumin at 10 EC in slightly
alkaline medium
Diagnostic aid in determining total
blood and plasma volumes,
circulation times, or cardiac output.
May cause sensitization.
131I Albumin,
aggregated
Mild iodination of human
albumin at 10 EC in slightly
alkaline medium
Diagnostic study of the lungs,
especially the diagnosis of
pulmonary embolisms.
Aggregates block a small
percentage (<0.5%) of the
fine capillaries.  Disintegrating
aggregates are cleared by
phagocytic Kupffer cells in the
liver.  Thyroid uptake may be
blocked by prior
administration of Lugol’s
solution.
197Hg
Chlormerodrin
Reflux allylurea with 197Hg 
mercuric acetate in
methanol; add aqueous
sodium chloride
Diagnostic aid in scanning the brain
for lesions.  Also used for scanning
kidneys for anatomical and
functional abnormalities.
Rapidly cleared by the
kidneys.  Provides smaller
radiation dose compared to
131I albumin.  A high
tumor:background ratio is
obtained within 4 hours,
allowing quicker scans with
greater resolution.
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine (continued)
Radionuclide Preparation Use Properties
203Hg
Chlormerodrin
Reflux allylurea with
203Hg mercuric acetate in
methanol; add aqueous
sodium chloride
Diagnostic aid in scanning the brain
for lesions.  Also used for scanning
kidneys for anatomical and
functional abnormalities.
Rapidly cleared by the
kidneys.  Provides smaller
radiation dose compared to
131I albumin.  A high
tumor:background ratio is
obtained within 4 hours,
allowing quicker scans with
greater resolution.
32P Chromic
phosphate
React Na2H32PO4 with
chromic nitrate in a saline-
carboxymethylcellulose
vehicle.
A neoplastic suppressant that
provides palliative treatment of
pleural and peritoneal effusions.
Emits virtually no gamma
radiation; delivers 10-fold
greater radiation dose per
millicurie compared to 198Au. 
Because it remains in situ
after injection, it may be
injected directly into a
malignancy.
60Co Neutron bombardment of
59Co
Replaced radium in various
therapeutic areas.
The gamma radiation
matches that of radium very
closely.
192Ir Neutron bombardment of
191Ir
Replaced radium in various
therapeutic areas.  May be enclosed
in nylon mesh for interstitial use.
Provides softer (i.e., less
penetrating) radiation
compared to radium. 
57Co
Cyanocobalamin
Vitamin B12 in which a
portion of the molecule
contains 57Co.
Diagnostic aid in studying the
absorption and deposition of
vitamin B12, especially the diagnosis
of pernicious anemia. 
60Co
Cyanocobalamin
Vitamin B12 in which a
portion of the molecule
contains 60Co.
Diagnostic aid in studying the
absorption and deposition of
vitamin B12, especially the diagnosis
of pernicious anemia. 
Although the half-life is 5.24
years, 60Co cyanocobalamin
may decompose in storage;
thus, frequent radiochemical
analysis may be required.
Exametazime 99mTcO is incorporated into
the exametazine molecule.
An adjunct in detecting regional
cerebral perfusion in stroke;
leukocyte labeling.
Is rapidly cleared from the
blood. Maximum brain uptake
(3.5-7.0%) is reached within 1
minute of injection. Must be
used within 30 minutes of
reconstitution due to
conversion of lipophilic
complex to second lipophilic
complex that will not cross the
blood-brain barrier.
113In Ferric
hydroxide
113In is stirred with FeCl3
while titrated with 0.5 N
NaOH to a pH of 11 to 12. 
While stirring, a 20% gelatin
is added to attain a pH of
7.6 to 8.5 while heating in a
boiling waterbath;
preparation is then
autoclaved.
A diagnostic aid in lung imaging. Particles are in the 20 to
50 µm range.
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine (continued)
Radionuclide Preparation Use Properties
59Fe Ferrous
Citrate
59Fe complexed with citrate;
neutron bombardment of
58Fe.
A diagnostic aid in studying the
kinetics of iron metabolism.  
It may be administered
directly into the bloodstream
where it reacts with the metal-
binding globulin.  
99mTc Ferrous
hydroxide
Add 99mTc to a vial
containing ferrous sulfate;
the hydroxide is precipitated
with 0.1N NaOH at a pH of
7.5 to 10.7.  Gelatin is
added to stabilize the
particles; final pH should be
7.1 to 8.3. 
A diagnostic aid in pulmonary
scintigraphy.
Most of the particles are in the
11 to 13 µm range; virtually all
particles fall in the 3 to 50 µm
range;.
125I Fibrinogen 125I in the form of I2, ICl or I- 
is combined with fibrinogen
and is oxidized by
chloramine-T, electrolytically
or enzymatically.  Unreacted
iodine is removed by the
addition of sodium
thiosulfate.
A diagnostic aid in the localization of
deep vein  thrombosis.  Other
applications include detection of
renal transplant rejection, tumors,
and the study of fibrinogen turnover.
Accumulates in clots, the
radiation is easily detected at
the external surface of the
affected limb.
67Ga Gallium
citrate
67Ga is produced by proton
irradiation of 67Zn-enriched
ZnO2 
Used in the diagnosis of lesions of
the lung, breast, maxillary sinuses
and liver.  A positive 67Ga uptake is
potentially indicative of
malignancies such as lymphomas,
bronchogenic carcinoma, and
Hodgkin’s disease.  Also useful for
placental localization and diagnosis
of pancreatitis and disk disc-space
infection.
Concentrates in tumors of soft
tissues and bone.  The half-
life of the isotope is 78 hours;
the biological half-life of the
citrate compound is 53 days.
111In Indium
chlorides
A cadmium target is bom-
barded with deuterons.  The
111In is then etched from the
target with HCl, carrier Fe3+
is added, and the mixture is
precipitated with NH4OH. 
The precipitate is dissolved
in HCl and the ferric iron is
removed by extraction with
isopropyl ether.
111In has been used as a tag for a
variety of compounds such as
transferrin, EDTA and DTPA (used
in cisternography), bleoycin (used
for tumor localization), platelets
(detection of coronary thrombi),
lymphocytes (monitoring cardiac
antirejection therapy), and
leukocytes (diagnosis of upper-
abdominal infections). 
Indium normally exists in
aqueous solution as a
trivalent cation.  In aqueous
solution InCl exists as a
mixture of hydrated chlorides.
111In Oxyquinoline Used to label various blood
components such as  neutrophils,
platelets and lymphocytes; cardiac
imaging (labeled platelets);
localization of infectious and
inflammatory processes (labeled
leukocytes).
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine (continued)
Radionuclide Preparation Use Properties
113mIn Indium
Chloride
113mIn is formed by the
radioactive transformation
of 113Sn.  113mIn is separated
from 113Sn using sterile,
pyrogen-free dilute HCl.  
Used in blood-pool studies,
including visualization of
aneurysms, and placental
scintigraphy; also used for bone,
liver, lung, brain, and renal imaging.  
Indium normally exists in
aqueous solution as a
trivalent cation.  In aqueous
solution InCl exists as a
mixture of hydrated chlorides. 
Urinary excretion is low,
resulting in low urinary
bladder activity.
113mIn Indium
hydroxide
113mIn Indium chloride is
adjusted to a pH of 4 or
more, whereupon the
indium is converted to the
insoluble hydroxide.  The
particle size and stability are
controlled by heating and
the addition of a stabilizer
(gelatin, mannitol, etc.).
Used in liver, spleen and bone
marrow scintigraphy.
125I or 131I Insulin Prepared by mild iodination
with high-specific-activity
radioactive iodine followed
by purification via dialysis,
ion-exchange or other
process.
Used for in vitro assay of circulating
insulin; study of in vivo insulin
kinetics
Longer shelf life than 131I;
emits no beta radiation (all
gamma emissions); lower
doses needed for correct
resolution compared to 131I
123 I or 131I Na
Iodohippurate
Iodobenzyl chloride is
condensed with glycine with
the aid of a
dehydrochlorinating agent. 
The resulting o-iodohippuric
acid is reacted with NaOH.
Used in the detection of renal
malfunction.
Excreted almost exclusively
by the kidneys.
81mKr gas A transformation product of
81Rb, which is produced by
alpha bombardment of 79Br.
Used for lung function, ventilation,
and perfusion.  Also used in
radiocardiology.
123I Iofetamine
Hydrochloride
Used in assessing regional cerebral
blood flow.
Crosses the intact blood-brain
barrier. Concentrates in
metabolically active brain
cells. Binding by relatively
nonspecific high-capacity
binding sites results in brain
retention.
125I or 131I
Liothyronine
Synthetic liothyronine is
exchanged with 131I.  The
mixture is then purified by
column or strip paper
chromatography.  
Used for in vitro evaluation of
thyroid function.
125 I binds to thyroxine-binding
proteins.  Due to the high
specific activity, this
compound may not be taken
internally as radiation damage
can occur easily. This may be
prevented in part by the use
of propylene glycol (50%) as a
solvent.  The materials should
be refrigerated or frozen and
should be used within 2
weeks.
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine (continued)
Radionuclide Preparation Use Properties
125I or 131I
Levothyroxine
Obtained by synthesis, with
the I-tag in the 3'-position. 
Used to study the endogenous
metabolism of endogenous
thyroxine; to measure thyroxine-
binding protein capacity.
Binds to thyroxine-binding
proteins.
111In Pentetate
Indium Disodium
Cyclotron-produced indium
chlorides mixed with
pentetic acid at low pH
(#3.5) to form an indium-
DTPA chelate.  A trisodium
salt of the complex is
formed by increasing the pH
to 7.0–7.5.
Used as a diagnostic aid for studies
of cardiac output, glomerular
filtration evaluation; used for
cisternography and renal
scintigraphy.
Shelf-life is limited by the half-
life of 111In (67.5 hours).
113mIn Pentetate
Indium Trisodium
Pentetic acid containing
some ferric ion and HCl is
mixed with 113mIn.  The
resulting chelate is
stabilized by increasing the
pH to 7.0–7.5, resulting in
the formation of a trisodium
salt. 
Used as a diagnostic aid for studies
of glomerular filtration; also used for
brain scanning and kidney imaging,
and cisternography of spinal fluid
circulation.
169Yb Pentetate
Ytterbium
Trisodium
Buffered, lyophilized
pentetic acid is mixed with
169Yb. 
Used as a diagnostic aid for brain
scanning and kidney imaging, and
cisternographic diagnosis of CSF
rhinorrhea.
May be administered orally or
intravenously.
42K Potassium
Chloride
By neutron bombardment of
natural potassium. 
Used for tumor localization and
studies of renal blood flow
measuring total exchangeable
potassium.
Suitable for intravenous
administration.
43K Potassium
Chloride
By alpha bombardment of a
natural argon target.  
Used as a diagnostic aid for heart
imaging.
131I Rose Bengal
Sodium
Prepared by thermal
condensation of
tetrachlorophthalic
anhydride with 2,4-
diiodoresorcinol.  The
resulting phthalein is
reacted with NaOH, and the
purified product is labeled
by isotope exchange 
A diagnostic aid for liver function;
especially useful for differential
diagnosis of hepatobiliary disease.
Accumulates in the polygonal
cells of the liver and is
excreted via the biliary
system.  If liver function is
impaired, it is excreted via the
kidneys.
75Se Seleno-
methionine
Extracted from yeast grown
on sulfur-free medium to
which trace amounts of
radiolabeled sodium
selenite have been added. 
Selenomethionine is
separated from separated
from the yeast proteins.
Used for scintigraphy of the
pancreas and parathyroid glands;
also used to visualize the parotid
and prostate glands.
Incorporated into newly-
formed proteins.  Blood levels
decline to a minimum value at
20 to 45 minutes after IV
injection; blood levels then
rise to about 3/4 that seen at
2 minutes postinjection.
22Na Sodium
Chloride
By deuteron bombardment
of 24Mg
Used for determination of circulation
times, sodium space, and total
exchangeable sodium.
The usual required tracer
dose is well within tolerated
levels.  Emits positrons which
are easily detected by
coincidence counting.
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine (continued)
Radionuclide Preparation Use Properties
51Cr Sodium
Chromate
By neutron bombardment of
enriched 50Cr.
Used as a biological tracer to
measure red-cell volume, red-cell
survival time, and whole-blood
volume.  Also used to detect blood
cell loss due to hemolytic anemia or
GI bleeding.
Requires 15–60 minutes to
diffuse into red cells; binds to
globin molecules. Has no
deleterious effect on
erythrocytes.
18F Sodium
Fluoride
By neutron bombardment of
enriched 6Li in the form of
lithium carbonate. 
Contamination with 3H must
be removed prior to use.
Useful for bone imaging, especially
areas of altered osteogenic activity.
123I Sodium Iodide By proton bombardment of
enriched 124Te or by
deuteron bombardment of
enriched 122Te or by
transformation of 123Xe.
For diagnostic procedures in thyroid
function studies; for organ imaging 
including the thyroid, liver, lung, and
brain.
Short half-life (13.2 hours)
and radiation characteristics
result in a smaller radiation
dose compared to other
iodine isotopes.
125I Sodium Iodide By neutron bombardment of
xenon gas.
For diagnostic procedures in thyroid
function studies; for organ imaging 
including the thyroid, liver, and
brain; treatment of deep-seated
non-resectable tumors.
For organ imaging, dose to
patient may be decreased
with better delineation of
organ and clearer resolution
than 131I.
131I Sodium Iodide By neutron bombardment of
enriched 131Te or as a
byproduct of uranium
fission.
For diagnostic procedures in thyroid
function studies; a neoplastic
suppressant.
99mTc Sodium
Pertechnetate
Produced by the elution of
sodium pertechnetate
through a generator
containing 99Mo which
decays to 99mTc.
Used in the detection and
localization of cranial lesions,
thyroid and salivary gland imaging,
placenta localization, and blood-
pool imaging.
99mTc has an ideal half-life
which is long enough for
diagnostic procedures but is
short enough to minimize
radiation doses to the patient.
Also, it lacks a beta radiation
component.  Pertechnetate is
readily absorbed by the
thyroid; this can be  reduced
by preinfusion of potassium
perchlorate.
32P Sodium
Phosphate
By neutron bombardment of
elemental sulfur in an
atomic reactor.  32P is then
separated by leaching with
NaOH.
A neoplastic and polycythemic
suppressant; a diagnostic aid for the
localization of certain ocular tumors.
85Sr Strontium By neutron bombardment of
a strontium salt enriched in
85Sr.
A diagnostic aid for scanning bones
and bony structures to detect and
define lesions and to study bone
growth and abnormal formations.
Has a long half-life (64 days),
resulting in high bone doses.
99mTc Albumin Albumin is tagged with a
reduced form of the
pertechnetate.  The
pertechnetate may be
reduced by one of several
methods.
Diagnostic aid in determining total
blood and plasma volumes,
circulation times, or cardiac output.
See earlier comment on
99mTc.
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine (continued)
Radionuclide Preparation Use Properties
99mTc Albumin,
Aggregated
Denatured human albumin
is tagged with a reduced
form of the pertechnetate. 
The pertechnetate may be
reduced by one of several
methods.
Diagnostic aid in study of the lungs.
Primary use is for diagnosing
pulmonary embolism.  Also useful
for static blood-pool imaging,
angiography, dynamic function tests
and visualization of placental
tissues.
See earlier comment on
99mTc.  99mTc is preferred over
131I as the radioactive tag
because of the smaller
delivered dose.
99mTc Etidronate
or 99mTc
Oxidronate
Acetic acid is treated with
PCl3; the disodium salt is
formed when a solution of
etidronic acid is adjusted to
a pH of 8.5.  Stannous
chloride and sometimes a
stabilizer such as sodium
ascorbate are added. 
Freshly eluted 99mTc is
added.
Useful for bone imaging. See earlier comment on
99mTc.  This compound is
superior to 18F bone scans
and to roentgen studies and is
frequently more sensitive in
detecting metastases to the
bone. 
99mTc
Iminodiacetic
Acid (IDA)
Usually provided in kit form,
the compound is
reconstituted and tagged by
adding sterile 99mTc sodium
pertechnetate.
Useful for hepatobiliary imaging. See earlier comment on
99mTc.
99mTc Ferpentate Usually in kit form, the
compound is made by
adding a solution of
99mTc sodium pertechnetate;
the pH is adjusted with
sodium hydroxide and a
solution of pentetic acid is
added.  The chelate is
formed by gentle mixing. 
Useful for kidney imaging. See earlier comment on
99mTc.
99mTc Pentetate Prepared by adding sterile
99mTc pertechnetate saline
solution to an aliquot of
buffered stock solution of
DTPA containing stannous
chloride as a reducing
agent.  Instant DTPA 99mTc
kits are available.
Useful for brain and kidney
visualization, for vascular dynamic
studies for measurement of
glomerular filtration and for lung
ventilation studies.
See earlier comment on
99mTc.  Does not concentrate
in any organ. DTPA is
uniformly distributed
throughout the extracellular
space and is rapidly cleared
by the kidneys without
retention.
99mTc
Pyrophosphate
Sodium pyrophosphate,
mixed with stannous tin, are
combined with a solution of
99mTc sodium pertechnetate.
Kits are available
commercially.
Used as a skeletal imaging agent;
used to demonstrate areas of
altered osteogenesis; also used as
a cardiac imaging agent, as an
adjunct in the diagnosis of
myocardial infarction. 
See earlier comment on
99mTc.  The pyrophosphate
compound has been found to
concentrate in muscle tissue,
especially contused muscle
tissue.  myocardium.
99mTc Sestamibi Usually in kit form, the
compound is reconstituted
and tagged with sterile 
99mTc sodium pertechnetate. 
Used as a myocardial perfusion
agent in the evaluation of ischemic
heart disease and distinguishing
and locating abnormal myocardium.
Accumulates in viable
myocardial tissue. 
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine (continued)
Radionuclide Preparation Use Properties
99mTc Succimer Usually in kit form, the
compound is reconstituted
and tagged with sterile 99mTc
sodium pertechnetate.
Used in renal cortical imaging. Use within 30 minutes of
formulation.
99mTc Sulfur
Colloid
A colloidal suspension of
sulfur labeled with 99mTc. 
Used as a diagnostic aid for liver,
spleen, and bone marrow scanning. 
Also used in detection of
intrapulmonary and lower GI
bleeding, as well as visualization of
the lungs by inhalation of the colloid.
See earlier comment on
99mTc.  Colloids are
phagocytized by the liver. 
The plasma clearance is rapid
(approximately 2.5 min).  At
least 80% of dose
accumulates in the liver.
99m Tc Tebroxime Used for myocardial perfusion
imaging for distinguishing normal
versus abnormal myocardium.
Use within 6 hours of
reconstitution.
99mTc Gluceptate Freshly eluted 99mTc sodium
pertechnetate is added to
sodium glucoheptonate in
combination with stannous
chloride.
Useful as a renal imaging agent;
possibly useful for localization of
brain, lung, and gallbladder lesions.
See earlier comment on
99mTc.  Optimal results are
obtained 1–2 hours after
administration.
99mTc Sodium
Methylene
Diphosphonate
Sodium methylene
diphosphonate, available in
kit form,  is mixed
reconstituted with
99mTc sodium pertechnetate. 
Useful for skeletal imaging. See earlier comment on
99mTc.  When administered by
IV, compound concentrates in
areas of altered osteogenesis.
99mTc Mertiatide Usually provided in kit form,
the compound is
reconstituted and tagged by
adding sterile 99m Tc
mertiatide.
Useful as a renal imaging agent;
provides information on renal
function, split function, renal
angiograms and renogram curves
for whole kidney & renal cortex.
Is reversibly bound to serum
protein and is excreted rapidly
by kidneys and cleared by the
blood.
99mTc Sodium
Phosphates
Polyphosphate polymer,
available in kit form mixed
with stannous chloride, is
mixed with
99mTc pertechnetate. 
Useful for bone and renal imaging. See earlier comment on
99mTc.
99mTc Sodium
Phytate
Sodium phytate, available in
kit form mixed with
stannous chloride,  is
reconstituted with
99mTc pertechnetate. 
Useful for liver and spleen imaging See earlier comment on
99mTc.  Cleared rapidly from
the blood by the
reticuloendothelial system. 
Over 80% of compound
localizes in the liver and
spleen within 30 minutes of an
iv injection.  The addition of
ionic calcium to the 99mTc
stannous phytate mixture
enhances splenic uptake.
99mTc Tetracycline Tetracycline, available in kit
form,  is reconstituted with
stannous chloride and
99mTc pertechnetate. 
For imaging kidneys and gall
bladder; myocardial imaging is
possible with larger doses.
See earlier comment on
99mTc.  The compound
localizes in the gall bladder.
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Table 6-4.  Some Radiopharmaceuticals Used in Medicine (continued)
Radionuclide Preparation Use Properties
201Tl Thallium
Chloride
Thallium target material is
bombarded with protons to
produce 201Pb.  The unused
thallium material is removed
by ion exchange, and the
remaining 201Pb
subsequently decays to
201Tl.
Used for myocardial perfusion
imaging for the localization of
myocardial ischemia and infarction;
used as an adjunct to angiography. 
Also useful for thyroid imaging,
particularly the detection of goiter
and thyroid carcinoma.
Thallium mimics potassium
ions and is taken up by the
cells of the heart; decreased
cell vitality is indicated by
decreased thallium uptake.
Rapidly disappears from the
blood.
15O Water Prepared by labeling with a
cyclotron-generated
radionuclide.
Used in blood-flow imaging using
positron emission tomography
scanning.
127Xe Xenon gas Produced by proton
bombardment of cesium-
133 with 127Xe.
As a gas, used for lung imaging to
detect alveolar block-age; also used
for mapping cerebral blood flow.
Dissolved in saline used as a tracer
for measurement of regional blood
flow.
The biological half-life of the
gas is approximately
15 minutes. 
133Xe Xenon A product of nuclear fission;
also formed by neutron
activation of 132Xe.
As a gas, used for lung imaging to
detect alveolar blockage; also used
for mapping cerebral blood flow.
Dissolved in saline used as a tracer
for measurement of regional blood
flow.
The biological half-life of the
gas is approximately
15 minutes. 
Source: Remington 1985; Remington and Gennaro 1995
6.6 EXPOSURE FROM CONSUMER PRODUCTS
Consumer products contribute an estimated 3% to the average population radiation dose.  Several
consumer products, used both within the home and in many public areas, emit minuscule amounts of
radiation.  Among these are ionization-type smoke detectors, television sets, and liquid propane gas
(LPG) appliances.  The first smoke detectors contained radium (approximately 20 µCi [0.7 MBq]), but
now contain americium-241 (241Am), which is more economical and produces much less radiation dose. 
While present-day detectors contain 0.5–1.0 µCi (0.02-0.04 MBq) of 241Am, the original units contained
approximately 80 µCi (3 MBq).  In the 1980s, annual sales of smoke detectors approached 12 million,
representing approximately 8.5 Ci (300 GBq) of 241Am.  Smoke detectors contain a small ionization
chamber in which the air between two electrodes is ionized by the source radionuclide.  This ionization
allows the flow of current across the gap between the electrodes.  When the flow is stopped by smoke
particles, the interruption in current flow is interpreted by the detector to indicate the presence of smoke. 
Television sets accelerate electrons that bombard the screen; in the process, low-energy x rays are
emitted.  The total annual dose associated with watching a color television has been estimated to be
2–3 mrad per year (0.02-0.03 mGy/yr).  Radon is found in LPG, which may be used in water heaters,
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stoves, and fireplaces; it has been estimated that exposure to radon in homes using natural gas results in
an average annual dose of approximately 5 mrem (0.05 mSv) in the United States.
Among consumer products of the past are items that contained radium, such as medicines, tonics,
luminous paints, and ceramic glazes.  After its discovery in the early part of the 20th century, radium was
used for many years in the treatment of rheumatism (arthritis) and mental disorders; oral solutions
contained 226Ra and 228Ra at concentrations up to 2 µCi/60 mL, while ampules for intravenous
administration contained 5–100 µg 226Ra and 228Ra.  Radium was also used to produce luminescent paints
that were applied to wristwatches, clocks, static eliminators, fire alarms, electron tubes, and military and
educational products.  During the peak years of production, approximately 3 million radium-laden
timepieces were sold annually in the United States.  The radium content of a man’s wristwatch ranged
from 0.01 to 0.36 µCi (370-13,000 Bq), resulting in potential gonadal doses of 0.5–6 mrem/year
(0.005—0.06 mSv/yr).  Radium has been replaced with 3H and prometium-147 (147Pm), and watch cases
are sufficiently thick to absorb the beta emissions from these radionuclides.  Uranium has been used as a
coloring agent for ceramic glazes, resulting in doses to the hands of up to 20 mrad/hour (0.02 mGy/hr). 
The dose from ceramics produced since 1944 is thought to be five-fold less than that from earlier pieces. 
For more than 40 years, 224Ra has been used in Europe to treat the symptoms of tuberculosis and
ankylosing spondylitis.  Although its use in children was curtailed in the 1950s,  224Ra has been used for
treating the pain associated with ankylosing spondylitis.  In two studies of patients treated with 224Ra,
average calculated skeletal doses ranged from 0.65–4.2 Gy (65–420 rad) (Eisenbud 1987; Harley 1996;
Harvard Medical School 1996; NCRP 1993).  
6.7 EXPOSURE FROM OTHER SOURCES
Other sources contribute less than 1% to the average population radiation dose.  This radiation exposure
may result from several anthropogenic sources, including the radioactive debris still remaining from
atmospheric and underground detonation of nuclear weapons, electrical energy production,
radiopharmaceuticals, and radionuclide production and use (Shapiro 1990; UNSCEAR 1993).
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Figure 6-2.  Schematic of the Nuclear Fuel Cycle 
6.7.1 Exposure from the Nuclear Fuel Cycle
The nuclear fuel cycle contributes around 0.1% to the
average population radiation dose and refers to the mining,
milling and enrichment of uranium; fabrication of fuel
elements; the production of electricity; and the recycling,
transportation, and waste storage/disposal of radioactive
m a t e r i a l s  u s e d  i n  n u c l e a r  w e a p o n s  o r
reactor-grade nuclear fuel.  The steps involved in the
uranium fuel cycle are depicted in Figure 6-2 and described
in the Toxicological Profile for Uranium (ATSDR 1999b).
The primary radionuclide components of nuclear weapons
and reactors include 239Pu, 235U, 238U, and 3H.
Radionuclides associated with uranium mining and milling
include 235U, 238U, and their natural decay chain radionuclides, such as 226Ra, 234Th, 234mPa, 230Th, and 222Rn,
while those associated with power production and subsequent waste disposal include  (but are not limited to)
60Co, 3H, 14C, 129I, 131I, 134Cs, and 137Cs.  Noble gas radionuclides of Kr, Xe, and Zr are only associated with
operational reactor releases.  The various steps within this cycle provide multiple opportunities for the
exposure of humans to these materials.  
Mining and milling.  Uranium ore typically contains uranium at concentrations ranging from a tenth of a
percent to a few percent; thus, millions of tons of ore are mined and processed annually to meet the needs of
nuclear power plants for uranium fuel.  Radon is the predominant radionuclide released from uranium mines. 
Radon containing air is discharged from mines at a rate of approximately 0.5–20 µCi/min/1,000 ft3; these are
point releases whose concentrations dilute quickly with distance from the release shaft and, thus, pose no
additional health risk to the general public.  Incomplete extraction of uranium during milling results in
uranium concentrations in mill tailings of 0.001–0.01%.  The presence of radon precursors (226Ra and 230Th) in
mill tailings presents a potential long-term source for atmospheric radon.  The rate of radon emanation varies
with meteorological factors such as barometric pressure and humidity.  The rate of soil and mill tailings
migration depends primarily on wind and water erosion of the site (Eisenbud 1987; UNSCEAR 1993).
IONIZING RADIATION 256
6.  SOURCES OF POPULATION EXPOSURE TO IONIZING RADIATION
Enrichment and fuel fabrication.  In both nuclear weapons and nuclear fuel production, after being
mined and milled, uranium must be converted to uranium hexafluoride gas, which is then enriched and
converted to uranium oxide or metal.  If enrichment is carried to about 90%, the uranium may be used to
make nuclear weapons or to fuel naval warships; alternatively, the uranium may be enriched by only a small
percentage for use in civilian nuclear energy facilities.  Metallic uranium is capable of reacting with both air
and water exothermically; because of this reactivity, the more stable uranium oxide is the most commonly
used fuel in reactors.  While this form is more stable, it has poor thermal conductivity, necessitating the use
of small-diameter fuel rods.  The fuel is in the form of high melting point ceramic pellets, about 0.5 inches in
diameter and 1 inch long, in which UO2-enriched to 3–4% 235U is dispersed.  These pellets are stacked end to
end in zirconium alloy or stainless steel tubes about 12 feet long (called cladding) and then sealed to retain
the fission products that are produced during operation.  These fuel filled tubes are then assembled in groups
of 8 x 8 to 17 x 17 arrays into fuel rod assemblies.  About 500 of these assemblies make up the core of a
nuclear power reactor.  For a frame of reference, a single pellet contains the energy equivalent of about one
ton of coal or 3 barrels of oil.  Emissions from fabrication facilities usually consist of the long-lived isotopes
234U, 235U, and 238U, and the short-lived nuclides 234Th and 234mPa; however, the relative value of the refined
and enriched uranium and the high level of accountability for uranium stock preclude any long-term or
widespread loss of material.  The major route of exposure from this source is inhalation (Eisenbud 1987;
UNSCEAR 1993).  More information about the toxicological properties of uranium can be found in the
Toxicological Profile for Uranium (ATSDR 1999b).
Power generation.  Power production from nuclear plants has increased steadily since the industry’s
birth in the 1950s.  During the years between 1970 and 1989, the number of nuclear reactors worldwide
increased from 77 to 426, and total nuclear power generation increased from 9 to 212 gigawatts per year. 
In 1996, nuclear power plants produced 17% and 19.4% of the world’s and U. S. electrical energy,
respectively (DOE 1997c).  The annual worldwide production of uranium from 1979 to 1989 ranged from
19,000 to 44,000 tons; from 1985 to 1990, the annual production was approximately 50,000 tons. 
USNRC regulations require that all the component parts of the nuclear fuel cycle be designed and
operated to limit the annual dose to a member of the public from the total nuclear fuel cycle to a
maximum of 25 mrem (0.25 mSv).  Various regulations identified in Chapter 7 of this profile are
designed to limit human exposure to radiation and radioactive materials.  Guidance documents, such as
the ANSI air sampling standard (ANSI 1999), are available to aid in establishing monitoring programs for
assessing discharges from nuclear facilities.  During the energy production phase, radioactive
contamination of the coolant occurs through small defects in the protective cladding surrounding the fuel
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pellets, through fission of “tramp” uranium contamination on the outside surface of the fuel rods and
through neutron activation of contaminants in the cooling medium.  
In general, the levels of radionuclide emissions from reactors are not typically detectable, except at points
close to effluent discharges; because of this, estimates of radionuclide discharge levels must be modeled. 
Based on such models, the total collective dose due to reactor discharges through 1989 was estimated to
be 370,000 man•rem (3,700 man•Sv) over a 45-year period.  This may be compared to the collective dose
to the U.S. public from the natural radioactive potassium within everyone’s body, which is about
5,000,000 man•rem (50,000 man•Sv) each year .   A 1981 U.S. Nuclear Regulatory Commission
(USNRC) study of the doses received by 98 million people living within 80 km of 48 nuclear facilities
concluded, on the basis of a zero threshold model, that 0.02 excess fatal cancers per year, or 1 every 50
years, could be attributed to exposures from nuclear facilities (USNRC 1981).  A study of the cancer rates
in populations surrounding 62 U.S. nuclear facilities, performed by the National Cancer Institute (NCI) in
1990, found no evidence of a relationship between proximity to a nuclear facility and the occurrence of
cancer (Eisenbud 1987; NCI 1990; UNSCEAR 1993).
Weapons production. There is little public information regarding the amount of radioactive materials
produced for use as weapons.  The atmospheric content of krypton-85 (85Kr), a by-product of plutonium
extraction, has been used to estimate the plutonium stockpiles in both the United States and Russia.  After
adjusting for production and release of 85Kr from nuclear reactors, it is estimated from the atmospheric content
of 85Kr that plutonium stockpiles in both the United States and Russia is about 100 tons each.  United Nations
estimates from 1981 and 1990 state that nuclear arsenals are comprised of 40,000 weapons with a combined
explosive power of 13,000 Mt.  Tritium, which has a half-life of 12.32 years, must be continually produced
to replace aging stockpiles.  It is estimated that an annual production of 3 kg is sufficient to replace that lost
by transformation in the United States.  By inference, this would indicate a total U.S. stockpile of 55 kg and
a world stockpile of about 110 kg (UNSCEAR 1993).
The dose from nuclear weapons research, development, and production is less than 1% of the dose from
atmospheric testing.  Variations in local exposure from former weapons plants have been reported.  In the
United States, the Hanford nuclear weapons facility has released a significant amount of radioactive
material into the atmosphere and the Columbia River from its plutonium production and reprocessing
plants.  The majority of the radioactive material (131I) was released between 1944 and 1946 (18 PBq;
486 kCi), although additional releases are known to have occurred from 1947 to 1956 (2 PBq; 54kCi).  A 
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recent study reconstructed the radiation doses to individuals who were exposed to the 131I released from
the Hanford site, medically determined their thyroid health, and found that the Hanford releases had not
caused thyroid problems.  The thyroid radiation doses to the 3,193 participants averaged 0.186 Gy
(18.6 rad) and ranged from 0–2.842 Gy (0–284.2 rad).  Health impacts to the thyroid which have been
related to radiation exposure in other studies include thyroid cancer, benign thyroid nodules,
hypothyroidism, and autoimmune thyroiditis.  The study assessed these conditions and concluded that the
occurrence of these diseases in the population were not related to the Hanford releases’ radiation dose to
the thyroid (CDC 1999). 
The Chelyabinsk-40 center, located near Kyshtym in the Soviet Union, was the first nuclear weapons
processing facility in Russia.  A uranium-graphite-moderated reactor and a fuel reprocessing plant were
opened in 1948.  Due to poor waste handling and the storage of radioactive wastes in the open, significant
liquid releases (100 PBq; 2.7MCi) to the Techa River occurred from 1949 to 1956, with the majority of
the releases (95%) occurring from March 1950 to November 1951.  The main nuclides released included
89Sr, 137Cs, 95Zr, 95Nb, and ruthenium and rare-earth nuclides.  The population along the Techa River was
exposed to both external and internal doses of radiation; a total of 20 settlements (7,500 people) were
eventually evacuated.  The average doses to persons living in the village of Metlino, 7 km downstream
from the plant, were estimated to be as much as 140 rad (1.4 Gy) (UNSCEAR 1993).
Fuel reprocessing.  Fuel reprocessing allows the recovery of uranium and plutonium from the
irradiated fuel pellets.  Less than 10% of the nuclear fuel is consumed in a spent fuel rod.  The
radionuclides most commonly associated with reprocessing waste are: 3H, 14C, 85Kr, 129I, 131I, 134Cs, 137Cs
and transuranium nuclides.  At present, reprocessing is carried out in only a few countries, and only a
small portion of the total fuel inventory is being reprocessed (4% from 1985 to 1990).  The remainder is
retrievably stored (UNSCEAR 1993).
The reprocessing of nuclear fuel has been performed almost exclusively at government-owned facilities
designed to meet military needs. Only 1 operable reprocessing facility exists in the U.S.  As with nuclear
reactors, the facility and the equipment used have been designed with numerous safeguards to prevent
criticality and to ensure containment of radioactive material in the event of a non-nuclear explosion or
system failure.  The estimated collective dose due to reprocessing to date is estimated to be 460,000
man•rem (4,600 man•Sv); the main radionuclide constituents (>90%) of these releases have been 137Cs
and 106Ru.  Releases of gaseous 85Kr and 3H from reprocessing facilities have also been reported.  The
main pathways of exposure are consumption of locally caught fish and shellfish, external (whole-body)
irradiation from intertidal areas, and external (dermal) irradiation of fishermen handling pots and nets. 
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Figure 6-3.  Replicas of the “Little Boy” and “Fat Man” Bombs
Dropped on Hiroshima and Nagasaki (adapted from A-Bomb WWW
Museum, http://www.csi.ad.jp/ABOMB).
Annual individual doses were estimated for critical populations living near three foreign reprocessing
plants (Sellafield, England; Cap de la Hage, France; and Tokai-Mura, Japan) for which records of
radioactive effluent exist.  For the critical population living near Sellafield, annual individual doses from
ingestion were estimated to be approximately 350 mrem (3.5 mSv) during the early 1980s and declined to
approximately 20 mrem (0.2 mSv) by 1986.  The estimated doses in the same group due to external
irradiation were estimated to be about 100 mrem (1 mSv) in the early 1980s and 30 mrem (0.3 mSv) by
1986.  In contrast, annual individual doses for critical populations living near the Cap de la Hage and
Tokai-Mura reprocessing plants were approximately 25 mrem (0.25 mSv) and 0.1 mrem (1 µSv)
(Eisenbud 1987; UNSCEAR 1993).  A nuclear criticality accident occurred at the Tokai-Mura, Japan
uranium reprocessing plant on September 30, 1999 with acute exposures to workers and general
population (UPI 1999).
Waste disposal.  Solid wastes derived from reactor operations and from the handling, processing, and
disposal of spent fuel are classified as low-, intermediate-, or high-level wastes.  While low- and
intermediate-level wastes had been packaged and placed into shallow burial sites, high-level waste
disposal strategies have only recently been implemented.  Some low-level wastes were packaged and
disposed at sea from 1946 to 1982.  Currently, some high level waste is being vitrified (mixed with hot
liquid glass), solidified inside double-walled stainless steel containers, and prepared for long-term
retrievable storage.  Exposure to uncontained buried wastes is thought to occur throught groundwater
migration from leakage at the burial site.  The major radionuclide found in reactor waste is 14C
(UNSCEAR 1993).
 6.7.2 Japanese Atomic Bomb
Exposure
A large human cohort (86,572 people who
survived the detonation of two atomic bombs
in Japan in 1945 and whose radiation doses
are reasonably well known) are being studied
for the effects of external exposure to ionizing
radiation.  The Japanese survivors are not the
largest cohort; some medically exposed
populations are larger.  However, the
Japanese survivors are probably the most
important because of the length of follow-up
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and the wide range of doses received.  The first atomic bomb was detonated on July 16, 1945, in Alamogordo,
New Mexico.  The U.S. military, in an effort to bring a swifter end to World War II and to avoid a costly
ground invasion of Japan, which could claim more U.S. and Japanese lives, detonated a 235U atomic bomb,
nicknamed “Little Boy,” (see Figure 6-3) over the city of Hiroshima, Japan, on August 6, 1945.  Three days
later, an atomic bomb using 239Pu, nicknamed “Fat Man,” was detonated over the city of Nagasaki, Japan. 
The uranium used in the “Little Boy” bomb was enriched to >80% 235U.  (Natural uranium contains 0.7%
235U, and reactor fuel is enriched to 3–4% 235U).  The uranium bomb design of Little Boy used a standard
explosion trigger, called the "gun" method, because it was originally made using a gun barrel.  In this
configuration,  a sub-critical uranium mass, referred to as the “bullet,” was propelled inside the gun barrel
toward a second sub-critical portion of the uranium mass (called the “target”), which was located at the
end of the gun barrel.  The target contained slightly less than the amount of uranium needed to achieve
critical mass (the amount necessary to create a chain reaction).  The instant the two subcritical pieces of
uranium came together, super-criticality was attained, and an explosion with a force equivalent to 15,000
tons (15 kt) of trinitrotoluene (TNT) occurred (Roesch 1987).  In the case of Little Boy, the bullet was a
cylindrical stack of nine 235U wafers about 10 cm wide and 16 cm long, containing 40% of the bomb’s
total 235U mass (25.6 kg).  The target was a hollow cylinder 16 cm long and wide;  it weighed 38.4 kg and
was composed of two separate rings that were inserted into the bomb separately to prevent reaching
critical mass during assembly.  The complete Little Boy weapon was 10.5 feet long, 28–29 inches in
diameter, and reportedly weighed between 8,900 and 9,700 pounds.  The firing mechanism was so simple
and was considered so failproof that it was not tested prior to its use over Hiroshima.  The gun-type firing
mechanism was, however, an unsafe weapon design, in that once the firing mechanism was loaded with
high explosive, anything that ignited it would cause a nuclear explosion.  Also, a crash or even an
accidental drop of the bomb could have driven the bullet into the target, potentially resulting in a nuclear
explosion.  No other weapon of this design was ever tested, and although several Little Boy units were
built, none ever entered the U.S. nuclear arsenal.
The plutonium bomb, Fat Man, was dramatically different from the Little Boy design.  The gun-type
firing mechanism could not be used to unite two pieces of plutonium fast enough to achieve a nuclear
blast; impurities in the plutonium would have caused premature detonation.  Fat Man contained a ball of
subcritical plutonium (plutonium core), which was surrounded with high explosives.  The high explosives
were cast into spheres, called lenses, and were wired so they would all fire at the same instant.  The
instantaneous pressure from all sides compressed the plutonium core in on itself, causing it to reach
critical mass and density, and create a nuclear blast.  The combat configuration for the Fat Man bomb 
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consisted of the implosion device encapsulated in a steel armor egg.  Fat Man was 5 feet in diameter,
12 feet in length, and weighed 10,300 pounds (American Airpower Heritage Museum 1996; Sublette
1996).  The explosion of Fat Man at Nagasaki was equivalent to 21,000 tons (21 kt) of TNT (Roesch
1987).
In Hiroshima and Nagasaki, a total of 64,000 people within 1 km of the hypocenter (the point on the
ground directly below where the bomb exploded in the air) died on the first day.  The total numbers of
acute deaths from the explosions were 90,000–140,000 in Hiroshima and 60,000–80,000 in Nagasaki. For
bombs the size (approximate yield of 15 kilotons) and type of Little Boy, the energy released within the
first minute after detonation was in the forms of thermal radiation (35%), blast wave (50%), and ionizing
radiation (15%); most casualties (including fatalities) resulted from the heat and blast.  Two-thirds of
those who died during the first day were burned.  People close enough to suffer from radiation illness
were also well within the lethal zones from blast and heat; thus, the proportion of survivors experiencing
radiation illness (30%) was much smaller than the expected proportion based solely on exposure to
radiation.  People within 1–2 km of the hypocenter who initially survived the blast and received several
hundred rad (several grays) of radiation, suffered the ill effects of acute radiation syndrome.  It is
estimated that all persons whose bodies received a dose of 600 rad (6 Gy) and half of those whose
radiation doses were 450 rad (4.5 Gy) died shortly thereafter, as a direct result of radiation exposure.  Of
those who survived the immediate radiation illness effects, a portion would suffer from the latent effects
of radiation-induced cancer (the excess cancer death rate among the exposed population is on the order of
5% greater than that of an unexposed population).  It is estimated that approximately 500 survivors have
died of radiation induced cancers since 1945.  Given the estimated altitudes at which Little Boy and Fat
Man detonated (1,900±50 ft. and 1,650±33 ft., respectively), little or no soil was carried up into the
fireball, so the fallout produced came mainly from the detonation itself.  Of that, very little radioactive
material was deposited on the ground in the vicinity of ground zero; the majority was carried high into the
atmosphere by heat convection.  A small amount of fallout did occur in areas close to the cities due to
rainfall that occurred shortly after the explosions; the affected areas were to the west and northwest of
Hiroshima and a few miles east of Nagasaki.  Fatality rates in the Hiroshima and Nagasaki attacks were
1–2 orders of magnitude greater than rates from conventional bombings because of the nearly
instantaneous destruction of buildings that occurred without warning, and because survivors were so
incapacitated that they could not escape the rapidly ensuing fire storms.  Approximately one-third of all
Japanese bombing fatalities occurred in these two cities (Masse 1996; Sublette 1995, 1996; Uranium
Information Center 1995; Zajtchak 1989). 
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6.7.3 Exposure from Nuclear Weapons Testing
Nuclear weapons testing is conducted to assess design efficiency and magnitude of resulting damage. 
Nuclear explosions world wide were carried out above ground from 1945 to 1980, with the periods of
greatest activity occurring from 1952 to 1958, and from 1961 to 1962.  A total of 520 tests with an
estimated total equivalent energy of 545 megatons (Mt) of TNT was performed, resulting in the release of
220 PBq (6 MCi) of radioactive material.  The first U.S. testing of nuclear weapons after World War II
was performed in the Marshall Islands in the Pacific Ocean from 1946 to 1948.  The Soviet Union
conducted its first weapons test in 1948.  In the 1950s, as the frequency of weapons testing escalated, so
did public concerns over radioactive fallout.  In the fall of 1958, the United States, Britain, and Russia,
declared a moratorium on weapons testing; however, Russia broke the agreement in 1961, and another
rapid escalation in testing ensued.  In 1963, the United States, Britain, and Russia, signed the Limited
Test Ban Treaty, which prohibited atmospheric testing.  Although these three countries have remained
faithful to the treaty, other countries such as France, China, India, and Pakistan have since conducted
weapons testing (Eisenbud 1987; PBS 1999; UNSCEAR 1993).
The energy from nuclear weapons devices is generated by one or both of the following reactions:  (1) the
fission of 235U or 239Pu in a chain reaction and (2) the fusion of the hydrogen isotopes deuterium and
tritium.  Fission-type weapons accounted for 217 Mt of the total test yield, while fusion-type weapons
accounted for 328 Mt.  Many radionuclides are produced by U and Pu fission.  Fusion reactions produce
helium and result in the neutron activation of the surrounding substance.  The most notable neutron
activation product is 14C, which is formed from the neutron bombardment of atmospheric nitrogen. 
Unused weapons material is also liberated after detonation due to premature loss of critical mass (Radnet
1996; UNSCEAR 1993).
The most important radionuclides associated with nuclear weapons testing exposures are 14C; 137Cs;
zirconium-95 (95Zr); niobium-95 (95Nb); 90Sr; ruthenium-106 (106Ru); manganese-54 (54Mn); 144Ce; 131I;
and 3H.  This is in addition to the large amounts of 14C and 3H in the biosphere’s carbon and hydrogen
inventories which are produced by the interaction of cosmic rays with atmospheric gases. 
The disposition of ingested strontium-90 (90Sr)  has been studied extensively due to its abundance
(15 MCi of that introduced into the atmosphere as a result of nuclear weapons testing fell to the earth by
January 1970), its long half-life (28 years), and its tendency to localize in bones.  Metabolically, Sr
follows the pathways of calcium (Ca); however, the body discriminates against Sr in favor of Ca.  
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Because of this parallel mechanism, Sr concentrations are often expressed as activity of Sr per gram of
Ca.  In 1965, bone levels of 90Sr in 1- to 4-year-old Norwegian children averaged 11.8 pCi/g Ca.  In New
York City, bone levels of 90Sr in 1- to 2-year-olds varied from 7 pCi/g Ca in 1965 to 1.6 pCi/g Ca in
1975.  In 5- to 19-year-olds, bone levels varied from 3 pCi/g Ca during 1956–1968 to 1.4 pCi/g Ca in
1975 (Shapiro 1990).  In an effort to quantify exposure resulting from nuclear testing, 90Sr deposition has
been monitored worldwide at 50 to 200 stations in cooperation with the Environmental Measurements
Laboratory (EML), and by a network of 26 stations organized by the United Kingdom Atomic Energy
Authority.  These data are compiled into a report called Environmental Radiation Data (ERD), which is
distributed quarterly by the Office of Radiation and Indoor Air’s National Air and Radiation
Environmental Laboratory (NAREL).  The report contains data from the Environmental Radiation
Ambient Monitoring System (ERAMS).  ERAMS was established in 1973 by the EPA to provide air,
surface and drinking water, and milk samples from which environmental radiation levels are derived. 
These samples are collected from locations that provide adequate population coverage and function to
monitor fallout from nuclear devices and other radioactive contamination from the environment.  Samples
are subjected to analysis for gross alpha and beta emissions; gamma analyses for fission products; and
more specific analysis for uranium plutonium, strontium, iodine, radium, and tritium (EPA 1997). 
Zirconium-95 (95Zr) deposition has been monitored as an indicator of exposure to short-lived radio-
nuclides.  Monitoring levels of  3H and 14C is more difficult due to the rapid recycling of these elements in
a biosphere that contains large cosmogenically produced amounts of these same radionuclides.  
Interhemispheric transfer is limited due to prevailing trade winds and the scavenging effect of
precipitation in the tropics.  The best estimate of the average total per person dose, for persons in the
northern and southern hemispheres, for all 22 major radionuclides resulting from nuclear testing is 440
and 310 mrem (4.4 and 3.1 mSv), respectively.  Worldwide, the average total cumulative dose is
370 mrem (3.7 mSv).  However, as noted below, extreme variations in local exposures due to testing have
been noted (UNSCEAR 1993).
Approximately 23 billion Ci of 131I have been introduced into the atmosphere as a result of nuclear
weapons testing.  In October 1961, the air concentration of 131I in the United States averaged 3.8 pCi/m3. 
This was estimated to result in an annual dose of 24 mrad to a 1-year-old child.  In 1962, the
concentration of 131I in milk in the United States averaged 32 pCi/L.  Although about two-thirds of orally
administered 131I is excreted in the urine within the first 24 hours, the remainder concentrates in the
thyroid.  It has been estimated that an infant receiving milk from cows that grazed on forage contaminated
with 1 µCi 131I/m2 could receive a dose to the thyroid of 30 rad (Shapiro 1990; UNSCEAR 1993).  In
addition, studies of pregnant women who died suddenly of non-radiation-induced causes (e.g., car
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accidents) found that fetal tissue concentrations of 131I were 30% greater than those in maternal tissues
(Shapiro 1990).  Due to the short 8-day half-life of 131I, there is no 131I remaining in the atmosphere or in
food from nuclear weapons testing.
Plutonium (Pu) has been introduced into the atmosphere from sources such as weapons testing (>5,000 kg
[>320 kCi]) and the vaporization of energy power packs from a Russian satellite (20 kg  [0.27 TBq] of
239Pu) and U.S. satellites (1 kg [17 kCi] of 238Pu ) that burned up upon re-entry.  Air activity of Pu,
monitored in New York, peaked in 1963 at a concentration of 1.7 fCi/m3.  The cumulative inhalation
intake from 1954 to 1975 averaged 43 pCi per person.  For comparison, the EPA’s annual limit on intake
(ALI) for 239Pu for occupational exposure is 2,000 pCi. Cumulative individual tissue doses (through the
year 2000) due to inhalation are predicted to be: lungs, 1.6 mrad; liver, 1.7 mrad; and bone lining cells,
1.5 mrad (Shapiro 1990). 
Radioactive debris from nuclear explosions falls into three categories: large particles, which fall out close
to the explosion site within hours of the explosion; smaller particles, which penetrate the troposphere,
behave like aerosols, and may not fall out for days; and the smallest particles, which penetrate the
stratosphere, distribute worldwide, and fall out over many months or years.  The greatest portion of
fallout from nuclear weapons testing was injected into the stratosphere (78%), while 10% and 12% were
injected into the troposphere and in the locality of the test, respectively.  As of 1993, the total cumulative
worldwide collective dose due to fallout was estimated to be 7x106 man•Sv.  The collective dose will
continue to climb, mainly due to long-lived 14C (Eisenbud 1987; UNSCEAR 1993).
Airborne radioactive materials, both naturally occurring and fallout-derived, usually attach to dust
particles; the potential for inhalation of radionuclides bound to particles, and the respective threat this
poses to animal and human health, varies considerably.  In regions downwind of nuclear weapons test
sites or nuclear weapons production facilities, or areas with abnormally high concentrations of naturally
occurring radionuclides (e.g., New York state or Denver, Colorado), the potential for inhalation of
particulate-bound radionuclides increases.  Although most inhaled radioactive particles are eliminated
from the lungs by normal clearing mechanisms, some of the particles remain in the lungs for extended
periods.  Others are carried to lymph nodes by scavenger cells (Eisenbud 1987; Shapiro 1990).
Radiation dose from atmospheric testing is attributed to external exposure to radionuclides on the earth's
surface,  internal exposure from inhalation of gases or particulate matter, and ingestion of contaminated
foods and water.  Approximately 80% of the radiation dose from nuclear testing is estimated to be 
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delivered through ingestion, with 16% and 4% of the dose delivered through external exposure and
inhalation, respectively.  Radioactive particles resulting from fallout can contaminate food supplies
directly by foliar deposition, or indirectly by entry into the soil and subsequent incorporation into plants,
although this delayed incorporation through root uptake accounts for a small portion of that ingested. 
Surface waters can be contaminated through soil runoff or direct contamination from the atmosphere. 
The degree of radionuclide incorporation into plants through root uptake varies considerably among
radionuclides.  For example, 137Cs and radium bind tightly to clay or organic minerals upon entering the
soil and are not amenable to root uptake; thus, foliar deposition is the primary route for oral exposure to
137Cs.  Likewise, 131I poses little threat through root uptake due to its short half-life (8 days).  The
concentrations of radionuclides in food vary considerably across food types.  The concentration of 226Ra
ranges from 0.15 pCi/kg in cow’s milk to 2,000 pCi/kg in Brazil nuts.  Concentrations of 137Cs range from
20 pCi/kg in cow’s milk to 5,000 pCi/kg in beef.  More important than concentrations in foods is the rate
of intake and absorption of a radionuclide.  Individual intake varies considerably; for a given radionuclide
and locality, intake may vary as much as 500-fold.  Likewise, the extent of absorption varies among the
various nuclides, from almost completely in the case of 40K, 137Cs, and 131I, to very poorly (0.003%) in the
case of Pu radionuclides.  Many alpha emitters, such as 226Ra, are taken up and retained in the bone,
resulting in sustained alpha irradiation of the bone-forming cells and bone surface lining cells
(Eisenbud 1987; McClellan 1982; Shapiro 1990). 
The primary radionuclides of concern are 90Sr, 137Cs, and 131I.  Within the first year, 45% of 137Cs is
transferred to the food chain (through milk, grain and meat).  90Sr enters the food chain primarily through
milk and grain products.  Exposure to 14C and 3H is through ingestion and inhalation; however, the
contribution of 14C and 3H by ingestion is trivial.  The dose rate from naturally occurring 14C is about 1
mrem per year.  At its peak effect, the dose rate from 14C due to weapons testing also was about 1 mrem
per year, and is now decreasing.  The dose from the tritium due to weapons is considered to be even less. 
At the peak, the additional 3H contributed less than 0.1 mrem per year (UNSCEAR 1993).  The radiation
dose from 131I occurs largely during the first 2 months following detonation, due to its short 8-day half-
life, and the primary exposure route is via the pasture-cow’s milk ingestion pathway.
In addition to exposures from inhalation and ingestion, radiation exposure also occurs externally from
particles deposited on the ground.  Since the debris spends more time on the ground than in the air, the
radiation dose from earthbound particles ranges from 100 to 1,000,000 times that from airborne particles
(UNSCEAR 1993).
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6.7.3.1 Atmospheric Testing
Atmospheric testing refers to the detonation of nuclear bombs above the earth’s surface.
Nevada Test Site Fallout.    A total of 100 surface or near-surface tests with a total explosive yield of
about 1 Mt were performed at the Nevada test site between 1951 and 1962.  The population around the
site at this time was approximately 180,000 persons.  Within this population, thyroid doses in children
may have been as high as 100 rad (1 Gy).  The collective dose received by this population was
approximately 50,000 man•rem (500 man•Sv); 90% of this dose was delivered between 1953 and 1957. 
The dust from these tests also drifted over the United States, producing bands of exposure to radioactive
material.  Deposition of fallout varied considerably because of meteorological conditions.  For example,
the greatest (non-local) fallout levels from one of the Nevada test explosions occurred in New York State,
some 2,000 miles away, due to rainfall.  The cumulative dose from gamma radiation in New York,
approximately 100 mrad (1 mGy), exceeded the doses received by any remote U.S. location for all of
1953  (Eisenbud 1987; UNSCEAR 1993).
Bikini Atoll Fallout.    Operation Crossroads was a series of nuclear weapons tests that began in the
Marshall Islands, a group of atolls in the Pacific, on July 1, 1946.  Prior to testing, the inhabitants of the
Bikini Island Atoll were evacuated.  The second test in this series, designated “Baker,” was a 21-kiloton
bomb that was detonated underwater.  This resulted in contamination of ships staged nearby and the atoll
itself.  Local soil contamination prevented the return of the Bikini native population until 1969.  Although
the island was still contaminated in 1969, it was thought that dietary restrictions and the importation of
foods would allow safe habitation.  However, body burdens of plutonium began to increase in the natives,
resulting in their re-evacuation in 1978.
During Operation Castle, another series of nuclear tests, the second test, “Bravo,” resulted in significant
fallout and contamination of humans.  Abrupt changes in wind direction after the 15-Mt detonation on
March 1, 1954, resulted in the inadvertent exposure of residents of the Rongelap and Utirik islands, which
lie 210 and 570 km to the east of Bikini, as well as exposure of a group of 23 Japanese fishermen whose
boat was caught in the fallout approximately 80 miles downwind.  Since the device was mounted on a
barge situated in shallow water, a considerable amount of coral was incorporated into the fireball.  The
fishermen reported that the fallout particles resembled snow and that deposits of fallout on the boat were
of sufficient depth to allow one to see footprints.  Because they were unaware of the circumstances, the
fishermen took no precautionary measures to minimize exposure; they remained on the contaminated boat 
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until returning to port some 13 days later.  Within 1–2 days after exposure to the fallout, the fishermen
began to experience itching and burning sensations on exposed skin.  By the third day, skin lesions and
epilation began to develop; the skin lesions became ulcerous in about 70% of the fishermen.  Lesions
were less severe in those who had worn protective clothing such as hats (ACHRE 1995; Eisenbud 1987). 
A more detailed description is available (Simon and Vetter 1997).
Within 78 hours of the explosion, 82 and 159 persons were evacuated from Rongelap and Utirik,
respectively.  However, as with the fishermen, the island inhabitants took no precautionary measures to
minimize exposure to radioactive fallout.  Within 1–2 days after exposure to fallout, itching and burning
sensations on exposed skin were experienced by the natives of Rongelap, but not those of Utirik.  Skin
lesions and epilation occurred within 21 days of exposure, becoming ulcerous in about 25% of the
Rongelaps; lesions were less severe in those who had worn protective clothing or bathed during the
period prior to evacuation.  The island of Utirik was not heavily contaminated, and its residents were
allowed to return within a few months; however, the Rongelap residents were not allowed to return to
their island until 1957, and they were monitored annually by U.S. medical teams thereafter.  Despite the
monitoring, fears among the island residents that exposure-related health problems were occurring
prompted a second evacuation, initiated by the residents, in 1985.  External doses, ranging from 10 to 190
rad (0.1 to 1.9 Sv), were mostly from short-lived radionuclides.  Mean thyroid doses to adults, 9-year-
olds, and 1-year-olds, were 1,300, 2,200, and 5,200 rad (13, 22, and 52 Gy), respectively.  Maximum
thyroid doses to these groups were 4,200, 8,200, and 20,000 rad (42, 82, and 200 Gy), respectively
(ACHRE 1995; Eisenbud 1987; NAS 1994; UNSCEAR 1993).  
Average gamma dose rates 3 feet above ground level on Rongelap island, estimated from a survey
performed in July 1956, were 0.2–0.5 mR/hr (mean of 0.4 mR/hr) (DOE 1994b).  Environmental samples
collected in 1964 showed 239Pu concentrations of 11 pCi/g (0.4 Bq/g) in a soil sample collected at a depth
of 0.5–1.0 inch.  A more extensive survey that included 14 of the atoll islands was performed in April and
May of 1967.  External radiation, as well as the radioactive content of food, vegetation, and soil, was
measured.  On the islands closest to the detonations, the major contributor to the external gamma
radiation field was 60Co, which was associated with neutron activation of scrap metal; the major
contributor to the external gamma radiation field on distant islands was 137Cs.  Additional samples were
collected during the U.S. cleanup operations in 1969.  239Pu concentrations on Bikini Island ranged from
1.3 to 190 pCi/g (0.1–7 Bq/g).  239Pu concentrations on Eneu Island ranged from 0.5 to <3 pCi/g
(0.02–<0.1 Bq/g) (DOE 1970).  Measurements of gamma radiation exposure performed in June 1975
showed  highly variable exposure rates on Bikini island (10–20 µR/hr at the shore versus 30–100 µR/hr in 
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the interior), while exposure rates on Eneu island were relatively constant (<10 µR/hr) over the entire
island.  Thirty-year cumulative doses were estimated to be 0.057 and 0.027 Sv (5.7 and 2.7 rem) for those
living on Bikini Island (interior portions) and Eneu Island, respectively (USERD 1975).  Water samples
collected from Eneu Island in 1975 showed 90Sr and 137Cs at concentrations that would lead to a combined
30-year whole-body and skeletal dose of 25 mrem (0.25 mSv).  Sampling of cistern water on Bikini
Island during the same period revealed 90Sr concentrations, which would lead to a 30-year skeletal dose of
9.1 mrem (0.09 mSv), and 137Cs at concentrations that would lead to a 30-year whole-body dose of
1.9 mrem (0.02 mSv) (DOE 1975).  Whole-body counting of Bikini Island residents in 1974, 1977, and
1978 showed that the major contributor to whole body doses was 137Cs.  The average body burden for
137Cs increased 10-fold between 1974 and 1977 and by 72% between 1977 and 1978.  Nine persons had
body burdens exceeding the federal standards for non-occupational dose in that year (0.5 rem/year [0.005
Sv/yr]); the highest body burdens were approximately twice the permissible levels (DOE 1978). 
Semipalatinsk Test Site Fallout (Russia).    Approximately 10,000 people living near the
Semipalatinsk test site in the Kazakh region of Russia were exposed to radioactive materials from
atmospheric testing between the years of 1949 and 1962.  Underground testing, which typically retains
the radioactive material underground, was conducted between 1964 and 1989.  The collective doses to
this population from external and internal radiation were estimated to be 260,000 and 200,000 man•rem
(2,600 and 2,000 man•Sv), respectively (UNSCEAR 1993).  
Australian Test Site Fallout (United Kingdom).    The United Kingdom performed a total of
12 nuclear tests at 3 sites in Australia with total explosive yields at each site of 100, 16, and 60 kilotons,
respectively.  The collective dose delivered to the Australian population was estimated to be 70,000
man•rem (700 man•Sv).  In addition, several hundred smaller experiments were performed, resulting in
the contamination of hundreds of square kilometers with a total of 24 kg of 239Pu.  Potential annual
exposures to individuals in these areas, assuming continuous habitation, is estimated to range up to
several rem (several hundredths of a Sv) (UNSCEAR 1993).
Lop Nor Test Site Fallout (People’s Republic of China).    China has performed more than 40
nuclear weapons tests.  Approximately 23 tests were atmospheric; the last atmospheric test was performed
on October 16, 1980 and the fallout was measured worldwide.  The remaining tests have been performed
underground; the most recent underground test occurred on August 17, 1995.  All Chinese nuclear testing
occurs at the Lop Nor site, located in the Xinjian region in northwest China.  China has not allowed
independent assessments of the ecological or health impacts of its testing program; however, increased 
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mortality rates due to fallout of radioactive materials have been reported by a political advocacy group in
neighboring eastern Turkestan (Eastern Turkestan Information Bulletin 1996).   Both the data and the
claims are unsubstantiated.
6.7.3.2 Underground Testing
Underground testing refers to the detonation of nuclear bombs below the earth’s surface.  About 1,400
underground nuclear tests have been performed worldwide, with a total explosive yield of 90 Mt.  The
frequency of underground testing increased dramatically after the 1963 signing of the Limited Test Ban
Treaty, which banned atmospheric testing.  The nature of underground tests typically causes all the
radioactive material produced to be retained underground.  However, some radioactive material can be
released if the blast penetrates the surface or if inadvertent leaks occur due to ground structure damage or
the gradual diffusion of gases.  Of the 500 underground tests performed at the Nevada test site, only 32
led to off-site contamination.  The total activity of 131I inadvertently released was about 5 PBq (135 kCi),
which is about five orders of magnitude lower than that released during atmospheric testing.  Based on
calculations of theoretical yields, it is estimated that the total release of noble gases from underground
testing resulted in a population dose of 500 man•rem (5 man•Sv).  Of the noble gases, 133Xe is the
predominant radionuclide.  It is estimated that the total dose from 3H resulting from underground testing
is 0.1 man•rem (0.001 man•Sv) (UNSCEAR 1993).
In addition to military-sponsored nuclear explosions, a series of about 100 test detonations was carried
out during the 1960s for the purpose of developing peaceful applications for nuclear explosives, such as
building flood prevention reservoirs and interoceanic canals similar to the Panama canal (designated as
Project Plowshare).  As the benefits were far outweighed by the issues of contamination, the project was
subsequently terminated.  Of these tests, six were performed at the Nevada test site.  The estimated
collective dose delivered to the surrounding population (180,000 persons) from one of these tests (Sedan;
104 kt explosion) was estimated to be 300 man•rem (3 man•Sv).  As a result of the Schooner cratering
experiment carried out in the United States in 1968, tungsten-181 (181Tu) generated from the neutron
shield was detected as far away as Europe.  The estimated collective dose from this explosion to the
population living in the 40º–50º latitude band of the northern hemisphere was estimated to be 2,000
man•rem (20 man•Sv) (UNSCEAR 1993). 
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6.7.4 Occupational Exposure
Occupational exposure to radiation occurs when workers handle radioactive materials or are exposed to
radiation sources (e.g., x rays and radioactive sources).  The history of occupational exposure to
radioactivity is as old as its use.  In the period between the discovery of x rays and the early 1930s, more
than 100 radiologists died of skin cancer, anemia, and leukemia, largely because they knew very little
about the hazards of radiation and how to protect themselves adequately from it.  The frequencies of
anemia and noncancerous skin damage were also elevated.  The concept of a “tolerance dose” was
developed early, based initially upon the levels of exposure that resulted in erythema.  Originally, limits
of 5 R/month or 0.2 R/day were established, and these limits were successively lowered as the body of
knowledge concerning radiation health effects grew.  The current limits are 5 rem/year (0.05 Sv/year)
total effective dose equivalent; 50 rem/year (0.5 Sv/year) for the sum of deep-dose equivalent (from
external radiation) and committed dose equivalent (from internal radionuclides) to any individual organ or
tissue other than the lens of the eye; 15 rem/year (0.15 Sv/year) shallow dose equivalent to the skin or to
any extremity.  While most exposure is external,  internal exposure occurrs in several occupations, such
as radium dial painters, powerplant workers, uranium miners, radiopharmaceutical manufacturers, and
nuclear medicine support staff.  
In the early 1900s, it was discovered that radium, when mixed with zinc sulfide causes the zinc sulfide to
glow.  This discovery spurred the development of radioluminescent paints, which consists of a mixture of
finely powdered radium salt and zinc sulfide crystals in an appropriate volatile vehicle.  This paint was
used in the manufacture of dial faces, wristwatches, static eliminators, emergency exit signs, electron
tubes, and educational products.  In 1924, bone damage that looked like phosphorus poisoning was
observed in radium dial painters employed at a northern New Jersey plant, and later it was determined to
be bone cancer caused by radium.  It was determined that the young women were inadvertently ingesting
radium due to the practice of lip-pointing the brush tips when painting fine numerals.  A group of 24 dial
painters ingested approximately 900–1,300 µCi (33–48 MBq) radium during the course of their careers,
which resulted in the formation of bone cancers (see Chapter 3 of this toxicological profile) (Eisenbud
1987; Shapiro 1990; UNSCEAR 1993).  
Exposure to airborne uranium ore dust occurs in uranium miners and millers, while exposure to airborne
elemental uranium or uranium salts occurs in uranium processors.  Uranium ore contains other radio-
nuclides including 226Ra, 222Rn, 220Rn, 218Po, 214Po, and 210Po.  Radon diffuses from the rock into the mine
air, where the radon progeny become attached to particles of dust or moisture and are inhaled into the 
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lungs.  In the 1800s, silver and uranium miners in Europe were dying of a mysterious malady; the illness
was diagnosed as intrathoracic malignancy (lung cancer) in 1879.  At that time, it was estimated that the
life expectancy of these miners was 20 years after entering the occupation.  Death rates from lung cancer
in these miners were much higher than expected; as early as 1942, the deaths were attributed to radon
exposure.  It has been estimated that as much as 40% of all lung cancers in miners may be due to
exposure to radon and its progeny (Archer et al. 1973a; Gottlieb and Husen 1982; Lubin et al. 1969,
1995; Samet et al. 1984, 1986).  Although radon and its transformation products have been implicated as
causative agents in miners with lung cancer, it is difficult to isolate the cancer risk that may be specific to
the miners’ exposure because they were concurrently exposed to other suspected or known carcinogens
such as tobacco smoke, silica and other dusts, and diesel engine exhaust fumes (ACHRE 1995; Auerbach
et al. 1978; Band et al. 1980; Lundin et al. 1969; Saccomanno et al. 1971, 1976, 1986; Whittemore and
McMillan 1983).  
A study of 16 male Navajo uranium miners who developed lung cancer between February 1965 and May
1979 found that the mean cumulative radon exposure was 1,140 working level months (WLM) (Gottlieb
and Husen 1982).  The working level is a measure of airborne concentration of radon progeny.  The
WLM is a measure of total exposure.  It is the product of the concentration, in WL’s and the exposure
time, in months (1 working month = 170 hrs).  One WLM corresponds to an alpha dose to the
tracheobronchial epithelium of approximately 1 rad (0.01 Gy).  An excess of lung cancer deaths was also
found in uranium miners who had worked underground for at least 1 year in the Grants mineral belt area
of New Mexico.  Mean exposures in these studies ranged from 2.6 to 42 WLM from 1954 to 1966 and
from 0.3 to 21.8 WLM from 1967 to 1982 (Acquavella et al. 1985; Samet et al. 1986).  A National
Institutes of Health study (NIH 1994) summarized cumulative WLM for several mining cohorts and
Colorado miners had the highest average WLM of 807 (follow-up period 1950–1987).  Exposed New
Mexico miners had an average WLM estimate of 110 and non- U.S. miners ranged from an average WLM
of 7 to 370.  It should be noted that, in several of these studies, exposure to dust and cigarette smoke was
also found to be related in varying degrees to the incidence of cancer.
With the discovery of fission and the development of particle accelerators (Cockcroft-Walton, Van de
Graaff generator, cyclotron), numerous new radionuclides and new elements could be readily produced. 
The number of users and frequency of radionuclide use are both steadily increasing. 
Other professions in which workers receive elevated radiation doses include: commercial airline
personnel (pilots and flight attendants), military pilots, astronauts, industrial and nuclear power plant
workers, radiographers, and dental and medical personnel.  A person flying cross-country receives about
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5 mrem (0.05 mSv) per flight due to the increased levels of cosmic radiation associated with the increase
in elevation; it has been estimated that pilots and flight attendants receive an annual dose that is
approximately 160 mrem (1.6 mSv) higher than that of the average population.  Astronauts are exposed to
intense radiation emanating from solar flares, the earth’s radiation belts, and ambient cosmic radiation.  The
average radiation doses for crews of the Apollo missions (5–12 days/mission) were 0.16–1.14 rad
(0.0016–0.0114 Gy); the average doses for the Skylab missions, which lasted 20–90 days, were
1.6–7.7 rad (0.016–0.77 Gy).  These high doses of radiation require attention if people begin living in the
environments of outer space (space stations, interplanetary travel, etc.).  The processing and blending of
LPG tends to enhance radon concentrations, and the long-lived radon daughters (210Pb and 210Po) tend to
accumulate inside LPG processing machinery, resulting in a possible risk of exposure to maintenance
workers.  A nuclear power plant worker averages 300 mrem (3 mSv) additional dose per year, resulting in
doses about 80% higher than the average population (DOE 1996; Eisenbud 1987).
6.8 ADEQUACY OF THE DATABASE
The database is considered to be adequate for use as the basis for radiation safety standards.
6.9 CONCLUSIONS
The issue of radiation exposure is a matter of interest to the general public; however, radiation exposure is
inevitable as it is a natural part of the environment.  Indeed, radioactive materials have always existed
around and even within us.  While the risk of exposure to radiation from man-made sources exists, with
the exception of locally high exposures, the average individual dose received from man-made radiation is
small compared to that received from natural sources.  When assessing the risks associated with a
radiation exposure, one must weigh the potential benefits (e.g., gain in quality of life related to medical
diagnoses and treatments) against the potential detriments (acute radiation sickness, cancer risk )
associated with the exposure.  Conversely, in situations presenting minimal risks of exposure to radiation
and radioactive materials, one may also compare the potential risks associated with the use of alternatives. 
For example, in the case of nuclear power versus power from fossil fuels, one may want to weigh the risk
of exposure to coal dust, radioactive materials, combustion products , and waste materials associated with
coal power versus the risk of radiation exposure from nuclear power production and waste disposal.  The
regulations concerning radiation exposure limitations are based upon the studies and recommendations of
numerous scientific organizations to ensure the health of occupational workers and the public.
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Because of the potential for ionizing radiation to cause deterministic (acute radiation syndrome, cataracts)
and nondeterministic (cancer) health effects in exposed individuals, safe dose guidelines and regulations
have been established for both external radiation exposure and radionuclides in air and water by a number
of international and national agencies.  International and national regulations and guidelines pertinent to
human exposure to ionizing radiation are summarized in Table 7-1.  Those that protect against deter-
ministic effects are based on identified acute thresholds doses for those effects, with a reduction to protect
sensitive populations and provide safety margins that account for uncertainties.  Those that protect against
nondeterministic effects use the observed frequencies with which those effects occur at high doses,
account for uncertainties that may exist, and assume a linear dose-effect relationship to calculate the doses
at which the effects would be presumed to occur at some acceptable frequency, such as the range of 10-4
to 10-6 which EPA often considers.  This proportionality assumes a linear no threshold (LNT) dose effect
curve.  During the last decade, there have been reductions in LNT-based public radiation dose limits and
site cleanup levels that have increased the scope and cost of medical, occupational, and environmental
radiation protection efforts.  Some recent studies found a reduction in health effects when the dose was
delivered at lower dose rates, indicating a potential application to future protection guidelines and
regulations.
An MRL of 0.004 mSv (0.4 rem) has been derived for acute-duration external exposure (14 days or less),
based on the developmental studies of Schull et al. (1988) and the IQ studies of Burt (1966).
An MRL of 0.001 Sv/yr (0.1 rem/yr) above background has been derived for chronic-duration external
exposure (365 days or more) to radiation based on information that identified radiation doses that have
not been reported to have detrimental effects on humans (BEIR V 1990).
The health effects of radiation have been recognized since early in the twentieth century, and by 1928 the
International X-Ray and Radium Protection Committee (now the International Commission on
Radiological Protection [ICRP]) was established.  In the United States, a year later, the Advisory
Committee on X Ray and Radiation Protection, now called the National Council on Radiation Protection
and Measurements (NCRP), was formed. The NCRP was chartered in 1964 by the U.S. Congress to:
(1) disseminate information of public interest and recommend radiation levels to protect the public, (2)
support cooperation among organizations concerned with radiation protection, (3) develop basic concepts 
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about radiation protection, and (4) cooperate with the ICRP and the International Commission on
Radiation Units and Measurements.  Even though the NCRP is a nongovernmental organization, it
provides recommendations that guide the establishment of federal radiation policies, agency
requirements, and statutory laws.  Through the governmental agencies that rely on NCRP
recommendations, the work of this organization has a significant impact on the many activities in the
United States involving the use of radiation and radioactive materials. 
In the United States, the Environmental Protection Agency (EPA) sets radiation safety policy and basic
safety standard.  The execution of this policy is assigned to the various regulatory agencies, including the
EPA itself, for application to the specific activities that they regulate.  The U.S. Nuclear Regulatory
Commission (USNRC), an independent government agency, regulates commercial nuclear power
reactors; research/test/training reactors; fuel cycle facilities; and the transport, storage and disposal of
nuclear materials and waste (USNRC 1997b).  The EPA is responsible for protecting the public and the
environment and for clean up of radioactively contaminated sites (EPA 1997).  The Mine Safety and
Health Administration (Department of Labor) is responsible for protecting miners from exposure to radon
and its daughters and gamma rays in underground or surface mines (MSHA 1997).  The Food and Drug
Administration (FDA) develops standards for equipment that emits ionizing radiation, such as
radiographic and fluoroscopic equipment (FDA 1997), radioactive material concentrations in food (FDA
1998), and medical devices used in radiation therapy (FDA 1997).  
A mammogram device, for example, uses low-dose x rays to produce a radiographic image of breast
tissue.  Unfortunately, mammograms are among the most difficult radiographic images to read.  To
reduce the chance of false negative and false positive diagnoses, the image must be of high quality (FDA
1997).  Senate hearings on breast cancer held in 1992 found a wide range of problems with
mammography practices in the United States.  In response to these issues and to the growing incidence of
breast cancer and its associated mortality rate, the U.S. Congress enacted the Mammography Quality
Standards Act (MQSA).  The enactment of the MQSA in 1992 was a statutory means of certifying and
inspecting mammography facilities.  Regulations established by the FDA to implement the MQSA
ensured that only facilities accredited by an approved accreditation body and certified by the Secretary of
Health and Human Services would lawfully continue to operate after October 1, 1994.  In order to meet
the October deadline, however, the MQSA needed to be amended and the process for issuing standards
for facilities and the standards to be met by the accrediting bodies needed to be shortened.  The 
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amendments gave the FDA the authority to issue interim regulations, which were published on December
21, 1993 (FDA 1997, 1999a, 1999b).  Final regulations for the MQSA, published on October 28, 1997,
mandated that facilities would  incorporate new requirements into their programs by April 28, 1999, the
effective date for most of the regulations.  Regulations concerning equipment will become effective on
October 28, 2002 (FDA 1999b). Except for the Department of Veterans Affairs, all mammography
facilities that produce, process, or interpret mammograms must meet the requirements of the MQSA.  In
order to keep the basic safeguards in place beyond the year 2000, the Mammography Quality Standards
Reauthorization Act of 1998 was passed by Congress on October 9, 1998 (U.S. Congress 1998).  The
FDA recently announced the availability of its guidance document, Compliance Guidance: The
Mammography Standards Act Final Regulations Document #1, which is intended to assist mammography
facilities in meeting the MQSA final regulations (FDA 1999a). 
The FDA recently updated its guidance document that presents recommended action levels for
radionuclides in foods, both domestic and imported (FDA 1998).  These derived intervention levels
(DILs) are estimated levels in food that could lead to individuals receiving a radiation equivalent dose
equal to the FDA protection action guide (PAG) that is set as the more limiting of either 0.5 rem (5 mSv)
for committed effective dose or 5 rem (50 mSv) committed dose equivalent to any individual tissue or
organ.  Table 7-4 presents the most restrictive food DILs.
 Transport of radioactive materials is regulated by the Department of Transportation (DOT) in
conjunction with the USNRC.  Coordinating government emergency response to accidents involving
radioactive materials is the responsibility of the Federal Emergency Management Administration
(FEMA).
National regulations governing the occupational exposure to ionizing radiation include USNRC
regulations (10CFR20), EPA standards for uranium and thorium mills (40 CFR 192), Occupational Safety
and Health Administration (OSHA) standards for ionizing radiation (29 CFR 1910.1096), the Department
of Energy (DOE) standards for occupational radiation protection (10 CFR 835), and MSHA’s radon and
gamma ray standards (60 FR 33719).  National regulations concerning general population exposure to
radiation have been developed by the EPA and USNRC based on the dose limit recommendations of the
ICRP (ICRP 1997) and the NCRP (NCRP 1993).
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Currently there are 29 "NRC Agreement States."  An agreement state is any state that has entered into an
agreement with the USNRC under Section 274 of the Atomic Energy Act of 1954, as amended.  The
USNRC relinquishes to these states the majority of its regulatory authority over source, by-product, and
special nuclear material in quantities not sufficient to form a critical mass.  However, the regulation of
nuclear reactors is under USNRC jurisdiction.  In the remaining states, USNRC still handles all of the
inspection, enforcement, and licensing responsibilities.  States can regulate exposure to workers from
electronic sources, as well as from naturally occurring and accelerator-produced radioactive materials. 
State regulations for 226Ra and strontium isotopes are listed in Tables 7-2 and 7-3, respectively.  
The basic philosophy of radiation safety is to minimize unnecessary radiation exposure.  The specific
objectives of radiation safety guidance as stated by NCRP are (1) to prevent the occurrence of severe
radiation-induced deterministic (nonstochastic) disease, and (2) to limit the risk of the nondeterministic
(stochastic) effects (fatal cancer, and genetic effects) to a reasonable level compared with nonradiation
risks and in relation to societal needs, benefits gained, and economic factors.  In addition to regulations
that set upper limits on radiation dose, the concept of ALARA (As Low As Reasonably Achievable) was
introduced to ensure that work place endeavors resulting in exposures to radiation provide sufficient
benefits which offset any potential detriment they cause (ACGIH 1998).  The goal is not to eliminate all
radiation exposure, which would not be possible, but instead to strive for an appropriate balance between
protection of public health and reasonable costs (economic, social, etc.) while maintaining desirable dose
limits.  The American Conference of Governmental Industrial Hygienists (ACGIH) has adopted the
occupational exposure guidance of the ICRP (ACGIH 1998).  The values used by ACGIH as guidelines
for exposure to radiation are given in Table 7-1.
The USNRC has set dose limits for individual members of the public of 0.1 rem/year, 5 rem/year for
occupationally exposed workers, and 0.5 rem (0.005 Sv) during the gestation period to the fetus of a
pregnant worker (USNRC 1996).  More specific information on regulations pertaining to ionizing
radiation exposure can be found in the references listed in Table 7-1 of this profile.
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AND RADIOACTIVE MATERIAL
To help public health professionals and others address the needs of those who are exposed to radiation
and radioactive material, the information in this section on ionizing radiation is organized first by route of
exposure—inhalation, oral, dermal and external; and then by health effect—death, systemic, immuno-
logical, neurological, reproductive, developmental, genotoxic, and carcinogenic effects.  The systemic
effects are subdivided into respiratory, cardiovascular, gastrointestinal, hematological, musculoskeletal,
hepatic, renal, dermal, ocular, and body weight effects.  
The data for the observed effects from radiation and radioactive material  are presented in the following
tables.  These tables are  not meant to be exhaustive reviews of all of the literature that reports biological
effects  resulting from exposure to ionizing radiation.  It does, however, provide health care professionals,
persons exposed (or potentially exposed) to radiation in their occupations, and the general public an
overview of the types of effects observed in each category. The tables report no-observed-adverse-effect
levels (NOAELs) or lowest-observed-adverse-effect levels (LOAELs), which reflect the actual radiation
doses (or concentration of radioactive material) used in the studies.  LOAELS have been further classified
into "less serious" or "serious" effects.  "Serious" effects are those that evoke failure in a biological
system and can lead to morbidity or mortality (e.g., acute radiation sickness  or death).  "Less serious"
effects are those that are not expected to cause significant dysfunction or death, or those whose
significance to the organism is not entirely clear.  ATSDR acknowledges that a considerable amount of
judgment may be required in establishing whether an end point should be classified as a NOAEL, "less
serious" LOAEL, or "serious" LOAEL, and that in some cases, there will be insufficient data to decide
whether the effect is indicative of significant dysfunction.  However, the Agency has established
guidelines and policies that are used to classify these end points.  ATSDR believes that there is sufficient
merit in this approach to warrant an attempt at distinguishing between "less serious" and "serious" effects. 
The distinction between "less serious" effects and "serious" effects is considered to be important because
it helps the users of the profiles to identify radiation doses at which major health effects may start to
appear.  LOAELs or NOAELs should also help in determining whether or not the effects vary with dose
and/or duration, and place into perspective the possible significance of these effects to human health.
A range of radiological units were used in the studies and these are reported in Tables 8-1 to 8-4.  In these
studies, some authors reported units of absorbed dose (rad, Gy) or dose equivalent (rem, Sv), while other
authors reported effects in terms of units of concentration, transformations (disintegrations) or activity
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(µCi/kg or Bq/kg, etc).  Conversions between units is possible when given specific information about the
exposed animal, organ weights, and the nuclide; however, the specific information required to perform
those conversions was, in many cases, not complete or not reported at all.  Many of the activities reported
in Ci or Bq could not be converted into absorbed dose (rad, Gy) or dose equivalent (rem, Sv) to determine
a dose-response relationship.  Since these conversions were not practical, the unit  information (rad, Gy,
rem, Si) with the corresponding NOAEL or LOAEL are listed first under each heading (death, respiratory,
gastrointestinal, etc).  This information is then immediately followed by the studies that examined end
points in terms of concentration or activity (µCi/kg or Bq/kg) for each organ system route of exposure. 
This provides the reader an opportunity to more clearly observe any dose-response effects resulting from
exposure to ionizing radiation, both from an absorbed dose (rad, Gy) aspect as well as from a radionuclide
activity (Ci, Bq) perspective.
The significance of the exposure levels shown in Tables 8-1 to 8-4  may differ depending on the user's
perspective.  Public health officials and others concerned with appropriate actions to take at hazardous
waste sites may want information on levels of exposure associated with more subtle effects in humans or
animals (LOAELs) or exposure levels below which no adverse effects (NOAELs) have been observed. 
Levels of exposure associated with carcinogenic effects (Cancer Effect Levels, CELs) of ionizing
radiation are also indicated in Tables 8-1 through 8-4.
Estimates of exposure levels posing minimal risk to humans may be of interest to health professionals and
citizens alike.  Estimates of the acute radiation dose and chronic radiation dose rate that pose minimal risk
to humans (Minimal Risk Levels or MRLs) have been made for ionizing radiation.  An MRL is defined as
an estimate of daily human exposure to a substance that is likely to be without an appreciable risk of
adverse effects (noncarcinogenic) over a specified duration of exposure.  MRLs are derived when reliable
and sufficient data exist to identify the target organ(s) of effect or the most sensitive health effect(s) for a
specific duration within a given route of exposure.  MRLs are based on noncancerous health effects only
and do not consider carcinogenic effects.  MRLs can be derived for acute, intermediate, and chronic
duration exposures for inhalation and oral routes as well as for external exposure.  Appropriate
methodology does not exist to develop chemical MRLs for dermal exposure.
Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 1990),
uncertainties are always associated with these techniques.  ATSDR acknowledges additional uncertainties
inherent in the application of the procedures to derive less than lifetime MRLs.  As an example, acute
inhalation MRLs may not be protective for health effects that are delayed in development or are acquired
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following repeated acute insults, such as hypersensitivity reactions, asthma, or chronic bronchitis.  As
these kinds of health effects data become available and methods to assess levels of significant human
exposure improve, these MRLs will be revised. 
MRLs have been derived for radiation effects.  During the evaluation process, ATSDR examined many
factors, including (1) which specific studies would lend themselves to be most suitable for deriving an
MRL, and (2) what health effect(s) an MRL should be based upon (cataract formation, reduction in IQ,
etc.). 
The tables showing Levels of Significant Exposure (LSE) to Radiation and Radioactive Material consist
of the following information:
(1) Route of Exposure  One of the first considerations when reviewing the toxicity of ionizing radiation
using these tables and figures should be the relevant and appropriate route of exposure.  When
sufficient data exist, four tables are presented in the document by the four principal routes of
exposure, i.e., inhalation, oral, dermal, and external (Levels of Significant Exposure to Radiation
and Radioactive Material tables 8-1, 8-2, 8-3 and 8-4, respectively).  Not all studies will have data
on each route of exposure.
(2) Health Effect  The major categories of health effects included in Levels of Significant Exposure to
Radiation and Radioactive Material tables are death, systemic, immunological, neurological,
developmental, reproductive, and cancer.  NOAELs and LOAELs can be reported in the tables and
figures for all effects but cancer.  Systemic effects are further defined in the "System" column of the
table.
(3) Species  The test species, whether animal or human, are identified in this column. 
(4) Duration/ Frequency of Administration The duration of the study and the weekly and daily
exposure regimen are provided in this column.  This permits comparison of NOAELs and LOAELs
from different studies.
(5) System  This column further defines the systemic effects.  These systems include:  respiratory,
cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and dermal/ocular.
Other systems considered separately in these tables are immunological/lymphoreticular,
neurological, reproductive, developmental, genotoxic, and cancer.  "Other" refers to any systemic
effect (e.g., a decrease in body weight) not covered in these systems.
(6) NOAEL  A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure level at which no
harmful effects were seen in the organ system studied.
(7) LOAEL  A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest dose used in the study
that caused a harmful health effect.  LOAELs have been arbitrarily classified into "Less Serious"
and "Serious" effects.  These distinctions help readers identify the levels of exposure at which
adverse health effects first appear and the gradation of effects with increasing dose.  A brief
description of the specific endpoint used to quantify the adverse effect accompanies the LOAEL.
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(8) CEL  A Cancer Effect Level (CEL) is the lowest exposure level associated with the onset of
carcinogenesis in experimental or epidemiologic studies.  CELs are always considered serious
effects.
(9) Chemical Form  The nuclide, the chemical form (chloride, oxide, etc.) and the type of emission
(alpha or beta particle and gamma ray) is indicated in this column.
(10) Reference  The complete reference citation is given in chapter 10 of the profile.
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Absorbed Dose—The energy imparted by ionizing radiation per unit mass of irradiated material.  The
units of absorbed dose are the rad and the gray (Gy). (See also Rad, Gray, and Units, Radiological.)
Absorbed dose is defined per unit mass of absorbing material.  
Absorbed Fraction—A term used in internal dosimetry.  It is that fraction of energy radiated by the
source organ that is absorbed by the target organ.  For example, for 131I in the thyroid (source organ), the
absorbed fraction could be the fraction of gamma radiation absorbed in the liver (one of the target
organs).
Absorber—Any material that absorbs or lessens the intensity of ionizing radiation.  Neutron absorbers
(boron, hafnium, and cadmium) are used as material in control rods for reactors.  Concrete, steel, and lead
are typical absorbers for x rays and gamma rays.  A thin sheet of paper or metal will absorb alpha
particles and all except the most energetic beta particles.
Absorption—The process by which radiation imparts some or all of its energy to any material through
which it passes.
Absorption Ratio, Differential—The ratio of concentration of a nuclide in a given organ or tissue to the
concentration that would be obtained if the same administered quantity of this nuclide were uniformly
distributed throughout the body.
Activation—The process of inducing radioactivity by neutron irradiation of a target material.
Activity—The number of nuclear transformations occurring in a given quantity of material per unit time. 
(See Curie, Becquerel, and Units, Radiological, for more information on activity.)
Activity Median Aerodynamic Diameter (AMAD)—The diameter of a unit density sphere with the
same terminal settling velocity in air as that of the aerosol particle whose activity is the median for the
entire aerosol.
Acute Exposure—An exposure to ionizing radiation for a duration of less than 15 days.  Regarding acute
radiation syndrome, high radiation levels involve an exposure period up to 2 days.
Acute Radiation Syndrome—The signs and symptoms which, taken together, characterize a person
suffering from the effects of intense radiation.  The effects occur within hours of exposure.
ALARA—The acronym for “As Low As is Reasonably Achievable.”  This term refers to the practice of
making every reasonable effort to keep exposure to radiation as far below the dose limit as possible while
still achieving the purpose for which radiation is licensed to be used. The benefits of reducing dose must
be weighed against economic, engineering, and social costs of doing so.
Alpha Particle (symbolized by Greek letter α)—A charged particle emitted from the nucleus of certain
radioactive atoms.  An alpha particle has a mass of 4 atomic mass units (amu) and is equal to a helium
nucleus (i.e., two protons and two neutrons, and a charge of +2).
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Annihilation Radiation—The photons produced when an electron and a positron unite and cease to
exist.  The annihilation of a positron-electron pair results in the production of two photons, each of
0.51 MeV in energy (see pair production).
Annual Limit on Intake (ALI)—The derived limit for the amount of radioactive material taken into the
body of an adult worker by inhalation or ingestion in a year.  For a given radionuclide, ALI is defined as
the smaller of the intakes that would result in a committed effective dose equivalent of 5 rem or a
committed dose equivalent of 50 rem to any individual organ or tissue (see also Committed Effective
Dose).
Antineutrino—  A neutral particle of rest mass near zero that is emitted during beta transformation
(nucleus with a neutron excess) which occurs via the pathway by converting a neutron into a proton: 
n---> p + e- + anti-nu(e), where n means neutron, p means proton, e- means electron, and anti-nu(e) means
an antineutrino of the electron type.
Artificial Radioactivity—The radioactivity produced by particle bombardment or electromagnetic
irradiation in an accelerator or reactor and not existing in nature.
Atomic Mass—The mass of a neutral atom of a nuclide, usually expressed in terms of "atomic mass
units."  The "atomic mass unit" is one-twelfth the mass of one neutral atom of carbon-12; equivalent to
1.6604x10-24 gm.  (Symbol: u)
Atomic Mass Number—The total number of nucleons (neutron plus protons) in the nucleus of an atom.
Atomic Number—The number of protons in the nucleus of  an atom.  The "effective atomic number" is
calculated from the composition and atomic numbers of a compound or mixture.  An element of this
atomic number would interact with photons in the same way as the compound or mixture.  (Symbol: Z).
Atomic Weight—The weighted mean of the masses of the neutral atoms of an element expressed in
atomic mass units.
Background Radiation—Radiation resulting from cosmic rays and naturally occurring radioactive
material.  Background radiation is always present and its level can change with altitude and the amount of
radioactive material present in soil and building materials.
Becquerel (Bq)—A unit of measure for the quantity of radioactive material; one becquerel is that
quantity of radioactive material in which one atom decays in one second. (See also Units, Radiological.)
Beta Particle (symbolized by Greek letter β) —A charged particle emitted from the nucleus of some
radioactive atoms.  A beta particle has a mass and charge equal in magnitude to that of the electron.  The
charge may be either +1 or -1, and may be shown with the respective symbol, β+ or β-.
Bioassay—A determination of the kind, quantity, concentration, or location of radioactive material in the
body by either direct measurement or the analysis and evaluation of materials excreted or removed from
the body.
Bone Seeker—Any compound or ion in the body that preferentially migrates into actively forming bone
to become part of the hydroxyapatite mixture. 
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Branching—The occurrence of two modes by which a radionuclide can undergo radioactive
transformation.  For example, 214Bi can undergo α or β- transformation, 64Cu can undergo β-, β+, or
electron capture transformation.  An individual atom of a nuclide exhibiting branching disintegrates by
one mode only.  The fraction disintegrating by a particular mode is the "branching fraction" for that
mode.  The "branching ratio" is the ratio of two specified branching fractions (also called multiple
transformation or disintegration).
Bremsstrahlung—Electromagnetic radiation (photons) produced by the acceleration that a fast charged
particle (usually an electron) undergoes from the effect of an electric or magnetic field, for instance, from
the field of another charged particle (usually a nucleus).  Bremsstrahlung is emitted when beta particles or
electrons are stopped by a shield.
Cancer Effect Level (CEL)—The lowest dose of chemical in a study, or group of studies, that produces
significant increases in the incidence of cancer (or tumors) between the exposed population and its
appropriate control.
Carcinogen—A chemical capable of inducing cancer.
Carcinoma—A malignant neoplasm composed of epithelial cells, regardless of their derivation.
Cataract—A clouding of the crystalline lens of the eye that obstructs the passage of light.
Chronic Exposure—An exposure to ionizing radiation for 365 days or more, as specified in the ATSDR
toxicological profiles.
Collective Dose—The sum of the individual doses received in a given period of time by a specified
population from exposure to a specified source of radiation, in units such as person @ rem or person @ Sv.
Committed Dose Equivalent (HT50)—The dose equivalent to organs or tissues of reference (T) that will
be received from an intake of radioactive material by an individual during the 50-year period following
the intake.
Committed Effective Dose—The International Commission on Radiological Protection (ICRP) term for
committed effective dose equivalent.  (See Committed Effective Dose Equivalent.)
Committed Effective Dose Equivalent (HE50)—The sum of the products of the weighting factors
applicable to each of the body organs or tissues that are irradiated and the committed dose equivalent to
the organs or tissues (HE50 = 3WTHT50).  The committed effective dose equivalent is used in radiation
safety because it implicitly includes the relative carcinogenic sensitivity of the various tissues.
Compton Scattering—An attenuation process observed for x or gamma radiation in which an incident
photon interacts with an orbital electron of an atom to produce a recoil electron and a scattered photon of
energy less than the incident photon.
Contamination, Radioactive—The deposition of radioactive material in any place where it is not
desired.
Cosmic Rays—High-energy particulate and electromagnetic radiations that originate outside the earth's
atmosphere.
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Count (Radiation Measurements)—The external indication of a radiation-measuring device designed to
enumerate ionizing events.  It may refer to a single detected event or to the total number registered in a
given period of time.  This term can be used with equipment and geometry efficiencies to quantify the
rate of transformation of ionizing events.
Counter—A general description applied to radiation detection instruments or survey meters that detect
and measure radiation.  The signal that announces the detection of an ionization event is called a count. 
(See also Counter, Geiger-Mueller and Counter, Scintillation.)
Counter, Geiger-Mueller—A sensitive, gas-filled radiation-measuring device that responds to
individual ionizing particles.
Counter, Scintillation—The combination of phosphor, a photomultiplier tube, and associated
circuits for counting light emissions produced in the phosphors by ionizing radiation.
Cumulative Dose—The total dose resulting from continuous or intermittent exposures of radiation to the
same region of the body, or to the whole body, from internally deposited radioisotopes over a period of
time.  (See Also Weighting Factor.)
Curie (Ci)— The quantity of radioactive material in which 37 billion radioactive atoms transform per
second, which is approximately the activity of 1 gram of radium.  
Decay Constant—See transformation constant.
Decay Product (Daughter Product, Progeny)—Isotopes that are formed by the radioactive
transformation of some other nuclide.  In the case of 226Ra, for example, there are 10 successive daughter
products or progeny, ending in the stable isotope 206Pb.
Decay, Radioactive—Transformation of the nucleus of an unstable nuclide by spontaneous emission of
charged particles and/or photons.
Deep Dose Equivalent (Hd)—The dose equivalent at a tissue depth of 1 cm inside the body surface from
external whole-body radiation. 
Delayed Health Effects—The health effects that manifest themselves after an extended period.
Derived Air Concentration (DAC)—The concentration of a given radionuclide in the air which, if
breathed by the reference man for one working year (2,000 hours) under conditions of light work, results
in an intake of one ALI.
Detector—A material or device that is sensitive to radiation and can produce a response signal suitable
for measurement or analysis.
Deterministic Effects—Health effects for which there exists a definite threshold and which become more
severe as the dose is increased.  The dose response curve is sigmoid-shaped.  Examples of deterministic
effects are acute radiation syndrome and cataracts (previously referred to as non-stochastic effects)
Developmental Toxicity—The occurrence of adverse effects on a developing organism that may result
from exposure to a chemical or to ionizing radiation prior to conception (either parent), during prenatal
development, or postnatally to the time of sexual maturation.  Adverse developmental effects may be
detected at any point in the life span of the organism.
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Disintegration, Nuclear—A spontaneous nuclear transformation (radioactivity) characterized by the
emission of energy and/or mass from the nucleus.  When large numbers of nuclei are involved, the
process is characterized by a physical half-life.  (See also Transformation, Nuclear.)
Dose (or Radiation Dose)—A general term denoting the amount of energy from radiation that is
absorbed per unit mass of absorber.  A generic term meaning absorbed dose, dose equivalent, deep dose
equivalent, effective dose, effective dose equivalent, committed dose equivalent, committed effective
dose equivalent, equivalent dose, or total effective dose equivalent.  For special purposes it must be
appropriately qualified.  If unqualified, it refers to the absorbed dose.
Dose Assessment—An estimate of the radiation dose to an individual or a population group usually by
means of predictive modeling techniques, often supplemented by the results of measurement.
Dose Conversion Coefficient (or dose conversion factor)—A factor (Sv/Bq or rem/Ci) that is
multiplied by the intake quantity of a radionuclide (Bq or Ci) to estimate the committed dose equivalent
from radiation (Sv or rem).  The dose conversion factor depends on the route of entry (inhalation or
ingestion), the lung clearance class (D, W, or Y) for inhalation, the fractional uptake from the small
intestine to blood (f1) for ingestion, and the organ of interest.  EPA provides separate dose conversion
factor tables for inhalation and ingestion, and each provides factors for the gonads, breast, lung, red
marrow, bone surface, thyroid, remainder, and effective whole body.
Dose Equivalent (DE)—A quantity used in radiation protection.  It expresses all radiations on a common
scale for calculating the dose for purposes of radiation safety.  It is the product of the absorbed dose in rad
or gray and a quality factor, whose value depends on the radiation.  (The unit of dose equivalent is the
rem.  In SI units, the dose equivalent is the sievert, which equals 100 rem.)
Dose, Fractionation—The division of a therapeutic radiation dose into fractions that are administered
over a period of time. Dose is delivered during discrete time periods.  Between fractions, there is no dose. 
Dose, Radiation—The amount of energy imparted to matter by ionizing radiation per the unit mass of
matter, usually expressed as the rad, or in SI units, the gray (Gy), 100 rad = 1 Gy  (See also Absorbed
Dose.)
Dose Rate—The radiation dose delivered per unit time.  The rate can be measured, for example, in gray
per hour, sievert per hour, rem per hour, or rad per hour.
Dosimetry—Quantification of radiation doses to individuals or populations resulting from specified
exposures.
Early Effects (of radiation exposure)—Effects which appear within 60 days of an acute exposure;
usually associated with acute radiation syndrome when whole body is exposed.
Effective Dose—The sum of the weighted equivalent doses in all the tissues and organs of the body.
Effective Dose Equivalent (HE)—The sum of the products of the dose equivalent to the organ or tissue
(HT) and the weighting factors (WT) applicable to each of the body organs or tissues that are irradiated
(HE = 3WTHT).  The effective dose equivalent recognizes the carcinogenic radiosensitivity of the several
different tissues of the body.
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Effective Half-Life (also effective half-time)—The time required for a radioactive element in an animal
body to be diminished 50% as a result of the combined action of radioactive transformation and
biological elimination.  It is described by the following equation:
Effective Half-Life = (Biological half-life x radioactive half-life) / (biological half-life + radioactive
half-life).
Electron—A stable elementary particle having an electric charge equal to ±1.60210 x 10-19 Coulombs
(C), and a rest mass equal to 9.1091 x 10-31 kg.  A positron is a positively charged "electron" (see
Positron).
Electron Capture—A mode of radioactive transformation involving the capture of an orbital electron by
its nucleus.  Capture from a particular electron shell is designated as "K-electron capture," "L-electron
capture," and so on.  The atom then emits x rays.
Electron Volt—A unit of energy equivalent to the energy gained by an electron in passing through a
potential difference of one volt.   It is the energy unit for an ionizing particle or photon often expressed as
keV for thousand or kilo electron volts or MeV for million or mega electron volts.  (symbol:  eV, as in
1eV'1.6x10-12 erg.)
Embryo/Fetus—The developing human (or animal) from the time of conception up to the time of birth.
Embryotoxicity and Fetal toxicity—Any toxic effect on the conceptus as a result of prenatal exposure to
ionizing radiation or a chemical; the distinguishing feature between the two terms is the stage of
development during which the insult occurred.  The terms, as used here, include malformations and
variations, altered growth, and in utero death.
Enriched Material—(1) Any material in which the relative amount of one or more isotopes of a
constituent has been increased over its natural abundance.  (2) Uranium in which the percentage of  235U
to total uranium of all isotopes is increased from its natural value of 0.72% to a higher value.
Equilibrium, Radioactive—In a radioactive series, the state that prevails when the ratios between the
activities of two or more successive members of the series remain constant, or when the activities are
equal.
Eventration—Disembowelment or protrusion of the bowels from the abdomen.
Excitation Energy—The energy required to change a system from its ground state to an excited state. 
Each different excited state has a different excitation energy.
Excitation—The addition of energy to a system, thereby transferring it from its ground state to an excited
state.  Excitation of a nucleus, an atom, or a molecule can result from absorption or scattering of photons
or from inelastic collisions with  particles.  The excited state of an atom is an unstable state and will
return to the ground state by radiation of the excess energy.
Exposure—A measure of the intensity of an x ray or gamma ray field in air, whose value depends on the
ionization produced in air by x or gamma radiation.  The traditional unit of exposure is the roentgen (R),
and the SI unit is the coulomb per kilogram.
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External Dose—The amount of energy, expressed per unit mass of matter, imparted to an organism by
ionizing radiation from a source outside the body.
External Radiation—Radiation exposure from a source outside the body.
Eye Dose Equivalent—The dose equivalent of radiation received by the lens of the eye which is at a
depth of 0.3 cm below the outside surface (cornea) of the eye, delivered by an external radiation source.
Fission, Nuclear—A nuclear transformation characterized by the splitting of a nucleus into two or three
other nuclei and two or three neutrons, and the release of a relatively large amount of energy.
Fundus—the bottom or base of anything.  Pertaining to hollow organs, it is the portion farthest from its
mouth or opening.  Pertaining to the eye, the fundus is the back portion of the interior of the eyeball.
Tapetal fundus—a highly reflective structure in the dorsal portion of the fundus of the eye.
Nontapetal fundus—the nonreflective ventral portion of the fundus of the eye.
Gamma Ray (synbolized by Greek letter γ)—A short wavelength electromagnetic radiation of nuclear
origin (range of energy from about 10 keV to about 9 MeV, which is sufficient to cause ionization).
Genetic Effect of Radiation—An inheritable change, chiefly mutations, produced by the absorption of
ionizing radiation by germ cells.  
Gray (Gy)—The SI unit of the absorbed dose.  One Gy equals the absorption of 1 joule of energy (about
1/4 of a calorie) per kilogram of absorber. One gray equals 100 rad.  (See also Units.)
Half-Life, Biological (or biological half-time)—The time required for the body to eliminate one-half of
any absorbed substance by regular physiological processes of elimination. It is the same for both stable
and radioactive isotopes of a particular element.  
Half-Life, Effective—The time required for a radioactive element in an animal body to be diminished
50% as a result of the combined action of radioactive transformation and biological elimination.
Half-Life, Physical (see Half-Life Radioactive)
 Half-Life, Radioactive—The time required for a radioactive substance to lose 50% of its activity by
transformation.  Each radionuclide has a unique half-life.
Half-Time (see Half-Life, Biological)
High-LET—The characteristic ionization patterns by alpha particles, protons, or fast neutrons having a
high relative specific ionization per unit path length.
Immunologic Toxicity—The occurrence of adverse effects on the immune system that may result from
exposure to  agents such as radiation or chemicals.
In Vitro—The condition of being isolated from a living organism and artificially maintained, as in a test
tube.
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In Vivo—Any condition occurring within a living organism.
Induced Radioactivity—The radioactivity produced in a substance after bombardment with neutrons or
other particles.  The resulting activity is “natural radioactivity” if formed by nuclear reactions occurring
in nature, and “artificial radioactivity” if the reactions are caused by humans.
Intensity—The amount of energy per unit time passing through a unit area perpendicular to the line of
propagation at the point in question.
Intermediate Exposure—An exposure to radiation for a duration of 15–364 days.
Internal Conversion—One of the possible mechanisms of transformation from the metastable state
(isomeric transition) in which the transition energy is transferred to an orbital electron, causing its
ejection from the atom.  The ratio of the number of internal conversion electrons to the number of gamma
quanta emitted in the de-excitation of the nucleus is called the "conversion ratio."
Internal Radiation— Radiation from radionuclides inside the body.
Ion—An atomic particle, atom or chemical radical bearing a net electrical charge, either negative or
positive.
Ion Pair—Two particles of opposite charge, usually referring to the electron and positive atomic or
molecular residue resulting after the interaction of ionizing radiation with the orbital electrons of atoms.
Ionization— The process by which ionizing radiation (photons or particles) remove electrons from an
atom.  The process in chemical reactions by which a neutral atom or molecule acquires a positive or
negative charge.
Ionizing Energy—The average energy lost by ionizing radiation in producing an ion pair.  For air, the
ionizing energy is about 34eV per ion pair by beta particles.
Ionizing Density—The number of ion pairs per unit volume.
Ionization Path (Track)—The trail of ion pairs produced by ionizing radiation in its passage through
matter.
Ionization Potential —The energy, in electron-volts (eV), necessary to separate one electron from an
atom, resulting in the formation of an ion pair.
Ionizing Radiation—Any electromagnetic or particulate radiation capable of producing ions, directly or
indirectly, in its passage through matter.
Isotopes—Any nuclide of the same element having the same number of protons in their nuclei, and hence
the same atomic number, but differing in the number of neutrons and therefore in the mass number. 
Almost identical chemical properties exist between isotopes of a particular element, but physical
properties such as diffusion through a membrane may differ.  This term should not be used as a synonym
for nuclide.
Joule—The unit for work and energy, equal to one newton expended along a distance of one meter 
(1 J =1 N x l m).  There are 4.2 joules per calorie. In terms of radiological units, 1 J = 1 Gy-kg.
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Kerma (k)—The initial kinetic energy of the primary ionizing particles produced by the interaction of the
incident radiation per unit mass of interacting medium, expressed as J/kg or grays (rads).
Labeled Compound—A compound consisting, in part, of labeled molecules.  These are molecules
including radionuclides in their structure.  By observations of radioactivity or isotopic composition, this
compound or its fragments may be followed through physical, chemical, or biological processes.
Late Effects (of radiation exposure)—Any effects that appear 60 days or more following an acute
exposure.
Lethal Dose50 (LD50)—The dose of  radiation or a chemical that has been found to cause death in 50% of
a defined population.
Lethal Dose50/30 (LD50/30)—The dose of radiation or a chemical which kills 50% of the population within
30 days.  
Linear Energy Transfer (LET)—The average amount of energy transferred locally to the medium per
unit of particle or electromagnetic radiation track length.
Linear Hypothesis or Linear No Threshold (LNT) Hypothesis—The assumption that a dose-response
curve derived from data in the high dose and high dose-rate ranges may be extrapolated linearly through
the low dose and low dose-rate ranges to zero, implying that, theoretically, any amount of radiation will
cause some damage.
Low-LET—The characteristic ionization patterns of electrons, x rays, and gamma rays having a low
relative specific ionization per unit path length compared to high LET radiation.
Lowest-Observed-Adverse-Effect Level (LOAEL)—The lowest dose of chemical in a study, or group
of studies, that produces statistically or biologically significant increases in the frequency or severity of
adverse effects between the exposed population and its appropriate control.
Malformations—Any permanent structural changes that may adversely affect survival, development, or
function as a result of in utero exposure.
Mass Absorption Coefficient—The linear absorption coefficient per centimeter divided by the density of
the absorber in grams per cubic centimeter.  This is the fraction of incident radiation that is absorbed per
unit mass of the absorber.
Mass Number—The number of nucleons (protons and neutrons) in the nucleus of an atom.  (Symbol:  A)
Median Lethal Dose (MLD)—The dose of radiation required to kill 50% of the individuals in a large
group of animals or organisms within a specific period, usually 30 days.  Also called LD30.
Megacurie—One million curies.   (Symbol:  MCi)
Microcurie—One-millionth of a curie. Amount of material in which 3.7 x 104 radioactive atoms
transform per second.   (Symbol:  µCi)
Millicurie—One-thousandth of a curie. Amount of material in which 3.7 x 107 radioactive atoms
transform per second.   (Symbol:  mCi)
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Minimal Risk Level (MRL)—An estimate of daily human exposure to a dose of radiation or a chemical
that is likely to be without an appreciable risk of adverse noncancerous effects over a specified duration
of exposure.
Monoenergetic Radiation—Radiation of a given type (alpha, neutron, gamma, etc.) in which all
particles or photons originate with  the same energy.
Mutagen—A substance that causes mutations.
Mutation—A mutation is a change in the genetic material in a body cell.  Mutations in germ cells can
lead to birth defects and miscarriages; mutations in somatic cells may lead to cancer.
 
Nanocurie—One-billionth of a curie.  Amount of material in which 37 radioactive atoms transform per
second.  (Symbol:   nCi)
Natural Radioactivity—The property of radioactivity exhibited by more than 50 naturally occurring
radionuclides.
Neurotoxicity—The occurrence of adverse effects on the nervous system following exposure to radiation
or a chemical.
Neutrino—A neutral particle of very nearly zero rest mass emitted during the beta-decay process.  It
plays no role in radiation bio-effects.
Non-deterministic Effects (stochastic effects) —Health effects which appear to be related to random
events. Dose-response is assumed to be linear without threshold in radiation protection.
No-Observed-Adverse-Effect Level (NOAEL)—The dose of radiation or a chemical that produces no
statistically or biologically significant increases in frequency or severity of adverse effects seen between
the exposed population and its appropriate control.  Effects may be produced at this dose, but they are not
considered to be adverse.
Nucleon—Generic name for a constituent particle of the nucleus.  Applied to a proton or neutron.
Nuclide—A species of atom characterized by the constitution of its nucleus.  The nuclear constitution is
specified by the number of protons (Z), number of neutrons (N), and energy content; or, alternatively, by
the atomic number (Z), mass number A'(N+Z), and atomic mass.  
Pair Production—An absorption process for x ray and gamma radiation in which the incident photon is
annihilated in the vicinity of the nucleus of the absorbing atom, and its energy is converted into an
electron and positron pair.   This reaction only occurs for incident photon energies exceeding 1.02 MeV,
which is the energy equivalence of the masses of the positron and electron.
Parent Radionuclide—A radionuclide which, upon transformation, yields a specified nuclide, either
directly or as a later member of a radioactive series. The radionuclide from which a new nuclide was
made as a result of radioactive transformation.
Photoelectric An interaction between an x ray or gamma ray (photon) and an atom in which an orbital
electron is knocked out.  The photon disappears because it gives up all of its energy in the collision. 
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Photon—A quantity of electomagnetic radiation whose energy content depends on the frequency or
wavelength of the radiation. The equation is:  E=hν.  Photon energy for ionizing radiation purposes is
usually measured in eV, keV and MeV. 1 eV = 1.6 x 10-19J.
Picocurie—One-trillionth of a curie (3.7x10-2 transformations per second or 2.22 transformations per
minute).   (Symbol:  pCi)
Positron—A particle equal in mass to the electron (9.1091x10-31 kg) and having an equal but positive
charge (+1.60210x10-19 Coulombs).  (See also Electron).
Primary Ionization—(1) In collision theory, the ionization produced by the primary particles
(photoelectron, Compton electron, or positron-electron pair) as contrasted with the total ionization, which
includes the secondary ionization produced by delta rays; (2) In counter tubes, the total ionization
produced by incident radiation without gas amplification.
Progeny—The transformation products resulting after a series of radioactive decays.  Progeny can also be
radioactive, and the chain continues until a stable nuclide is formed.
Proton—An elementary nuclear particle with a positive electric charge equal numerically to the charge of
the electron and a rest mass of 1.007277 atomic mass units.
Public Dose—The dose received by a member of the public from exposure to radiation  caused by a
licensee or to any other source of radiation under the control of a licensee, excluding background and
occupational doses.
Quality—A term describing the distribution of the energy deposited by a particle along its tract;
radiations that produce different densities of ionization per unit track length are said to have different
qualities.
Quality Factor (Q)—The linear-energy-transfer-dependent factor by which absorbed doses are
multiplied to obtain (for radiation protection purposes) a quantity that expresses the biological
effectiveness of the absorbed dose on a common scale for all ionizing radiation.
Rad—The unit of absorbed dose equal to 0.01 J/kg in any medium.  (See also Absorbed Dose.)
Radiant Energy—The energy of electromagnetic radiation, such as radio waves, visible light, x  and
gamma rays.
Radiation—(1) The emission and propagation of energy through space or through a material medium in
the form of waves: for instance, the emission and propagation of electromagnetic waves, or of sound and
elastic waves.  (2) The energy propagated through space or through a material medium such as waves; for
example, energy in the form of electromagnetic waves or of elastic waves.  The term radiation or radiant
energy, when unqualified, usually refers to electromagnetic radiation.  Such radiation commonly is
classified, according to frequency, as with Hertzian, infrared, visible (light), ultraviolet, x ray and gamma
ray (see also Photon).  (3) By extension, corpuscular emission, such as alpha and beta radiation, or rays of
mixed or unknown type, such as cosmic radiation.
Radioactivity—The property of certain nuclides to spontaneously transform into another element by
emitting alpha or beta particles, or undergoing electron capture.  
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Radioisotope—Radioactive atomic species of an element with the same atomic number and  identical
chemical properties.
Radionuclide—A radioactive species of an atom characterized by the constitution of its nucleus.
Radiosensitivity—The relative susceptibility of cells, tissues, organs, organisms, or any living substance
to the injurious action of radiation.  Radiosensitivity and its antonym, radioresistance, are currently used
in a comparative sense, rather than in an absolute one. Radiosensitivity depends upon the biological
response being measured.
Reaction (Nuclear)—An induced nuclear transformation (i.e., a process occurring when a nucleus comes
in contact with a photon, an elementary particle, or another nucleus).  In many cases, the reaction can be
represented by the symbolic equation:  X+a6Y+b or, in abbreviated form, X(a,b) Y, where X is the target
nucleus, a is the incident particle or photon, b is an emitted particle or photon, and Y is the product
nucleus.
Reference Man —A theoretical human male on which dosimetry calculations related to ionizing
radiation exposure are based.  Reference man is 70 kg and consists of detailed organ mass data for all
major human body organs.  Models, which can be other than 70 kg, are also available for different ages
and for females (pregnant and non-pregnant).
Relative Biological Effectiveness (RBE)—The RBE is a factor used to compare the biological effective-
ness of absorbed radiation doses due to different types of ionizing radiation.  More specifically, it is the
experimentally determined ratio of an absorbed dose of a radiation in question to the absorbed dose of a
reference radiation required to produce an identical biological effect in a particular experimental organism
or tissue (see also Quality Factor). RBE depends on several experimental factors including dose, dose
rate, and biological end point.  RBE is not used in radiation protection practice.  Quality factor is used in
radiation protection but is derived from LET. RBE is an index of comparison of radiations of different
quality.
Rem—A unit of dose equivalent.  The dose equivalent in rem is numerically equal to the absorbed dose
in rad multiplied by the quality factor.  It is used only in the context of radiation safety, administrative,
and engineering design purposes.
Reproductive Toxicity—The occurrence of adverse effects on the reproductive system that may result
from exposure to radiation or a chemical.  The toxicity may be directed to the reproductive organs and/or
the related endocrine system.  The manifestation of such toxicity may be noted as alterations in sexual
behavior, fertility, pregnancy outcomes, or modifications in other functions that are dependent on the
integrity of this system.
Roentgen (R)—A unit of exposure to photon radiation whose energy #3 MeV.  One roentgen generates 
2.58x10-4 Coulomb of charge of either sign per kilogram of air at standard temperature and pressure (0
EC, 1 atm).  The roentgen is defined for x and gamma rays only.
Scattered Radiation—Radiation that, during its passage through a substance, has been deviated in
direction.  It usually will have been modified by a decrease in energy.
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Scientific Units
Prefix (Symbol) Power of 10 Decimal Equivalent
atto (a) 10-18 0.000000000000000001
femto (f) 10-15 0.000000000000001
pico (p) 10-12 0.000000000001
nano (n) 10-9 0.000000001
micro (µ) 10-6 0.000001
milli (m) 10-3 0.001
centi (c) 10-2 0.01
deci (d) 10-1 0.1
kilo (k) 103 1,000.0
mega (M) 106 1,000,000.0
giga (G) 109 1,000,000,000.0
tera (T) 1012 1,000,000,000,000.0
peta (P) 1015 1,000,000,000,000,000.0
exa (E) 1018 1,000,000,000,000,000,000.0
Secondary Radiation—Radiation that results from the interaction of other radiation in matter.  It may be
either electromagnetic or particulate.
Secular Equilibrium—If a parent element has a much longer half-life than its  progeny (so that there is
no appreciable change in its amount in the time interval required for later products to attain equilibrium),
then after equilibrium is reached, equal numbers of atoms of all members of the series that are in equilib-
rium transform in unit time.  This means that each has the same activity measured in curies or becquerels.
This condition is never exactly attained, but is essentially established after 6 or 7 daughter half-lives.  For
example, the half-life of radium is about 1,600 years; of radon, approximately 3.82 days; and for each of
the subsequent members, a few minutes.  After about a month, the equilibrium amount of radon is
present; then (and for a long time) all members of the series transform at the same number of atoms per
unit time. Thus contained radon gas is in secular equilibrium with its parent 226Ra after about 27 days.
Self-Absorption—The absorption of radiation (emitted by radioactive atoms) by the material in which
the atoms are located (in particular, the absorption of radiation within a sample being assayed).
Shallow Dose Equivalent (HS)—The dose equivalent at a tissue depth of 0.007 cm averaged over an area
of 1 cm2 from external exposure of the skin or an extremity.
SI Units—The International System of Units as defined by the General Conference of Weights and
Measures in 1960.  These units are generally based on the meter/kilogram/second units, with special
quantities for radiation including the becquerel, gray, and sievert.
Sickness, Radiation —(1) A syndrome characterized by nausea, vomiting, diarrhea, and psychic
depression following exposure to appreciable doses of ionizing radiation within a short period of hours to
weeks.  Its mechanism is known, and remedies include fluid replacement, antibiotics, electrolyte replace-
ment, and in some cases, marrow stem cell support.  It usually appears a few hours after irradiation and
may subside within a day.  In nuclear medicine applications, it may be sufficiently severe to necessitate
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interrupting the treatment series or to incapacitate the patient.  (2) The syndrome associated with intense
acute exposure to ionizing radiations.  The rapidity with which symptoms develop is a rough measure of
the dose level. The syndrome also includes certain signs such as changes in peripheral blood cell counts.
Sievert—The SI unit of radiation dose equivalent.  It is equal to dose in grays times a quality factor;
1 sievert equals 100 rem.
Somatic Effects—Effects of radiation limited to the exposed individual, as distinguished from genetic
effects, which may subsequently affect unexposed future generations.
Specific Activity—The total activity of a given nuclide per volume or mass.  It is a concentration defined
as the ratio of the amount of radioactivity divided by the mass or volume of radioactive substance, e.g. the
specific activity of 238U metal is 0.33 µCi/g.  
Stable Isotope—A nonradioactive isotope of an element.
Standard Mortality Ratio (SMR)—The ratio of the disease or accident mortality rate in a certain
population compared with that in a standard population.  The SMR is usually expressed in percent.  Thus,
an SMR is the mortality rate for the standard population.  
Stopping Power—The average rate of energy loss of a charged particle per unit thickness or per unit
mass of a material traversed as a result of Coulomb interactions with electrons and with atomic nuclei. 
Stochastic effects—See Non-Deterministic Effects.
Surface-seeking Radionuclide—A bone-seeking  radioactive material that is deposited and remains on
the surface for a long period of time.  This contrasts with a volume seeker, which deposits more uniformly
throughout the bone volume.
Target Theory (Hit Theory)—A theory explaining some biological effects of radiation on the basis that
ionization, occurring in a discrete volume (the target) within the cell, directly causes a lesion that
subsequently results in a physiological response to the damage at that location.  One, two, or more "hits"
(ionizing events within the target) may be necessary to elicit the response. When the target is “hit,” it is
inactivated.  A specific biological response (e.g., cell death) may require the inactivation of more than one
target. A critical characteristic of target theory in the context of the linear no-threshold theory, is that
targets are not repairable once they are hit or inactivated. 
Teratogen—Radiation or a chemical that can lead to birth defects. 
Tissue Dose—The absorbed dose received by tissue in the region of interest, expressed in Gray or rad. 
(See also Dose and Rad.)
Total Effective Dose Equivalent (TEDE)—The sum of the effective deep dose equivalent from external
exposures and the committed effective dose equivalent from internal exposures.
Total Ionization—The total electric charge of one sign on the ions produced by radiation in a material.  It
is frequently used as a measure of radiation energy absorbed per unit mass of gas.
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Total Organ Dose Equivalent (TODE)—The sum of the dose equivalent to an organ or tissue from
external radiation and the committed dose equivalent to that organ or tissue from radioactive materials
deposited within the body.
Transformation Constant—The fraction of the number of atoms of a radioactive nuclide that transforms
in unit time.  λ is the symbol for the transformation constant in the equation N'N0e-λt, where N0 is the
initial number of atoms present, and N is the number of atoms present after some time, t.
Transformation, Nuclear—The process by which a nuclide is transformed into a different nuclide by
absorbing or emitting a particle.
Transient Equilibrium—If the half-life of the parent is short enough, so that the quantity present
decreases appreciably during the period under consideration, but is still longer than that of successive
members of the series, a stage of equilibrium will be reached after which all members of the series
decrease in activity exponentially with the period of the parent.  An example of this is radon (half-life of
approximately 3.82 days), and successive members of the series to 210Pb.
Transition, Isomeric—The process by which an excited nuclide decays to the ground state to produce an
isomeric nuclide (i.e., one of the same mass number and atomic number) by emitting a gamma ray. 
Tritium—The hydrogen isotope with one proton and two neutrons in the nucleus (Symbol: 3H or T). 
Tritium is radioactive, with a half-life of 12.3 years; it emits very low energy beta particles.
Unattached Fraction—That fraction of the radon daughters, usually 218Po (Radium A), that has not yet
electrostatically attached to an airborne dust particle.  As a free atom, it has a high probability of being
retained within the lung and depositing alpha energy when it decays.
Units, Radiological
Units Equivalents
becquerel* 1 Bq = 1 transformation or disintegration per second = 2.7x10-11 Ci
curie 1 Ci = 3.7x1010 transformations or disintegrations per second = 3.7x1010 Bq
gray* 1 Gy = 1 J/kg = 100 rad
rad  1 rad = 100 erg/g = 0.01 Gy
sievert* 1 Sv = 100 rem
rem 1 rem = 0.01 sievert
Roentgen 1 R = 2.58x10-4 coulomb of charge of either sign produced in 1 kilogram of
air at STP 
    *International Units are designated as SI.
Weighting Factor (WT)—A dosimetric factor used in the practice of health physics (radiation safety) to
account for the relative carcinogenic susceptibility of the various tissues. 
Whole Body—For the purposes of radiation exposure, the part of the body composed of the head, trunk,
arms above the elbow, legs above the knee, and gonads.
IONIZING RADIATION 350
9.  GLOSSARY
Working Level (WL)—A unit for measuring the atmospheric concentration of radon progeny.  It
corresponds to the equilibrium concentration of radon progeny due to 100 pCi radon per liter of air, or
any combination of short-lived radon daughters in 1 liter of air that will result in the ultimate emission of
1.3x105 MeV of potential alpha energy.
Working Level Month (WLM)—Inhalation of air with a concentration of 1 WL of radon daughters for
170 working hours results is an exposure of 1 WLM.
X rays—Penetrating electromagnetic radiations whose wave lengths are shorter than those of ultraviolet
light.   X rays can be classified as characteristic x rays or bremsstrahlung.  Characteristic x rays are
produced deliberately in x ray machines or directly when ionizing radiation passes through matter.  These
x rays occur when electrons are ejected from an atom and electrons in higher energy orbitals cascade
down to fill in those vacancies, releasing the energy difference between those orbitals as electromagnetic
radiation (x rays). Bremsstrahlung is x rays that are radiated from a beta particle as it accelerates (changes
direction) in the strong electrostatic field of an atomic nucleus, as occurs when electrons are stopped in a
high atomic number element, such as lead. 
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APPENDIX A
ATSDR MINIMAL RISK LEVELS AND WORKSHEETS
The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) [42 U.S.C.
9601 et seq.], as amended by the Superfund Amendments and Reauthorization Act (SARA) [Pub. L.
99–499], requires that the Agency for Toxic Substances and Disease Registry (ATSDR) develop jointly
with the U.S. Environmental Protection Agency (EPA), in order of priority, a list of hazardous substances
most commonly found at facilities on the CERCLA National Priorities List (NPL); prepare toxicological
profiles for each substance included on the priority list of hazardous substances; and assure the initiation
of a research program to fill identified data needs associated with the substances.
The toxicological profiles include an examination, summary, and interpretation of available toxicological
information and epidemiologic evaluations of a hazardous substance.  During the development of
toxicological profiles, Minimal Risk Levels (MRLs) are derived when reliable and sufficient data exist to
identify the target organ(s) of effect or the most sensitive health effect(s) for a specific duration for a
given route of exposure.  An MRL is an estimate of the daily human exposure to a hazardous substance
that is likely to be without appreciable risk of adverse noncancer health effects over a specified duration
of exposure.  MRLs are based on noncancer health effects only and are not based on a consideration of
cancer effects.  These substance-specific estimates, which are intended to serve as screening levels, are
used by ATSDR health assessors to identify contaminants and potential health effects that may be of
concern at hazardous waste sites.  It is important to note that MRLs are not intended to define clean-up or
action levels.
MRLs are derived for hazardous substances using the no-observed-adverse-effect level/uncertainty factor
approach.  They are below levels that might cause adverse health effects in the people most sensitive to
such effects.  MRLs are derived for acute (1–14 days), intermediate (15–364 days), and chronic (365 days
and longer) durations and for the oral,  inhalation, and external routes of exposure.  Currently, MRLs for
the dermal route of exposure are not derived because ATSDR has not yet identified a method suitable for
this route of exposure.  MRLs are generally based on the most sensitive end point considered to be of
relevance to humans.  Serious health effects (such as irreparable damage to the liver or kidneys, or birth
defects) are not used as a basis for establishing MRLs.  Exposure to a level above the MRL does not mean
that adverse health effects will occur.
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APPENDIX A
MRLs are intended only to serve as a screening tool to help public health professionals decide where to
look more closely.  They may also be viewed as a mechanism to identify those hazardous waste sites that
are not expected to cause adverse health effects.  Most MRLs contain a degree of uncertainty because of
the lack of precise toxicological information on the people who might be most sensitive (e.g., infants,
elderly, nutritionally or immunologically  compromised) to the effects of hazardous substances.  ATSDR
uses a conservative (i.e., protective) approach to address this uncertainty consistent with the public health
principle of prevention.  Although human data are preferred, MRLs often must be based on animal studies
because relevant human studies are lacking.  In the absence of evidence to the contrary, ATSDR assumes
that humans are more sensitive to the effects of hazardous substance than animals and that certain persons
may be particularly sensitive.  Thus, the resulting MRL may be as much as a hundredfold below levels
that have been shown to be nontoxic in laboratory animals.
Proposed MRLs undergo a rigorous review process:  Health Effects/MRL Workgroup reviews within the
Division of Toxicology, expert panel peer reviews, and agencywide MRL Workgroup reviews, with
participation from other federal agencies and comments from the public.  They are subject to change as
new information becomes available concomitant with updating the toxicological profiles.  Thus, MRLs in
the most recent toxicological profiles supersede previously published levels.  For additional information
regarding MRLs, please contact the Division of Toxicology, Agency for Toxic Substances and Disease
Registry, 1600 Clifton Road, Mailstop E-29, Atlanta, Georgia 30333.
IONIZING RADIATION A-3
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MINIMAL RISK LEVEL (MRL) WORKSHEET
Chemical name: Ionizing Radiation
CAS number: Multiple
Date: October 1, 1999
Profile status: Final
Route: [ ] Inhalation [ ] Oral [X] External
Duration: [X] Acute [ ] Intermediate [ ] Chronic
Species: Human
MRL: 4 [ ] mg/kg/day  [ ] ppm  [ ] mg/m3 [X] mSv (400mrem)
References:
Schull WJ, Otake M and Yoshimaru H (1988). Effect on intelligence test score of prenatal exposure to
ionizing radiation in Hiroshima and Nagasaki: A comparison of the T65DR and DS86 dosimetry systems.
Burt C. (1966). The genetic determination of differences in intelligence: A study of monozygotic twins
reared together and apart. Brit. J. Psychol. 57 (1& 2): pp. 137-153
Experimental design:
Schull et al. (1988) study: Schull et al. (1988) evaluated the quantitative effect of exposure to ionizing
radiation on the developing fetal and embryonic human brain. The end point measured was changes in
intelligence test scores. The effects on individuals exposed in utero to the atomic bombing of Hiroshima
and Nagasaki were based on the original PE86 samples (n=1759; data on available intelligence testing) and
a clinical sample (n=1598). The original PE86 sample included virtually all prenatally exposed individuals
who received tissue-absorbed doses of 0.50 Gy or more. There were many more individuals in the dose
range 0-0.49 Gy in the PE86 sample than in the clinical sample. The clinical sample does not include
children prenatally exposed at distances between 2,000-2,999 m in Hiroshima and Nagasaki. Children
exposed at greater distances or not present in the city were selected as controls. In 1955-1956, Tanaka-B
(emphasis on word-sense, arithmetic abilities, and the like which were associated with the more subtle
processing of visual clues than their simple recognition and depended more on connectedness) and the Koga
(emphasis on perception of spatial relationships) intelligence tests were conducted in Nagasaki and the
Koga test in Hiroshima.
Burt (1966) study: This study determined differences in intelligence in monozygotic twins reared together
(n=95) and apart (n=53). All tests conducted in school consisted of (1) a group test of intelligence
containing both non-verbal and verbal items, (2) an individual test (the London Revision of the
Terman-Binet Scale) used primarily for standardization and for doubtful cases, and (3) a set of
performance tests, based on the Pitner-Paterson tests and standardization. The methods and standard
remained much the same throughout the study. Some of the reasons for separation of the twins were given
as follows: death of the mother (n=9), unable to bring them up properly, mother’s poor health (n=12),
unmarried (n=6), and economic difficulties. The children were brought up by parents or foster parents
(occupation ranged from unskilled to professional). IQ scores in the study group ranged from 66 to 137.
The standard deviation of the group of separated monozygotic twins was reported at 15.3 as compared to
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15.0 of ordinary siblings. Twins brought up in different environments were compared with those brought
up in similar circumstances.
Effects noted in study and corresponding doses:
Schull et al. (1986) study: No evidence of radiation-related effect on intelligence was observed among
individuals exposed within 0-7 weeks after fertilization or in the 26th or subsequent weeks. The highest
risk of radiation damage to the embryonic and fetal brain occurs 8-15 weeks after fertilization under both
dosimetric systems. The regression of intelligence score on estimated DS86 uterine absorbed dose is linear
with dose, the diminution in intelligence score is 21-29 points per Gy for the 8-15 week group and 10-26
points per Gy for the 16-25 week group. The results for 8-15 weeks applies regardless whether the
mentally retarded individuals were included. The cumulative distribution of test scores suggested a
progressive shift downwards in individual scores with increasing exposure. The mean IQ scores decrease
significantly and systematically with uterine or fetal tissue dose within the 8-15 and 16-25 week groups.
In summary, analysis of intelligence test scores at 10-11 years of age of individuals exposed prenatally
showed that:
 There is no evidence of a radiation-related effect on intelligence scores among those individuals
exposed within 0-7 weeks of fertilization or in the 26th week of gestation and beyond;
 The cumulative distribution of test scores suggests a progressive shift downwards in intelligence
scores with increasing exposure to ionizing radiation (dose-response relationship).
 The most sensitive group was the 8-15 weeks exposure group. The regression in intelligence scores
was found to be linear, with 1 Gy dose resulting in a 21-29 point decline in intelligence scores.
 There was no indication of groups of individuals with differing sensitivities to radiation.
Burt (1966) study:  The average intelligence of the twins measured on a conventional IQ scale (SD=15)
was 97.8 for the separated monozygotes, 98.1 for monozygotes brought up together, 99.3 for the dizygotes
as compared with 100.2 for the siblings, and 100.0 for the population as a whole. The difference of 0.3 IQ
point between the separated and unseparated identical twins is considered a no-observed-adverse-effect
level (NOAEL) for this study.
Dose endpoint used for MRL derivation:
[X] NOAEL [ ] LOAEL 0.3 IQ point reduction in twins, between those raised together and those
raised apart.
Uncertainty factors (UF) used in MRL derivation:
[X] 1 [ ] 3 [ ] 10 (for use of a NOAEL)
[X] 1 [ ] 3 [ ] 10 (for extrapolation from animals to humans)
[ ] 1 [X] 3 [ ] 10 (for human variability/sensitive population)
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Was a conversion factor used from nnm in food or water to a me/body weight dose?
If so, explain:
No.
If an inhalation study in animals, list conversion factors used in determining human eauivalent dose:
Not applicable.
Was a conversion used from intermittent to continuous exposure?
No.
Other additional studies or pertinent information that lend sunport to this MRL:
Husen (1959) reported a study involving 269 pairs of Swedish monozygotic (identical) twins where the
intrapair IQ difference was 4 IQ points for a combination of twins raised together and apart. This is
somewhat lower than the value of 7 IQ points for identical twins raised apart, and just larger than the range
of IQ scores for Washington DC children repetitively tested (Jacobi and Glauberman 1995).
Supporting evidence for the acute MRL is provided by Jacobi and Glauberman (1995). Children in the Ist,
3rd, and 5th grades born in Washington DC were tested, and average IQ levels of 94.2,97.6, and 94.6 were
reported. The range of 3.4 IQ points is considered to be a LOAEL for this study, which, if used for MRL
derivation, would yield an MRL of 0.004 Sv (3.4 IQ points x 1 Sv/25 IQ points ÷ 30 [10 for use of a
LOAEL and 3 for a sensitive population]).
Additional supporting evidence for the acute MRL is provided by Berger et al. 1997, in a case study of
accidental radiation injury to the hand. A Mexican engineer suffered an accidental injury to the hand while
repairing an x ray spectrometer. The day after the accident, his symptoms included a tingling sensation and
itching in the index and middle fingers. On days 4 and 7, a “pinching” sensation, swelling, and slight
erythema were observed. By day 7, the tip of his index fingers was erythematous and a large blister
developed with swelling on other fingers. On day 10, examination by a physician showed that the lesions
had worsened and the fingers and palms were discolored. On day 10, he was admitted to the hospital where
hyperbaric oxygen therapy was administered without success. One month after the accident, the patient
entered the hospital again with pain, discoloration, and desquamation of his hand. Clinical examination
showed decreased circulation in the entire hand, most notably in the index and middle finger. Total white
blood count decreased to 3,000/µL (normal range 4,300-10,800/µL). Cytogenic studies of peripheral
blood lymphocytes revealed four dicentrics, two rings, and eight chromosomal fragments in the 300
metaphases studied. The estimated whole body dose was reported to be 0.382 Gy (38.2 rad). This dose is
a potential LOAEL for acute ionizing radiation and would yield an MRL of 0.004 Sv (0.38 Sv ÷100
[10 for use of LOAEL and 10 for sensitive human population]).
The Nuclear Regulatory Commission set a radiation exposure limit of 0.5 rems (50 mSv) for pregnant
working women over the full gestational period (USNRC 1991). For the critical gestational period of 8 to
15 weeks ATSDR believes that the conservative acute MRL of 4 mSv is consistent with the NRC limit and
could be applied to either acute (0-14 day) or intermediate (15-365 day) exposure periods.
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Calculations
Given: 0.3 IQ point is a NOAEL. A 1 Sv dose results in a 25 IQ point reduction (range = 21-29 pts;
mean = 25) and provides a conversion factor from IQ prediction to radiation dose. Assume that the
radiation dose and the subsequent reduction in IQ is a linear relationship.
MRL=NOAEZL x CF ÷ UF
MRL = 0.3 x 1/25 ÷ 3
MRL = 0.004 Sv = 4 mSv (400 mrem)
Agency Contact (Chemical Manager): Sam Keith.
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MINIMAL RISK LEVEL (MRL) WORKSHEET
Chemical name: Ionizing Radiation
CAS number: Multiple
Date: October 1, 1999
Profile status: Final
Route: [ ] Inhalation [ ] Oral [X] External
Duration: [ ] Acute [ ] Intermediate [X] Chronic
Species: Human
MRL: 1 [] mg/kg/day [ ] ppm [ ] mg/m3 [X] mSv/yr (100 mrem/yr)
Reference: BEIR V. 1990. Health effects of exposure to low levels of ionizing radiation. Committee on
the Biological Effects of Ionizing Radiations, National Research Council. National Academy Press.
Washington, DC.
Experimental design: Not applicable
Effects noted in study and corresnonding doses:
No individual studies were identified that could be used to base a chronic-duration external exposure MRL
that did not result in a cancer-producing end point. However, two sources of information were identified
that did provide doses of ionizing radiation that have not been reported to be associated with detrimental
effects (NOAELs). These sources provide estimates of background levels of primarily natural sources of
ionizing radiation that have not been implicated in producing cancerous or non-cancerous toxicological
endpoints. BEIR V states that the average annual effective dose to the U.S. population is 3.6 mSv/yr. A
total annual effective dose equivalent of 3.6 mSv (360 mrem)/year to members of the U.S. population is
obtained mainly by naturally occuring radiation from external sources, medical uses of radiation, and
radiation from consumer products. The largest contribution (82%) is from natural sources, two-thirds of
which if from naturally occurring radon and its decay products. Specific sources’ of this radiation are
demonstrated in Table A- 1.
The annual dose of 3.6 mSv per year has not been associated with adverse health effects or increases in the
incidences of any type of cancers in humans or other animals.
Dose endpoint used for MRL derivation: 3.6 rnSv/yr
[X] NOAEL [ ] LOAEL 3.6 mSv/yr
Uncertainty factors (UF) used in MRL derivation:
[X] 1 [ ] 3 [ ] 10 (for use of a NOAEL)
[X] 1 1 ] 3 [ ] 10 (for extrapolation from animals to humans)
[ ] 1 [X] 3 [ ] 10 (for human variability)
Was a conversion factor used from ppm in food or water to a mg/bodv weight dose?
If so, explain: No.
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Other additional studies or pertinent information that lend support to this MRL:
ICRP has developed recommended dose limits for occupational and public exposure to ionizing radiation
sources. The ICRP recommends limiting public exposure to 1 mSv/yr (100 mrem/yr), but does note that
values at high altititues above sea level and in some geological areas can sometimes be twice that value
(≥2 mSv). In Annex C of ICRP 60, the commission provides data that suggests increasing the dose from 1
mSv to 5 mSv results in a very small, but detectable, increase in age-specific human mortality rate. ICRP
states that the value of 1 mSv/yr was chosen over the 5 mSv value because 5 mSv/yr (500 mremlyr) causes
this increase in age specific mortality rate, and 1 mSv/yr (100 rnrem/yr) is typical of the annual effective
dose from background, less radon (ICRP 1991). The 1 mSv estimate may underestimate the annual
exposure to external sources of ionizing radiation to the U.S. population, as it does not include radiation
from radon. Conversely, the 5 mSv estimate may be high, in that increases in mortality rate been reported.
The most useful estimate appears to be the BEIR V estimate of 3.6 mSv, in that it accounts for an annual
exposure to radon, is specific to the U.S. population, has not been associated with increases mortality, and
it falls short of the 5 mSv value associated with small increases in human mortality.
Calculations
MRL = NOAEL(ADJ) ÷ Uf
MRL = 3.6 mSv/yr ÷ 3
MRL = 1.20 mSv/yr
MRL = 1.0 mSv/yr = 100 mrem/yr above background
Agency Contact (Chemical Manager): Sam Keith.
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USER'S GUIDE
Chapter 1.  Public Health Statement
This chapter of the profile is a health effects summary written in non-technical language.  Its intended
audience is the general public, especially people living in the vicinity of a hazardous waste site or
chemical release.  If the Public Health Statement were separate from the rest of the document, it would
still communicate to the lay public essential information about the chemical.
The major headings in the Public Health Statement are useful for finding specific topics of concern.  The
topics are written in a question and answer format.  The answer to each question includes a sentence that
direct the reader to chapters in the profile that provide more information on the given topic.
Chapter 2.  Principles of Ionizing Radiation
This chapter is an introductory discussion of the principles of ionizing radiation.  It addresses what
ionizing radiation is and provides a brief overview of the history of ionizing radiation as it pertains to
health effects and uses, both peaceful and military.  The chapter goes on to discuss the concept of
radioactive transformation and the concept of half-life, characteristics of nuclear radiation, how radiation
interacts with matter, ionizing radiation and DNA interactions, energy deposition in biological tissues,
radiation dosimetry, and internal vs. external exposure.  Chapter 2 also introduces the concept of dose-
response and the concept of acute and chronic (delayed) health effects, in addition to briefly summarizing
the major health effects caused by exposure to ionizing radiation.  This chapter concludes with a thorough
discussion of how ionizing radiationis measured, internally, externally, and in media using a variety of
instruments.
Chapter 3.  Summary of Health Effects of Ionizing Radiation
This chapter provides an overview of the health effects related to ionizing radiation exposure in humans
and laboratory animals.  The top 25 radionuclides present currently or in the past at Department of Energy
(DOE) waste sites are identified and some information on their physical half-life and retention
characteristics in the body are summarized.  The health effects associated with exposure to ionizing
radiation are summarized and divided into non-carcinogenic and carcinogenic responses for discussion
purposes.  A discussion of the non-carcinogenic health effects by major organ system iss presented,
followed by a discussion of the carcinogenic responses using data from laboratory animals and the limited
amount of human data available.  The effects of ionizing radiation on teratogenesis, reproduction,
genotoxicity, and ocular toxicities, including the available information on human risk assessments, are
also addressed.  Readers are encouraged to use Chapter 8 as a supplement to the discussion of the health
effects presented in Chapter 3 of this profile.
Chapter 4.  Radiation Accidents
This chapter discusses the major radiation accidents of this century, including health effects data, if such
data were reported.
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Chapter 5.  Mechanisms of Biological Effects
This chapter discusses the major mechanisms by which ionizing radiation exerts it toxic effects on
cellular activities and organ systems.  This discussion addresses the major target molecules of ionizing
radiation, with emphasis on how ionizing radiation interacts with DNA.  The concept of direct vs. indirect
damage to DNA and other macromolecules is also introduced, followed by a discussion of how these
mechanisms induce specific types of damage to macromolecules, cells, tissues, and organs to elicit a toxic
or adverse event.  A brief discussion of the mechanisms by which ionizing radiation induces cancer in
laboratory animals and humans is presented, along with a number of models that reflect possible
mechanisms of cancer induction and a brief discussion of the three steps of cancer formation. 
Chapter 6.  Sources of Population Exposure to Ionizing Radiation
There are many ways humans and animals can be exposed to ionizing radiation.  This chapter addresses
the potential for exposure to sources of ionizing radiation to the human population.  Exposure to ionizing
radiation is divided into natural external (cosmic rays, terrestrial, coal production, crude oil and natural
gas, hot springs and caves, etc.), anthropogenic external (nuclear weapons, fallout, nuclear fuel cycle,
medical, dental, and occupational) and internal exposure (inhalation, oral and dermal routes).  Discussion
of the human health hazards associated with each type of exposure is also presented in this chapter.
Chapter 7.  Regulations
This chapter provides summarizes the regulations pertaining to radionuclides.
Chapter 8.  Levels of Significant Exposure to Radiation and Radioactive Material
Tables 8-1 (inhalation exposure), 8-2 (oral exposure), 8-3 (dermal exposure), and 8-4 (external exposure)
are used to summarize health effects associated with exposure to ionizing radiation.  These tables cover
the health effects observed at increasing radiation doses and durations, the specific isotope and activity
used, and the differences in response by species.  These tables provide a quick review of the health effects
and a convenient way to locate data for a specific exposure scenario.  The tables should be used in
conjunction with the text in chapters 2, 3 and 4.  All entries in these tables represent studies that provide
reliable, quantitative estimates of no-observed-adverse-effect levels (NOAELs),
lowest-observed-adverse-effect levels (LOAELs), or cancer effect levels (CELs).  
Chapter 9.  Glossary
This chapter contains of definitions and terminology pertaining to ionizing radiation and should be
consulted when reviewing and interpreting the data present in chapters 2 through 8 of this toxicological
profile.
Chapter 10.  References
This chapter lists the references used to construct this profile and references that the reader may use to
obtain more information on many of the topics discussed in this profile.
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ACRONYMS, ABBREVIATIONS, AND SYMBOLS
AMAD Activity Median Aerodynamic Diameter 
ATSDR Agency for Toxic Substances and Disease Registry
Bq becquerel
C Centigrade
CDC Centers for Disease Control
CEL Cancer Effect Level
CERCLA Comprehensive Environmental Response, Compensation, and Liability Act
CFR Code of Federal Regulations
Ci curie
cm centimeter
CNS central nervous system
d day
DHHS Department of Health and Human Services
DOD Department of Defense
DOE Department of Energy
DOT Department of Transportation
ECG electrocardiogram
ED50 Effective Dose 50%
EEG electroencephalogram
EPA Environmental Protection Agency
EKG see ECG
ERAMS Environmental Radiation Ambient Monitoring System
ERD Environmental Radiation Data
F Fahrenheit
F1 first filial generation
ft foot
g gram
Gy gray
HPS Health Physics Society
hr hour
IAEA International Atomic Energy Agency
IARC International Agency for Research on Cancer
ICRP International Commission on Radiological Protection
ILB Initial Lung Burden
IPB Initial Pulmonary Burden
in inch
J joule
kg kilogram
L liter
LC50 lethal concentration, 50% kill
LDLo lethal dose, low
LD50 lethal dose, 50% kill
LD50/30 Lethal Dose 50%/30 days
LOAEL lowest-observed-adverse-effect level
mg milligram
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min minute
mL milliliter
mm millimeter
MRL Minimal Risk Level
NAREL National Air and Radiation Environmental Laboratory
NCRP National Council on Radiation Protection and Measurements
NRC Nuclear Regulatory Commission
ng nanogram
nm nanometer
NPL National Priorities List
NRC Nuclear Regulatory Commission
NTIS National Technical Information Service
NTP National Toxicology Program
OSHA Occupational Safety and Health Administration
PHS Public Health Service
ppm parts per million
R roentgen
sec second
SCE sister chromatid exchange
SMR standard mortality ratio
STEL short term exposure limit
STORET STORAGE and RETRIEVAL
STP standard temperature and pressure
Sv sievert
TWA time-weighted average
U.S. United States
yr year
wk week
> greater than
> greater than or equal to
= equal to
< less than
< less than or equal to
% percent
Greek letters
α alpha
β beta
γ gamma
µ micro
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Prefixes for radiological and physical units 
a atto 10-18
c centi 10-2
d deci 10-1
E exa 1018
f femto 10-15
G giga 109
k kilo 103
p pico 10-12
m milli 10-3
M mega 106
n nano 10-9
P peta 1015
T tera 1012
µ micro 10-6
Radiation units
Bq becquerel
Ci Curie
Gy Gray
R roengten
Sv Seivert
.
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INDEX
acute radiation sickness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251, 276
Acute Radiation Syndrome (ARS) . . . . . . . . . . . . . . . . . . . . . . . . . . 58, 100, 101, 107, 108, 113, 132, 139
alpha spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68, 82
American Conference of Governmental Industrial Hygienists (ACGIH) . . . . . . . . . . . . . . . . . . . 279, 280
Annual Limits on Intake (ALI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
atmospheric nuclear testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243
Atomic Bomb Casualty Commission (ABCC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
atomic bomb survivors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15, 24, 61, 63
Bare Reactor Experiment Nevada (BREN) experiment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
beta rays (see Radiation-beta)
Bikini Atoll . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254-256
boiling water reactor (BWR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
bomb
atomic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26, 31-34, 60, 61, 63, 85, 89, 117, 249-251, 254
fission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
hydrogen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
nuclear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
bomb, atomic
Alamogordo, NM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
Bikini Atoll . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93, 167
fetal exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Hiroshima . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152, 167, 169
in utero exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117, 158
Japan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88, 160
Japanese survivors . . . . . . 88, 153-155, 159, 161, 164, 165, 167, 169-173, 180, 183, 193, 194, 197
Nagasaki . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117, 134, 152, 154, 158, 167, 169, 170
testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118, 158, 169
cancer . . . . . . . . . . . . . . . . . . . . 13, 28, 29, 33, 51, 61, 62, 64, 87, 88, 92, 87, 88, 92, 95, 97, 98, 104, 142,
149-151, 159-163, 168, 169, 171, 172, 180-184, 186-188, 191-197, 219,
222, 224, 225, 229-234, 236, 240, 243, 251, 260, 262, 275, 276, 279
cancer-specific
adenocarcinoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
adenoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
bladder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97, 166, 171
bone . . . . . . . . . . . . . . . . . . . . . . . . . . . 34, 61, 85, 127, 163, 167, 178, 184-187, 190-192, 196, 274
bone sarcoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176, 177, 179
brain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35, 171, 182
brain/CNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163, 167, 182
breast . . . . . . . . . . . . . . . . . . . . . . . . . . . 96, 126, 159, 162, 166, 171, 172, 183, 191, 193, 194, 278
carcinoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
cervix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
childhood . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63, 180
CNS except brain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
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cancer-specific (continued)
colon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171, 172
colon/rectum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163, 166
digestive organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
esophagus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162, 166, 171
fibrosarcoma(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184, 188, 191
gallbladder/bile ducts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166, 171
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pancreas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165, 166, 171, 183
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secondary metastatic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169-171
skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56, 61, 190, 191, 274
skin (except melanoma) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
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testicles/testis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61, 163
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cellular function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
DNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94, 107, 142, 149
eye . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
fetal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100, 116, 118, 124, 156-158, 160, 188, 195, 197
genetic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149, 150, 155
intestine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
lung . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104, 107, 130, 131
radiation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
skeletal muscle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
spermatocyte . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
stem cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
stomach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
vascular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127, 130, 133
APPENDIX D
IONIZING RADIATION D-4
deoxyribonucleic acid (DNA) . . . . . . . . . . . . . . . . . . . . . . . . . . . 85, 94, 107, 142, 149, 150, 165, 217-231
derived air concentrations (DAC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
drinking water . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13, 16, 20, 236, 242, 252, 253, 256
fallout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12, 93, 98, 193
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Federal Emergency Management Administration (FEMA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279
fertilizer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
food . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5, 13, 16, 236, 241, 246, 247, 253-255
fuel cycle facility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278
gamma ray (see Radiation-gamma)
genetic damage, radiation-induced . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
half-life . . . . . . . . . . . . . . . . . . . . . 4, 10, 13, 15, 31, 38, 40, 41, 44, 46, 50, 65, 85, 86, 176, 178, 187, 192
half-time (t1/2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86, 185
hazard
chemical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99, 156
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hazardous waste site(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1, 23, 24
hereditary disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150, 153, 155, 195
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liquefied petroleum gas (LPG) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240, 264, 275, 276
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luminous paint/painters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 264, 274
macrophage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
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Mammography Quality Standards Act (MQSA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278
Mammography Quality Standards Reauthorization Act of 1998 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278
mill/miller/milling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 257, 258
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phosphate processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
phosphogypsum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241
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power plant
coal-fired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12, 243
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Savannah Naval Storage Facility, Aiken, SC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
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chemical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246
radioactive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133, 248, 257
weapons
nuclear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7, 10, 13, 93, 118, 199, 200, 245, 246,250
thermonuclear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128, 199
x rays . . . . . . . . . . . . . . . . . . . . . . 2, 23, 30, 37, 40, 93, 95, 96, 98, 99, 105, 116, 126, 134, 136, 157, 165,
236, 237, 261, 262, 264, 273, 274, 278
